0001647488-15-000172.txt : 20151116 0001647488-15-000172.hdr.sgml : 20151116 20151116170639 ACCESSION NUMBER: 0001647488-15-000172 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20150930 FILED AS OF DATE: 20151116 DATE AS OF CHANGE: 20151116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SKINVISIBLE INC CENTRAL INDEX KEY: 0001085277 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880344219 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-25911 FILM NUMBER: 151236094 BUSINESS ADDRESS: STREET 1: 6320 S SANDHILL ROAD STREET 2: SUITE 10 CITY: LAS VEGAS STATE: NV ZIP: 89120 BUSINESS PHONE: 7024337154 MAIL ADDRESS: STREET 1: 6320 S SANDHILL ROAD STREET 2: SUITE 10 CITY: LAS VEGAS STATE: NV ZIP: 89120 10-Q 1 mainbody.htm SKVI10Q093015

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

[X]	Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

	For the quarterly period ended September 30, 2015

[ ]	Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934

	For the transition period from __________ to __________

	Commission File Number: 000-25911

Skinvisible, Inc.

(Exact name of Registrant as specified in its charter)

Nevada	88-0344219
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

6320 South Sandhill Road, Suite 10, Las Vegas, NV 89120

(Address of principal executive offices)

702.433.7154

(Registrant’s telephone number)

_______________________________________________________________

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days

[X] Yes [ ] No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.


[ ] Large accelerated filer	[ ] Accelerated filer
[ ] Non-accelerated filer	[X] Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). [ ] Yes [X] No

State the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 114,157,969 common shares as of October 25, 2015

Table of Contents

	TABLE OF CONTENTS	Page
PART I – FINANCIAL INFORMATION
Item 1:	Financial Statements	3
Item 2:	Management’s Discussion and Analysis of Financial Condition and Results of Operations	4
Item 3:	Quantitative and Qualitative Disclosures About Market Risk	12
Item 4:	Controls and Procedures	12
PART II – OTHER INFORMATION
Item 1:	Legal Proceedings	13
Item 2:	Unregistered Sales of Equity Securities and Use of Proceeds	13
Item 3:	Defaults Upon Senior Securities	13
Item 4:	Mine Safety Disclosure	13
Item 5:	Other Information	13
Item 6:	Exhibits	13

Table of Contents

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

Our consolidated financial statements included in this Form 10-Q are as follows:

F-1	Consolidated Balance Sheets as of September 30, 2015 and December 31, 2014 (unaudited);

F-2	Consolidated Statements of Operations for the three and nine months ended September 30, 2015 and 2014 (unaudited);

F-3	Consolidated Statements of Cash Flow for the nine months ended September 30, 2015 and 2014 (unaudited);

F-4	Notes to Consolidated Financial Statements.

These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and the SEC instructions to Form 10-Q. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the interim period ended September 30, 2015 are not necessarily indicative of the results that can be expected for the full year.

Table of Contents

SKINVISIBLE, INC.
CONSOLIDATED BALANCE SHEETS
(UNAUDITED)

	September 30, 2015			December 31, 2014
ASSETS
Current assets
Cash	$	—		$	196,602
Accounts receivable		6,833			9,457
Inventory		89,751			83,155
Due from related party		1,145			1,145
Prepaid expense and other current assets		—			—
Total current assets		97,729			290,359
Fixed assets, net of accumulated depreciation of $325,460 and $324,275, respectively		2,090			3,275
Intangible and other assets:
Patents and trademarks, net of accumulated amortization of $330,215 and $288,203, respectively		315,954			352,420
Total assets	$	415,773		$	646,054

LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities
Accounts payable and accrued liabilities	$	728,582		$	420,762
Bank overdraft		32,787			—
Accrued interest payable		497,899			348,111
Loans from related party		1,910			1,910
Loans payable		1,549,900			—
Convertible notes payable, net of unamortized debt discount of $38,046 and $26,822, respectively		1,149,040			1,112,764
Convertible notes payable related party, net of unamortized discount of $634,320 and $874,163, respectively		1,413,111			1,173,178
Total current liabilities		5,373,229			3,056,725
Loans payable		731,600			1,940,000
Total liabilities		6,104,829			4,996,725

Stockholders' deficit
Common stock; $0.001 par value; 200,000,000 shares authorized; 113,957,969 and 111,813,969 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively		114,158			111,814
Additional paid-in capital		21,527,741			21,378,656
Stock payable		—			—
Accumulated deficit		(27,330,955	)		(25,841,141	)
Total stockholders' deficit		(5,689,056	)		(4,350,671	)
Total liabilities and stockholders' deficit	$	415,773		$	646,054

See Accompanying Notes to Consolidated Financial Statements.

F-1

Table of Contents

SKINVISIBLE, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

	Three months ending						Nine months ending
	September 30, 2015			September 30, 2014			September 30, 2015			September 30, 2014
Revenues	$	30,377		$	22,303		$	158,428		$	41,276
Cost of revenues		9,859			674			56,047			3,907
Gross profit		20,518			21,629			102,381			37,369
Operating expenses
Depreciation and amortization		14,631			9,680			43,377			28,027
Selling general and administrative		255,436			373,101			900,605			758,997
Total operating expenses		270,067			382,781			943,982			787,024
Loss from operations		(249,549	)		(361,152	)		(841,601	)		(749,655	)
Other income and (expense)
Other income		—			70			26			258
Interest expense		(232,107	)		(200,944	)		(650,079	)		(551,872	)
Gain on extinguishment of debt		400			(4,054	)		1,840			(5,044	)
Total other expense		(231,707	)		(204,928	)		(648,213	)		(556,658	)
Net loss	$	(481,256	)	$	(566,080	)	$	(1,489,814	)	$	(1,306,313	)
Basic loss per common share	$	(0.00	)	$	(0.01	)	$	(0.01	)	$	(0.01	)
Basic weighted average common shares outstanding		113,957,969			111,609,529			113,957,969			111,317,222

See Accompanying Notes to Consolidated Financial Statements.

F-2

Table of Contents

SKINVISIBLE, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	Nine Months Ended
	September 30, 2015			September 30, 2014
Cash flows from operating activities:
Net loss	$	(1,489,814	)	$	(1,306,313	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		43,377			28,027
Stock-based compensation		8,800			31,050
Amortization of debt discount		327,478			250,558
Gain (Loss) on extinguishment of debt		(1,840	)		5,044
Bank overdraft		32,787			—
Changes in operating assets and liabilities:
Increase in inventory		(6,596	)		(59,393	)
Decrease (increase) in accounts receivable		2,624			(9,030	)
Increase (decrease) in prepaid assets		—			1
Increase in accounts payable and accrued liabilities		321,020			105,803
Increase in accrued interest		149,788			133,516
Net cash used in operating activities		(612,376	)		(820,737	)
Cash flows from investing activities:
Purchase of fixed and intangible assets		(5,726	)		(15,855	)
Net cash used in investing activities		(5,726	)		(15,855	)
Cash flows from financing activities:
Proceeds from sale of common stock		80,000			—
Proceeds from related party loans, net of payments		—			78
Payments on notes payable		(89,500	)		—
Proceeds from notes payable		431,000			594,400
Payments on convertible notes payable		—			(13,000	)
Net cash provided by (used in) financing activities		421,500			581,478
Net change in cash		(196,602	)		(255,114	)
Cash, beginning of period		196,602			513,420
Cash, end of period	$	—		$	258,306
Supplemental disclosure of cash flow information:
Cash paid for interest	$	211,564		$	144,708
Cash paid for tax	$	—		$	—
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Non-cash investing and financing activities:
Accrued expenses converted to notes	$	118,126		$	156,684
Common stock issued on extiguishment of debts	$	5,760		$	20,644

See Accompanying Notes to Consolidated Financial Statements.

F-3

Table of Contents

SKINVISIBLE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

1. DESCRIPTION OF BUSINESS, HISTORY AND SUMMARY OF SIGNIFICANT POLICIES

Description of business – Skinvisible, Inc., (referred to as the “Company”) is focused on the development and manufacture and sales of innovative topical, transdermal and mucosal polymer-based delivery system technologies and formulations incorporating its patent-pending formula/process for combining hydrophilic and hydrophobic polymer emulsions. The technologies and formulations have broad industry applications within the pharmaceutical, over-the-counter, personal skincare and cosmetic arenas. Additionally, the Company’s non-dermatological formulations, offer solutions for a broad spectrum of markets women’s health, pain management, and others. The Company maintains executive and sales offices in Las Vegas, Nevada.

History – Skinvisible, Inc. (referred to as the “Company”) was incorporated in Nevada on March 6, 1998, under the name of Microbial Solutions, Inc. The Company underwent a name change on February 26, 1999, when it changed its name to Skinvisible, Inc. The Company’s subsidiary’s name of Manloe Labs, Inc. was also changed to Skinvisible Pharmaceuticals, Inc.

On September 9, 2014, the Company formed Kinatri USA Inc., a new wholly-owned subsidiary, to market a premium line of scientifically formulated skincare products powered by our patented Invisicare® technology. As part of our strategic focus on revenue generation and creating shareholder value, Kintari USA Inc. products will be sold via network marketing.

The Kintari product portfolio consists of anti-aging products to help fight the signs of aging. These products have been developed using proven anti-aging ingredients with scientific evidence of their effectiveness at reducing the look of fine lines and wrinkles resulting in youthful looking skin. These potent ingredients will be powered by patented Invisicare technology, providing consumers with unique, effective products which we believe cannot be duplicated. Additional products will be added to enhance this product line as the company grows and expands.

Skinvisible, Inc. together with its subsidiary shall herein be collectively referred to as the “Company”.

Going concern – The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred cumulative net losses of $27,330,955 since its inception and requires capital for its contemplated operational and marketing activities to take place. The Company’s ability to raise additional capital through the future issuances of common stock is unknown. The obtainment of additional financing, the successful development of the Company’s contemplated plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability to successfully resolve these factors raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties.

Principles of consolidation – The consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated.

Use of estimates – The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Cash and cash equivalents

For purposes of the statement of cash flows, the Company considers all highly liquid investments and short-term debt instruments with original maturities of three months or less to be cash equivalents. There are $0 and $196,602 in cash and cash equivalents as of September 30, 2015 and December 31, 2014, respectively.

Fair Value of Financial Instruments

The carrying amounts reflected in the balance sheets for cash, accounts payable and accrued expenses approximate the respective fair values due to the short maturities of these items.

F-4

Table of Contents

SKINVISIBLE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

As required by the Fair Value Measurements and Disclosures Topic of the FASB ASC, fair value is measured based on a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

The three levels of the fair value hierarchy are described below:

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2: Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability;

Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

Revenue recognition

Product sales – Revenues from the sale of products (Invisicare® polymers) are recognized when title to the products are transferred to the customer and only when no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive reasonably assured payments for products sold and delivered.

Royalty sales – The Company also recognizes royalty revenue from licensing its patented product formulations only when earned, when no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive and retain reasonably assured payments.

Distribution and license rights sales – The Company also recognizes revenue from distribution and license rights only when earned (and are amortized over a five year period), when no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive and retain reasonably assured payments.

Costs of Revenue – Cost of revenue includes raw materials, component parts, and shipping supplies. Shipping and handling costs is not a significant portion of the cost of revenue.

Accounts Receivable – Accounts receivable is comprised of uncollateralized customer obligations due under normal trade terms requiring payment within 30 days from the invoice date. The carrying amount of accounts receivable is reviewed periodically for collectability. If management determines that collection is unlikely, an allowance that reflects management’s best estimate of the amounts that will not be collected is recorded. Management reviews each accounts receivable balance that exceeds 30 days from the invoice date and, based on an assessment of creditworthiness, estimates the portion, if any, of the balance that will not be collected. As of September 30, 2015, the Company had not recorded a reserve for doubtful accounts. The Company has $1,000,000 in convertible notes payable which are secured by the accounts receivable of a license agreement the Company has with Women's Choice Pharmaceuticals, LLC on its proprietary prescription product, ProCort®.

Inventory – Substantially all inventory consists of finished goods and are valued based upon first-in first-out ("FIFO") cost, not in excess of market. The determination of whether the carrying amount of inventory requires a write-down is based on an evaluation of inventory.

Goodwill and intangible assets – The Company follows Financial Accounting Standard Board’s (FASB) Codification Topic 350-10 (“ASC 350-10”), “Intangibles – Goodwill and Other”. According to this statement, goodwill and intangible assets with indefinite lives are no longer subject to amortization, but rather an annual assessment of impairment by applying a fair-value based test. Fair value for goodwill is based on discounted cash flows, market multiples and/or appraised values as appropriate. Under ASC 350-10, the carrying value of assets are calculated at the lowest level for which there are identifiable cash flows.

F-5

Table of Contents

SKINVISIBLE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Income taxes – The Company accounts for its income taxes in accordance with FASB Codification Topic ASC 740-10, “Income Taxes”, which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

Stock-based compensation – The Company follows the guidelines in FASB Codification Topic ASC 718-10 “Compensation-Stock Compensation”, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees and directors including employee stock options and employee stock purchases related to a Employee Stock Purchase Plan based on the estimated fair values.

Stock based compensation expense recognized under ASC 718-10 for the year ended September 30, 2015 and December 31, 2014 totaled $8,800 and $54,450, respectively.

Earnings (loss) per share – The Company reports earnings (loss) per share in accordance with FASB Codification Topic ASC 260-10 “Earnings Per Share”, Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted average number of common shares available. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Diluted earnings (loss) per share has not been presented since the effect of the assumed exercise of options and warrants to purchase common shares (common stock equivalents) would have an anti-dilutive effect.

2. FIXED ASSETS

Fixed assets consist of the following as of September 30, 2015 and December 31, 2014:

		September 30, 2015		December 31, 2014
Machinery and equipment	$	48,163	$	48,163
Furniture and fixtures		113,635		113,635
Computers, equipment and software		39,722		39,722
Leasehold improvements		12,569		12,569
Lab equipment		113,461		113,461
Total		327,550		327,550
Less: accumulated depreciation		(325,460)		(324,275)
Fixed assets, net of accumulated depreciation	$	2,090	$	3,275

Depreciation expense for the nine months ended September 30, 2015 and 2014 was $1,185 and $1,067, respectively.

3. INVENTORY

Inventory consist of the following as of September 30, 2015 and December 31, 2014

		September 30, 2015		December 31, 2014
Shipping and Packing materials	$	13,033	$	14,758
Marketing Supplies		19,761		-
Finished Goods		7,084	$	51,756
Raw Materials		49,873		16,641
Total		89,751		83,155

F-6

Table of Contents

SKINVISIBLE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

4. INTANGIBLE AND OTHER ASSETS

Patents and trademarks are capitalized at their historical cost and are amortized over their estimated useful lives. As of September 30, 2015, patents and trademarks total $646,169, net of $330,215 of accumulated amortization. Amortization expense for the nine months ended September 30, 2015 and 2014 was $42,192 and $26,960 respectively.

License and distributor rights (“agreement”) were acquired by the Company in January 1999 and provide exclusive use distribution of polymers and polymer based products. The Company has a non-expiring term on the license and distribution rights. Accordingly, the Company annually assesses this license and distribution rights for impairment and has determined that no impairment write-down is considered necessary as of September 30, 2015.

5. STOCK OPTIONS AND WARRANTS

The following is a summary of option activity during the nine months ended September 30, 2015.

	Number of Shares		Weighted Average Exercise Price
Balance, December 31, 2014		9,750,000	$	0.05

Options granted and assumed		200,000		0.05
Options expired		200,000		0.05
Options canceled		—		—
Options exercised		—		—

Balance, September 30, 2015		9,750,000	$	0.05

As of September 30, 2015, 9,750,000 stock options are exercisable.

On March 31, 2015, the Company granted stock options for 200,000 shares of its common stock with a strike price of $0.05. The stock options were exercisable upon grant and have a life of 5 years. The stock options were valued at $8,800 using the Black-Scholes option pricing model based upon the following assumptions: term of 5 years, risk free interest rate of 1.37%, a dividend yield of 0% and volatility rates of 483%. The Company recorded an expense of $8,800 for the nine months ended September 30, 2015.

Stock warrants -

The following is a summary of warrants activity during the nine months ended September 30, 2015.

	Number of Shares		Weighted Average Exercise Price
Balance, December 31, 2014		2,541,030	$	0.05

Warrants granted and assumed		1,000,000		0.07
Warrants expired		1,196,280		0.05
Warrants canceled		—		—
Warrants exercised		—		—

Balance, September 30, 2015		2,344,750	$	0.07

All warrants outstanding as of September 30, 2015 are exercisable.

F-7

Table of Contents

SKINVISIBLE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

6. NOTES PAYABLE

On May 22, 2013 the Company approved a financing plan to offer accredited investors up to $1,000,000 in secured promissory notes. During the year ended December 31, 2013 the Company entered into twenty-four 9% notes payable to investors and received total proceeds of $1,000,000. The notes are due two years from the anniversary date of execution. The Notes are secured by the US Patent rights granted for the Company's Sunscreen Products: US patent number #8,128,913: "Sunscreen Composition with Enhanced UV-A Absorber Stability and Methods". As of September 30, 2015 several notes had reached their initial maturity date, all note holders executed agreements extending the note for an additional 12 months upon the same terms. During the nine months ending September 30, 2015 the Company made principal payments of $89,000.

On May 19, 2014 the Company approved a financing plan to offer accredited investors up to an additional $1,000,000 in secured promissory notes. For the period from May 19, 2014 to March 31, 2015 the Company entered into twenty-seven 9% notes payable to investors and received total proceeds of $1,000,000. The notes are due two years from the anniversary date of execution. The Notes are secured by the US Patent rights granted for the Company's Sunscreen Products: US patent number #8,128,913: "Sunscreen Composition with Enhanced UV-A Absorber Stability and Methods".

During the three months ended June 30, 2015 the Company entered into eight additional 9% notes payable to investors and received total proceeds of $208,000. The notes are due two years from the anniversary date of execution. The Notes are secured by the US Patent rights granted for the Company's Sunscreen Products: US patent number #8,128,913: "Sunscreen Composition with Enhanced UV-A Absorber Stability and Methods".

During the three months ended June 30, 2015 the Company entered into five additional 9% notes payable to investors and received total proceeds of $131,000. The notes are due two years from the anniversary date of execution. The Notes are secured by the US Patent rights granted for the Company's Sunscreen Products: US patent number #8,128,913: "Sunscreen Composition with Enhanced UV-A Absorber Stability and Methods".

As of September 30, 2015 $1,549,900 of the Notes were due in less than 12 months and have been classified as Current notes payable.

7. RELATED PARTY TRANSACTIONS

During the year ended 2013 various officers advanced funds to support the daily operations of the company. As of September 30, 2015, $1,910 remained due to related parties as repayment for advanced monies, all related other party notes have been extinguished or re-negotiated as convertible notes. See note 10.

8. CONVERTIBLE NOTES PAYABLE

Convertible Notes Payable at consists of the following:	September 30,			December 31,
	2015			2014
$52,476 face value,10% unsecured note payable to an investor, note interest and principal are due on demand. The note could be converted to option rights for Skinvisible, Inc. shares at ten cents per share ($0.10), these rights expired January 12, 2010. The Note is currently in default, no penalties occur due to default.	$	28,476		$	28,476
Unamortized debt discount		—			—
Total, net of unamortized discount		28,476			28,476
$1,000,000 face value 9% unsecured notes payable to investors, due in 2015. At the investor’s option until the repayment date, the note and related interest may be converted to shares of the Company’s common stock a discount of 90% of the current share price after the first anniversary of the note. The Notes are secured by the accounts receivable of a license agreement the Company has with Womens Choice Pharmaceuticals, LLC on its proprietary prescription product, ProCort®. The Company has determined the value associated with the beneficial conversion feature in connection with the notes and interest to be $111,110. The aggregate original issue discount feature has been accreted and charged to interest expenses as a financing expense in the amount of $31,078 during the nine months ended September 30, 2015. The original issue discount feature is valued under the intrinsic value method. On the Company executed extension agreements with several note holder who's note had reached maturity. The notes were extended for an additional 12 months.		1,000,000			1,000,000
Original issue discount		111,110			111,110
Unamortized debt discount		(3,724	)		(26,822	)
Total, net of unamortized discount		1,107,386			1,084,288

On July 28, 2015, we entered into a convertible promissory note pursuant to which we borrowed $47,500. Interest under the convertible promissory note is 8% per annum, and the principal and all accrued but unpaid interest is due on April 30, 2016. The note is convertible at any time following 180 days after the issuance date at noteholders option into shares of our common stock at a variable conversion price of 58% of the lowest average three day market price of our common stock during the 10 trading days prior to the notice of conversion, subject to adjustment as described in the note. The holder’s ability to convert the note, however, is limited in that it will not be permitted to convert any portion of the note if the number of shares of our common stock beneficially owned by the holder and its affiliates, together with the number of shares of our common stock issuable upon any full or partial conversion, would exceed 9.99% of our outstanding shares of common stock. The Company has determined the value associated with the beneficial conversion feature in connection with the notes negotiated on July 28, 2015 to be $34,397. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $7,947 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method		47,500			—
Unamortized debt discount		(34,322	)		—
Total, net of unamortized discount		13,178			—

	$	1,149,040		$	1,112,764

F-8

Table of Contents

SKINVISIBLE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

10. CONVERTIBLE NOTES PAYABLE RELATED PARTY

Convertible Notes Payable Related Party at consists of the following:	September 30,			December 31,
	2015			2014
On December 31, 2011, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, the notes dated before December 31, 2010, and all salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.06 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes negotiated on December 31, 2011 to be $1,123,078. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $124,544 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method. In the year ending December 2013, the Company made $51,485 in cash payments to reduce the note balance.		1,071,593			1,071,593
Unamortized debt discount		(208,939	)		(333,483	)

On June 30, 2012, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, the notes dated before July 1, 2011, and all salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.06 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $209,809. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $31,098 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method. On January 18, 2013, the Company made a $3,990 cash payment to reduce the note balance.		321,032			321,032
Unamortized debt discount		(72,788	)		(103,886	)

On December 30 and 31, 2012, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, $182,083 of related party notes accrued interest and salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $182,083 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.03 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.04 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $182,083. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $27,223 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method.		182,083			182,083
Unamortized debt discount		(82,054	)		(109,277	)

F-9

Table of Contents

SKINVISIBLE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

On June 30, 2013, the Company re-negotiated accrued salaries and interest for two employees. Under the terms of the agreements, $106,153 of accrued interest and salaries were converted to promissory notes convertible into common stock with a warrant feature. The $106,153 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.03 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.04 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $70,768. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $10,579 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method.		106,152			106,152
Unamortized debt discount		(38,912	)		(49,491	)
On December 31, 2013, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, $142,501 of accrued interest and salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $142,501 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.03 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.04 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $94,909. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $14,189 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method.		142,501			142,501
Unamortized debt discount		(61,748	)		(75,937	)
On June 30, 2014, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, $118,126 of accrued salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $118,126 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.025 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.03 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $118,126. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $17,661 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method.		118,126			118,126
Unamortized debt discount		(88,562	)		(106,223	)
On September 30, 2014, the Company re-negotiated accrued salaries and interest for two employees. Under the terms of the agreements, $40,558 of accrued salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $40,558 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.05 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $40,466. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $6,050 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method.		40,558			40,558
Unamortized debt discount		(32,377	)		(38,427	)
On December 31, 2014, the Company re-negotiated accrued salaries and interest for two employees. Under the terms of the agreements, $65,295 of accrued salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $65,295 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.05 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $57,439. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $8,589 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method.		65,295			65,295
Unamortized debt discount		(48,850	)		(57,438	)

	$	1,413,110		$	1,173,178

F-10

Table of Contents

SKINVISIBLE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

11. STOCKHOLDERS’ DEFICIT

The Company is authorized to issue 200,000,000 shares of $0.001 par value common stock. The Company had 113,957,969 and 111,813,969 issued and outstanding shares of common stock as of September 30, 2015 and December 31, 2014, respectively.

On January 26, 2015 the Company received $50,000 pursuant to a private placement agreement with an investor to purchase 1,250,000 shares of Skinvisible Inc. $0.001 par value common stock and 625,000 warrants. The warrants allow the holder to purchase shares of the Company's common stock at $0.07 on or before January 21, 2016.

On January 27, 2015 the Company received $30,000 pursuant to a private placement agreement with an investor to purchase 750,000 shares of Skinvisible Inc. $0.001 par value common stock and 375,000 warrants. The warrants allow the holder to purchase shares of the Company's common stock at $0.07 on or before January 21, 2016.

On April 1, 2015, 72,000 shares were issued to settle $3,600 of accrued expenses due to a director of the Company.

On June 30, 2015, 72,000 shares were issued to settle $3,600 of accrued expenses due to a director of the Company. A gain of $1,440 was recognized as a result of this settlement.

On August 24, 2015, the company settled $6,000 of debt due to two parties with 200,000 shares of common stock. A gain of $400 was recognized as a result of this settlement.

12. COMMITMENTS AND CONTINGENCIES

Lease obligations – The Company has operating leases for its offices. Future minimum lease payments under the operating leases for the facilities as of September 30, 2015, are as follows:

2015 12,042

2016 5,717

Rental expense, resulting from operating lease agreements, approximated $32,619 and $31,368 for the nine months ended September 30, 2015 and 2014, respectively.

13. SUBSEQUENT EVENTS

On October 26, 2015, we entered into a convertible promissory note pursuant to which we borrowed $135,000. Interest under the convertible promissory note is 9% per annum, and the principal and all accrued but unpaid interest is due on October 26, 2017. The note is convertible at any time following the third month anniversary after the issuance date at noteholders option into shares of our common stock at a variable conversion price of 90% of the average of the Trading Prices for the common stock during the five Trading Day period ending on the latest complete Trading Day prior to the Conversion Date, subject to adjustment as described in the note. The holder’s ability to convert the note, however, is limited in that it will not be permitted to convert any portion of the note if the number of shares of our common stock beneficially owned by the holder and its affiliates, together with the number of shares of our common stock issuable upon any full or partial conversion, would exceed 4.99% of our outstanding shares of common stock.

On October 1, 2015, we entered into a convertible promissory note with Greg McCartney a director of the Company. The $10,800 face value promissory note is unsecured, due five years from issuance, and bears an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.02 per share along with an additional warrant to purchase one share for every two shares issued at the exercise price of $0.03 per share for three years after the conversion date.

F-11

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. We intend such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and are including this statement for purposes of complying with those safe-harbor provisions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse affect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Further information concerning our business, including additional factors that could materially affect our financial results, is included herein and in our other filings with the SEC.

Company Overview

We, through our wholly owned subsidiary Skinvisible Pharmaceuticals Inc., are a pharmaceutical research and development (“R&D”) company that has developed and patented an innovative polymer delivery system, Invisicare® and formulated over forty topical skin products, which we out-license globally. We were incorporated in 1998, and target an estimated $80 billion global skincare and dermatology market and a $30 billion global over-the-counter market as well as other healthcare / medical and consumer goods markets.

With the research and development complete on forty products and numerous patents issued (technology and product patents), we are ready to monetize our investment. Our business model will continue to be to out-license our patented prescription and over-the-counter (“OTC”) products featuring Invisicare to established manufacturers and marketers of brands internationally and to maximize profits from the products we have already out-licensed. We have also formed a commercial subsidiary, Kintari USA Inc., in order to take our cosmeceutical and select OTC products with Invisicare to market.

The opportunity for us to license our products continues to be a viable model as the need for pharmaceutical companies to access external R&D companies for new products due to their own down-sizing or elimination of internal R&D departments. The demand for our products is enhanced due to the granting of key US and international patents and the completed development of a number of unique products.

Table of Contents

Our Plan for the Next Twelve Months

Our growth strategy is to:

Generate revenue from direct sales of our cosmeceutical/OTC product line;

Capitalize on the success of current licensees;

Increase the value of our current pipeline; and

4. Boost licensing revenues by securing additional licensees globally and develop a robust royalty revenue stream that will finance our future growth.

•

Kintari USA Inc.:

On September 9, 2014, we formed Kinatri USA Inc., a new wholly-owned subsidiary of Kintari International Inc., wholly-owned subsidiary of Skinvisible Inc., to market a premium line of scientifically formulated skincare products powered by our patented Invisicare® technology. The company was officially launched January 15, 2015. As part of our strategic focus on revenue generation and creating shareholder value, Kintari USA Inc. products will be sold via network marketing. The products will be sold initially in the US and then in Canada in 2016.

The Kintari product portfolio consists of 2 anti-aging products to help fight the signs of aging. These products have been developed using proven anti-aging ingredients with scientific evidence of their effectiveness at reducing the look of fine lines and wrinkles resulting in youthful looking skin. These potent ingredients will be powered by patented Invisicare technology, providing consumers with unique, effective products which we believe cannot be duplicated. Additional products will be added to enhance this product line as the company grows and starting with our Skinbrella® SPF 30 sunscreen which was launched in April 2015.

•

Capitalize On Current Licensees:

We have licensees around the globe. Two of these licensees are currently in the marketplace: Avon Products globally and Women’s Choice Pharmaceuticals in the United States.

We continue to work diligently with our licensees to ensure they have a smooth manufacturing process, ongoing R&D support and marketing feedback.

Table of Contents

Avon Products, Inc:

Product: We have a long-term contract with Avon globally for over ten years to provide Invisicare polymer for their long-lasting lipsticks.

Sales: Invisicare polymers are purchased directly from Skinvisible.

Women’s Choice Pharmaceuticals:

Product: ProCort®, long lasting prescription hemorrhoid cream launched in the United States August 2011.

Sales and Royalties: Skinvisible receives a royalty based on net sales of ProCort. This past year Women's Choice Pharmaceuticals LLC partnered with Advanced Medical Enterprises, LLC to market ProCort® in Puerto Rico. With over thirty pharmaceutical sales reps calling on OBGYNs in the US, Women’s Choice has been successfully growing their sales of ProCort® and we look forward to increased growth for the rest of 2015. Women’s Choice is seeking to form other strategic alliances in order to increase its sales efforts by targeting new territories and targeting medical specialists which previously were not called upon.

Product Updates:

We have additional information on specific products which add value to Skinvisible’s product pipeline.

DermSafe® Hand Sanitizer

Skinvisible’s hand sanitizer formulated with Invisicare® and chlorhexidine gluconate has received registration in Belgium on behalf of Skinvisible. This registration allows Skinvisible to make DermSafe® available in most of Europe through a simple registration process. The Company is currently seeking licensees and/or distributors to begin the sale of DermSafe in the EU. This registration has recently been granted for a ten year term to expire in 2024. The product will be sold through Kintari Canada Inc. when it launches in 2016.

Sunless Tanning Products: We have developed a new sunless tanning mousse / foam which uses a unique foam with Invisicare®, developed specifically for its foaming properties. This adds to Skinvisible’s line of sunless tanning products which includes sunless tanning lotions (light, medium and dark), pre-sun moisturizer and after-sun moisturizer along with sunless tanning spray products for commercial use. The addition of a sunless tanning mousse enhances this line of products.

Sunscreen Products: We have developed 3 broad spectrum sunscreens, with SPF 15, 30 and 50 (the highest SPF allowed by the FDA). All are formulated with Avobenzone, the only UVA sun filter allowed under the US FDA monograph. This UVA/UVB sunscreen was granted a patent from the United States patent office in 2013. Avobenzone is known for breaking down in the sun after only two hours – thus the requirement to reapply every 2 hours. Skinvisible’s patent was granted based on Invisicare's® minimum 8 hour photo stability. For countries outside the United States, Skinvisible has additionally patented UVA/UVB sunscreens formulated with Tinosorb S.

In March 25, 2014, we announced that we have successfully completed independent testing to validate our broad spectrum sunscreen claims according to new labeling guidelines by the FDA which are designed to help reduce the incidents of skin cancer in the U.S.

Table of Contents

Skinvisible sunscreens can be labeled with the following claims:

Claim # 1 – Broad-Spectrum: According to the FDA, in order for a sunscreen to be labeled “broad spectrum” it must prove it protects against both UVA and UVB rays by having an SPF (Sun Protection Factor) of at least 15 and a critical wave length of at least 370 nm. Skinvisible’s sunscreen has surpassed both of these criteria, allowing Skinvisible’s broad spectrum sunscreen label to also state “prevents sunburn, skin cancer and aging due to the sun.”

Claim # 2 – Water-Resistant 80 Minutes: The FDA sunscreen water resistant claim requires that a sunscreen must have the same SPF after being in water or sweating for 40 or 80 minutes. Skinvisible’s testing was conducted at an independent laboratory specializing in sunscreen testing. The test involved human subjects that applied sunscreen to their arm, followed by the immersion of the arm into a Jacuzzi for 80 minutes (10 minutes in / 10 minutes out). Skinvisible’s sunscreen successfully completed this testing and is allowed to use “Water-resistant for 80 Minutes” on its sunscreen label, the longest length of time allowed by the FDA.

Claim # 3 – Unique Patented Technology / Eight-Hour Photostability: As previously announced, Skinvisible was granted a patent from the United States Patent and Trademark Office entitled “Sunscreen Composition with Enhanced UVA Absorber Stability and Methods”, which provides protection until November 2029. Skinvisible successfully formulated a unique Invisicare® delivery system specifically for stabilizing avobenzone; the key sunscreen used in the USA. Data submitted to the US patent office proved that Skinvisible’s sunscreen provides a minimum of eight hours of photostability.

•

Increasing The Value Of Skinvisible’s Pipeline: Clinical Enhancement Of Pipeline

We have a pipeline of over forty products which are available for licensing. Testing is conducted in-house generating proof of concept including release of the active ingredient as well as long term shelf life (stability). Additional studies conducted on specific products including skin sensitivity, toxicity and product efficacy are outsourced to FDA compliant laboratories. These studies are critical in attracting potential licensees. Our clinical strategy is to:

Add new studies for our prescription products. Our clinical strategy is to increase the amount of outsourced studies, specifically for our prescription products. Additional studies including skin penetration and skin irritation studies will add to the integrity and value of our products available for licensing.

Add new long-term efficacy studies for our DermSafe® hand sanitizer. In 2013, we commissioned an independent laboratory to further analyze the long-term effectiveness of DermSafe® when put in contact with two bacteria; the “super bug” MRSA and E. coli, the “restaurant bug” since it is often transmitted by food and food handlers. The long-term effectiveness of two bacteria; Methicillin-resistant Staphylococcus aureus or MRSA (ATCC #33591) and Escherichia coli or E. coli (ATCC #43888") were tested up to four hours after application. The results showed that the individual arms of subjects which had DermSafe® applied and were even rinsed prior to each bacteria challenge, showed a 95.83% reduction at the 4 hour time point for MRSA and 99.38% for E. coli. In 2013, we obtained the registration rights for DermSafe® in Belgium. This designation allows for the sale and/ or registration of DermSafe in most EU countries. A strategy is being developed along with a larger global strategy to bring DermSafe to the EU and. Skinvisible has also commissioned further testing of DermSafe against the (Middle East Respiratory Syndrome Coronavirus (MERS-CoV); a SARS-like virus and the avian influenza A virus, H7N9.

We continue to look for avenues to obtain orphan drug status for our Netherton syndrome product. Netherton syndrome is a disease caused by a genetic defect which causes the skin to continually exfoliate, never forming a skin bond. This leaves the patient highly susceptible to infection and dealing with a life-long condition that has no cure. Our product has shown excellent results in lab studies blocking the enzyme that breaks down the skin and we are seeking “Orphan Drug” designation in both the US (FDA) and Europe (EMA). We have reformulated our product to better meet the demands of this very debilitating disease and will be undergoing a clinical Netherton syndrome study with a subject before the end of 2015.

Table of Contents

•

Secure Additional Licensees:

We are in discussions and undergoing internal discussions with various pharmaceutical companies for licenses.

To facilitate further expansion, we are seeking an exclusive license with a proven US or global based Pharmaceutical Company for our existing Rx product formulations. The licensee would be expected to pay all costs in getting FDA approval. The licensee would pay Skinvisible for the license in milestone payments as Clinical Phases are proven.

Results of Operations for the Three and Nine Months Ended September 30, 2015 and 2014

Revenues

Our revenue from product sales, royalties on patent licenses and license fees for the three months ended September 30, 2015 was $30,377, an increase from $22,303 for the same period ended September 30, 2014. Our revenue from product sales, royalties on patent licenses and license fees for the nine months ended September 30, 2015 was $158,428, an increase from $41,276 for the same period ended September 30, 2014.

The increase in revenue for the three and nine months ended September 30, 2015 was mainly due to an increase in product sales. With the launch of Kintari USA Inc., we expect increased revenue from our line of anti-aging products and select over-the-counter products.

Cost of Revenues

Our cost of revenues for the three months ended September 30, 2015 increased to $9,859 from the prior year period when cost of revenues was $674. Our cost of revenues for the nine months ended September 30, 2015 increased to $56,047 from the prior year period when cost of revenues was $3,907. Our cost of revenues increased for the three and nine months ended September 30, 2015 over the prior year period as a result of increased product sales. We expect this trend to continue with sales from Kintari USA Inc.

Gross Profit

Gross profit for the three months ended September 30, 2015 was $20,518, or approximately 67% of sales. Gross profit for the three months ended September 30, 2014 was $21,629, or approximately 96% of sales. Gross profit for the nine months ended September 30, 2015 was $102,381, or approximately 65% of sales. Gross profit for the nine months ended September 30, 2014 was $37,369, or approximately 90% of sales. Our gross profit margin fell in 2015 as compared with 2014 as a result of increased cost of revenues from product sales. We expect this trend to continue for the last quarter of 2015 and into 2016.

Operating Expenses

Operating expenses decreased to $270,067 for the three months ended September 30, 2015 from $382,781 for the same period ended September 30, 2014. Operating expenses increased to $943,982 for the nine months ended September 30, 2015 from $787,024 for the same period ended September 30, 2014.

Our operating expenses for the nine months ended September 30, 2015 consisted mainly of accrued salaries and wages of $238,950, salaries and wages of $153,828, commissions of $115,483, consulting fees of $105,234, travel expenses of $64,875, depreciation and amortization expenses of $43,377, rent of $32,619, accounting and audit expenses of $28,092, license and permit fees of $20,232 and payroll tax expense of $19,320. In comparison, our operating expenses for the nine months ended September 30, 2014 consisted mainly of salaries and wages of $136,318, accrued salaries and wages of $165,652, consulting fees of $182,748, research and development of $48,231, accounting and audit expenses of $30,069, rent of $31,368, depreciation and amortization expenses of $28,027, legal fees of $24,539 and travel of $19,949.

Table of Contents

Other Expenses

We had other expenses of $231,707 for the three months ended September 30, 2015, compared with other expenses of $204,928 for the three months ended September 30, 2014. This was largely the result of $232,107 in interest expenses for the three months ended September 30, 2015 from $200,944 in the prior period ended September 30, 2014.

We had other expenses of $648,213 for the nine months ended September 30, 2015, compared with other expenses of $556,658 for the nine months ended September 30, 2014. This was largely the result of $650,079 in interest expenses for the nine months ended September 30, 2015 from $551,872 in the prior period ended September 30, 2014.

We expect to continue to experience high interest payments in the future as a result of our outstanding liabilities. If we are unable to generate sufficient revenues and/or additional financing to service this debt, there is a risk the lenders will call the notes and we will be unable to repay the loans. If this happens, we could go out of business.

Net Loss

We recorded a net loss of $481,256 for the three months ended September 30, 2015, as compared with a net loss of $566,080 for the three months ended September 30, 2014. We recorded a net loss of $1,489,814 for the nine months ended September 30, 2015, as compared with a net loss of $1,306,313 for the nine months ended September 30, 2014.

Liquidity and Capital Resources

As of September 30, 2015, we had total current assets of $97,729 and total assets in the amount of $415,773. Our total current liabilities as of September 30, 2015 were $5,373,229. We had a working capital deficit of $5,275,500 as of September 30, 2015.

Operating activities used $612,376 in cash for the nine months ended September 30, 2015. Our net loss of $1,489,814 was the main component of our negative operating cash flow, offset mainly by amortization of debt discount of $327,478, an increase in accounts payable and accrued liabilities of $321,020 and an increase of accrued interest of $149,788.

Cash flows used by investing activities during the nine months ended September 30, 2015 was $5,726 as a result of the purchase of fixed and intangible assets.

Cash flows provided by financing activities during the nine months ended September 30, 2015 amounted to $421,500 and consisted of $431,000 in proceeds from notes payable and $80,000 in proceeds from the sale of common stock, offset by $89,500 in payments on notes payable.

During the year ended December 31, 2013, we entered into twenty-four 9% notes payable to investors and received total proceeds of $1,000,000. The notes are due two years from the anniversary date of execution. The Notes are secured by the US Patent rights granted for the Company's Sunscreen Products: US patent number #8,128,913: "Sunscreen Composition with Enhanced UV-A Absorber Stability and Methods." As of September 30, 2015 several notes had reached their initial maturity date. All note holders executed agreements extending the note for an additional 12 months upon the same terms.

On May 19, 2014, we approved a financing plan to offer accredited investors up to an additional $1,000,000 in secured promissory notes. For the period from May 19, 2014 to June 30, 2015, we entered into forty 9% notes payable to investors and received total proceeds of $1,339,000. The notes are due two years from the anniversary date of execution. The Notes are secured by the US Patent rights granted for the Company's Sunscreen Products: US patent number #8,128,913: "Sunscreen Composition with Enhanced UV-A Absorber Stability and Methods".

On July 28, 2015, we entered into a convertible promissory note pursuant to which we borrowed $47,500. Interest under the convertible promissory note is 8% per annum, and the principal and all accrued but unpaid interest is due on April 30, 2016. The note is convertible at any time following 180 days after the issuance date at noteholders option into shares of our common stock at a variable conversion price of 58% of the lowest average three day market price of our common stock during the 10 trading days prior to the notice of conversion, subject to adjustment as described in the note.

Table of Contents

The holder’s ability to convert the note, however, is limited in that it will not be permitted to convert any portion of the note if the number of shares of our common stock beneficially owned by the holder and its affiliates, together with the number of shares of our common stock issuable upon any full or partial conversion, would exceed 9.99% of our outstanding shares of common stock. The holder has the right to waive this term upon 61 days’ notice to us.

During the first 180 days following the date of the note we have the right to prepay the principal and accrued but unpaid interest due under the note, together with any other amounts we may owe the holder under the terms of the note, at a graduating premium ranging from 125% to 150%. After this initial 180 day period, we do not have a right to prepay the note.

There are certain covenants we agreed to, including without limitation, a right of first refusal in favor of the holder, price protection on dilutive issuances, a restriction on stock repurchases, a prohibition on borrowing under certain circumstances and the sale of our assets outside of the ordinary course of business.

All amounts due under the note become immediately due and payable by us upon the occurrence of an event of default, which includes (i) our failure to pay the amounts due at maturity, (ii) our failure to deliver shares of our common stock upon any conversion of the note, (iii) a breach of the covenants, representations or warranties, (iv) the appointment of a trustee, a judgment against us in excess of $50,000 (subject to a cure period), a liquidation of our company or the filing of a bankruptcy petition, (v) failure to remain current in our reporting obligations under the Securities Exchange Act of 1934 or the removal of our common stock from quotation on the OTC markets, (vi) any restatement of our financial statements, or (vii) a reverse stock split without notice to the lender, as well as certain other provisions as set forth in the note.

On October 1, 2015, we entered into a convertible promissory note with Greg McCartney, our director. The $10,800 face value promissory note is unsecured, due five years from issuance, and bears an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of our common stock at a fixed price of $0.02 per share along with an additional warrant to purchase one share for every two shares issued at the exercise price of $0.03 per share for three years after the conversion date.

The note is secured by the accounts receivable of a license agreement we have with Women's Choice Pharmaceuticals, LLC on its proprietary prescription product, ProCort®. The form of convertible promissory note is attached as an exhibit to the Form 8-K we filed on January 1, 2013.

Based upon our current financial condition, we do not have sufficient cash to operate our business at the current level for the next twelve months. We intend to fund operations through increased sales and debt and/or equity financing arrangements, which may be insufficient to fund expenditures or other cash requirements. We plan to seek additional financing in a private equity offering to secure funding for operations. There can be no assurance that we will be successful in raising additional funding. If we are not able to secure additional funding, the implementation of our business plan will be impaired. There can be no assurance that such additional financing will be available to us on acceptable terms or at all.

Table of Contents

Off Balance Sheet Arrangements

As of September 30, 2015, there were no off balance sheet arrangements.

Critical Accounting Policies

In December 2001, the SEC requested that all registrants list their most “critical accounting polices” in the Management Discussion and Analysis. The SEC indicated that a “critical accounting policy” is one which is both important to the portrayal of a company’s financial condition and results, and requires management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.

Going concern – The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. We have incurred cumulative net losses of $27,330,955 since our inception and require capital for our contemplated operational and marketing activities to take place. Our ability to raise additional capital through the future issuances of common stock is unknown. The obtainment of additional financing, the successful development of our contemplated plan of operations, and our transition, ultimately, to the attainment of profitable operations are necessary for us to continue operations. The ability to successfully resolve these factors raise substantial doubt about our ability to continue as a going concern. These consolidated financial statements do not include any adjustments that may result from the outcome of these aforementioned uncertainties.

Product sales – Revenues from the sale of products (Invisicare® polymers) are recognized when title to the products are transferred to the customer and only when no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive reasonably assured payments for products sold and delivered.

Royalty sales – We also recognize royalty revenue from licensing our patented product formulations only when earned, with no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive and retain reasonably assured payments.

Distribution and license rights sales – We also recognize revenue from distribution and license rights only when earned (and are amortized over a five year period), with no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive and retain reasonably assured payments.

Costs of Revenue – Cost of revenue includes raw materials, component parts, and shipping supplies. Shipping and handling costs is not a significant portion of the cost of revenue.

Accounts Receivable – Accounts receivable is comprised of uncollateralized customer obligations due under normal trade terms requiring payment within 30 days from the invoice date. The carrying amount of accounts receivable is reviewed periodically for collectability. If management determines that collection is unlikely, an allowance that reflects management’s best estimate of the amounts that will not be collected is recorded. Management reviews each accounts receivable balance that exceeds 30 days from the invoice date and, based on an assessment of creditworthiness, estimates the portion, if any, of the balance that will not be collected. As of September 30, 2015, the Company had not recorded a reserve for doubtful accounts. The Company has $1,000,000 in convertible notes payable which are secured by the accounts receivable of a license agreement the Company has with Women's Choice Pharmaceuticals, LLC on its proprietary prescription product, ProCort®.

Recently Issued Accounting Pronouncements

We do not expect the adoption of recently issued accounting pronouncements to have a significant impact on our results of operations, financial position or cash flow.

Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk

A smaller reporting company is not required to provide the information required by this Item.

Item 4. Controls and Procedures

Disclosure Controls and Procedures

We carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of September 30, 2015. This evaluation was carried out under the supervision and with the participation of our Chief Executive Officer and our Chief Financial Officer. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2015, our disclosure controls and procedures were not effective due to the presence of material weaknesses in internal control over financial reporting.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. Management has identified the following material weaknesses which have caused management to conclude that, as of September 30, 2015, our disclosure controls and procedures were not effective: (i) inadequate segregation of duties and effective risk assessment; and (ii) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of both US GAAP and SEC guidelines.

Remediation Plan to Address the Material Weaknesses in Internal Control over Financial Reporting

Our company plans to take steps to enhance and improve the design of our internal controls over financial reporting. During the period covered by this quarterly report on Form 10-Q, we have not been able to remediate the material weaknesses identified above. To remediate such weaknesses, we plan to implement the following changes during our fiscal year ending December 31, 2015: (i) appoint additional qualified personnel to address inadequate segregation of duties and ineffective risk management; and (ii) adopt sufficient written policies and procedures for accounting and financial reporting. The remediation efforts set out are largely dependent upon our securing additional financing to cover the costs of implementing the changes required. If we are unsuccessful in securing such funds, remediation efforts may be adversely affected in a material manner.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the three months ended September 30, 2015 that have materially affected, or are reasonable likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

We are not a party to any pending legal proceeding. We are not aware of any pending legal proceeding to which any of our officers, directors, or any beneficial holders of 5% or more of our voting securities are adverse to us or have a material interest adverse to us.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The information set forth below relates to our issuances of securities without registration under the Securities Act of 1933 during the reporting period which were not previously included in a Quarterly Report on Form 10-Q or Current Report on Form 8-K.

During the three months ended September 30, 2015, we issued a total of 272,000 shares of common stock for the conversion of debts totaling $9,600.

These securities were issued pursuant to Section 4(2) of the Securities Act and/or Rule 506 promulgated thereunder. The holders represented their intention to acquire the securities for investment only and not with a view towards distribution. The investors were given adequate information about us to make an informed investment decision. We did not engage in any general solicitation or advertising. We directed our transfer agent to issue the stock certificates with the appropriate restrictive legend affixed to the restricted stock.

Item 3. Defaults upon Senior Securities

None

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None

Item 6. Exhibits

Exhibit Number	Description of Exhibit
10.1	July 28, 2015 Convertible Promissory Note
10.2	October 1, 2015 Convertible Promissory Note
31.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101**	The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2015 formatted in Extensible Business Reporting Language (XBRL).
**Provided herewith

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Skinvisible, Inc.

Date:	November 16, 2015

	By: /s/ Terry Howlett Terry Howlett Title: Chief Executive Officer, Chief Financial Officer and Director

EX-31.1 2 ex31_1.htm EXHIBIT 31.1

CERTIFICATIONS

I, Terry Howlett, certify that;

I have reviewed this quarterly report on Form 10-Q for the quarter ended September 30, 2015 of Skinvisible, Inc. (the “registrant”);

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 16, 2015

/s/ Terry Howlett

By: Terry Howlett

Title: Chief Executive Officer

EX-31.2 3 ex31_2.htm EXHIBIT 31.2

CERTIFICATIONS

I, Terry Howlett, certify that;

I have reviewed this quarterly report on Form 10-Q for the quarter ended September 30, 2015 of Skinvisible, Inc. (the “registrant”);

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 16, 2015

/s/ Terry Howlett

By: Terry Howlett

Title: Chief Financial Officer

EX-32.1 4 ex32_1.htm EXHIBIT 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly Report of Skinvisible, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2015 filed with the Securities and Exchange Commission (the “Report”), I, Terry Howlett, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.

By:	/s/ Terry Howlett
Name:	Terry Howlett
Title:	Principal Executive Officer, Principal Financial Officer and Director
Date:	November 16, 2015

This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

EX-10.1 5 ex10_1.htm EXHIBIT 10.1

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

Principal Amount: $47,500.00	Issue Date: July 28, 2015
Purchase Price: $47,500.00

CONVERTIBLE PROMISSORY NOTE

FOR VALUE RECEIVED, SKINVISIBLE, INC., a Nevada corporation (hereinafter called the “Borrower”), hereby promises to pay to the order VIS VIRES GROUP, INC., a New York corporation, or registered assigns (the “Holder”) the sum of $47,500.00 together with any interest as set forth herein, on April 30, 2016 (the “Maturity Date”), and to pay interest on the unpaid principal balance hereof at the rate of eight percent (8%) (the “Interest Rate”) per annum from the date hereof (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. This Note may not be prepaid in whole or in part except as otherwise explicitly set forth herein. Any amount of principal or interest on this Note which is not paid when due shall bear interest at the rate of twenty two percent (22%) per annum from the due date thereof until the same is paid (“Default Interest”). Interest shall commence accruing on the date that the Note is fully paid and shall be computed on the basis of a 365-day year and the actual number of days elapsed. All payments due hereunder (to the extent not converted into common stock, $0.001 par value per share (the “Common Stock”) in accordance with the terms hereof) shall be made in lawful money of the United States of America. All payments shall be made at such address as the Holder shall hereafter give to the Borrower by written notice made in accordance with the provisions of this Note. Whenever any amount expressed to be due by the terms of this Note is due on any day which is not a business day, the same shall instead be due on the next succeeding day which is a business day and, in the case of any interest payment date which is not the date on which this Note is paid in full, the

extension of the due date thereof shall not be taken into account for purposes of determining the amount of interest due on such date. As used in this Note, the term “business day” shall mean any day other than a Saturday, Sunday or a day on which commercial banks in the city of New York, New York are authorized or required by law or executive order to remain closed. Each capitalized term used herein, and not otherwise defined, shall have the meaning ascribed thereto in that certain Securities Purchase Agreement dated the date hereof, pursuant to which this Note was originally issued (the “Purchase Agreement”).

This Note is free from all taxes, liens, claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights of shareholders of the Borrower and will not impose personal liability upon the holder thereof.

The following terms shall apply to this Note:

ARTICLE I. CONVERSION RIGHTS

1.1 Conversion Right. The Holder shall have the right from time to time, and at any time during the period beginning on the date which is one hundred eighty (180) days following the date of this Note and ending on the later of: (i) the Maturity Date and (ii) the date of payment of the Default Amount (as defined in Article III) pursuant to Section 1.6(a) or Article III, each in respect of the remaining outstanding principal (and accrued interest) amount of this Note to convert all or any part of the outstanding and unpaid principal amount of this Note into fully paid and non- assessable shares of Common Stock, as such Common Stock exists on the Issue Date, or any shares of capital stock or other securities of the Borrower into which such Common Stock shall hereafter be changed or reclassified at the conversion price (the “Conversion Price”) determined as provided herein (a “Conversion”); provided, however, that in no event shall the Holder be entitled to convert any portion of this Note in excess of that portion of this Note upon conversion of which the sum of (1) the number of shares of Common Stock beneficially owned by the Holder and its affiliates (other than shares of Common Stock which may be deemed beneficially owned through the ownership of the unconverted portion of the Notes or the unexercised or unconverted portion of any other security of the Borrower subject to a limitation on conversion or exercise analogous to the limitations contained herein) and (2) the number of shares of Common Stock issuable upon the conversion of the portion of this Note with respect to which the determination of this proviso is being made, would result in beneficial ownership by the Holder and its affiliates of more than 9.99% of the outstanding shares of Common Stock. For purposes of the proviso to the immediately preceding sentence, beneficial ownership shall be determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Regulations 13D-G thereunder, except as otherwise provided in clause (1) of such proviso, provided, further, however, that the limitations on conversion may be waived by the Holder upon, at the election of the Holder, not less than 61 days’ prior notice to the Borrower, and the provisions of the conversion limitation shall continue to apply until such 61st day (or such later date, as determined by the Holder, as may be specified

in such notice of waiver). The number of shares of Common Stock to be issued upon each conversion of this Note shall be determined by dividing the Conversion Amount (as defined below) by the applicable Conversion Price then in effect on the date specified in the notice of conversion, in the form attached hereto as Exhibit A (the “Notice of Conversion”), delivered to the Borrower by the Holder in accordance with Section 1.4 below; provided that the Notice of Conversion is submitted by facsimile or e-mail (or by other means resulting in, or reasonably expected to result in, notice) to the Borrower before 6:00 p.m., New York, New York time on such conversion date (the “Conversion Date”). The term “Conversion Amount” means, with respect to any conversion of this Note, the sum of (1) the principal amount of this Note to be converted in such conversion plus (2) at the Holder’s option, accrued and unpaid interest, if any, on such principal amount at the interest rates provided in this Note to the Conversion Date, plus

(3) at the Holder’s option, Default Interest, if any, on the amounts referred to in the immediately preceding clauses (1) and/or (2) plus (4) at the Holder’s option, any amounts owed to the Holder pursuant to Sections 1.3 and 1.4(g) hereof.

1.2

Conversion Price.

(a) Calculation of Conversion Price. The conversion price (the “Conversion Price”) shall equal the Variable Conversion Price (as defined herein) (subject to equitable adjustments for stock splits, stock dividends or rights offerings by the Borrower relating to the Borrower’s securities or the securities of any subsidiary of the Borrower, combinations, recapitalization, reclassifications, extraordinary distributions and similar events). The "Variable Conversion Price" shall mean 58% multiplied by the Market Price (as defined herein) (representing a discount rate of 42%). “Market Price” means the average of the lowest three (3) Trading Prices (as defined below) for the Common Stock during ten (10) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date. “Trading Price” means, for any security as of any date, the closing bid price on the Over-the-Counter Bulletin Board, Pink Sheets electronic quotation system or applicable trading market (the “OTC”) as reported by a reliable reporting service (“Reporting Service”) designated by the Holder (i.e. Bloomberg) or, if the OTC is not the principal trading market for such security, the closing bid price of such security on the principal securities exchange or trading market where such security is listed or traded or, if no closing bid price of such security is available in any of the foregoing manners, the average of the closing bid prices of any market makers for such security that are listed in the “pink sheets”. If the Trading Price cannot be calculated for such security on such date in the manner provided above, the Trading Price shall be the fair market value as mutually determined by the Borrower and the holders of a majority in interest of the Notes being converted for which the calculation of the Trading Price is required in order to determine the Conversion Price of such Notes. “Trading Day” shall mean any day on which the Common Stock is tradable for any period on the OTC, or on the principal securities exchange or other securities market on which the Common Stock is then being traded.

(b) Conversion Price During Major Announcements. Notwithstanding anything contained in Section 1.2(a) to the contrary, in the event the Borrower (i) makes a public announcement that it intends to consolidate or merge with any other corporation (other than a merger in which the Borrower is the surviving or continuing corporation and its capital stock is unchanged) or sell or transfer all or substantially all of the assets of the Borrower or (ii) any person, group or entity (including the Borrower) publicly announces a tender offer to purchase 50% or more of the Borrower’s Common Stock (or any other takeover scheme) (the date of the announcement referred to in clause (i) or (ii) is hereinafter referred to as the “Announcement Date”), then the Conversion Price shall, effective upon the Announcement Date and continuing through the Adjusted Conversion Price Termination Date (as defined below), be equal to the lower of (x) the Conversion Price which would have been applicable for a Conversion occurring on the Announcement Date and (y) the Conversion Price that would otherwise be in effect. From and after the Adjusted Conversion Price Termination Date, the Conversion Price shall be determined as set forth in this Section 1.2(a). For purposes hereof, “Adjusted Conversion Price Termination Date” shall mean, with respect to any proposed transaction or tender offer (or takeover scheme) for which a public announcement as contemplated by this Section 1.2(b) has been made, the date upon which the Borrower (in the case of clause (i) above) or the person, group or entity (in the case of clause (ii) above) consummates or publicly announces the termination or abandonment of the proposed transaction or tender offer (or takeover scheme) which caused this Section 1.2(b) to become operative.

1.3 Authorized Shares. The Borrower covenants that during the period the conversion right exists, the Borrower will reserve from its authorized and unissued Common Stock a sufficient number of shares, free from preemptive rights, to provide for the issuance of Common Stock upon the full conversion of this Note issued pursuant to the Purchase Agreement. The Borrower is required at all times to have authorized and reserved six times the number of shares that is actually issuable upon full conversion of the Note (based on the Conversion Price of the Notes in effect from time to time)(the “Reserved Amount”). The Reserved Amount shall be increased from time to time in accordance with the Borrower’s obligations hereunder. The Borrower represents that upon issuance, such shares will be duly and validly issued, fully paid and non-assessable. In addition, if the Borrower shall issue any securities or make any change to its capital structure which would change the number of shares of Common Stock into which the Notes shall be convertible at the then current Conversion Price, the Borrower shall at the same time make proper provision so that thereafter there shall be a sufficient number of shares of Common Stock authorized and reserved, free from preemptive rights, for conversion of the outstanding Notes. The Borrower (i) acknowledges that it has irrevocably instructed its transfer agent to issue certificates for the Common Stock issuable upon conversion of this Note, and

(ii) agrees that its issuance of this Note shall constitute full authority to its officers and agents who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for shares of Common Stock in accordance with the terms and conditions of this Note.

If, at any time the Borrower does not maintain the Reserved Amount it will be considered an Event of Default under Section 3.2 of the Note.

1.4

Method of Conversion.

(a) Mechanics of Conversion. Subject to Section 1.1, this Note may be converted by the Holder in whole or in part at any time from time to time after the Issue Date, by

(A) submitting to the Borrower a Notice of Conversion (by facsimile, e-mail or other reasonable means of communication dispatched on the Conversion Date prior to 6:00 p.m., New York, New York time) and (B) subject to Section 1.4(b), surrendering this Note at the principal office of the Borrower.

(b) Surrender of Note Upon Conversion. Notwithstanding anything to the contrary set forth herein, upon conversion of this Note in accordance with the terms hereof, the Holder shall not be required to physically surrender this Note to the Borrower unless the entire unpaid principal amount of this Note is so converted. The Holder and the Borrower shall maintain records showing the principal amount so converted and the dates of such conversions or shall use such other method, reasonably satisfactory to the Holder and the Borrower, so as not to require physical surrender of this Note upon each such conversion. In the event of any dispute or discrepancy, such records of the Borrower shall, prima facie, be controlling and determinative in the absence of manifest error. Notwithstanding the foregoing, if any portion of this Note is converted as aforesaid, the Holder may not transfer this Note unless the Holder first physically surrenders this Note to the Borrower, whereupon the Borrower will forthwith issue and deliver upon the order of the Holder a new Note of like tenor, registered as the Holder (upon payment by the Holder of any applicable transfer taxes) may request, representing in the aggregate the remaining unpaid principal amount of this Note. The Holder and any assignee, by acceptance of this Note, acknowledge and agree that, by reason of the provisions of this paragraph, following conversion of a portion of this Note, the unpaid and unconverted principal amount of this Note represented by this Note may be less than the amount stated on the face hereof.

(c) Payment of Taxes. The Borrower shall not be required to pay any tax which may be payable in respect of any transfer involved in the issue and delivery of shares of Common Stock or other securities or property on conversion of this Note in a name other than that of the Holder (or in street name), and the Borrower shall not be required to issue or deliver any such shares or other securities or property unless and until the person or persons (other than the Holder or the custodian in whose street name such shares are to be held for the Holder’s account) requesting the issuance thereof shall have paid to the Borrower the amount of any such tax or shall have established to the satisfaction of the Borrower that such tax has been paid.

(d) Delivery of Common Stock Upon Conversion. Upon receipt by the Borrower from the Holder of a facsimile transmission or e-mail (or other reasonable means of communication) of a Notice of Conversion meeting the requirements for conversion as provided

in this Section 1.4, the Borrower shall issue and deliver or cause to be issued and delivered to or upon the order of the Holder certificates for the Common Stock issuable upon such conversion within three (3) business days after such receipt (the “Deadline”) (and, solely in the case of conversion of the entire unpaid principal amount hereof, surrender of this Note) in accordance with the terms hereof and the Purchase Agreement.

(e) Obligation of Borrower to Deliver Common Stock. Upon receipt by the Borrower of a Notice of Conversion, the Holder shall be deemed to be the holder of record of the Common Stock issuable upon such conversion, the outstanding principal amount and the amount of accrued and unpaid interest on this Note shall be reduced to reflect such conversion, and, unless the Borrower defaults on its obligations under this Article I, all rights with respect to the portion of this Note being so converted shall forthwith terminate except the right to receive the Common Stock or other securities, cash or other assets, as herein provided, on such conversion. If the Holder shall have given a Notice of Conversion as provided herein, the Borrower’s obligation to issue and deliver the certificates for Common Stock shall be absolute and unconditional, irrespective of the absence of any action by the Holder to enforce the same, any waiver or consent with respect to any provision thereof, the recovery of any judgment against any person or any action to enforce the same, any failure or delay in the enforcement of any other obligation of the Borrower to the holder of record, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder of any obligation to the Borrower, and irrespective of any other circumstance which might otherwise limit such obligation of the Borrower to the Holder in connection with such conversion. The Conversion Date specified in the Notice of Conversion shall be the Conversion Date so long as the Notice of Conversion is received by the Borrower before 6:00 p.m., New York, New York time, on such date.

(f) Delivery of Common Stock by Electronic Transfer. In lieu of delivering physical certificates representing the Common Stock issuable upon conversion, provided the Borrower is participating in the Depository Trust Company (“DTC”) Fast Automated Securities Transfer (“FAST”) program, upon request of the Holder and its compliance with the provisions contained in Section 1.1 and in this Section 1.4, the Borrower shall use its best efforts to cause its transfer agent to electronically transmit the Common Stock issuable upon conversion to the Holder by crediting the account of Holder’s Prime Broker with DTC through its Deposit Withdrawal Agent Commission (“DWAC”) system.

(g) Failure to Deliver Common Stock Prior to Deadline. Without in any way limiting the Holder’s right to pursue other remedies, including actual damages and/or equitable relief, the parties agree that if delivery of the Common Stock issuable upon conversion of this Note is not delivered by the Deadline (other than a failure due to the circumstances described in Section 1.3 above, which failure shall be governed by such Section) the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the Deadline that the Borrower fails to deliver such Common Stock. Such cash amount shall be paid to Holder by the

fifth day of the month following the month in which it has accrued or, at the option of the Holder (by written notice to the Borrower by the first day of the month following the month in which it has accrued), shall be added to the principal amount of this Note, in which event interest shall accrue thereon in accordance with the terms of this Note and such additional principal amount shall be convertible into Common Stock in accordance with the terms of this Note. The Borrower agrees that the right to convert is a valuable right to the Holder. The damages resulting from a failure, attempt to frustrate, interference with such conversion right are difficult if not impossible to qualify. Accordingly the parties acknowledge that the liquidated damages provision contained in this Section 1.4(g) are justified.

1.5 Concerning the Shares. The shares of Common Stock issuable upon conversion of this Note may not be sold or transferred unless (i) such shares are sold pursuant to an effective registration statement under the Act or (ii) the Borrower or its transfer agent shall have been furnished with an opinion of counsel (which opinion shall be in form, substance and scope customary for opinions of counsel in comparable transactions) to the effect that the shares to be sold or transferred may be sold or transferred pursuant to an exemption from such registration or (iii) such shares are sold or transferred pursuant to Rule 144 under the Act (or a successor rule) (“Rule 144”) or (iv) such shares are transferred to an “affiliate” (as defined in Rule 144) of the Borrower who agrees to sell or otherwise transfer the shares only in accordance with this Section 1.5 and who is an Accredited Investor (as defined in the Purchase Agreement). Except as otherwise provided in the Purchase Agreement (and subject to the removal provisions set forth below), until such time as the shares of Common Stock issuable upon conversion of this Note have been registered under the Act or otherwise may be sold pursuant to Rule 144 without any restriction as to the number of securities as of a particular date that can then be immediately sold, each certificate for shares of Common Stock issuable upon conversion of this Note that has not been so included in an effective registration statement or that has not been sold pursuant to an effective registration statement or an exemption that permits removal of the legend, shall bear a legend substantially in the following form, as appropriate:

“NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”

The legend set forth above shall be removed and the Borrower shall issue to the Holder a new certificate therefore free of any transfer legend if (i) the Borrower or its transfer agent shall have received an opinion of counsel, in form, substance and scope customary for opinions of counsel in comparable transactions, to the effect that a public sale or transfer of such Common Stock may be made without registration under the Act, which opinion shall be accepted by the Company so that the sale or transfer is effected or (ii) in the case of the Common Stock issuable upon conversion of this Note, such security is registered for sale by the Holder under an effective registration statement filed under the Act or otherwise may be sold pursuant to Rule 144 without any restriction as to the number of securities as of a particular date that can then be immediately sold. In the event that the Company does not accept the opinion of counsel provided by the Holder with respect to the transfer of Securities pursuant to an exemption from registration, such as Rule 144 or Regulation S, at the Deadline, it will be considered an Event of Default pursuant to Section 3.2 of the Note.

1.6

Effect of Certain Events.

(a) Effect of Merger, Consolidation, Etc. At the option of the Holder, the sale, conveyance or disposition of all or substantially all of the assets of the Borrower, the effectuation by the Borrower of a transaction or series of related transactions in which more than 50% of the voting power of the Borrower is disposed of, or the consolidation, merger or other business combination of the Borrower with or into any other Person (as defined below) or Persons when the Borrower is not the survivor shall either: (i) be deemed to be an Event of Default (as defined in Article III) pursuant to which the Borrower shall be required to pay to the Holder upon the consummation of and as a condition to such transaction an amount equal to the Default Amount (as defined in Article III) or (ii) be treated pursuant to Section 1.6(b) hereof. “Person” shall mean any individual, corporation, limited liability company, partnership, association, trust or other entity or organization.

(b) Adjustment Due to Merger, Consolidation, Etc. If, at any time when this Note is issued and outstanding and prior to conversion of all of the Notes, there shall be any merger, consolidation, exchange of shares, recapitalization, reorganization, or other similar event, as a result of which shares of Common Stock of the Borrower shall be changed into the same or a different number of shares of another class or classes of stock or securities of the Borrower or another entity, or in case of any sale or conveyance of all or substantially all of the assets of the Borrower other than in connection with a plan of complete liquidation of the Borrower, then the Holder of this Note shall thereafter have the right to receive upon conversion of this Note, upon the basis and upon the terms and conditions specified herein and in lieu of the shares of Common Stock immediately theretofore issuable upon conversion, such stock, securities or assets which the Holder would have been entitled to receive in such transaction had

this Note been converted in full immediately prior to such transaction (without regard to any limitations on conversion set forth herein), and in any such case appropriate provisions shall be made with respect to the rights and interests of the Holder of this Note to the end that the provisions hereof (including, without limitation, provisions for adjustment of the Conversion Price and of the number of shares issuable upon conversion of the Note) shall thereafter be applicable, as nearly as may be practicable in relation to any securities or assets thereafter deliverable upon the conversion hereof. The Borrower shall not affect any transaction described in this Section 1.6(b) unless (a) it first gives, to the extent practicable, thirty (30) days prior written notice (but in any event at least fifteen (15) days prior written notice) of the record date of the special meeting of shareholders to approve, or if there is no such record date, the consummation of, such merger, consolidation, exchange of shares, recapitalization, reorganization or other similar event or sale of assets (during which time the Holder shall be entitled to convert this Note) and (b) the resulting successor or acquiring entity (if not the Borrower) assumes by written instrument the obligations of this Section 1.6(b). The above provisions shall similarly apply to successive consolidations, mergers, sales, transfers or share exchanges.

(c) Adjustment Due to Distribution. If the Borrower shall declare or make any distribution of its assets (or rights to acquire its assets) to holders of Common Stock as a dividend, stock repurchase, by way of return of capital or otherwise (including any dividend or distribution to the Borrower’s shareholders in cash or shares (or rights to acquire shares) of capital stock of a subsidiary (i.e., a spin-off)) (a “Distribution”), then the Holder of this Note shall be entitled, upon any conversion of this Note after the date of record for determining shareholders entitled to such Distribution, to receive the amount of such assets which would have been payable to the Holder with respect to the shares of Common Stock issuable upon such conversion had such Holder been the holder of such shares of Common Stock on the record date for the determination of shareholders entitled to such Distribution.

(d) Purchase Rights. If, at any time when any Notes are issued and outstanding, the Borrower issues any convertible securities or rights to purchase stock, warrants, securities or other property (the “Purchase Rights”) pro rata to the record holders of any class of Common Stock, then the Holder of this Note will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which such Holder could have acquired if such Holder had held the number of shares of Common Stock acquirable upon complete conversion of this Note (without regard to any limitations on conversion contained herein) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights or, if no such record is taken, the date as of which the record holders of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights.

(e) Notice of Adjustments. Upon the occurrence of each adjustment or readjustment of the Conversion Price as a result of the events described in this Section 1.6, the Borrower, at its expense, shall promptly compute such adjustment or readjustment and prepare

and furnish to the Holder a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Borrower shall, upon the written request at any time of the Holder, furnish to such Holder a like certificate setting forth (i) such adjustment or readjustment, (ii) the Conversion Price at the time in effect and (iii) the number of shares of Common Stock and the amount, if any, of other securities or property which at the time would be received upon conversion of the Note.

1.7 Trading Market Limitations. Unless permitted by the applicable rules and regulations of the principal securities market on which the Common Stock is then listed or traded, in no event shall the Borrower issue upon conversion of or otherwise pursuant to this Note and the other Notes issued pursuant to the Purchase Agreement more than the maximum number of shares of Common Stock that the Borrower can issue pursuant to any rule of the principal United States securities market on which the Common Stock is then traded (the “Maximum Share Amount”), which shall be 9.99% of the total shares outstanding on the Closing Date (as defined in the Purchase Agreement), subject to equitable adjustment from time to time for stock splits, stock dividends, combinations, capital reorganizations and similar events relating to the Common Stock occurring after the date hereof. Once the Maximum Share Amount has been issued, if the Borrower fails to eliminate any prohibitions under applicable law or the rules or regulations of any stock exchange, interdealer quotation system or other self-regulatory organization with jurisdiction over the Borrower or any of its securities on the Borrower’s ability to issue shares of Common Stock in excess of the Maximum Share Amount, in lieu of any further right to convert this Note, this will be considered an Event of Default under Section 3.3 of the Note.

1.8 Status as Shareholder. Upon submission of a Notice of Conversion by a Holder, (i) the shares covered thereby (other than the shares, if any, which cannot be issued because their issuance would exceed such Holder’s allocated portion of the Reserved Amount or Maximum Share Amount) shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a Holder of such converted portion of this Note shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Borrower to comply with the terms of this Note. Notwithstanding the foregoing, if a Holder has not received certificates for all shares of Common Stock prior to the tenth (10th) business day after the expiration of the Deadline with respect to a conversion of any portion of this Note for any reason, then (unless the Holder otherwise elects to retain its status as a holder of Common Stock by so notifying the Borrower) the Holder shall regain the rights of a Holder of this Note with respect to such unconverted portions of this Note and the Borrower shall, as soon as practicable, return such unconverted Note to the Holder or, if the Note has not been surrendered, adjust its records to reflect that such portion of this Note has not been converted. In all cases, the Holder shall retain all of its rights and remedies (including, without limitation, (i) the right to receive Conversion Default Payments pursuant to Section 1.3 to the extent required thereby for such Conversion Default and any subsequent Conversion Default and (ii) the right to

have the Conversion Price with respect to subsequent conversions determined in accordance with Section 1.3) for the Borrower’s failure to convert this Note.

1.9 Prepayment. Notwithstanding anything to the contrary contained in this Note, at any time during the periods set forth on the table immediately following this paragraph (the “Prepayment Periods”), the Borrower shall have the right, exercisable on not less than three

(3) Trading Days prior written notice to the Holder of the Note to prepay the outstanding Note (principal and accrued interest), in full, in accordance with this Section 1.9. Any notice of prepayment hereunder (an “Optional Prepayment Notice”) shall be delivered to the Holder of the Note at its registered addresses and shall state: (1) that the Borrower is exercising its right to prepay the Note, and (2) the date of prepayment which shall be not more than three (3) Trading Days from the date of the Optional Prepayment Notice. On the date fixed for prepayment (the “Optional Prepayment Date”), the Borrower shall make payment of the Optional Prepayment Amount (as defined below) to Holder, or upon the order of the Holder as specified by the Holder in writing to the Borrower, at least one (1) business day prior to the Optional Prepayment Date. If the Borrower exercises its right to prepay the Note, the Borrower shall make payment to the Holder of an amount in cash (the “Optional Prepayment Amount”) equal to the percentage (“Prepayment Percentage”) as set forth in the table immediately following this paragraph opposite the applicable Prepayment Period, multiplied by the sum of: (w) the then outstanding principal amount of this Note plus (x) accrued and unpaid interest on the unpaid principal amount of this Note to the Optional Prepayment Date plus (y) Default Interest, if any, on the amounts referred to in clauses (w) and (x) plus (z) any amounts owed to the Holder pursuant to Sections 1.3 and 1.4(g) hereof. If the Borrower delivers an Optional Prepayment Notice and fails to pay the Optional Prepayment Amount due to the Holder of the Note within two (2) business days following the Optional Prepayment Date, the Borrower shall forever forfeit its right to prepay the Note pursuant to this Section 1.9.

Prepayment Period	Prepayment Percentage
1. The period beginning on the Issue Date and ending on the date which is thirty (30) days following the Issue Date.	125%
2. The period beginning on the date which is thirty- one (31) days following the Issue Date and ending on the date which is sixty (60) days following the Issue Date	130%
3. The period beginning on the date which is sixty-one (61) days following the Issue Date and ending on the date which is	135%

ninety (90) days following the Issue Date
4. The period beginning on the date that is ninety-one (91) day from the Issue Date and ending one hundred twenty (120) days following the Issue Date	140%
5. The period beginning on the date that is one hundred twenty-one (121) day from the Issue Date and ending one hundred fifty (150) days following the Issue Date	145%
6. The period beginning on the date that is one hundred fifty-one (151) day from the Issue Date and ending one hundred eighty (180) days following the Issue Date	150%

After the expiration of one hundred eighty (180) days following the Issue Date, the Borrower shall have no right of prepayment.

ARTICLE II. CERTAIN COVENANTS

2.1 Distributions on Capital Stock. So long as the Borrower shall have any obligation under this Note, the Borrower shall not without the Holder’s written consent (a) pay, declare or set apart for such payment, any dividend or other distribution (whether in cash, property or other securities) on shares of capital stock other than dividends on shares of Common Stock solely in the form of additional shares of Common Stock or (b) directly or indirectly or through any subsidiary make any other payment or distribution in respect of its capital stock except for distributions pursuant to any shareholders’ rights plan which is approved by a majority of the Borrower’s disinterested directors.

2.2 Restriction on Stock Repurchases. So long as the Borrower shall have any obligation under this Note, the Borrower shall not without the Holder’s written consent redeem, repurchase or otherwise acquire (whether for cash or in exchange for property or other securities or otherwise) in any one transaction or series of related transactions any shares of capital stock of the Borrower or any warrants, rights or options to purchase or acquire any such shares.

2.3 Borrowings. So long as the Borrower shall have any obligation under this Note, the Borrower shall not, without the Holder’s written consent, (a) create, incur, assume guarantee, endorse, contingently agree to purchase or otherwise become liable upon the obligation of any other person, firm, partnership, joint venture or corporation, except by the endorsement of negotiable instruments for deposit or collection, or (b) suffer to exist any liability

for borrowed money, except any borrowings that does not render the Borrower a "Shell" company as defined in Rule 12b-2 under the Securities Exchange Act of 1934.

2.4 Sale of Assets. So long as the Borrower shall have any obligation under this Note, the Borrower shall not, without the Holder’s written consent, sell, lease or otherwise dispose of any significant portion of its assets outside the ordinary course of business. Any consent to the disposition of any assets may be conditioned on a specified use of the proceeds of disposition.

2.5 Advances and Loans. So long as the Borrower shall have any obligation under this Note, the Borrower shall not, without the Holder’s written consent, lend money, give credit or make advances to any person, firm, joint venture or corporation, including, without limitation, officers, directors, employees, subsidiaries and affiliates of the Borrower, except loans, credits or advances (a) in existence or committed on the date hereof and which the Borrower has informed Holder in writing prior to the date hereof, (b) made in the ordinary course of business or (c) not in excess of $100,000.

ARTICLE III. EVENTS OF DEFAULT

If any of the following events of default (each, an “Event of Default”) shall occur:

3.1 Failure to Pay Principal or Interest. The Borrower fails to pay the principal hereof or interest thereon when due on this Note, whether at maturity, upon acceleration or otherwise.

3.2 Conversion and the Shares. The Borrower fails to issue shares of Common Stock to the Holder (or announces or threatens in writing that it will not honor its obligation to do so) upon exercise by the Holder of the conversion rights of the Holder in accordance with the terms of this Note, fails to transfer or cause its transfer agent to transfer (issue) (electronically or in certificated form) any certificate for shares of Common Stock issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note, the Borrower directs its transfer agent not to transfer or delays, impairs, and/or hinders its transfer agent in transferring (or issuing) (electronically or in certificated form) any certificate for shares of Common Stock to be issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note, or fails to remove (or directs its transfer agent not to remove or impairs, delays, and/or hinders its transfer agent from removing) any restrictive legend (or to withdraw any stop transfer instructions in respect thereof) on any certificate for any shares of Common Stock issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note (or makes any written announcement, statement or threat that it does not intend to honor the obligations described in this paragraph) and any such failure shall continue uncured (or any written announcement, statement or threat not to honor its

obligations shall not be rescinded in writing) for three (3) business days after the Holder shall have delivered a Notice of Conversion. It is an obligation of the Borrower to remain current in its obligations to its transfer agent. It shall be an event of default of this Note, if a conversion of this Note is delayed, hindered or frustrated due to a balance owed by the Borrower to its transfer agent. If at the option of the Holder, the Holder advances any funds to the Borrower’s transfer agent in order to process a conversion, such advanced funds shall be paid by the Borrower to the Holder within forty eight (48) hours of a demand from the Holder.

3.3 Breach of Covenants. The Borrower breaches any material covenant or other material term or condition contained in this Note and any collateral documents including but not limited to the Purchase Agreement and such breach continues for a period of ten (10) days after written notice thereof to the Borrower from the Holder.

3.4 Breach of Representations and Warranties. Any representation or warranty of the Borrower made herein or in any agreement, statement or certificate given in writing pursuant hereto or in connection herewith (including, without limitation, the Purchase Agreement), shall be false or misleading in any material respect when made and the breach of which has (or with the passage of time will have) a material adverse effect on the rights of the Holder with respect to this Note or the Purchase Agreement.

3.5 Receiver or Trustee. The Borrower or any subsidiary of the Borrower shall make an assignment for the benefit of creditors, or apply for or consent to the appointment of a receiver or trustee for it or for a substantial part of its property or business, or such a receiver or trustee shall otherwise be appointed.

3.6 Judgments. Any money judgment, writ or similar process shall be entered or filed against the Borrower or any subsidiary of the Borrower or any of its property or other assets for more than $50,000, and shall remain unvacated, unbonded or unstayed for a period of twenty

(20) days unless otherwise consented to by the Holder, which consent will not be unreasonably withheld.

3.7 Bankruptcy. Bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings, voluntary or involuntary, for relief under any bankruptcy law or any law for the relief of debtors shall be instituted by or against the Borrower or any subsidiary of the Borrower.

3.8 Delisting of Common Stock. The Borrower shall fail to maintain the listing of the Common Stock on at least one of the OTC (which specifically includes the Pink Sheets electronic quotation system) or an equivalent replacement exchange, the Nasdaq National Market, the Nasdaq SmallCap Market, the New York Stock Exchange, or the American Stock Exchange.

3.9 Failure to Comply with the Exchange Act. The Borrower shall fail to comply with the reporting requirements of the Exchange Act; and/or the Borrower shall cease to be subject to the reporting requirements of the Exchange Act.

3.10 Liquidation. Any dissolution, liquidation, or winding up of Borrower or any substantial portion of its business.

3.11 Cessation of Operations. Any cessation of operations by Borrower or Borrower admits it is otherwise generally unable to pay its debts as such debts become due, provided, however, that any disclosure of the Borrower’s ability to continue as a “going concern” shall not be an admission that the Borrower cannot pay its debts as they become due.

3.12 Maintenance of Assets. The failure by Borrower to maintain any material intellectual property rights, personal, real property or other assets which are necessary to conduct its business (whether now or in the future).

3.13 Financial Statement Restatement. The restatement of any financial statements filed by the Borrower with the SEC for any date or period from two years prior to the Issue Date of this Note and until this Note is no longer outstanding, if the result of such restatement would, by comparison to the unrestated financial statement, have constituted a material adverse effect on the rights of the Holder with respect to this Note or the Purchase Agreement.

3.14 Reverse Splits. The Borrower effectuates a reverse split of its Common Stock without twenty (20) days prior written notice to the Holder.

3.15 Replacement of Transfer Agent. In the event that the Borrower proposes to replace its transfer agent, the Borrower fails to provide, prior to the effective date of such replacement, a fully executed Irrevocable Transfer Agent Instructions in a form as initially delivered pursuant to the Purchase Agreement (including but not limited to the provision to irrevocably reserve shares of Common Stock in the Reserved Amount) signed by the successor transfer agent to Borrower and the Borrower.

3.16 Cross-Default. Notwithstanding anything to the contrary contained in this Note or the other related or companion documents, a breach or default by the Borrower of any covenant or other term or condition contained in any of the Other Agreements, after the passage of all applicable notice and cure or grace periods, shall, at the option of the Holder, be considered a default under this Note and the Other Agreements, in which event the Holder shall be entitled (but in no event required) to apply all rights and remedies of the Holder under the terms of this Note and the Other Agreements by reason of a default under said Other Agreement or

hereunder. “Other Agreements” means, collectively, all agreements and instruments between, among or by: (1) the Borrower, and, or for the benefit of, (2) the Holder and any affiliate of the Holder, including, without limitation, promissory notes; provided, however, the term “Other Agreements” shall not include the related or companion documents to this Note. Each of the loan transactions will be cross-defaulted with each other loan transaction and with all other existing and future debt of Borrower to the Holder.

Upon the occurrence of any Event of Default specified in Section 3.1 (solely with respect to failure to pay the principal hereof or interest thereon when due at the Maturity Date), the Note shall become immediately due and payable and the Borrower shall pay to the Holder, in full satisfaction of its obligations hereunder, an amount equal to the Default Sum (as defined herein). UPON THE OCCURRENCE OF ANY EVENT OF DEFAULT SPECIFIED IN SECTION 3.2, THE NOTE SHALL BECOME IMMEDIATELY DUE AND PAYABLE AND THE BORROWER SHALL PAY TO THE HOLDER, IN FULL SATISFACTION OF ITS OBLIGATIONS HEREUNDER, AN AMOUNT EQUAL TO: (Y) THE DEFAULT SUM (AS

DEFINED HEREIN); MULTIPLIED BY (Z) TWO (2). Upon the occurrence of any Event of Default, other than Section 3.2, exercisable through the delivery of written notice to the Borrower by such Holders (the “Default Notice”), the Note shall become immediately due and payable and the Borrower shall pay to the Holder, in full satisfaction of its obligations hereunder, an amount equal to the greater of (i) 150% times the sum of (w) the then outstanding principal amount of this Note plus (x) accrued and unpaid interest on the unpaid principal amount of this Note to the date of payment (the “Mandatory Prepayment Date”) plus (y) Default Interest, if any, on the amounts referred to in clauses (w) and/or (x) plus (z) any amounts owed to the Holder pursuant to Sections 1.3 and 1.4(g) hereof (the then outstanding principal amount of this Note to the date of payment plus the amounts referred to in clauses (x), (y) and (z) shall collectively be known as the “Default Sum”) or (ii) the “parity value” of the Default Sum to be prepaid, where parity value means (a) the highest number of shares of Common Stock issuable upon conversion of or otherwise pursuant to such Default Sum in accordance with Article I, treating the Trading Day immediately preceding the Mandatory Prepayment Date as the “Conversion Date” for purposes of determining the lowest applicable Conversion Price, unless the Default Event arises as a result of a breach in respect of a specific Conversion Date in which case such Conversion Date shall be the Conversion Date), multiplied by (b) the highest Closing Price for the Common Stock during the period beginning on the date of first occurrence of the Event of Default and ending one day prior to the Mandatory Prepayment Date (the “Default Amount”) and all other amounts payable hereunder shall immediately become due and payable, all without demand, presentment or notice, all of which hereby are expressly waived, together with all costs, including, without limitation, legal fees and expenses, of collection, and the Holder shall be entitled to exercise all other rights and remedies available at law or in equity.

If the Borrower fails to pay the Default Amount within five (5) business days of written notice that such amount is due and payable, then the Holder shall have the right at any time, so long and to the extent that there are sufficient authorized shares, to require the Borrower, upon

written notice, to convert the Default Amount into shares of Common Stock of the Borrower pursuant to Section 1.1 hereof.

ARTICLE IV. MISCELLANEOUS

4.1 Failure or Indulgence Not Waiver. No failure or delay on the part of the Holder in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other right, power or privileges. All rights and remedies existing hereunder are cumulative to, and not exclusive of, any rights or remedies otherwise available.

4.2 Notices. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted by hand delivery, telegram, or facsimile, addressed as set forth below or to such other address as such party shall have specified most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine, at the address or number designated below (if delivered on a business day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received) or (b) on the second business day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall be:

If to the Borrower, to: SKINVISIBLE, INC.

6320 S. Sandhill Road - Suite 10 Las Vegas, NV

Attn: TERRY HOWLETT, Chief Executive Officer facsimile:

With a copy by fax only to (which copy shall not constitute notice): [enter name of law firm]

Attn: [attorney name] [enter address line 1] [enter city, state, zip]

facsimile: [enter fax number]

If to the Holder:

VIS VIRES GROUP, INC.

111 Great Neck Road – Suite 216, Great Neck, NY 11021

Attn: Curt Kramer, President

e-mail: info@visviresgroup.com

With a copy by fax only to (which copy shall not constitute notice): Naidich Wurman LLP

111 Great Neck Road – Suite 214 Great Neck, NY 11021

Att: Judah A. Eisner, Esq. facsimile: 516-466-3555

4.3 Amendments. This Note and any provision hereof may only be amended by an instrument in writing signed by the Borrower and the Holder. The term “Note” and all reference thereto, as used throughout this instrument, shall mean this instrument (and the other Notes issued pursuant to the Purchase Agreement) as originally executed, or if later amended or supplemented, then as so amended or supplemented.

4.4 Assignability. This Note shall be binding upon the Borrower and its successors and assigns, and shall inure to be the benefit of the Holder and its successors and assigns. Each transferee of this Note must be an “accredited investor” (as defined in Rule 501(a) of the 1933 Act). Notwithstanding anything in this Note to the contrary, this Note may be pledged as collateral in connection with a bona fide margin account or other lending arrangement.

4.5 Cost of Collection. If default is made in the payment of this Note, the Borrower shall pay the Holder hereof costs of collection, including reasonable attorneys’ fees.

4.6 Governing Law. This Note shall be governed by and construed in accordance with the laws of the State of New York without regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by this Note shall be brought only in the state courts of New York or in the federal courts located in the state and county of Nassau. The parties to this Note hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. The Borrower and Holder waive trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorney's fees and costs. In the event that any provision of this Note or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable

statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement. Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding in connection with this Agreement or any other Transaction Document by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

4.7 Certain Amounts. Whenever pursuant to this Note the Borrower is required to pay an amount in excess of the outstanding principal amount (or the portion thereof required to be paid at that time) plus accrued and unpaid interest plus Default Interest on such interest, the Borrower and the Holder agree that the actual damages to the Holder from the receipt of cash payment on this Note may be difficult to determine and the amount to be so paid by the Borrower represents stipulated damages and not a penalty and is intended to compensate the Holder in part for loss of the opportunity to convert this Note and to earn a return from the sale of shares of Common Stock acquired upon conversion of this Note at a price in excess of the price paid for such shares pursuant to this Note. The Borrower and the Holder hereby agree that such amount of stipulated damages is not plainly disproportionate to the possible loss to the Holder from the receipt of a cash payment without the opportunity to convert this Note into shares of Common Stock.

4.8 Purchase Agreement. By its acceptance of this Note, each party agrees to be bound by the applicable terms of the Purchase Agreement.

4.9 Notice of Corporate Events. Except as otherwise provided below, the Holder of this Note shall have no rights as a Holder of Common Stock unless and only to the extent that it converts this Note into Common Stock. The Borrower shall provide the Holder with prior notification of any meeting of the Borrower’s shareholders (and copies of proxy materials and other information sent to shareholders). In the event of any taking by the Borrower of a record of its shareholders for the purpose of determining shareholders who are entitled to receive payment of any dividend or other distribution, any right to subscribe for, purchase or otherwise acquire (including by way of merger, consolidation, reclassification or recapitalization) any share of any class or any other securities or property, or to receive any other right, or for the purpose of determining shareholders who are entitled to vote in connection with any proposed sale, lease or conveyance of all or substantially all of the assets of the Borrower or any proposed liquidation, dissolution or winding up of the Borrower, the Borrower shall mail a notice to the Holder, at least twenty (20) days prior to the record date specified therein (or thirty (30) days prior to the consummation of the transaction or event, whichever is earlier), of the date on which any such

record is to be taken for the purpose of such dividend, distribution, right or other event, and a brief statement regarding the amount and character of such dividend, distribution, right or other event to the extent known at such time. The Borrower shall make a public announcement of any event requiring notification to the Holder hereunder substantially simultaneously with the notification to the Holder in accordance with the terms of this Section 4.9.

4.10 Remedies. The Borrower acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder, by vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, the Borrower acknowledges that the remedy at law for a breach of its obligations under this Note will be inadequate and agrees, in the event of a breach or threatened breach by the Borrower of the provisions of this Note, that the Holder shall be entitled, in addition to all other available remedies at law or in equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing any breach of this Note and to enforce specifically the terms and provisions thereof, without the necessity of showing economic loss and without any bond or other security being required.

IN WITNESS WHEREOF, Borrower has caused this Note to be signed in its name by its duly authorized officer this July 28, 2015.

SKINVISIBLE, INC.

By: /s/ TERRY HOWLETT

Chief Executive Officer

EXHIBIT A -- NOTICE OF CONVERSION

The undersigned hereby elects to convert $_______ principal amount of the Note (defined below) into that number of shares of Common Stock to be issued pursuant to the conversion of the Note (“Common Stock”) as set forth below, of SKINVISIBLE, INC., a Nevada corporation (the “Borrower”) according to the conditions of the convertible note of the Borrower dated as of July 28, 2015 (the “Note”), as of the date written below. No fee will be charged to the Holder for any conversion, except for transfer taxes, if any.

Box Checked as to applicable instructions:

[ ] The Borrower shall electronically transmit the Common Stock issuable pursuant to this Notice of Conversion to the account of the undersigned or its nominee with DTC through its Deposit Withdrawal Agent Commission system (“DWAC Transfer”).

Name of DTC Prime Broker: Account Number:

[ ] The undersigned hereby requests that the Borrower issue a certificate or certificates for the number of shares of Common Stock set forth below (which numbers are based on the Holder’s calculation attached hereto) in the name(s) specified immediately below or, if additional space is necessary, on an attachment hereto:

VIS VIRES GROUP, INC.

111 Great Neck Road – Suite 216,

Great Neck, NY 11021 Attention: Certificate Delivery

e-mail: info@visviresgroup.com

Date of Conversion:______

Applicable Conversion Price: $ ______

Number of Shares of Common Stock to be Issued

Pursuant to Conversion of the Notes: ______

Amount of Principal Balance Due remaining

Under the Note after this conversion: ______

VIS VIRES GROUP, INC.

By:

Name: Curt Kramer

Title: President

EX-10.2 6 ex10_2.htm EXHIBIT 10.2

PROMISSORY NOTE – Debt

$10,800.00

Date: October 1, 2015

FOR VALUE RECEIVED, the undersigned, Skinvisible, Inc., of 6320 South Sandhill Road, Suite 10, Las Vegas, NV 89120 promises to pay to the order of Greg McCartney ("Debtor"), whose address is #307 - 15338 18th Ave., Surrey, B.C. V4A 1W8 Canada, or such other place as the Lender may designate in writing to the undersigned, the principal sum of Ten Thousand Eight Dollars ($10,800.00), together with interest thereon from the date hereof until paid, at the rate of ten percent (10%) per annum as follows: The entire principal and interest amount shall be repaid on or before December 30, 2020.

All or any part of the aforesaid principal sum plus interest may be prepaid at any time and from time to time without penalty. This note is in regards to debt for Director fees due to Mr. McCartney as of October 1, 2015 for the 9 months of 2015.

Upon written request by Debtor, the principal of this debt and accrued interest may be converted to common shares of Skinvisible, Inc. at the price of Two cents ($0.02) per share at any time up until December 30, 2020. In addition, the Company will issue a warrant agreement in the name of your designate, which will give the holder the right to purchase further shares at Three Cents ($0.03) per share if exercised within 3 years following the conversion date. The warrant agreement will give the holder the right to purchase one share for every two shares acquired by the holder in this transaction for an aggregate total of Two Hundred and Seventy Thousand (270,000) additional shares at the above price.

This note is made and executed under, and is in all respects governed by, the laws of the State of Nevada.

/s/ Terry Howlett

Skinvisible, Inc.

TOTAL

$10,800.00

GRAND TOTAL

$10,800.00

# of Shares @ 2¢ = 540,000

Warrants @ 3¢ = 270,000

GRAPHIC 7 image_001.jpg GRAPHIC begin 644 image_001.jpg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end GRAPHIC 8 image_002.jpg GRAPHIC begin 644 image_002.jpg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end GRAPHIC 9 image_003.jpg GRAPHIC begin 644 image_003.jpg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end

GRAPHIC 10 image_004.jpg GRAPHIC begin 644 image_004.jpg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end GRAPHIC 11 image_005.jpg GRAPHIC begin 644 image_005.jpg M_]C_X 02D9)1@ ! 0 0 ! #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#8S^5.' %1 M9-.!S[U!H29IP]*CZ#K3UY[@&D,=29I"<=Q^%)NH$.S2@^]1Y XH+*!UH DS MWI2:K><,]:7SQZT6%PI-SYZ&@+DA MXIC=*3Y\=*:4D)ZBBPA":82,U!>7-O8>5]JG,?FG:ORDY-/:ZL88DE:;S%9B MH9 6 QUSCH!W]*%$-!ZMS3B&X)! ^E3075G,XCMYXG;('RL#GKT]>AJ17##V M-.P7*6VBG2C9(1CCM119#+].%-S1GWIC'YI=WI^=1 T,^VD!(33.T9J#6+K7=+L7O8 M4LKN.(;I(@C(V.Y!RCE=KH+EM/,<_ MZJ4J;8'!FVML!^N,5>AEAN85F@E26) MAE71L@_C2::"Y1=;A2 MNSC'7>!SZ5.D#%06RK$II?LX]Z9J-Y M]CA C :5_NY[>]+#IP*!KIFFE(R=S' ]@*?)9E0 MWNF(]NQM]R2+R &.#CMBK/VB-+5)Y6VJR@\]S196NAJ;NU)6&>2/2G"*CSWV M[A;3%>O;/Y9I8KB*="T1+E>J8PP_ TN5E*<=KAY='EBFQW:R3-$L4N]>H('' MZU)#U;&B7@73K[4%63RXX\#Y>6)XP*3C) IQ;W,>[TZUN@J7,*R["2 ?X3C%5 MSHU@81"8/W8[]^X[U8BO%FEC7RI!Y@W XR/7K5EEP<4[-;E)IZHR MH=&L[6]6[A38Z(P SQSW^O %+&Q\M.>PJ^P /S?2LY#^[7/H*3 9HH MIMR>4XSQ14V&C2--S5JV@62,LXSS@5.+6'^Y3L,SLU7G?FMG[/#_ ,\Q44T, M0:-1&N6//%-"*5C$=OF-G+' SZ5:[T^3Y2I]Z3Y?44Q#:\]O_P!Y\7+,'HI3 M]$)KT3>M><:@GVSXI+!'-);OE2)8\;EQ'GC-:4^OH1+H=WK%U#9:->7$Y C2 M%LY[DC 'XUYWX+CE7PKXCD((B,.T>A8*V?T(KKKOPE#J;+_:.K:C=1JI(]>Y-$6DK('=ZG,Z'KL&D^ 8EGLKF4-Y MD8Q%^[8DG +=,74TI5;F1]T2JVX1[\ ]6632 MAI-P1'>6A($;'ET)R"OJ/I6YKNL1:/ILLKG,[ K!".6D<] !U-923YRE;E.) M\)7\]U:BWN7+FT=44MSA<]/PYKTS%IK,OOL]CJ4,T;LSR<,%& >U6U MD1T#JX*GG(/%9SI]OU!) /\ 1X?X^S'VHINSU"OJE;>X+,4UFY(B9L+T49/: MDL@;N_EO,!8R-@7//XT6TB'6+IMZXQ@'/7I3 W]GZJY?B";G/8&M'U76QBM+ M2>UV7KT 6$P X"$ 58TMROAN*,'AI-S#Z=*IWEQ$UA,5=3E<#!ZU8LIDBT" M_>.X\#KG( 'YFLK/D^9O=>U^7ZDH"0QEC\J(,GV J-)A,&(5E(."K#!!ZTHF MCEMY&XNX+/XL-<74R0PI M]YW. /W==_*#+$T:RO%GC>F,CZ9JE;:%I5M*95LHY)F.6EF_>.Q]RV:J,DKB M:N59/'&E E;2.\OF_P"G:W9@?Q.*Q=4\86\S!KWPE?Z7XX\-PS*XT8V3CCS(HU;'Y8-=5;SZ!X@=)XQ9 M75^AZBBUTFQLY/-M[2-)>GF8W-^9YK"LO M$/B#0T6.YT5[J-<\G]Z#^(YK3B^)$#OB7PK]9XTJ2"7?:W!3/9JLCQ3'?H!#X;O8S_?D<(/UJ,_;YS\TT5NOI&N]O MS/%$7*)$X0GJQ7@DV9O;H>6.JCY0?J:8VJVP&R!7GQQB),C\^E2)86VX/*&G M?^],V[].E6@0 H 'H*')#4&MO\ ,R&>=F)CTD*#_>_PI6OKU%Q)9+L]-IQ6 MOFC-/VBZHETGTE^1CQZE;])+15]U -7X[FUN1M#JW^RW^!ITUK!-_K(P3ZC@ MU1DTA2S"JO3EY$6K0[-?<:)CC)&44XX&5JTT,36,49C7:^[<,=>:P5L M]0BXCG&/][_&M/RM0?38S]H574NN0._4?SI.*7VC13;WBS N++3+6%]MZWVA M.(U3'+=L@]3GJ2:;%NMI;2\E2=K)"%0RMEHFP0V5_P![^7TK5L-)@A\QY(68 ML<*L["0J,JR$JQ]^#48D(R#51V$R\)/>J4^H7$$9*Q!G\[: 3E/7ZT"0U6;^T,MY=U M$ 22NZ+.!Z=:8BS;:GOYT\KJ"X,=[&S 9DB_,\?A3NA:EI-:DVIYEFZE@#G/ M]SQP/_K4'6I6P4LGVYPQ)^O X]N?2H%;5#&=UU;A\<%8S@'(]?;/YT%]7(&) MK3(QD%6YHNNPK,L)KCNH9;*4\9(SR!^7Y>M.;7&6W@E^RRDR[OES]W':S"2'9OX4]2N1W]<9_.C3L.S'-K[J6/V.0JI M(SD_,>.G'^>*M6.JO<^:'M9%,8'W>=V?0&J\$NH;PT[Q%<\HGISW_+\C4;3: MR8%*&#S0#N!^Z>>WIQBE==A:FK)X');G@_D*IG4[Q79C$IC5 MP&VJ2<8[>_7]*KO/K>08T@VX&02.3QGO]:FN+C5_WOV:.+[P\O<1]W'?GKFD MFAD\^K21S3)':F18NK GTZ=.O(I/[6N,.WZ5I6H$B21[L M$#@YJ_(JB3Y? MN.,K]#5*3;0!3,8STJ![?+ M$[Y 3SPY&*T-O-1L@S2NP* @8* )YN&SDMDGV^E(8I0.+J;COQS^E72F.U)L MHYF!2"W*GB[8CT:-:>K7(C(,JL_&&*8^O>K7ETGE@TB12\L)CSSA M"#C\Z#+?@\"V8>Y85;\OG%!CYHY@(XIIBS>8$5?X=IR3]:F$O^U31'QTI/+[ MXI\PK$HG]ZD6X]ZJ^5D4>4?I2Y@L71<4];@5G>6WJ:,.#]XT^9#L:,E]%;P/ M-*X6-%+,Q[ 5''K>GR+N2\A88+<-DX').*H$.X*M@KZ,,YJ$6L$>[;:0#>I5 ML(!D$8(_*CF0C8M]9L+I9&@NXI%C7KV#IO6[B*[E3.[NW0?C M6&EO:QI(BV:*DJE7"\!@?;\338[:PAVA;4J%<2 !CC!14CU)0:7'-%% M,88[TT]:**8(:3@T=:** $[XII7O114L0W:*"HS1128!M%)M'Y444( VC-*5 M%%%"$)M@@Q112&&T"D(&3110 FT=*78,T44D##RUS2%!C-%%,!C1+33"I M&:**!#&MT(J(VJ=N***$421O*B[%F?8?X3R*M+,Y'.TGZ444[@! GRAPHIC 12 image_006.jpg GRAPHIC begin 644 image_006.jpg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skvi-20150930.xml XBRL INSTANCE FILE 0001085277 2015-01-01 2015-09-30 0001085277 2015-09-30 0001085277 2014-09-30 0001085277 SKVI:ConvertibleNote1Member 2015-01-01 2015-09-30 0001085277 SKVI:ConvertibleNote2Member 2015-01-01 2015-09-30 0001085277 us-gaap:ConvertibleNotesPayableMember 2015-09-30 0001085277 SKVI:ConvertibleNotesPayable1Member 2015-09-30 0001085277 SKVI:ConvertibleNotesPayable2Member 2015-09-30 0001085277 SKVI:ConvertibleNotesPayable3Member 2015-09-30 0001085277 2014-01-01 2014-09-30 0001085277 SKVI:ConvertibleNotesPayable4Member 2015-09-30 0001085277 SKVI:ConvertibleNotesPayable5Member 2015-09-30 0001085277 SKVI:ConvertibleNote1Member 2014-12-31 0001085277 SKVI:ConvertibleNote2Member 2014-12-31 0001085277 SKVI:TwentyFourNotesPayableMember 2015-01-01 2015-09-30 0001085277 SKVI:TwentyFourNotesPayableMember 2015-09-30 0001085277 SKVI:TwentySevenNotesPayableMember 2014-05-20 0001085277 SKVI:TwentySevenNotesPayableMember 2015-01-01 2015-09-30 0001085277 us-gaap:ConvertibleNotesPayableMember 2015-01-01 2015-09-30 0001085277 SKVI:ConvertibleNotesPayable1Member 2015-01-01 2015-09-30 0001085277 SKVI:ConvertibleNotesPayable2Member 2015-01-01 2015-09-30 0001085277 SKVI:ConvertibleNotesPayable3Member 2015-01-01 2015-09-30 0001085277 SKVI:ConvertibleNotesPayable4Member 2015-01-01 2015-09-30 0001085277 SKVI:ConvertibleNotesPayable5Member 2015-01-01 2015-09-30 0001085277 SKVI:ConvertibleNotesPayable6Member 2015-09-30 0001085277 SKVI:ConvertibleNotesPayable6Member 2015-01-01 2015-09-30 0001085277 SKVI:StockOptionsGranted1Member 2015-01-01 2015-09-30 0001085277 SKVI:Issuance1Member 2015-01-01 2015-09-30 0001085277 SKVI:Issuance2Member 2015-01-01 2015-09-30 0001085277 SKVI:ConvertibleNotesPayable8Member 2015-01-01 2015-09-30 0001085277 SKVI:ConvertibleNotesPayable8Member 2015-09-30 0001085277 2013-12-31 0001085277 SKVI:Issuance1Member 2015-09-30 0001085277 SKVI:Issuance2Member 2015-09-30 0001085277 2014-01-01 2014-12-31 0001085277 2015-10-25 0001085277 2015-07-01 2015-09-30 0001085277 2014-07-01 2014-09-30 0001085277 2014-12-31 0001085277 SKVI:EightNotesPayableMember 2015-04-01 2015-06-30 0001085277 SKVI:EightNotesPayableMember 2015-09-30 0001085277 SKVI:FiveNotesPayableMember 2015-01-01 2015-09-30 0001085277 SKVI:FiveNotesPayableMember 2015-09-30 0001085277 SKVI:ConvertibleNote1Member 2015-09-30 0001085277 SKVI:ConvertibleNote2Member 2015-09-30 0001085277 SKVI:ConvertibleNote3Member 2015-09-30 0001085277 SKVI:ConvertibleNote1Member 2014-12-31 0001085277 SKVI:ConvertibleNote2Member 2014-12-31 0001085277 SKVI:ConvertibleNote3Member 2014-12-31 0001085277 SKVI:ConvertibleNote1and2Member 2015-09-30 0001085277 SKVI:ConvertibleNote1and2Member 2014-12-31 0001085277 SKVI:ConvertibleNote3Member 2015-01-01 2015-09-30 0001085277 SKVI:Issuance3Member 2015-01-01 2015-09-30 0001085277 SKVI:Issuance4Member 2015-01-01 2015-09-30 0001085277 SKVI:Issuance5Member 2015-01-01 2015-09-30 0001085277 SKVI:ConvertibleNote4Member 2015-01-01 2015-09-30 0001085277 SKVI:ConvertibleNotesPayable9Member 2015-01-01 2015-09-30 0001085277 SKVI:ConvertibleNote4Member 2015-09-30 0001085277 SKVI:ConvertibleNotesPayable9Member 2015-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure SKINVISIBLE INC 0001085277 10-Q 2015-09-30 false --12-31 No No Yes Smaller Reporting Company Q3 2015 .001 .001 .001 0.001 200000000 200000000 113957969 111813969 325460 324275 330215 288203 38046 26822 111110 1123078 209809 182083 70768 94909 118126 40466 57439 34397 1998-03-06 48163 48163 113635 113635 39722 39722 12569 12569 113461 113461 327550 327550 1185 1067 42192 26960 34322 3724 26822 32619 31368 12042 5717 -5689056 -4350671 158428 41276 30377 22303 56047 3907 9859 674 102381 37369 20518 21629 900605 758997 255436 373101 943982 787024 270067 382781 -841601 -749655 -249549 -361152 -26 -258 -70 -648213 -556658 -231707 -204928 -0.01 -0.01 -0.00 -0.01 113957969 111317222 113957969 111609529 258306 513420 196602 1071593 1071593 -208939 -333483 321032 321032 -72788 -103886 182083 182083 -82054 -109277 106152 106152 -38912 -49491 142501 142501 -61748 -75937 1 1 1 1 1 1 1 1 6833 9457 1145 1145 97729 290359 2090 3275 315954 352420 415773 646054 728582 420762 497899 348111 1910 1910 1549900 1413111 1173178 5373229 3056725 6104829 4996725 114158 111814 21527741 21378656 -27330955 -25841141 415773 646054 -1840 5044 -400 4054 1440 400 1000000 634320 874163 -650079 -551872 -232107 -200944 89751 83155 7084 51756 49873 16641 118126 118126 -88562 -106223 2013-05-22 2014-05-19 1000000 1000000 0.1 0.09 0.09 0.09 0.09 0.09 0.08 1000000 1000000 208000 131000 P2Y P2Y P2Y P2Y 20689 124544 31098 27223 10579 14189 17661 6050 8589 7947 1071593 321032 182083 106153 142501 118126 52476 1000000 40558 65295 50000 30000 47500 135000 108000 .04 0.04 0.03 0.03 0.03 .025 0.04 .04 0.06 0.06 0.04 0.04 .04 .03 .05 .05 .07 .07 0.10 2010-01-12 2016-10-01 2016-04-30 40558 40558 -32377 -38427 1250000 750000 72000 72000 P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y .10 .10 .10 .10 .10 .10 .10 .10 0.09 0.10 P3Y P3Y P3Y P3Y P3Y P3Y P3Y P3Y 51485 3990 646169 13033 14758 200000 .05 P5Y 8800 8800 2015-03-31 2015-01-26 2015-01-27 2015-04-01 2015-06-30 2015-08-24 2015-10-26 2015-10-01 80000 65295 65295 -48850 -57438 -1489814 -1306313 -481256 -566080 43377 28027 14631 9680 327478 250558 -6596 -59393 2624 -9030 321020 105803 149788 133516 -612376 -820737 -5726 -15855 -5726 -15855 431000 594400 421500 581478 -196602 -255114 211564 144708 5760 20644 731600 1940000 8800 31050 54450 78 19761 2334750 2541030 0.07 0.05 9750000 625000 375000 114157969 89500 -89000 13000 1 118126 156684 1000000 0.07 1196280 0.05 200000 0.05 200000 0.05 9750000 9750000 0.05 0.05 32787 32787 Description of business Skinvisible, Inc., (referred to as the Company) is focused on the development and manufacture and sales of innovative topical, transdermal and mucosal polymer-based delivery system technologies and formulations incorporating its patent-pending formula/process for combining hydrophilic and hydrophobic polymer emulsions. The technologies and formulations have broad industry applications within the pharmaceutical, over-the-counter, personal skincare and cosmetic arenas. Additionally, the Companys non-dermatological formulations, offer solutions for a broad spectrum of markets womens health, pain management, and others. The Company maintains executive and sales offices in Las Vegas, Nevada.   History Skinvisible, Inc. (referred to as the Company) was incorporated in Nevada on March 6, 1998, under the name of Microbial Solutions, Inc. The Company underwent a name change on February 26, 1999, when it changed its name to Skinvisible, Inc. The Companys subsidiarys name of Manloe Labs, Inc. was also changed to Skinvisible Pharmaceuticals, Inc.   On September 9, 2014, the Company formed Kinatri USA Inc., a new wholly-owned subsidiary, to market a premium line of scientifically formulated skincare products powered by our patented Invisicare® technology. As part of our strategic focus on revenue generation and creating shareholder value, Kintari USA Inc. products will be sold via network marketing. The Kintari product portfolio consists of anti-aging products to help fight the signs of aging. These products have been developed using proven anti-aging ingredients with scientific evidence of their effectiveness at reducing the look of fine lines and wrinkles resulting in youthful looking skin. These potent ingredients will be powered by patented Invisicare technology, providing consumers with unique, effective products which we believe cannot be duplicated. Additional products will be added to enhance this product line as the company grows and expands. Skinvisible, Inc. together with its subsidiary shall herein be collectively referred to as the Company.   Going concern The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred cumulative net losses of $27,330,955 since its inception and requires capital for its contemplated operational and marketing activities to take place. The Companys ability to raise additional capital through the future issuances of common stock is unknown. The obtainment of additional financing, the successful development of the Companys contemplated plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability to successfully resolve these factors raise substantial doubt about the Companys ability to continue as a going concern. The consolidated financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties.   Principles of consolidation The consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated.   Use of estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.   Cash and cash equivalents For purposes of the statement of cash flows, the Company considers all highly liquid investments and short-term debt instruments with original maturities of three months or less to be cash equivalents. There are $0 and $196,602 in cash and cash equivalents as of September 30, 2015 and December 31, 2014, respectively.   Fair Value of Financial Instruments The carrying amounts reflected in the balance sheets for cash, accounts payable and accrued expenses approximate the respective fair values due to the short maturities of these items.   As required by the Fair Value Measurements and Disclosures Topic of the FASB ASC, fair value is measured based on a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.   The three levels of the fair value hierarchy are described below:   Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;   Level 2: Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability;   Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).   Revenue recognition Product sales Revenues from the sale of products (Invisicare® polymers) are recognized when title to the products are transferred to the customer and only when no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive reasonably assured payments for products sold and delivered.   Royalty sales The Company also recognizes royalty revenue from licensing its patented product formulations only when earned, when no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive and retain reasonably assured payments. Distribution and license rights sales The Company also recognizes revenue from distribution and license rights only when earned (and are amortized over a five year period), when no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive and retain reasonably assured payments. Costs of Revenue Cost of revenue includes raw materials, component parts, and shipping supplies. Shipping and handling costs is not a significant portion of the cost of revenue. Accounts Receivable Accounts receivable is comprised of uncollateralized customer obligations due under normal trade terms requiring payment within 30 days from the invoice date. The carrying amount of accounts receivable is reviewed periodically for collectability. If management determines that collection is unlikely, an allowance that reflects managements best estimate of the amounts that will not be collected is recorded. Management reviews each accounts receivable balance that exceeds 30 days from the invoice date and, based on an assessment of creditworthiness, estimates the portion, if any, of the balance that will not be collected. As of September 30, 2015, the Company had not recorded a reserve for doubtful accounts. The Company has $1,000,000 in convertible notes payable which are secured by the accounts receivable of a license agreement the Company has with Women's Choice Pharmaceuticals, LLC on its proprietary prescription product, ProCort®.   Inventory Substantially all inventory consists of finished goods and are valued based upon first-in first-out ("FIFO") cost, not in excess of market. The determination of whether the carrying amount of inventory requires a write-down is based on an evaluation of inventory.   Goodwill and intangible assets The Company follows Financial Accounting Standard Boards (FASB) Codification Topic 350-10 (ASC 350-10), Intangibles Goodwill and Other. According to this statement, goodwill and intangible assets with indefinite lives are no longer subject to amortization, but rather an annual assessment of impairment by applying a fair-value based test. Fair value for goodwill is based on discounted cash flows, market multiples and/or appraised values as appropriate. Under ASC 350-10, the carrying value of assets are calculated at the lowest level for which there are identifiable cash flows.    Income taxes The Company accounts for its income taxes in accordance with FASB Codification Topic ASC 740-10, Income Taxes, which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.   Stock-based compensation The Company follows the guidelines in FASB Codification Topic ASC 718-10 Compensation-Stock Compensation, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees and directors including employee stock options and employee stock purchases related to a Employee Stock Purchase Plan based on the estimated fair values.   Stock based compensation expense recognized under ASC 718-10 for the year ended September 30, 2015 and December 31, 2014 totaled $8,800 and $54,450, respectively.   Earnings (loss) per share The Company reports earnings (loss) per share in accordance with FASB Codification Topic ASC 260-10 Earnings Per Share, Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted average number of common shares available. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Diluted earnings (loss) per share has not been presented since the effect of the assumed exercise of options and warrants to purchase common shares (common stock equivalents) would have an anti-dilutive effect. Skinvisible, Inc., (referred to as the Company) is focused on the development and manufacture and sales of innovative topical, transdermal and mucosal polymer-based delivery system technologies and formulations incorporating its patent-pending formula/process for combining hydrophilic and hydrophobic polymer emulsions. The technologies and formulations have broad industry applications within the pharmaceutical, over-the-counter, personal skincare and cosmetic arenas. Additionally, the Companys non-dermatological formulations, offer solutions for a broad spectrum of markets womens health, pain management, and others. The Company maintains executive and sales offices in Las Vegas, Nevada. Skinvisible, Inc. (referred to as the Company) was incorporated in Nevada on March 6, 1998, under the name of Microbial Solutions, Inc. The Company underwent a name change on February 26, 1999, when it changed its name to Skinvisible, Inc. The Companys subsidiarys name of Manloe Labs, Inc. was also changed to Skinvisible Pharmaceuticals, Inc.   On September 9, 2014, the Company formed Kinatri USA Inc., a new wholly-owned subsidiary, to market a premium line of scientifically formulated skincare products powered by our patented Invisicare® technology. As part of our strategic focus on revenue generation and creating shareholder value, Kintari USA Inc. products will be sold via network marketing. The Kintari product portfolio consists of anti-aging products to help fight the signs of aging. These products have been developed using proven anti-aging ingredients with scientific evidence of their effectiveness at reducing the look of fine lines and wrinkles resulting in youthful looking skin. These potent ingredients will be powered by patented Invisicare technology, providing consumers with unique, effective products which we believe cannot be duplicated. Additional products will be added to enhance this product line as the company grows and expands. Skinvisible, Inc. together with its subsidiary shall herein be collectively referred to as the Company. The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred cumulative net losses of $27,330,955 since its inception and requires capital for its contemplated operational and marketing activities to take place. The Companys ability to raise additional capital through the future issuances of common stock is unknown. The obtainment of additional financing, the successful development of the Companys contemplated plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability to successfully resolve these factors raise substantial doubt about the Companys ability to continue as a going concern. The consolidated financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties. The consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated. The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. For purposes of the statement of cash flows, the Company considers all highly liquid investments and short-term debt instruments with original maturities of three months or less to be cash equivalents. There are $0 and $196,602 in cash and cash equivalents as of September 30, 2015 and December 31, 2014, respectively. The carrying amounts reflected in the balance sheets for cash, accounts payable and accrued expenses approximate the respective fair values due to the short maturities of these items.   As required by the Fair Value Measurements and Disclosures Topic of the FASB ASC, fair value is measured based on a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.   The three levels of the fair value hierarchy are described below:   Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;   Level 2: Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability;   Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity). Product sales Revenues from the sale of products (Invisicare® polymers) are recognized when title to the products are transferred to the customer and only when no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive reasonably assured payments for products sold and delivered.   Royalty sales The Company also recognizes royalty revenue from licensing its patented product formulations only when earned, when no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive and retain reasonably assured payments. Distribution and license rights sales The Company also recognizes revenue from distribution and license rights only when earned (and are amortized over a five year period), when no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive and retain reasonably assured payments. Costs of Revenue Cost of revenue includes raw materials, component parts, and shipping supplies. Shipping and handling costs is not a significant portion of the cost of revenue. Accounts receivable is comprised of uncollateralized customer obligations due under normal trade terms requiring payment within 30 days from the invoice date. The carrying amount of accounts receivable is reviewed periodically for collectability. If management determines that collection is unlikely, an allowance that reflects managements best estimate of the amounts that will not be collected is recorded. Management reviews each accounts receivable balance that exceeds 30 days from the invoice date and, based on an assessment of creditworthiness, estimates the portion, if any, of the balance that will not be collected. As of September 30, 2015, the Company had not recorded a reserve for doubtful accounts. The Company has $1,000,000 in convertible notes payable which are secured by the accounts receivable of a license agreement the Company has with Women's Choice Pharmaceuticals, LLC on its proprietary prescription product, ProCort®. Substantially all inventory consists of finished goods and are valued based upon first-in first-out ("FIFO") cost, not in excess of market. The determination of whether the carrying amount of inventory requires a write-down is based on an evaluation of inventory. The Company follows Financial Accounting Standard Boards (FASB) Codification Topic 350-10 (ASC 350-10), Intangibles Goodwill and Other. According to this statement, goodwill and intangible assets with indefinite lives are no longer subject to amortization, but rather an annual assessment of impairment by applying a fair-value based test. Fair value for goodwill is based on discounted cash flows, market multiples and/or appraised values as appropriate. Under ASC 350-10, the carrying value of assets are calculated at the lowest level for which there are identifiable cash flows. The Company accounts for its income taxes in accordance with FASB Codification Topic ASC 740-10, Income Taxes, which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company follows the guidelines in FASB Codification Topic ASC 718-10 Compensation-Stock Compensation, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees and directors including employee stock options and employee stock purchases related to a Employee Stock Purchase Plan based on the estimated fair values.   Stock based compensation expense recognized under ASC 718-10 for the year ended September 30, 2015 and December 31, 2014 totaled $8,800 and $54,450, respectively. The Company reports earnings (loss) per share in accordance with FASB Codification Topic ASC 260-10 Earnings Per Share, Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted average number of common shares available. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Diluted earnings (loss) per share has not been presented since the effect of the assumed exercise of options and warrants to purchase common shares (common stock equivalents) would have an anti-dilutive effect. <table align="center" cellspacing="0" cellpadding="0" style="font-size: 10pt; line-height: normal; width: 50%; font-size-adjust: none; font-stretch: normal; background-color: white"> <tr style="background-color: transparent"> <td style="width: 58%; text-align: justify; vertical-align: bottom"> </td> <td style="width: 1%; text-align: justify; vertical-align: bottom"> </td> <td style="width: 20%; text-align: center; vertical-align: bottom; border-bottom: black 1pt solid">September 30, 2015</td> <td style="width: 1%; text-align: justify; vertical-align: top"> </td> <td style="width: 20%; text-align: center; vertical-align: bottom; border-bottom: black 1pt solid">December 31, 2014</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify">Machinery and equipment</td> <td style="text-align: justify">$</td> <td style="text-align: right">            48,163</td> <td style="text-align: right">$</td> <td style="text-align: right">            48,163</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Furniture and fixtures</td> <td style="text-align: justify"> </td> <td style="text-align: right">113,635</td> <td style="text-align: right"> </td> <td style="text-align: right">113,635</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify">Computers, equipment and software</td> <td style="text-align: justify"> </td> <td style="text-align: right">39,722</td> <td style="text-align: right"> </td> <td style="text-align: right">39,722</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Leasehold improvements</td> <td style="text-align: justify"> </td> <td style="text-align: right">12,569</td> <td style="text-align: right"> </td> <td style="text-align: right">12,569</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify">Lab equipment</td> <td style="text-align: justify"> </td> <td style="text-align: right; border-bottom: black 1pt solid">113,461</td> <td style="text-align: right"> </td> <td style="text-align: right; border-bottom: black 1pt solid">113,461</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; padding-bottom: 1.5pt"> Total</td> <td style="text-align: justify"> </td> <td style="text-align: right">327,550</td> <td style="text-align: right"> </td> <td style="text-align: right">327,550</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify; padding-bottom: 1.5pt">Less: accumulated depreciation</td> <td style="text-align: justify"> </td> <td style="text-align: right; border-bottom: black 1pt solid">(325,460)</td> <td style="text-align: right"> </td> <td style="text-align: right; border-bottom: black 1pt solid">(324,275)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; padding-bottom: 3pt">Fixed assets, net of accumulated depreciation</td> <td style="text-align: justify">$</td> <td style="text-align: right; border-top: black 1pt solid; border-bottom: black 1.5pt double">2,090</td> <td style="text-align: right">$</td> <td style="text-align: right; border-top: black 1pt solid; border-bottom: black 1.5pt double">3,275</td></tr> </table> Fixed assets consist of the following as of September 30, 2015 and December 31, 2014:   <table align="center" cellspacing="0" cellpadding="0" style="font-size: 10pt; line-height: normal; width: 50%; font-size-adjust: none; font-stretch: normal; background-color: white"> <tr style="background-color: transparent"> <td style="width: 58%; text-align: justify; vertical-align: bottom"> </td> <td style="width: 1%; text-align: justify; vertical-align: bottom"> </td> <td style="width: 20%; text-align: center; vertical-align: bottom; border-bottom: black 1pt solid">September 30, 2015</td> <td style="width: 1%; text-align: justify; vertical-align: top"> </td> <td style="width: 20%; text-align: center; vertical-align: bottom; border-bottom: black 1pt solid">December 31, 2014</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify">Machinery and equipment</td> <td style="text-align: justify">$</td> <td style="text-align: right">            48,163</td> <td style="text-align: right">$</td> <td style="text-align: right">            48,163</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Furniture and fixtures</td> <td style="text-align: justify"> </td> <td style="text-align: right">113,635</td> <td style="text-align: right"> </td> <td style="text-align: right">113,635</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify">Computers, equipment and software</td> <td style="text-align: justify"> </td> <td style="text-align: right">39,722</td> <td style="text-align: right"> </td> <td style="text-align: right">39,722</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Leasehold improvements</td> <td style="text-align: justify"> </td> <td style="text-align: right">12,569</td> <td style="text-align: right"> </td> <td style="text-align: right">12,569</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify">Lab equipment</td> <td style="text-align: justify"> </td> <td style="text-align: right; border-bottom: black 1pt solid">113,461</td> <td style="text-align: right"> </td> <td style="text-align: right; border-bottom: black 1pt solid">113,461</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; padding-bottom: 1.5pt"> Total</td> <td style="text-align: justify"> </td> <td style="text-align: right">327,550</td> <td style="text-align: right"> </td> <td style="text-align: right">327,550</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify; padding-bottom: 1.5pt">Less: accumulated depreciation</td> <td style="text-align: justify"> </td> <td style="text-align: right; border-bottom: black 1pt solid">(325,460)</td> <td style="text-align: right"> </td> <td style="text-align: right; border-bottom: black 1pt solid">(324,275)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; padding-bottom: 3pt">Fixed assets, net of accumulated depreciation</td> <td style="text-align: justify">$</td> <td style="text-align: right; border-top: black 1pt solid; border-bottom: black 1.5pt double">2,090</td> <td style="text-align: right">$</td> <td style="text-align: right; border-top: black 1pt solid; border-bottom: black 1.5pt double">3,275</td></tr> </table>   Depreciation expense for the nine months ended September 30, 2015 and 2014 was $1,185 and $1,067, respectively. <table align="center" cellspacing="0" cellpadding="0" style="font-size: 10pt; line-height: normal; width: 50%; font-size-adjust: none; font-stretch: normal; background-color: white"> <tr style="background-color: transparent"> <td style="width: 58%; text-align: justify; vertical-align: bottom"> </td> <td style="width: 1%; text-align: justify; vertical-align: bottom"> </td> <td style="width: 20%; text-align: center; vertical-align: bottom; border-bottom: black 1pt solid">September 30, 2015</td> <td style="width: 1%; text-align: justify; vertical-align: top"> </td> <td style="width: 20%; text-align: center; vertical-align: bottom; border-bottom: black 1pt solid">December 31, 2014</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify">Shipping and Packing materials</td> <td style="text-align: justify">$</td> <td style="text-align: right">13,033</td> <td style="text-align: right">$</td> <td style="text-align: right">14,758</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Marketing Supplies</td> <td style="text-align: justify"> </td> <td style="text-align: right">19,761</td> <td style="text-align: right"> </td> <td style="text-align: right">-</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify">Finished Goods</td> <td style="text-align: justify"> </td> <td style="text-align: right">           7,084</td> <td style="text-align: right">$</td> <td style="text-align: right">           51,756</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Raw Materials</td> <td style="text-align: justify"> </td> <td style="text-align: right; border-bottom: black 1pt solid">49,873</td> <td style="text-align: right"> </td> <td style="text-align: right; border-bottom: black 1pt solid">16,641</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify; padding-bottom: 1.5pt"> Total</td> <td style="text-align: justify"> </td> <td style="text-align: right">89,751</td> <td style="text-align: right"> </td> <td style="text-align: right">83,155</td></tr> </table> Patents and trademarks are capitalized at their historical cost and are amortized over their estimated useful lives. As of September 30, 2015, patents and trademarks total $646,169, net of $330,215 of accumulated amortization. Amortization expense for the nine months ended September 30, 2015 and 2014 was $42,192 and $26,960 respectively.   License and distributor rights (agreement) were acquired by the Company in January 1999 and provide exclusive use distribution of polymers and polymer based products. The Company has a non-expiring term on the license and distribution rights. Accordingly, the Company annually assesses this license and distribution rights for impairment and has determined that no impairment write-down is considered necessary as of September 30, 2015. Inventory consist of the following as of September 30, 2015 and December 31, 2014   <table align="center" cellspacing="0" cellpadding="0" style="font-size: 10pt; line-height: normal; width: 50%; font-size-adjust: none; font-stretch: normal; background-color: white"> <tr style="background-color: transparent"> <td style="width: 58%; text-align: justify; vertical-align: bottom"> </td> <td style="width: 1%; text-align: justify; vertical-align: bottom"> </td> <td style="width: 20%; text-align: center; vertical-align: bottom; border-bottom: black 1pt solid">September 30, 2015</td> <td style="width: 1%; text-align: justify; vertical-align: top"> </td> <td style="width: 20%; text-align: center; vertical-align: bottom; border-bottom: black 1pt solid">December 31, 2014</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify">Shipping and Packing materials</td> <td style="text-align: justify">$</td> <td style="text-align: right">13,033</td> <td style="text-align: right">$</td> <td style="text-align: right">14,758</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Marketing Supplies</td> <td style="text-align: justify"> </td> <td style="text-align: right">19,761</td> <td style="text-align: right"> </td> <td style="text-align: right">-</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify">Finished Goods</td> <td style="text-align: justify"> </td> <td style="text-align: right">           7,084</td> <td style="text-align: right">$</td> <td style="text-align: right">           51,756</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Raw Materials</td> <td style="text-align: justify"> </td> <td style="text-align: right; border-bottom: black 1pt solid">49,873</td> <td style="text-align: right"> </td> <td style="text-align: right; border-bottom: black 1pt solid">16,641</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify; padding-bottom: 1.5pt"> Total</td> <td style="text-align: justify"> </td> <td style="text-align: right">89,751</td> <td style="text-align: right"> </td> <td style="text-align: right">83,155</td></tr> </table>   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 50%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td colspan="3" style="text-align: center">Number of Shares</td><td> </td> <td colspan="3" style="text-align: center">Weighted Average Exercise Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="width: 54%; text-align: justify; padding-bottom: 1pt; padding-left: 0.75pt">Balance, December 31, 2014</td> <td style="width: 1%; border-bottom: Black 1pt solid; text-align: left"> </td><td style="width: 20%; border-bottom: Black 1pt solid; text-align: right">9,750,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</td><td style="width: 20%; border-bottom: Black 1pt solid; text-align: right">0.05</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.75pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 9pt">Options granted and assumed</td> <td style="text-align: left"> </td><td style="text-align: right">200,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.05</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 9pt">Options expired</td> <td style="text-align: left"> </td><td style="text-align: right">200,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.05</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 9pt">Options canceled</td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt">Options exercised</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 9pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.75pt">Balance, September 30, 2015</td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">9,750,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.05</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table align="center" cellspacing="0" cellpadding="0" style="font-size: 10pt; line-height: normal; width: 50%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td colspan="3" style="text-align: center">Number of Shares</td> <td> </td> <td colspan="3" style="text-align: center">Weighted Average Exercise Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="width: 55%; text-align: justify; padding-bottom: 1pt; padding-left: 0.75pt">Balance, December 31, 2014</td> <td style="width: 1%; text-align: left; border-bottom: black 1pt solid"> </td> <td style="width: 20%; text-align: right; border-bottom: black 1pt solid">2,541,030</td> <td style="width: 1%; text-align: left; padding-bottom: 1pt"> </td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 1%; text-align: left; border-bottom: black 1pt solid">$</td> <td style="width: 20%; text-align: right; border-bottom: black 1pt solid">0.05</td> <td style="width: 1%; text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; padding-left: 0.75pt"> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify; padding-left: 9pt">Warrants granted and assumed</td> <td style="text-align: left"> </td> <td style="text-align: right">1,000,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">0.07</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; padding-left: 9pt">Warrants expired</td> <td style="text-align: left"> </td> <td style="text-align: right">1,196,280</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">0.05</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify; padding-left: 9pt">Warrants canceled</td> <td style="text-align: left"> </td> <td style="text-align: right">  </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">  </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt">Warrants exercised</td> <td style="text-align: left; border-bottom: black 1pt solid"> </td> <td style="text-align: right; border-bottom: black 1pt solid">  </td> <td style="text-align: left; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left; border-bottom: black 1pt solid"> </td> <td style="text-align: right; border-bottom: black 1pt solid">  </td> <td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify; padding-left: 9pt"> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.75pt">Balance, September 30, 2015</td> <td style="text-align: left; border-bottom: black 2.5pt double"> </td> <td style="text-align: right; border-bottom: black 2.5pt double">2,344,750</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left; border-bottom: black 2.5pt double">$</td> <td style="text-align: right; border-bottom: black 2.5pt double">0.07</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> The following is a summary of option activity during the nine months ended September 30, 2015.   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 50%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td colspan="3" style="text-align: center">Number of Shares</td><td> </td> <td colspan="3" style="text-align: center">Weighted Average Exercise Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="width: 54%; text-align: justify; padding-bottom: 1pt; padding-left: 0.75pt">Balance, December 31, 2014</td> <td style="width: 1%; border-bottom: Black 1pt solid; text-align: left"> </td><td style="width: 20%; border-bottom: Black 1pt solid; text-align: right">9,750,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</td><td style="width: 20%; border-bottom: Black 1pt solid; text-align: right">0.05</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.75pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 9pt">Options granted and assumed</td> <td style="text-align: left"> </td><td style="text-align: right">200,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.05</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 9pt">Options expired</td> <td style="text-align: left"> </td><td style="text-align: right">200,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.05</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 9pt">Options canceled</td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt">Options exercised</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 9pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.75pt">Balance, September 30, 2015</td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">9,750,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.05</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   As of September 30, 2015, 9,750,000 stock options are exercisable.   On March 31, 2015, the Company granted stock options for 200,000 shares of its common stock with a strike price of $0.05. The stock options were exercisable upon grant and have a life of 5 years. The stock options were valued at $8,800 using the Black-Scholes option pricing model based upon the following assumptions: term of 5 years,  risk free interest rate of 1.37%, a dividend yield of 0% and volatility rates of 483%.   The Company recorded an expense of $8,800 for the nine months ended September 30, 2015.   Stock warrants -   The following is a summary of warrants activity during the nine months ended September 30, 2015.   <table align="center" cellspacing="0" cellpadding="0" style="font-size: 10pt; line-height: normal; width: 50%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td colspan="3" style="text-align: center">Number of Shares</td> <td> </td> <td colspan="3" style="text-align: center">Weighted Average Exercise Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="width: 55%; text-align: justify; padding-bottom: 1pt; padding-left: 0.75pt">Balance, December 31, 2014</td> <td style="width: 1%; text-align: left; border-bottom: black 1pt solid"> </td> <td style="width: 20%; text-align: right; border-bottom: black 1pt solid">2,541,030</td> <td style="width: 1%; text-align: left; padding-bottom: 1pt"> </td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 1%; text-align: left; border-bottom: black 1pt solid">$</td> <td style="width: 20%; text-align: right; border-bottom: black 1pt solid">0.05</td> <td style="width: 1%; text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; padding-left: 0.75pt"> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify; padding-left: 9pt">Warrants granted and assumed</td> <td style="text-align: left"> </td> <td style="text-align: right">1,000,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">0.07</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; padding-left: 9pt">Warrants expired</td> <td style="text-align: left"> </td> <td style="text-align: right">1,196,280</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">0.05</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify; padding-left: 9pt">Warrants canceled</td> <td style="text-align: left"> </td> <td style="text-align: right">  </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">  </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt">Warrants exercised</td> <td style="text-align: left; border-bottom: black 1pt solid"> </td> <td style="text-align: right; border-bottom: black 1pt solid">  </td> <td style="text-align: left; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left; border-bottom: black 1pt solid"> </td> <td style="text-align: right; border-bottom: black 1pt solid">  </td> <td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 204)"> <td style="text-align: justify; padding-left: 9pt"> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.75pt">Balance, September 30, 2015</td> <td style="text-align: left; border-bottom: black 2.5pt double"> </td> <td style="text-align: right; border-bottom: black 2.5pt double">2,344,750</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left; border-bottom: black 2.5pt double">$</td> <td style="text-align: right; border-bottom: black 2.5pt double">0.07</td> <td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table>   All warrants outstanding as of September 30, 2015 are exercisable. On May 22, 2013 the Company approved a financing plan to offer accredited investors up to $1,000,000 in secured promissory notes. During the year ended December 31, 2013 the Company entered into twenty-four 9% notes payable to investors and received total proceeds of $1,000,000. The notes are due two years from the anniversary date of execution. The Notes are secured by the US Patent rights granted for the Company's Sunscreen Products: US patent number #8,128,913: "Sunscreen Composition with Enhanced UV-A Absorber Stability and Methods". As of September 30, 2015 several notes had reached their initial maturity date, all note holders executed agreements extending the note for an additional 12 months upon the same terms. During the nine months ending September 30, 2015 the Company made principal payments of $89,000.   On May 19, 2014 the Company approved a financing plan to offer accredited investors up to an additional $1,000,000 in secured promissory notes. For the period from May 19, 2014 to March 31, 2015 the Company entered into twenty-seven 9% notes payable to investors and received total proceeds of $1,000,000. The notes are due two years from the anniversary date of execution. The Notes are secured by the US Patent rights granted for the Company's Sunscreen Products: US patent number #8,128,913: "Sunscreen Composition with Enhanced UV-A Absorber Stability and Methods".   During the three months ended June 30, 2015 the Company entered into eight additional 9% notes payable to investors and received total proceeds of $208,000. The notes are due two years from the anniversary date of execution. The Notes are secured by the US Patent rights granted for the Company's Sunscreen Products: US patent number #8,128,913: "Sunscreen Composition with Enhanced UV-A Absorber Stability and Methods".    During the three months ended June 30, 2015 the Company entered into five additional 9% notes payable to investors and received total proceeds of $131,000. The notes are due two years from the anniversary date of execution. The Notes are secured by the US Patent rights granted for the Company's Sunscreen Products: US patent number #8,128,913: "Sunscreen Composition with Enhanced UV-A Absorber Stability and Methods".   As of September 30, 2015 $1,549,900 of the Notes were due in less than 12 months and have been classified as Current notes payable. During the year ended 2013 various officers advanced funds to support the daily operations of the company. As of September 30, 2015, $1,910 remained due to related parties as repayment for advanced monies, all related other party notes have been extinguished or re-negotiated as convertible notes. See note 10. <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Convertible Notes Payable at consists of the following:</td> <td colspan="3" style="text-align: center">September 30,</td><td> </td> <td colspan="3" style="text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td> </td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="width: 75%; text-align: justify; padding-left: 5.4pt">$52,476 face value,10% unsecured note payable to an investor, note interest and principal are due on demand.  The note could be converted to option rights for Skinvisible, Inc. shares at ten cents per share ($0.10), these rights expired January 12, 2010. The Note is currently in default, no penalties occur due to default.</td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">28,476</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">28,476</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.5in">Unamortized debt discount</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.5in">Total, net of unamortized discount</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">28,476</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">28,476</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">$1,000,000 face value 9% unsecured notes payable to investors, due in 2015. At the investors option until the repayment date, the note and related interest may be converted to shares of the Companys common stock a discount of 90% of the current share price after the first anniversary of the note. The Notes are secured by the accounts receivable of a license agreement the Company has with Womens Choice Pharmaceuticals, LLC on its proprietary prescription product, ProCort®. The Company has determined the value associated with the beneficial conversion feature in connection with the notes and interest to be $111,110. The aggregate original issue discount feature has been accreted and charged to interest expenses as a financing expense in the amount of $31,078 during the nine months ended September 30, 2015. The original issue discount feature is valued under the intrinsic value method.   On the Company executed extension agreements with several note holder who's note had reached maturity. The notes were extended for an additional 12 months. </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 0.5in">Original issue discount</td> <td style="text-align: left"> </td><td style="text-align: right">111,110</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">111,110</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.5in">Unamortized debt discount</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,724</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(26,822</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.5in">Total, net of unamortized discount</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,107,386</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,084,288</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.5in"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 5.4pt">On July 28, 2015, we entered into a convertible promissory note pursuant to which we borrowed $47,500. Interest under the convertible promissory note is 8% per annum, and the principal and all accrued but unpaid interest is due on April 30, 2016. The note is convertible at any time following 180 days after the issuance date at noteholders option into shares of our common stock at a variable conversion price of 58% of the lowest average three day market price of our common stock during the 10 trading days prior to the notice of conversion, subject to adjustment as described in the note. The holders ability to convert the note, however, is limited in that it will not be permitted to convert any portion of the note if the number of shares of our common stock beneficially owned by the holder and its affiliates, together with the number of shares of our common stock issuable upon any full or partial conversion, would exceed 9.99% of our outstanding shares of common stock.   The Company has determined the value associated with the beneficial conversion feature in connection with the notes negotiated on July 28, 2015 to be $34,397. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $7,947 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method </td> <td style="text-align: left"> </td><td style="text-align: right">47,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.5in">Unamortized debt discount</td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(34,322</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.5in">Total, net of unamortized discount</td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">13,178</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.5in"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,149,040</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,112,764</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Convertible Notes Payable Related Party at consists of the following:</td> <td colspan="3" style="text-align: center">September 30,</td><td> </td> <td colspan="3" style="text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td> </td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="width: 75%; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">On December 31, 2011, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, the notes dated before December 31, 2010, and all salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investors option until the repayment date, the note may be converted to shares of the Companys common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.06 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes negotiated on December 31, 2011 to be $1,123,078. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $124,544 during the nine months ending September 30, 2015.  The beneficial conversion feature is valued under the intrinsic value method.  In the year ending December 2013, the Company  made $51,485 in cash payments to reduce the note balance.</td> <td style="width: 1%; border-bottom: Black 1pt solid; text-align: left"> </td><td style="width: 10%; border-bottom: Black 1pt solid; text-align: right">1,071,593</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: Black 1pt solid; text-align: left"> </td><td style="width: 10%; border-bottom: Black 1pt solid; text-align: right">1,071,593</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.5in">Unamortized debt discount</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(208,939</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(333,483</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 5.4pt">On June 30, 2012, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, the notes dated before July 1, 2011, and all salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investors option until the repayment date, the note may be converted to shares of the Companys common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.06 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the  notes to be $209,809. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $31,098 during the nine months ending September 30, 2015.  The beneficial conversion feature is valued under the intrinsic value method.  On January 18, 2013, the Company  made a $3,990 cash payment to reduce the note balance.</td> <td style="text-align: left"> </td><td style="text-align: right">321,032</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">321,032</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.5in">Unamortized debt discount</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(72,788</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(103,886</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 5.4pt">On December 30 and 31, 2012, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements,  $182,083 of related party notes accrued interest and salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $182,083 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investors option until the repayment date, the note may be converted to shares of the Companys common stock at a fixed price of $0.03 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.04 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $182,083. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $27,223 during the nine months ending September 30, 2015.  The beneficial conversion feature is valued under the intrinsic value method.</td> <td style="text-align: left"> </td><td style="text-align: right">182,083</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">182,083</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.5in">Unamortized debt discount</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(82,054</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(109,277</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 5.4pt; width: 75%">On June 30, 2013, the Company re-negotiated accrued salaries and interest for two employees. Under the terms of the agreements,  $106,153 of accrued interest and salaries were converted to promissory notes convertible into common stock with a warrant feature. The $106,153 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investors option until the repayment date, the note may be converted to shares of the Companys common stock at a fixed price of $0.03 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.04 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $70,768. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $10,579 during the nine months ending September 30, 2015.  The beneficial conversion feature is valued under the intrinsic value method.</td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 10%">106,152</td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 10%">106,152</td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.5in">Unamortized debt discount</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(38,912</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(49,491</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 5.4pt"> On December 31, 2013, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, $142,501 of accrued interest and salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $142,501 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investors option until the repayment date, the note may be converted to shares of the Companys common stock at a fixed price of $0.03 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.04 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $94,909. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $14,189 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method.</td> <td style="text-align: left"> </td><td style="text-align: right">142,501</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">142,501</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.5in">Unamortized debt discount</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(61,748</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(75,937</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 5.4pt">On June 30, 2014, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements,  $118,126 of accrued salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $118,126 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investors option until the repayment date, the note may be converted to shares of the Companys common stock at a fixed price of $0.025 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.03 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $118,126. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $17,661 during the nine months ending September 30, 2015.   The beneficial conversion feature is valued under the intrinsic value method.</td> <td style="text-align: left"> </td><td style="text-align: right">118,126</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">118,126</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.5in">Unamortized debt discount</td> <td style="text-align: left"> </td><td style="text-align: right">(88,562</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(106,223</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 5.4pt">On September 30, 2014, the Company re-negotiated accrued salaries and interest for two employees. Under the terms of the agreements,  $40,558 of accrued salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $40,558 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investors option until the repayment date, the note may be converted to shares of the Companys common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.05 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $40,466. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $6,050 during the nine months ending September 30, 2015.  The beneficial conversion feature is valued under the intrinsic value method.</td> <td style="text-align: left"> </td><td style="text-align: right">40,558</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40,558</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.5in">Unamortized debt discount</td> <td style="text-align: left"> </td><td style="text-align: right">(32,377</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(38,427</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 5.4pt">On December 31, 2014, the Company re-negotiated accrued salaries and interest for two employees. Under the terms of the agreements,  $65,295 of accrued salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $65,295 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investors option until the repayment date, the note may be converted to shares of the Companys common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.05 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $57,439. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $8,589 during the nine months ending September 30, 2015.  The beneficial conversion feature is valued under the intrinsic value method.</td> <td style="text-align: left"> </td><td style="text-align: right">65,295</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">65,295</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.5in">Unamortized debt discount</td> <td style="text-align: left"> </td><td style="text-align: right">(48,850</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(57,438</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="padding-left: 5.4pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,413,110</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,173,178</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Convertible Notes Payable at consists of the following:</td> <td colspan="3" style="text-align: center">September 30,</td><td> </td> <td colspan="3" style="text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td> </td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="width: 75%; text-align: justify; padding-left: 5.4pt">$52,476 face value,10% unsecured note payable to an investor, note interest and principal are due on demand.  The note could be converted to option rights for Skinvisible, Inc. shares at ten cents per share ($0.10), these rights expired January 12, 2010. The Note is currently in default, no penalties occur due to default.</td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">28,476</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">28,476</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.5in">Unamortized debt discount</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.5in">Total, net of unamortized discount</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">28,476</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">28,476</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">$1,000,000 face value 9% unsecured notes payable to investors, due in 2015. At the investors option until the repayment date, the note and related interest may be converted to shares of the Companys common stock a discount of 90% of the current share price after the first anniversary of the note. The Notes are secured by the accounts receivable of a license agreement the Company has with Womens Choice Pharmaceuticals, LLC on its proprietary prescription product, ProCort®. The Company has determined the value associated with the beneficial conversion feature in connection with the notes and interest to be $111,110. The aggregate original issue discount feature has been accreted and charged to interest expenses as a financing expense in the amount of $31,078 during the nine months ended September 30, 2015. The original issue discount feature is valued under the intrinsic value method.   On the Company executed extension agreements with several note holder who's note had reached maturity. The notes were extended for an additional 12 months. </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 0.5in">Original issue discount</td> <td style="text-align: left"> </td><td style="text-align: right">111,110</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">111,110</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.5in">Unamortized debt discount</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,724</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(26,822</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.5in">Total, net of unamortized discount</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,107,386</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,084,288</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.5in"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 5.4pt">On July 28, 2015, we entered into a convertible promissory note pursuant to which we borrowed $47,500. Interest under the convertible promissory note is 8% per annum, and the principal and all accrued but unpaid interest is due on April 30, 2016. The note is convertible at any time following 180 days after the issuance date at noteholders option into shares of our common stock at a variable conversion price of 58% of the lowest average three day market price of our common stock during the 10 trading days prior to the notice of conversion, subject to adjustment as described in the note. The holders ability to convert the note, however, is limited in that it will not be permitted to convert any portion of the note if the number of shares of our common stock beneficially owned by the holder and its affiliates, together with the number of shares of our common stock issuable upon any full or partial conversion, would exceed 9.99% of our outstanding shares of common stock.   The Company has determined the value associated with the beneficial conversion feature in connection with the notes negotiated on July 28, 2015 to be $34,397. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $7,947 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method </td> <td style="text-align: left"> </td><td style="text-align: right">47,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.5in">Unamortized debt discount</td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(34,322</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.5in">Total, net of unamortized discount</td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">13,178</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.5in"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,149,040</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,112,764</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Convertible Notes Payable Related Party at consists of the following:</td> <td colspan="3" style="text-align: center">September 30,</td><td> </td> <td colspan="3" style="text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td> </td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="width: 75%; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">On December 31, 2011, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, the notes dated before December 31, 2010, and all salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investors option until the repayment date, the note may be converted to shares of the Companys common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.06 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes negotiated on December 31, 2011 to be $1,123,078. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $124,544 during the nine months ending September 30, 2015.  The beneficial conversion feature is valued under the intrinsic value method.  In the year ending December 2013, the Company  made $51,485 in cash payments to reduce the note balance.</td> <td style="width: 1%; border-bottom: Black 1pt solid; text-align: left"> </td><td style="width: 10%; border-bottom: Black 1pt solid; text-align: right">1,071,593</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: Black 1pt solid; text-align: left"> </td><td style="width: 10%; border-bottom: Black 1pt solid; text-align: right">1,071,593</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.5in">Unamortized debt discount</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(208,939</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(333,483</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 5.4pt">On June 30, 2012, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, the notes dated before July 1, 2011, and all salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investors option until the repayment date, the note may be converted to shares of the Companys common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.06 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the  notes to be $209,809. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $31,098 during the nine months ending September 30, 2015.  The beneficial conversion feature is valued under the intrinsic value method.  On January 18, 2013, the Company  made a $3,990 cash payment to reduce the note balance.</td> <td style="text-align: left"> </td><td style="text-align: right">321,032</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">321,032</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.5in">Unamortized debt discount</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(72,788</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(103,886</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 5.4pt">On December 30 and 31, 2012, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements,  $182,083 of related party notes accrued interest and salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $182,083 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investors option until the repayment date, the note may be converted to shares of the Companys common stock at a fixed price of $0.03 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.04 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $182,083. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $27,223 during the nine months ending September 30, 2015.  The beneficial conversion feature is valued under the intrinsic value method.</td> <td style="text-align: left"> </td><td style="text-align: right">182,083</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">182,083</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.5in">Unamortized debt discount</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(82,054</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(109,277</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 5.4pt; width: 75%">On June 30, 2013, the Company re-negotiated accrued salaries and interest for two employees. Under the terms of the agreements,  $106,153 of accrued interest and salaries were converted to promissory notes convertible into common stock with a warrant feature. The $106,153 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investors option until the repayment date, the note may be converted to shares of the Companys common stock at a fixed price of $0.03 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.04 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $70,768. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $10,579 during the nine months ending September 30, 2015.  The beneficial conversion feature is valued under the intrinsic value method.</td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 10%">106,152</td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 10%">106,152</td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.5in">Unamortized debt discount</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(38,912</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(49,491</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 5.4pt"> On December 31, 2013, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, $142,501 of accrued interest and salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $142,501 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investors option until the repayment date, the note may be converted to shares of the Companys common stock at a fixed price of $0.03 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.04 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $94,909. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $14,189 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method.</td> <td style="text-align: left"> </td><td style="text-align: right">142,501</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">142,501</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.5in">Unamortized debt discount</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(61,748</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(75,937</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 5.4pt">On June 30, 2014, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements,  $118,126 of accrued salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $118,126 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investors option until the repayment date, the note may be converted to shares of the Companys common stock at a fixed price of $0.025 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.03 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $118,126. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $17,661 during the nine months ending September 30, 2015.   The beneficial conversion feature is valued under the intrinsic value method.</td> <td style="text-align: left"> </td><td style="text-align: right">118,126</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">118,126</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.5in">Unamortized debt discount</td> <td style="text-align: left"> </td><td style="text-align: right">(88,562</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(106,223</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 5.4pt">On September 30, 2014, the Company re-negotiated accrued salaries and interest for two employees. Under the terms of the agreements,  $40,558 of accrued salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $40,558 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investors option until the repayment date, the note may be converted to shares of the Companys common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.05 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $40,466. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $6,050 during the nine months ending September 30, 2015.  The beneficial conversion feature is valued under the intrinsic value method.</td> <td style="text-align: left"> </td><td style="text-align: right">40,558</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40,558</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.5in">Unamortized debt discount</td> <td style="text-align: left"> </td><td style="text-align: right">(32,377</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(38,427</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="text-align: justify; padding-left: 5.4pt">On December 31, 2014, the Company re-negotiated accrued salaries and interest for two employees. Under the terms of the agreements,  $65,295 of accrued salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $65,295 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investors option until the repayment date, the note may be converted to shares of the Companys common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.05 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $57,439. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $8,589 during the nine months ending September 30, 2015.  The beneficial conversion feature is valued under the intrinsic value method.</td> <td style="text-align: left"> </td><td style="text-align: right">65,295</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">65,295</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.5in">Unamortized debt discount</td> <td style="text-align: left"> </td><td style="text-align: right">(48,850</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(57,438</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,204)"> <td style="padding-left: 5.4pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,413,110</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,173,178</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   The Company is authorized to issue 200,000,000 shares of $0.001 par value common stock. The Company had 113,957,969 and 111,813,969 issued and outstanding shares of common stock as of September 30, 2015 and December 31, 2014, respectively.   On January 26, 2015 the Company received $50,000 pursuant to a private placement agreement with an investor to purchase 1,250,000 shares of Skinvisible Inc. $0.001 par value common stock and 625,000 warrants. The warrants allow the holder to purchase shares of the Company's common stock at $0.07 on or before January 21, 2016.   On January 27, 2015 the Company received $30,000 pursuant to a private placement agreement with an investor to purchase 750,000 shares of Skinvisible Inc. $0.001 par value common stock and 375,000 warrants. The warrants allow the holder to purchase shares of the Company's common stock at $0.07 on or before January 21, 2016.   On April 1, 2015, 72,000 shares were issued to settle $3,600 of accrued expenses due to a director of the Company.   On June 30, 2015, 72,000 shares were issued to settle $3,600 of accrued expenses due to a director of the Company. A gain of $1,440 was recognized as a result of this settlement.   On August 24, 2015, the company settled $6,000 of debt due to two parties with 200,000 shares of common stock. A gain of $400 was recognized as a result of this settlement. Lease obligations The Company has operating leases for its offices. Future minimum lease payments under the operating leases for the facilities as of September 30, 2015, are as follows:   2015 12,042 2016 5,717   Rental expense, resulting from operating lease agreements, approximated $32,619 and $31,368 for the nine months ended September 30, 2015 and 2014, respectively. On October 26, 2015, we entered into a convertible promissory note pursuant to which we borrowed $135,000. Interest under the convertible promissory note is 9% per annum, and the principal and all accrued but unpaid interest is due on October 26, 2017. The note is convertible at any time following the third month anniversary after the issuance date at noteholders option into shares of our common stock at a variable conversion price of 90% of the average of the Trading Prices for the common stock during the five Trading Day period ending on the latest complete Trading Day prior to the Conversion Date, subject to adjustment as described in the note. The holders ability to convert the note, however, is limited in that it will not be permitted to convert any portion of the note if the number of shares of our common stock beneficially owned by the holder and its affiliates, together with the number of shares of our common stock issuable upon any full or partial conversion, would exceed 4.99% of our outstanding shares of common stock.   On October 1, 2015, we entered into a convertible promissory note with Greg McCartney a director of the Company. The $10,800 face value promissory note is unsecured, due five years from issuance, and bears an interest rate of 10%. At the investors option until the repayment date, the note may be converted to shares of the Companys common stock at a fixed price of $0.02 per share along with an additional warrant to purchase one share for every two shares issued at the exercise price of $0.03 per share for three years after the conversion date. 28476 1000000 47500 28476 1000000 111110 111110 1149040 1112764 13178 1107386 1112764 3600 3600 200000 6000 2017-10-26 EX-101.SCH 14 skvi-20150930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - DESCRIPTION OF BUSINESS, HISTORY AND SUMMARY OF SIGNIFICANT POLICIES link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - FIXED ASSETS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - INVENTORY link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - INTANGIBLE AND OTHER ASSETS link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - STOCK OPTIONS AND WARRANTS link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - CONVERTIBLE NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - CONVERTIBLE NOTES PAYABLE RELATED PARTY link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - STOCKHOLDERS DEFICIT link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - DESCRIPTION OF BUSINESS, HISTORY AND SUMMARY OF SIGNIFICANT POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - FIXED ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - INVENTORY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - STOCK OPTIONS AND WARRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - CONVERTIBLE NOTES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - CONVERTIBLE NOTES PAYABLE RELATED PARTY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - DESCRIPTION OF BUSINESS, HISTORY AND SUMMARY OF SIGNIFICANT POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - FIXED ASSETS - Schedule of Property and Plan Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - FIXED ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - INVENTORY - Schedule of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - INTANGIBLE AND OTHER ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - STOCK OPTIONS AND WARRANTS - Summary of Options (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - STOCK OPTIONS AND WARRANTS - Summary of Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - STOCK OPTIONS AND WARRANTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - NOTES PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - CONVERTIBLE NOTES PAYABLE - Schedule of Conversions of Stock (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - CONVERTIBLE NOTES PAYABLE RELATED PARTY - Convertible Notes Payable Related Party Disclouser (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - CONVERTIBLE NOTES PAYABLE RELATED PARTY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - STOCKHOLDERS DEFICIT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 15 skvi-20150930_cal.xml XBRL CALCULATION FILE EX-101.DEF 16 skvi-20150930_def.xml XBRL DEFINITION FILE EX-101.LAB 17 skvi-20150930_lab.xml XBRL LABEL FILE Convertible Note 1 Scenario [Axis] Convertible Note 2 Convertible Notes Payable Related Party 1 Equity Components [Axis] Convertible Notes Payable Related Party 2 Convertible Notes Payable Related Party 3 Convertible Notes Payable Related Party 4 Convertible Notes Payable Related Party 5 Convertible Notes Payable Related Party 6 Twenty Four Notes Payble Debt Instrument [Axis] FourteenNotes Payble Twenty Seven Notes Payable Two Notes Payble Subsequent Event Type [Axis] Convertible Notes Payable Related Party 7 Stock Options Granted 1 Class of Warrant or Right [Axis] Stock Options Granted 2 Issuance 1 Shareholders' Equity Class [Axis] Issuance 2 Convertible Notes Payable Related Party 8 Eight Notes Payable Five Notes Payable Convertible Note 3 Convertible Note 1 & 2 Issuance 3 Issuance 4 Issuance 5 Convertible Note 4 Convertible Notes Payable Related Party 9 Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets Cash Accounts receivable Inventory Due from related party Prepaid expense and other current assets Total current assets Fixed assets, net of accumulated depreciation of $325,460 and $324,275, respectively Intangible and other assets: Patents and trademarks, net of accumulated amortization of $330,215 and $288,203, respectively Total assets LIABILITIES AND STOCKHOLDERS' DEFICIT Current liabilities Accounts payable and accrued liabilities Bank overdraft Accrued interest payable Loans from related party Loans payable Convertible notes payable, net of unamortized debt discount of $38,046 and $26,822, respectively Convertible notes payable related party, net of unamortized discount of $634,320 and $874,163, respectively Total current liabilities Loans payable Total liabilities Stockholders' deficit Common stock; $0.001 par value; 200,000,000 shares authorized; 113,957,969 and 111,813,969 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively Additional paid-in capital Stock payable Accumulated deficit Total stockholders' deficit Total liabilities and stockholders' deficit Common Stock, Par Value Common Stock, Shares Authorized Common Stock, Issued Accumulated Depreciation Convertible Notes Payable, net of unamortized debt discount Convertible Notes Payable, related party, net of unamortized discount Accumulated Amortization Income Statement [Abstract] Revenues Cost of revenues Gross profit Operating expenses Depreciation and amortization Selling general and administrative Total operating expenses Loss from operations Other income and (expense) Other income Interest expense Gain on extinguishment of debt Total other expense Net loss Basic loss per common share Basic weighted average common shares outstanding Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Stock-based compensation Amortization of debt discount Gain (Loss) on extinguishment of debt Bank overdraft Changes in operating assets and liabilities: Increase in inventory Decrease (increase) in accounts receivable Increase (decrease) in prepaid assets Increase in accounts payable and accrued liabilities Increase in accrued interest Net cash used in operating activities Cash flows from investing activities: Purchase of fixed and intangible assets Net cash used in investing activities Cash flows from financing activities: Proceeds from sale of common stock Proceeds from related party loans, net of payments Payments on notes payable Proceeds from notes payable Payments on convertible notes payable Net cash provided by (used in) financing activities Net change in cash Cash, beginning of period Cash, end of period Supplemental disclosure of cash flow information: Cash paid for interest Cash paid for tax Non-cash investing and financing activities: Accrued expenses converted to notes Common stock issued on extiguishment of debts Accounting Policies [Abstract] DESCRIPTION OF BUSINESS, HISTORY AND SUMMARY OF SIGNIFICANT POLICIES Property, Plant and Equipment [Abstract] FIXED ASSETS Inventory Disclosure [Abstract] INVENTORY Notes to Financial Statements INTANGIBLE AND OTHER ASSETS Temporary Equity Disclosure [Abstract] STOCK OPTIONS AND WARRANTS NOTES PAYABLE Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS CONVERTIBLE NOTES PAYABLE CONVERTIBLE NOTES PAYABLE RELATED PARTY Equity [Abstract] STOCKHOLDERS DEFICIT Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Subsequent Events [Abstract] SUBSEQUENT EVENTS Description of Business History Going Concern Principles of Consolidation Use of Estimates Cash and Cash Equivalents Fair Value of Financial Instruments Revenue Recognition Accounts Receivable Inventory Goodwill and Intangible Assets Income Taxes Stock-based Compensation Earnings (loss) Per Share Schedule of Property and Plan Equipment Schedule of Inventory Summary of Options Summary of Warrants Schedule of Conversions of Stock Convertible Notes Payable Related Party Disclosure Date of Incorporation Accumulated Deficit Convertible Notes Payable Stock based compenstation Machinery and equipment Furniture and fixtures Computers, equipment and software Leasehold improvements Lab equipment Total Less: accumulated depreciation Fixed assets, net of accumulated depreciation Depreciation expense Shipping and Packing Materials Marketing Supplies Finished Goods Raw Materials Total Patents and trademarks, Gross Amortization Expense Stock Options And Warrants - Summary Of Options Details Beginning Balance, number of shares Beginning Balance, weighted average exercise price Options granted and assumed, number of shares Options granted and assumed, weighted average exercise price Options expired, number of shares . Options cancelled, number of shares Options cancelled, weighted average exercise price Options exercised, number of shares Options exercised, weighted average exercise price Ending Balance, number of shares Ending Balance, weighted average exercise price Beginning Balance, number of shares Beginning Balance, weighted average exercise price Warrants granted and assumed, number of shares Warrants granted and assumed, weighted average exercise price Warrants expired, number of shares Warrants expired, weighted average exercise price Warrants cancelled, number of shares Warrants cancelled, weighted average exercise price Warrants exercised, number of shares Warrants exercised, weighted average exercise price Ending Balance, number of shares Ending Balance, weighted average exercise price Statement [Table] Statement [Line Items] Stock Options, Date Granted Stock Options, exercisable Stock Options, shares Stock Options, strick price Stock Options, expected life Stock Options, value Expense Date of Warrant Issuance Common Stock, Issued Exercise Price Warrant, expected life Consulting Expense Financing Plan Approved Secured Promissory Notes, max amount offered Promissory Notes, Interest Rate Promissory Notes, Proceeds Promissory Notes, Due Due to Related Party Related Party Transaction [Axis] Convertible Note Payable #1 Convertible Note Payable #2 Original issue discount Unamortized debt discount Convertible Notes Payable Convertible Note Payable #1 Unamortized Debt Discount Convertible Note Payable #2 Unamortized Debt Discount Convertible Note Payable #3 Unamortized Debt Discount Convertible Note Payable #4 Unamortized Debt Discount Convertible Note Payable #5 Unamortized Debt Discount Convertible Note Payable #6 Unamortized Debt Discount Convertible Note Payable #7 Unamortized Debt Discount Convertible Note Payable #8 Unamortized Debt Discount Convertible Notes Payable Convertible Notes Payable, Value Interest Rate Option Rights, Price per Share Expiration Date Beneficial conversion feature Financing expense Due Date Interest Rate Common Stock, Fixed Price Conversion Feature, number of warrants to purchase for every two shares issued Warrants, Exercise Price Conversion Date Beneficial Conversion Feature Financing Expense Cash payments to reduce note balance Date of Issuance Note, Face Amount Common Stock, Shares Issued Warrants, Issued Common Stock, Share Value Common Stock, Shares Issued, Debt Settlement Common Stock, Shares Issued, Debt Settlement, Value Operating leases for 2015 Operating leases for 2016 Rental expense Convertible Note Payable, Date Maturity Date Assets, Current Assets Liabilities, Current Loans Payable, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Other Income Other Expenses Proceeds from (Repayments of) Bank Overdrafts Net Cash Provided by (Used in) Investing Activities Repayments of Notes Payable RepaymentsOfConvertibleNotesPayable Net Cash Provided by (Used in) Financing Activities Inventory, Policy [Policy Text Block] Property, Plant and Equipment, Gross OptionsIssued OptionIssuedPrice WarrantsIssued WarrantsIssuedPrice Class of Warrant or Right, Number of Securities Called by Warrants or Rights UnamortizedDebtDiscount ConvertibleNotePayableRelatedParty1 ConvertibleNotePayableRelatedParty2 DebtInstrumentUnamortizedDiscount2 DebtInstrumentUnamortizedDiscount3 DebtInstrumentUnamortizedDiscount4 DebtInstrumentUnamortizedDiscount5 DebtInstrumentUnamortizedDiscount6 DebtInstrumentUnamortizedDiscount7 DebtInstrumentUnamortizedDiscount8 EX-101.PRE 18 skvi-20150930_pre.xml XBRL PRESENTATION FILE XML 19 R39.htm IDEA: XBRL DOCUMENT v3.3.0.814

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Commitments and Contingencies Disclosure [Abstract]

Operating leases for 2015 $ 12,042

Operating leases for 2016 5,717

Rental expense $ 32,619 $ 31,368

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Future rental payments receivable within the fourth year from the balance sheet date under an operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 4

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6454179&loc=d3e41551-112718

+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Future rental payments receivable within the third year from the balance sheet date under an operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 4

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6454179&loc=d3e41551-112718

+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41499-112717

+ Details

Name: us-gaap_OperatingLeasesRentExpenseNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

EXCEL 20 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`(R+<$],\DZWZ47#RM'8;`T;1?&11.C.V%\JY5EK6Z6J4M(OXV+I(8?.6PN_"Z9 M-GEHKIM]6I'O?_DL&R]Q8=IKKY[UAL%B;V/*Y](HW6T;U;/U\T=KY_^Y32@_ M54WUT/E4Z*/>LDM2\22I@:76?_)^VRF5]?0CPURXQX^B49[J^^C3?+=_&Q\+ M]I!*D>A*D?!*D?A*DQW8OG*\M"_V/Z'D4X$G1H>)%]2-F`Q+M*;V" M^GH`A3&^.R6:E((C-Z."N[_8_`)02P,$%`````@`C(MP1Q.#K'*E`0``]1@` M`!H```!X;"]?HZZZ<=OV!8B.8I1+F&E:W[[416,O\Z4+DV\#@4G._%<_""R;D"^>_+F, MQ[8)U;$+H_?ZW(3%<'^553%V"^?"MO)U&1[:SC?#ZK[MZS(.E_W!=>7V5!Z\ MTSR?N/YV3K9>_IP]VNQ66;_9239Z*?N#CZOLK>U/H?(^!G<]R<.PP;!\Z?Q_ MMF_W^^/6/[;;U]HW\8\*][5!YM)!F@Y22I"E@XP25*2#"DK0.!TTI@1-TD$3 M2M`T'32E!,W203-*T#P=-*<$20YDS#E)"&N.U@*X%H[7`L`6CM@"R!:.V0+0 M%H[:`M@6CML"X!:.W`+H%H[=`O`6CMX*]%:.W@KT5M*[-GK9YNBM0&_EZ*U` M;^7HK4!OY>BM0&_EZ*U`;^7HK4!OY>BM0&_EZ&U`;^/H;4!OX^AM0&\C?2M! M'TLX>AO0VSAZ&]#;.'H;T-LX>AO0VSAZ&]#;.'H;T-LX>A=`[X*C=W&C=ZC* MWN^>8W]L#N'>-=^&PZ(;O$.\G/W]4ZY38<.-UG'8R;OK\>Y/L^O4SQ#WZP_' M^@-02P,$%`````@`C(MP1VRPW6KL`@``W0H``!````!D;V-0&ULO5;?;YLP$/Y7K#QUTEIHFOU0E"(1RX@+]+B)$S$$XV5O+64VU#01K/F& MB3.`)+"[2O,-D_";WVOI:A4%W$Z#[88G4NOK^E>-/TJ>A#P\S0Y!>\:H8#&S M+(X")J,T,>91D*C[27`.4!D0D/MGDDGPR]Q%1-"D,"%G,+N(P5 MBP4O4?^,"F.EFXPE3UKY-XN2![',:&HSR:M>]8TR^IKE/`326O2#46&F3Y!G M7/A::Y;<\["*?;VYU^*:YZ+(]+Q_IL-WD&!O+V-S%D;)_8)%N3!&.SG<\4"F M^7.9=O*C50K3H"BZN*9P/M%#=TSP8GG9V[$\8HGL(1']@=]^KZ0MK6H=9T+F MQDV:/X@UYU*,M(-1+:O8ZCH:&`-=(6!51VJ'S(QGV6IY%Q8:R9@+;[5@N?Q/ M4JB<]D(,]%XE^WT(Q)(0X41".R(G*:F@>%5)#JLQBUD2<$1>J=8"02>0+)"L MN81K$7]J="$2FK4XBD#I"GG0;>H$S?'K8(N)-9K$Z>]FL(V)Y3L+ZG@N\B9H MO"2.BPGYC*8.H9[?Z#-Q?F$;F81@2AH!CGN-7?"^;=FEIGOEC&<8F:Z-/#K% M_EO1X!S6#^2I,Q+E(@JAB&FI MZ(UPRX-T?*H.?#QX*QHIVO8,I][,QCY!-IXXEM,,M+SYW*%S$+<4`LBHXUYA MUW)PBWC+,<$_E^"!<%&49M2;77#^_6@7H!/*[N#F-G?OH1W>AK776?EU5%M1 M=:]0_Z*[0/W!<8%.$8&)%6YC7ES*8A:]0U2;2Q;%`KDL+R[\CA^1MT[B)#L8 M`FG7.UC0=JT/$&^[^USHG?L`%#E^Z5\+UW$,M/.T]X[2OGN_77SIVM=%;A_@ M^?;NR5.1K_L00B?O&T/U&KUZ752?"2\>!5K],6O\!5!+`P04````"`",BW!' MG!,TP3X!``!I`P``$0```&1O8U!R;W!S+V-O&ULS9--3\,P#(;_"NJ] MR]*)@:*N!T".%K?X:7H\6[GZP23@D`-&@P&0D>49-6KV1K;F)(, M^JJ,CFL><&ZE6BF0=^U0]CL5.R-X'8YRD'W[]/=/#RE#LJYR'U1?U33-J)FD MNC@P)>_SIY=T-KDR`;D1$%5!,6P=S+)3Y[?)_;-#(M-WTFD(0@O'*HK+D(ES#?Q`D6 M=LM/$'@YJ!.FR[:%MK%>ABK=KR$ZO)RXLK7U[3'U(SI[5=474$L#!!0````( M`(R+<$>97)PC$`8``)PG```3````>&PO=&AE;64O=&AE;64Q+GAM;.U:6W/: M.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?A1%8C6QY9)&$?[]'-A#+E@WM MDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@V2_;UKNW+][@5S(D$4$P&:>O M\,`*I4Q>M5II`,,X?+&A`T%116F]?(+3E'S/X%/F7/Z3H= M,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1TDB`@LE]E`6Z2?:CTQ4(,@T[ M.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP'`3@4;N>PIWT;+^D00FTHVG0 M9-CVVJZ1IJJ-4T_3]WW?ZYMHG`J-6T_3:W?=TXZ)QJW0>`V^\4^'PZZ)QJO0 M=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@`%AP=M;,T@.67BGZ=90:V1V[W4%< M\%CN.8D1_L;%!-9ITAF6-$9RG9`%#@`WQ-%,4'RO0;:*X,*2TER0UL\IM5`: M")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']IJP&G[;N;SY/\<^CDGZ>3UTU" MSG"\+`GQ^R-;88 MC'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZY!$XM4D-,A,_")V&F&I0'`*D M"3&6H8;XM,:L$>`3?;>^",C?C8CWJV^:/5>A6$G:A/@01AKBG'/F<]%L^P>E M1M'V5;SOX%^9PU"AR1 M&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:CFED)O816:I^JAS0^J!XR"@7Q MN1X^Y7IX"C>6QKQ0KH)[`?_1VC?"J_B"P#E_+GW/I>^Y]#VATK\>WZV22$KYI9+2,6 MD$N!LT$DN/R+RO`JQ`GH9%LE"0AMNZ5/U2I77Y:^Y*+@\6^3I MKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KTL@'37[ M]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K34I!OP_GIQ7@:XCG9!+E]F%=M MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'>7M?F&>5QE`T%&ULK"0L1K=@ MN-?Q+!3@9&`MH`>#KU$"\E)58#%;Q@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5N MKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^:CVT%4[/_EFMR)\,$4X6"Q)( M8Y07IDJB\QE3ON>;G*YZ(G;ZEW?!8/+]<,E'#^4[YU_T74.N?O;= MX_INDSM(3)QYQ1$!=$4"(Y4U#VT%SU&\Z.9 MX!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83+$.D?L%]BHJ`$:MBOKJO3_DE MG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'?!^2!F.,6_0T7X\48JVFL:W& MVC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5`Y3_;U`UH]@TT')$%7C&9MC:C MY$X*/-S^[PVPPL2.X>V+OP%02P,$%`````@`C(MP1[I0VE=>`@``W@H```T` M``!X;"]S='EL97,N>&ULS59=:]LP%/TK0AFCA1';V>IVJVT8A4!A*X/F86]% MMF5'H`]/EC.GOW[Z<.S$+$N;I:5YT=71U;E'5]>YBFJUIOA^B;$"+:.\CN%2 MJ>J+Y]79$C-43T6%N5XIA&1(Z:DLO;J2&.6UV<2H-_/]T&.(<)A$O&%SIFJ0 MB8:K&'[J(>#VWX@ M0._II%/?WT]L%D?DX3/)_\4]HKX\0'U;UPWB&=Z3D]'R7U-S94)XW1TD42'X M_IX=*!W0[F>(32W>-I((DJI!26?*XGH+,7 MZTH?C@N.G4CK=\"[E&@=S"ZV-MA!QTV%S+'L(P=P`R41Q872&R0IEV94HC+2 MA5*":2,GJ!0<44.YV=$9FC;#E-Z;C_%GLYMVN-X05OT`?1N5%5T_962DC/LQ#IH+KK9(?I@#WT2H0TK6`I)'K6_ M*81,`UA"L,)2D6P;^2U1M<"MZBK8:XM]"H\]\DMJ.GW6!C6Z!%\[/4<'M]!= MPU(LY_8/\OF2/EX>OC+[=<*1S->MFB,DG"`YIG>^66GAVY7V,C5U$FE7_RG- MZSK#5OO9:3X]"M*&4$7X1@,RSX4[HYON](6A\6C.O!UZCEU5*-6/S9THFBS' M!6JH^D%60MG%&`[V-R,_"'NO14\1P\'^CG/2L,]6P?"B3?X`4$L#!!0````( M`(R+<$?*:-WD^@,``'T-```/````>&PO=V]R:V)O;VLN>&ULE9=;<]HX%(#_ MBL9/ZDUKLN#U;DM:-0A]?SP0A&%%>2LWM)/>,TW^#DUV@N!&;@A16[:';3%M MO<^?Y&1-&;DC0FHPPEV7X2V9>M^9AQB6*FFH(LW4&^I#_D1Z)\2NF^TH,PS+N%,O"(=A.-XSS&UWE#Q) M"#0G$*X5?205?IAZOH?P3O$E98J(!5;D4O!=1]NOFN6A-152E6:Z]LXM;>F6 M_C!YZR.YX4]77-`?O%68E;7@C-DH<\$&Z1'DSS,Z1T7KWHT*/Q2F$E-O[&O@ M(Y7T@3*J_IMZ]C\C9B:#-U.QR__Z#[5V<5Y*C'#;H*15FH+2=E\\O30F!WUS MVMB!Q83J/R)M@OU20=`,,]S6!-D92!`7@KCP5W'H;(6%3F=#[*0_`$X$.-$A MIU2Z"F8F$O$URCLB]K("PA`0AK\BS+'RV3+.D+/]`5VE9Y04`C0%H?`A:IO\F"Q2795*5(.H<1)T?1J7979+I<>Y! MR`4(N7"%5'%VF MSG.]>D5EE^)H*M#!P"'A40BR24(4E#%PV6@6]2J_7B1%B1;),IVGO7BH8N!P M<9[?W*35C19B7Q*=6I5FETDV3Y/>PD`5`X>+Y>VL3/ZYU2"4&+]ZP=#(P*'D MR2'PE$09%#A\BO]>^GE+:/NNESB():A\Y. M>[1MFB0A"FH=.K0^X95.^2P_8WA M;TL(4=#VR&'[\4Y_D%5OM_"N3FWE@"AH>^2P_>0S&(T@"MH>.9OVTA6!0D(4M#URV'[RK83.(`K:'KEL?_M>ZKL%]WW0 M]J'_O#E^W0_K3P+:DL9\+4@[C-YYUN830O_L]P[#D7F[F.,;_5DQ]7V_S M=XS-];F\O>;8[I#WY)>/AL__`U!+`P04````"`",BW!'^\X&,&<"``#!"``` M&````'AL+W=OV$[=O7-L2P-EJX!-M\/S,PDR'O*'OG)<;"^ZA) MPW=^*43['`3\5.(:\2?:XD;>N5!6(R&W[!KPEF%TUJ2:!#`,TZ!&5>,7N3Y[ M945.;X)4#7YE'K_5-6+_]IC0;N<#_W'P5EU+H0Z"(@\,[US5N.$5;3R&+SO_ M!3P?0*H@&O&[PAV?K#T5_)'2=[7Y>=[YH8H!$WP22@+)RQT?,"%*23K_'41' M3T6A[9WQ!-R+>:/<##SDD2O!$"=>_WNG& M!:T?%-^KT4=_K1I][?H[,1AH\P0X$*`AP/1+0C00(D,`L7HOPCRX*YD!L>\1<((`!A%([5D#^##8 M0X<./QL<7$2T;!"9#")-CR;T>)D>&WJLZ?&$GE@/P$6DRP:),4@<>F89](A$ M(YK^"8>;!&;9LDUJ;%+'9F/9N(CMLD%F##*'#NQ2F8&LJ)6-L=BX?*M8]C.0 M%=6R-19;EQ];%C.09-D"A&-/A:Y":G?5#&;%^P:3S@6N@OW*YS!K7.#H`EV% MK>WB8F"XPF7L81"Y"L!VF<'`%2YCJP.WDV%D_1D-F$_-"&*09-MT1;>`L>V! MV_?0KK0!DTXQ:TIM['K@-C5T2BUU4H*A4]+!9&+4F%WU).7>B=X:T0\,$%WF+KO@78M>JX=Z1"CFW]'2Y4"JP#"9\DF&4\GO";`B^"+7,Y)KU M$[;?"-H^/AC,5TOQ'U!+`P04````"`",BW!'0'<"FOP#``#Y$0``&````'AL M+W=OE9B)C94L5U+B[;\O)2NB/$/'NE@??H=\A^(\I+0Z5_7/9N]U?FS=?JY([^GY>J+O/67]:O27.J7;[K@\HB02'2I,P/ MQ^5ZU=_[7J]7U5M;'([N>[UHWLHRK__;N*(Z/RYA^7'CQ^%UWW8WDO4J&>-V MA](=FT-U7-3NY7'Y#1ZV4G227O'WP9V;R?FB,_]453^[BS]WCTO1>7"%>VZ[ M)G)_>'=;5Q1=2[[G?X=&0Y]=X/3\H_7?^W2]_:>\<=NJ^.>P:_?>K5@N=NXE M?RO:']7Y#S?DH+L&GZNBZ7\7SV]-6Y4?(@$,` MC@&@/@V00X`D`K2;P4 M)(F(!$@6%XGI)<=>`C9-!=YWHD8GBG=#!FNC6#=I)B7QX[T:,3 MS9V03C::=9)9H^FP1%02M+[O)1V]I-R+(EY2/OB@-+%R1W33B1F=&.Z$=+*) M2.B0?"JYZ2(;760\/B4N,I:J-692%1.QHQG(SE`"630$4EE38 MEHLDFAD/!T2`D6`@D#-``A.<`<_&4IX!=PK::D6I%M%I5"AF.`IL`V2.%(73 MH)GVI$`;0ZD0T:4J%1/GMQT%6H)DHZQF3%\(E`...44Q!QQA!C.=L;6#\]`/ ML4EG8!<"[8#C3E'<`2>9GZ&9H88BY)PS/`%WP'FG*.\&S=4CMR:SM,*!,T^J M#&".HX`]X,2B<-T,FJDCL$"K?%"96ZK;;@+^@/-/4?X-FBLW6EDKF*$(3.<, M3@`@<`(JM@?B=/-+CQ6TE+>#\'J-`C3IC!K%0$(4W%-&/`V:*T\*Y'1N7#S% MA&`DF#F;M,!6Y&Q5E*W(F:FEDF33]E, MBNC`*B'$C-F-`:_(MYJ:`G_07($8;.I!>?CE3UF$AA^P2\($1?-*FK@T@`$G0X:;WRT+//;&RH%?1-CUY8AZ_ M=AUF?_>DI>/.#_W[Q'-SJ86:",HB,+Y3TY&>-[3W&#GO_"_AMLJ50@M^-63D MB[ZGV`^4OJC!C]/.!PJ!M.0H5`0LFQNI2-NJ0#+QGSGF6TIE7/;OT;_I:B7] M`7-2T?9W\/#UAM=KB58UI1A)L7))S8L,4R)RQ193),D761",([L M?:W69!%,X\F MY]Z!"GD$ZH/J3*D@,B38R-IJ>3.904O.0G53V6?383T-!!WN5X^Y_\I_4$L# M!!0````(`(R+<$=H4<":!00``$81```8````>&PO=V]R:W-H965T&ULC9A9_BLOO"6H=2$HYKAH?4[L/6S4U#SO/Q):/&C`>P/'L MMU^!,9!N97"NFOS.TE/Y.CU4U?DEBLK-P65)^9R? MW?")=O&*$LCSE@<9'+?BDEY MR;*D^&_ATOSZ.H7IO>'[<7^HZH9H/HLZN^TQ_B-M:Q8VX*T![PRZ.&$#T1J(WD#^T4"V!G)L!-4: M*!0ANFEO>FZ55,E\5N3727E.ZOD$+QXO:B?><_W0#$7CU/==Z5O?Y[&91>^U MGQ99W!`^1.Q'9$41Z(C(QP\FP>])+#@QYQ\#+"FA&]/9&]HQ,>H8 M0\7(6"`M2TK9V.!532$IR()84XH;QD>,M^UD62H+15E8&D4I*9#Z)<7\&`%# M\E<4L[YZ,X6D44PK8^T(;<#Z79Y1=62;9U2>]AGAS2?`"<,UGJJK`&>EL`;O MR@%.&\VX'*%P4,>`*K18(9"M[HE+JR3>AUIPF-*3B`$4QQH#H)$0X\%>AT`M M;:Q&+#W@O4I.%J\94<*@KV$@2#_AD5L$&+)X6^;#J.&U&V!XC#LFP"@S0E)? M5H'653S)%D"KW!,7'!B9W9(.E#]56XGK4`B,%6-XUJU#H/)E8E#[/U?9UUB@ M1=;@(@NT[$G&L$(*/4FFB#Z*@9$,BPLX4TR.6;M]J05::PVNM4`KGQ]`T'0` M0R"3%I][5B$PEH:#P!H#H%)Q/&J:]G47-%6IL$I-IZDTP!6N,2'0I\1(_0R! M((TU(+',$"F8K]MBA,[^?`#T@&#P`:%EAK'(-+TA=I@.>R95=!RV?HA]KJP_ M(@`](QA\1@!:KP&$5=KB2],RB/K:814Y'8[WN@Y[]2N%<[SA1(-+8N:*?7,] M+R>;_'*J;O>>KK7[!/"%UY=,U+Z`ER4$VE?U)X/F4MJ[G\_.R=[]DQ3[XZF< MO.65O]HV%]!=GE?.*V#//O>#2[;=2^IV5?VHZQ&Y7?-O+U5^OG^UZ#Z=S/\' M4$L#!!0````(`(R+<$>5T,Z[800``&\4```8````>&PO=V]R:W-H965T&ULG9A-C^(X$(;_"N+>@ZMLQTF+1AI8K78/*XWFL'M.@_G0)(1- M0C/[[]<)(88JSV#-!9+PEOU6.7YL/+]4];=F;VT[^5X6Q^9MNF_;T^MLUJSW MMLR;3]7)'MTOVZHN\];=UKM9M*_#UL-NWW8/98CX;XS:'TAZ;0W6\??!7IJ[ZTEG_KVJOG4W?V[>IJ+S8`N[;KLFV*+J67,__ M#HWZ/KO`^^M;Z[_WZ3K[[WEC5U7QSV'3[IU;,9UL[#8_%^W7ZO*''7+078/K MJFCZS\GZW+15>0N93LK\^_7[<.R_+]=?3#*$A0-P",`Q8.PG'""'`.D#5)_I MU5F?UV]YFR_F=769-*>\&VUX=?*Z:\2UW%WTA>H;=9DU[NG'(DWGLX^NG4&R MO$KP3@*C8N8:#_:`MQZ6R,+QL8,55QCQO`'F?0_8\7HWQJH]7]_&: MU.`J,;WDV$M>0*59"HKD$A)*D4B0SQWIT9%F&641%4G&^(1E9!*2T56B[XPJ M*8TAZ7`5I@+-H,`)"I2. M2^!X?$D`)>7^*B1,41@9`77P*(64S5$0,6/O^0<<@&Y4:5X!!&J#+*L0*76J M]7-'Z"F('%T@*`:18S#D:)"97W'D48@ACV%OEN\06R)*&P6X6$J#5`S(SW8,4` M6(&"%?FN,>R)DU6#5!CS#\V350;("I2L`1%[DR2G+^I4BH@E57JLR@!68XHL M/59E`*M`L2HY5M&I$KJI"^A`*2,B7D9Y]S\XP%:@;`V(>)%_JOFQ%<]6J0(% MCMAA2,]#&>`A4!Y*SCDG`K8:AW0Z2=*8,?<\E`$>`N7A('I`KTDH?@(J%`G[ MUS:[.\:R;HZ']OK(SF)_RG?TK MKW>'8S-YK]JV*ONSH&U5M=:Y%)] M>,:X^!]02P,$%`````@`C(MP1S.=2!N@`0``L0,``!@```!X;"]W;W)KZ/UF?]Q%1`)\DS"YBYA$[R?$YYA\ M:0ZTB!9`0>VC@@C+&1Y`J2@4&O]8-%];1N)EO*I_2M,&]R?AX`'5=]GX/I@M M*&F@%:/R3SA]AF6$VRA8HW+I2^K1>=0KA1(M7N95FK1.\Y^[#POM.H$O!)X) M[XMD?&Z4;'X47E2EQ8FX0<2SV^P#W$:1H!R#-'<2#49=J)ZK#2]*=HY""^8X M8_@E)B-84+_:@J\MCOP/.O\W?9L=;A-]^\;A?_3?98%=$MC]=<1KF-]=LHL] MU6"[='4-(R?TX633_K>('H*5XN:6 MDCZ\GYPH:'T,WX78SE=J3CP.ZP/)K[3Z!5!+`P04````"`",BW!'SM*:E*`! M``"Q`P``&````'AL+W=O6CG-`^ MNQ[`DQ>MC#O2WOOAP)BK>]#"W>$`)OQIT6KA0VH[Y@8+HDDDK1C/L@],"VEH M5:;:HZU*'+V2!AXM<:/6POX^@<+I2'.Z%IYDU_M88%7)-EXC-1@GT1`+[9'> MYX=3$1$)\$/"Y*YB$KV?$9]C\JTYTBQ:``6UCPHB+!=X`*6B4&C\:]%\;1F) MU_&J_B5-&]R?A8,'5#]EX_M@-J.D@5:,RC_A]!66$?91L$;ETI?4H_.H5PHE M6KS,JS1IG>8_1;[0;A/X0N`;X5.6C,^-DLW/PHNJM#@1-XAX=ODAP&T4"JEROFN9);PUVB[]XX M+-X7*#:!(@D4_QWQ%F;_5Q-VM:<:;)>NCB,UCL;/6[I5M]MYS].9O,*KVD\:1,_IPLFG_6T0/P4IVMZ>D#^]G2Q2T/H8?0VSG*S4G'H?U@6ROM/H# M4$L#!!0````(`(R+<$><-!M'H`$``+$#```8````>&PO=V]R:W-H965T&ULA5/+;MLP$/P5@A\0RK3S@"$+B%,4[:%`D$-[IJ651(3DJB1E MI7]?DI(8MS6:B[B[FIF=Y:.^V'/F*M[T,+=X``F_&G1 M:N%#:COF!@NB222M&"^*.Z:%-+0J4^W95B6.7DD#SY:X46MA?QU!X72@&[H6 M7F37^UA@5C\AOL;D:W.@1;0` M"FH?%418SO`$2D6AT/CGHOG>,A(OXU7]*91H\3:OTJ1UFO]L^4*[3N`+@6?"0Y&,SXV2 MS4_"BZJT.!$WB'AVFWV`VR@2E&.0YDZBP:@+U7.UX7A!7.<,?P2DQ$L MJ%]MP=<61_X/G7],WV:'VT3?_N'P_F.!71;8)8'=?T>\AGGXJPF[V%,-MDM7 MQY$:1^/G+1I"3+L^P34UQH6I6Q]FBJ M$DSXC/(?G1'&D6+("$V@4%[I<+W(.40<@W?EDTWUH&XC9>U;_% M:;W[,[=PC_*W:%SOS6:4--#R4;HGG+[#,L)M$*Q1VO@E]6@=JI5"B>*O\RIT M7*?Y3Y$MM.N$?"'DB?`E$MC<*-I\X(Y7I<&)V(&'L]L=/-P$$:\<@CAW%/5& MK:]>JEW^M627(+1@3C,FWV(2@GGUJRWRM<4I_X>>?TPODL,BTHMM]R+[6&"? M!/918/_?$:]@BO=#LLV>*C!=O#J6U#AJ-V]IJJ;;>9?',WF#5^7`._C)32>T M)6=T_F3C_K>(#KR5[.:6DMZ_GY1(:%T(/_O8S%=J3AP.ZP-)K[3Z"U!+`P04 M````"`",BW!'YZ9@CZ`!``"Q`P``&0```'AL+W=O1I"3+L^P#4UQH6E>Q]FCJ"B_CB!Q/M`=W0I/HA]< M*+"Z8HG7"@7:"M3$0'>@=[O]L0R("/@A8+87,0G>3XC/(?G6'F@6+("$Q@4% M[I*C!]O#J6-#AI MMVQIJJ;;>9?',WF#U]7(>_C.32^T)2=T_F3C_G>(#KR5[.:6DL&_GY1(Z%P( M/_K8+%=J21R.VP-)K[3^#5!+`P04````"`",BW!'RB[V*J`!``"Q`P``&0`` M`'AL+W=OE=3V M0'OGACUCMNY!<7N#`VC_IT6CN/.IZ9@=#/`FDI1D>9;=,L6%IE49:R^F*G%T M4FAX,<2.2G'SZP@2IP/=T+7P*KK>A0*K2I9XC5"@K4!-#+0'>K?9'[AXSK- M?XILH5TGY`LA3X2OD<#F1M'F-^YX51J27FGU&U!+`P04```` M"`",BW!'"K=^0J$!``"Q`P``&0```'AL+W=OE-3V0'OGACUCMNY!<7N#`VC_IT6CN/.IZ9@= M#/`FDI1D>99]8HH+3:LRUIY,5>+HI-#P9(@=E>+FUQ$D3@>ZH6OA672]"P56 ME2SQ&J%`6X&:&&@/]'ZS/VX#(@)^")CL14R"]Q/B2TB^-0>:!0L@H79!@?OE M#`\@91#RC5\7S?>6@7@9K^I?XK3>_8E;>$#Y4S2N]V8S2AIH^2C=,TY?81GA M-@C6*&W\DGJT#M5*H43QMWD5.J[3_*?8+;3KA'PAY(FPRZ+QN5&T^<@=KTJ# M$[$##V>WV7NX"2)>.01Q[BCJC5I?/5>;XJYDYR"T8(XS)K_$)`3SZE=;Y&N+ M8_X//?^87B2'1:07?SC+5L:3&4;MY M2U,UW<[[/)[).[PJ!][!=VXZH2TYH?,G&_>_173@K60WMY3T_OVD1$+K0GCG M8S-?J3EQ.*P/)+W2ZC=02P,$%`````@`C(MP1]_J:MB?`0``L0,``!D```!X M;"]W;W)K&ULA5/;;IPP$/T5RQ\0LT#::L4B95-5 M[4.E*`_MLQ<&L&)[J&V6].]K&W!0NVI>\,QPSIDSOE0SFA<[`#CRJJ2V)SHX M-QX9L\T`BML['$'[/QT:Q9U/3<_L:("WD:0DR[/L`U-<:%I7L?9DZ@HG)X6& M)T/LI!0WO\\@<3[1`]T*SZ(?7"BPNF*)UPH%V@K4Q$!WH@^'X[D,B`CX(6"V MNY@$[Q?$EY!\:T\T"Q9`0N."`O?+%1Y!RB#D&_]:-=]:!N(^WM2_Q&F]^PNW M\(CRIVC=X,UFE+30\4FZ9YR_PCK"?1!L4-KX).01Q[BCJC5I?O=:' M,JO8-0BMF/."R?>8A&!>_6:+?&MQSO^AY^_3B^2PB/1BW[W(WA0;+>G"DP?KXXE#4[:+5N:JNEV/N3Q3-[@=37R'KYSTPMMR06=/]FX M_QVB`V\EN[NG9/#O)R42.A?"CSXVRY5:$H?C]D#2*ZW_`%!+`P04````"`", MBW!':T'%4)\!``"Q`P``&0```'AL+W=O>OL(YP'P0; ME#9^23-9AVJC9$3QUV45.J[S\J?,5]IM`EL)+!$^10)=&D6;G[GC=65P)G;D MX>P.1P\W0<0KAR#.'46]4>NKU_I0LHI>@]"*.2\8ML`M3_-6$[O94@>GCU;&DP4F[94M3-=W. M!Q;/Y`U>5R/OX3LWO="67-#YDXW[WR$Z\%;RN_N,#/[]I$1"YT+XT<=FN5)+ MXG#<'DAZI?4?4$L#!!0````(`(R+<$=<6.M7H`$``+$#```9````>&PO=V]R M:W-H965T6CG-"^N![`DU>MC#O2WOOAP)BK M>]#"W>$`)OQIT6KA0VH[Y@8+HDDDK1C/LGNFA32T*E/MR58ECEY)`T^6N%%K M87^=0.%TI#E="\^RZWTLL*ID&Z^1&HR3:(B%]D@?\L.IB(@$^"YA[/PL$CJA^R M\7TPFU'20"M&Y9]Q^@++"/LH6*-RZ4OJT7G4*X42+5[G59JT3O,?GB^TVP2^ M$/A&^)@EXW.C9/.3\*(J+4[$#2*>77X(+_T/G[]-WF<)?HNS\<[M\7*#:!(@D4_QWQ%N;^ MKR;L:D\UV"Y='4=J'(V?MW2K;K?S@:8-7Y2`Z^"9L)XTC9_3A9-/^MX@> M@I7L;D])'][/EBAH?0P_A-C.5VI./`[K`]E>:?4;4$L#!!0````(`(R+<$?: M+7&PO=V]R:W-H965T^>&/6.V[D%Q>X,#:/^G1:.X\ZGIF!T,\":2E&1Y MEGUBB@M-JS+6GDQ5XNBDT/!DB!V5XN;7$21.![JA:^%9=+T+!5:5+/$:H4!; M@9H8:`_T?K,_%@$1`3\$3/8B)L'["?$E)-^:`\V"!9!0NZ#`_7*&!Y`R"/G& MKXOF>\M`O(Q7]2]Q6N_^Q"T\H/PI&M=[LQDE#;1\E.X9IZ^PC+`+@C5*&[^D M'JU#M5(H4?QM7H6.ZS3_V>4+[3HA7PAY(MQET?C<*-I\Y(Y7I<&)V(&'L]OL M/=P$$:\<@CAW%/5&K:^>JTUQ6[)S$%HPQQF37V(2@GGUJRWRM<4Q_X>>?TS? M)H?;2-_^X?#N8X$B"111H/COB-PS:9MU/;%S(S/.7.&2SFA?78]@"@ MA;O#`4SXTZ+5PH?4=LP-%D232%HQ7A1OF!;2T*I,M4=;E3AZ)0T\6N)&K87] M<0*%TY%NZ%IXDEWO8X%5)^I!Z=1[U2*-'B95ZE2>LT_^'O%]IM`E\( M/!/>%W.02XC2)!.09I[B0:C+I0O52;?5&R2Q1: M,*<9PZ\Q&<&"^LT6?&UQXG_0^;_IV^QPF^C;7QS^1_]=%M@E@=U?1[R%^=TE MN]I3#;9+5\>1&D?CYRW-U7P[[WDZDU=X50ZB@R_"=M(X&PO=V]R:W-H965T?_QC'C M(>^Y^)`E8RKX;.I6;L-2J>XYBN2A9`V53[QCK7YRXJ*A2M^*C1!C5U MA.,XBQI:M6&1V[DW4>3\HNJJ96\BD)>FH>+?CM6\WX8HO$^\5^=2F8FHR",7 M=ZP:ULJ*MX%@IVWX@IYWB!B)5?RN6"\GX\`DO^?\P]S\/&[#V.3`:G90QH+J MRY6]LKHV3IK\]V8Z,DW@='QW_VZ7J]/?4\E>>?VG.JI29QN'P9&=Z*56[[S_ MP6YK2(WA@=?2_@:'BU2\N8>$04,_AVO5VFL_/%G'MS`X`-\"L!<0#2";YC>J M:)$+W@>RHV;ST+.6"V.BG,%_)4S6%F#U9W;\L MW.=-\1]02P,$%`````@`C(MP1UV&Y6^C`0``L0,``!D```!X;"]W;W)K&ULA5/+;J0P$/P5RQ\0@X=DHQ&#E$D4)8>5HAQVSQYH MP(H?Q#9#]N_7-N"PV9%RP=U-576U'^6DS9OM`1SZD$+9`^Z=&_:$V+H'R>R5 M'D#Y/ZTVDCF?FH[8P0!K(DD*0K/LADC&%:[*6'LQ5:E')[B"%X/L*"4S?XX@ M]'3`.5X+K[SK72B0JB2)UW`)RG*MD('V@._R_;$(B`CXQ6&RFQ@%[R>MWT+R MW!QP%BR`@-H%!>:7,]R#$$'(-WY?-#];!N(V7M4?X[3>_8E9N-?B-V]<[\UF MFLE&X5ST]P3+"=1"LM;#QB^K1.BU7"D:2?J[RV[PDYR"T8(XS MAFXQ"4&\^L46=&UQI/_1Z??T77*XB_3=MCLMOAI85.M1N7E+4S7=SCL:S^037I4#Z^`G,QU7%IVT\R<;][_5VH&W MDEU=8]3[]Y,2`:T+X0\?F_E*S8G3P_I`TBNM_@)02P,$%`````@`C(MP1R&ULA5/;3N,P M$/T5RQ^`4S<%5*61*&BU^[`2X@&>W6226/@2;*>!O\=V$I-E*_$2STS..7/& MEV+4YM5V``Z]2Z'L`7?.]7M";-6!9/9*]Z#\GT8;R9Q/34ML;X#5D20%H5EV M323C"I=%K#V:LM"#$US!HT%VD)*9CR,(/1[P!B^%)]YV+A1(69#$J[D$9;E6 MR$!SP'>;_3$/B`AXYC#:58R"]Y/6KR'Y4Q]P%BR`@,H%!>:7,]R#$$'(-WZ; M-;]:!N(Z7M1_Q6F]^Q.S<*_%"Z]=Y\UF&-70L$&X)SW^AGF$71"LM+#QBZK! M.BT7"D:2O4\K5W$=IS];.M,N$^A,H(EPFT7C4Z-H\X$Y5A9&C\CV+)S=9N_A M)HAXY1#$N:.H-VI]]5QN;O."G(/0C#E.&+K&)`3QZA=;T*7%D?Y'IS_3M\GA M-M*WZ^[TYF>!/`GD42#_9\3=MQ$O8:Z_-2&K/95@VGAU+*KTH-RTI:F:;N== M/$3R!2^+GK7PEYF6*XM.VOF3C?O?:.W`6\FN=AAU_OVD1$#C0GCC8S-=J2EQ MNE\>2'JEY2=02P,$%`````@`C(MP1T*%>YZQ`0``%@0``!D```!X;"]W;W)K M&ULA53!;J,P$/T5BP^H"23;)")(35>KW<-*50_M MV8$!K-H,:YO0_GUM`RZ;1LH%CX?WWKQA;+(!U9MN``QYEZ+5AZ@QIMM3JHL& M)--WV$%KWU2H)#-VJVJJ.P6L]"0I:!+'/ZADO(WRS.>>5)YA;P1OX4D1W4O) MU,<1!`Z':!7-B6=>-\8E:)[1P"NYA%9S;(F"ZA`]K/;'C4-XP`N'02]BXKR? M$-_B.^9FM]I;N'(B5MD%OF\O:HUJFSWGJ^U]1L]. M:,(<1TRRQ`0$M>I72R1SB6/RC9[KIZ;)ZFMX66`>!M1=8_]?B]J+% M:YC=[2*;4&3S76`77Q2YAKG\DG0Q.`FJ]N=3DP+[UHQS"]EP!1X2/_@O>)YU MK(:_3-6\U>2$QAX?/^0*T8"U$M]9+XV]I&$CH#(NO+>Q&L_MN#'8S;+YEO+0-S&J_JW.*UW?^(6[E'^%JT;O-D$RUT M?)+N">?O2!B?MEBU-U70[[U@\DS=X78V\AY_<]$);4*#R"$%W*-?Z^:KRT] M<1]OZE_#M,[]A1EX0/&+MW9P9M.$M-"Q2=@GG+_!.L+!"S8H3/B29C(6Y49) MB&0OR\I56.?ESR%;:;<)^4K((^%3&HPOC8+-+\RRNM(X$S,R?W;9T<&U%W'* M/@AS!U%GU+CJMJ$5 MX74ULAY^,-US9<@%K3O9L/\=H@5G);T[)&1P[R&ULC55-;YLP&/XKB/N*#1A(1)`*R;0=)E4];&;[\XH^TI^R-EX0(YZ.I6[YQ2R&ZM>?Q0TD:S)]H M1UKYYD19@X7LLK/'.T;P49.:VO,!B+P&5ZV;I7KLA64IO8BZ:LD+<_BE:3#[ MEY.:]AL7NM>!U^I<"C7@9:EG>,>J(2VO:.LP3MJ.R M[RE]4YV?QXT+5`12DX-0"E@^WDE!ZEH)2>._H^;-4A&G[:OZ=SU;F7Z/.2EH M_:/!4(C$&J! M\"[!RBKX'"/W]6,39$S0@H#US?(!$VM,JS'?_#@(P`HAJZY+2)2$$(9?F'ED M0D6S4('U!?,%B!6[B&9A9)8`6&MV.\#0!";7=02L5;6;JR$8A/X7BAV;><4+ MQ;9\\GCF`X'^/39*C%&R8!181LG,*$F`5>9B#@H@0/9VFJ-0&"([L3)/M,>=?'.FK$5"3MDEX#W# MZ*1-+0E@&*9!BYK.+PN]]LS*@EX%:3K\S#Q^;5O$_NTQHPK4"H)%KQN\$#GXP]!7^@]%5-?IYV?J@8,,%' MH2*0?-QPA0E12;+RWWOH>TUEG(X?Z=]UNQ+_@#BN*/G3G$0M:4/?.^$SNA+Q M0HJMA&%8'*,]NN!?B%V:CGL'*N2)K,_-,Z4"R\3P2797 MRYO23`@^"S64)[_'QKMCG`C:/ZY"&ULA53);MLP$/T5 M0A\02I0<%X8L('90M(<"00[MF99&"$%)2DK_?MRD6G%,9"+.!R^]V8A1^4L MU9ON`0QZYTSH?=(;,^XPUG4/G.H'.8*P)ZU4G!J[51W6HP+:>!)GF*3I(^9T M$$E5>M^+JDHY&38(>%%(3YQ3]>\`3,[[)$LNCM>AZXUSX*K$D=<,'(0>I$`* MVGWRE.V.A4-XP.\!9KVRDJ:%5J>2, M]$C=96<["U=.Q"H[PS?*B]K*M/6>*Y+E)3X[H05S"!BRPF01@:WZW1#D$N)` M/M')QP#'SXAM^G6$/!:1>WZ^3I`47PL44:#P`L6'+A0W70B8K<>($"3[MKFI MY`XH?=S>I()7E\-!=?[1:E3+29C0N.B-<_%$W.7>^`]V7L+SOLI4Y4@[^$55 M-PB-3M+8I^,ON)72@,TQ?=@DJ+<3'3<,6N/,K;55>.1A8^1X&=GXWZC^`U!+ M`P04````"`",BW!'X:[(B?\!``#C!0``&0```'AL+W=OOD/JR5ZG<`R%--6R(?>$\[_:?B MHB5*#\49R%Y04EI3RT`<11EH2=.%16[GGD61\XMB34>?12`O;4O$WT?*^+`/ M87B;>&G.M3(3H,B!\Y5-2SO9\"X0M-J'W^#N@(W""GXW=)"S?F#8CYR_FL'/ ME(F@>CF2@^4,1.D%WZ;,O\O:8SS_BW]R5:KZ8]$T@-G?YI2U1HV M"H.25N3"U`L??M"I!&0"3YQ)^PU.%ZEX>[.$04O>Q[;I;#N,?U`ZV=8-\62( MG0%^;D@F0^(9P$AFZ_I.%"ERP8=`]L0<-MQIN3`A.MET[$;94%V9U+/7(H8H M!U<3-&D>1TT\UWQ4'%84&R*2NJ%*,O5),ZF'0%!GLPHP;-E]GB#'HPRZ0$WB=!C@2MD&P\ M$K0@P=$F]4#08E<0Q"B[SY(YEFR%9>NQ9`N6=+O!_A$M53#+TB]L#'8P>`4F M\F#PHN;-%B/_B%94"43(@P&S^]B3,_U%Q+GI9'#D2E]M>P$KSA75B=&#KJS6 M+ZX;,%HIT\6Z+\9':!PHWM^>5/>N%_\`4$L#!!0````(`(R+<$=O^Z9A"`(` M`(\%```9````>&PO=V]R:W-H965TO;8C#0M1<8GOX?F;&SN2=D!^J M`M#!)V>-VH25UNT:(556P*EZ$2TTYLM)2$ZU.G0DSA".(H(XK9NP MR%WL31:YN&A6-_`F`W7AG,J_6V"BVX1Q>`N\U^=*VP`J#$!_V\..X"2.;`C`HM56@9KG"#ABS0L;XSZ!Y MM[3$\?ZF_LU5:[(_4`4[P7[71UV99*,P.,*)7IA^%]UW&$K(K&`IF'*_07E1 M6O`;)0PX_>S7NG%KUW_)E@/M,0$/!.P)WN0#H1T0D!]*:X1 M>ZIID4O1!:JE]G7$:P.75L0HVXWKK!,UK5`F>BTPCG)TM4(#9MMC\`@3>P0R MZ@\M\,UBBV=T_-5@-T1^#H3QT_&-2313 M^#9>[_I1<9X2>5Y[I1P4%H\Z]R;_\DA`:39/1B>E:9Z>@/#$[:;A=F M+_N!T1^T:&_CS\_@XA]02P,$%`````@`C(MP1VUR5]1@`@``J@@``!D```!X M;"]W;W)K&ULG9;1CJ(P%(9?A?```D5`#)*,;B:S M%YM,YF+WNFH5,D#9MLKLVV];L&!;)1DOH"W_.?]WL'#(.DP^:8$0<[[JJJ$; MMV"L77L>/12HAG2!6]3P*R=,:LCXE)P]VA($CS*HKCS@^[%7P[)Q\TRNO9,\ MPQ=6E0UZ)PZ]U#4D_[:HPMW&#=S;PD=Y+IA8\/+,4W''LD8-+7'C$'3:N"_! M>A>$0B(5OTO4T5$).&9Q4#>*)F45T;YZC4'(,R\JT@T:+:]!DPT<7HOV9F2($V4 MQN,(5@YPX]@"(P'0+"R*U;Q#J"H-97QX5^ER/L%2)5C*!,N[!)%VJWI-)#5- MK_'%;]XG4CZ1Q2?6?'I-.O'Q%WXT[Q(KE]CBDF@N\;>K291/8O%9:3[)-ZM9 M*9>5Q47;HUM3$P;:'GLJ>8B1*HS4Q`A]#8PR><$$%A2@HY@B$^6IYC$*&%&`!<5XV0%CTZ=)=+?K!YYYX6.H\;44 MA!:HI0X5/G]"!J(958_C35I#C9ZU\(Q^ M07(N&^KL,>,-2K:1$\8,<1A_P6],P3\!^CS) M_P-02P,$%`````@`C(MP1P>$T$&(`@``H`D``!D```!X;"]W;W)K&ULI9;;CILP$(9?!?$`BP\TIE\-'4K9B'>RD/SU$DUGO: M$/'$#K15_VP9;XA4CWP7B0.G9&."FCI"`*110ZHV+`LS]\K+@AUE7;7TE0?B MV#2$_UG0FIWG(0PO$V_5;B_U1%06D8W;5`UM1<7:@-/M/'R!STN8:(E1_*SH M68S&@89?,?:N'[YOYB'0#+2F:ZE3$'4[T26M:YU).?_NDPZ>.G`\OF3_:LI5 M^"LBZ)+5OZJ-W"M:$`8;NB7'6KZQ\S?:UV`(UZP6YC=8'X5DS24D#!KRT=VK MUMS/W3\9ZL/\`:@/0#;`^O@##%0!>,!7(2 MH(F%1S%[[(!MH=C$XS$BQH\3Q#9!;!+$5V\JG;RI3I,83=MIDA@"#!X;)=8H M\1AE$Z-.DX^,P!-('KNDUB7UN,PF+JE3#@3F>FR46:/,8Y1/C#)?.1FXNN!C MTYDUG;FF,9B8SMSJ8)ZBV2>JRZU1[C&:K(Y%_H\?"X)AF0*/#YJN4U>$G95Z M5W,;9=0QH`<%3U%MG:S#_2`G^J%T6A# M;"C?F8.""-;LV,IN/[2S]C#R8K;L:)"7Q8'LZ`_"=U4K@A63:ELVF^>6,4D5 M#'A2,'MU7+(/-=U*/5?4$L#!!0````(`(R+<$&PO=V]R:W-H965T-E@*7"!#_GG M_\8F,Y2]D.^J!M#1!V>MVL2UUMT:(;6O@5/U)#IHS9.CD)QJLY0GI#H)]."" M.$,$XQQQVK1Q5;J]5UF5XJQ9T\*KC-29623WPGQ;A<_#YL8VQR`P5Y;"VJ& M"[P`8];)D/^.II],&W@[O[I_=\^H@A?!_C0'79ML<1P=X$C/3+^)_@>, M9\BLX5XPY;ZC_5EIP:\A<<3IQS`VK1O[X4E:C&'A`#(&$!^P<`%H`+DTOU%- MJU**/E(=M3]>LC9R:4V,LYVX*I'F)+M9HU&P'#;G1)%Z!C'L0 M0:Z(+;D+)VDQ;[#P.2Z<0?K%8#G)<=!D3M,ZS:K(L/G,@U(/2@.@U;Q!Y@VR M>X,,3S(-:1ZXS]Q#\H`!F4#RN^L@^+';*#RG"'`6$TY(D\Y#EAZR#!AD$TA( MD\]#5AZR"A@4$\B@*6YN;+E\Y+X2_%E+.,"9OJBC:`:$;NJ7@SRY-J6BO3BW M>BA?O^M;X3-Q]?\IK\J.GN`7E:>F5=%.:--%7*T?A=!@DL%/Y@VI3;/V"P9' M;:>%F2>W5M"P,``*T-```9 M````>&PO=V]R:W-H965TR^-)=!-!L0A&WKZL:<-+ MUG@M/2S]1S3?XJ2#*,3ODE[Y9.QUR;\P]MK=_-PO_;#+@59T)SH)(B]O=$VK MJE.2D?\.HCIF1YR.;^I;M5R9_@OA=,VJ/^5>G&2VH>_MZ8%<*O',KC_HL`:5 MX8Y57'U[NPL7K+Y1?*\F[_VU;-3UVO\2WV@P`0\$/!+0YX1H($2NA'@@Q)H0 M?TI(!D+B2D@'0FH0@KY8JM0;(DBQ:-G5XV?2-2":2WC;B4CE;J">G1*5Q>9R M]JW`2;X(WCJA`;/J,7B"20W(VH:@$1'(!,`L\"V+%;;H.`V-$`#F(V)C(S)# MY#L@,OL(V4*Y."PF&DL:*8%X(A"GQEIZ2*8@35^N),[ST$S7EHH<4HG'5&*+ MC\+,R"6V=^H-D8:`8$,KL$PF3W@^1CD!P0,-I]G7]]-2C4VT@(A+(V"0"4 MN<29;%?(H:,'T'1-L]QM15A'PD"R#AV/]$:`;/O:+0N!,@=C(.UR9'O3ZMHM MLGWN_J"UC1'DX]2,!8$<.A=IMR/(RF;O#J"OK4F;'D&NMYH7`#DUK_8\`@R= M10X2VM$(LK2Y;X`@A_)C[6<,^=DH_VH`3`H2/D5GWM9PQ9U>Q]"&15/YB\ MV4UYM=HONG/$5JF6)S)D?XB[;%LN/?" MA'PA5J^M!\8$E3F&#S+'DSP[C3<5/8ANF,EQVY\F^AO!SK?#T7A"*_X#4$L# M!!0````(`(R+<$?_"`$^FP$``+$#```9````>&PO=V]R:W-H965TZ:ME46$Y*HD;:5_ M7SYD53&,MA=Q=SDSG"6UU8CFW?8`CGPHJ>V.]LX-6\;LH0?%[1T.H/U.AT9Q MYU-S9'8PP-M(4I(567;/%!>:UE6LO9JZPI.30L.K(?:D%#>_'D#BN*,YO13> MQ+%WH<#JBLV\5BC05J`F!KH=_9IOFS(@(N"[@-$N8A*\[Q'?0_+<[F@6+("$ M@PL*W"]G:$#*(.0/_CEI_CDR$)?Q1?TQ=NO=[[F%!N4/T;K>F\TH::'C)^G> M<'R"J85U$#R@M/%+#B?K4%THE"C^D5:AXSJFG?5FHMTF%!.AF`GYZJ^$5!3UG5E?/=?%9EVQFW^`DA6VN-V!'^&%FZ/0ENS1^8>*U]DA.O""V=V:DM[/SYQ(Z%P(-SXV MZ9=*B6;$ZL+(F2W/@>\JBDYZJ`B#Q``25"0K/0W*SWV6F]6 M["KRK*2OM<>O14'J?UN:LV;M0_\^\):=+T(-!)M58.*.64%+GK'2J^EI[7^% MRQW$"J(1OS/:\$';4^+WC+VKSL_CV@=*`\WI02@*(A\WNJ-YKIADYK\=:9]3 M!0[;=_;ONEPI?T\XW;'\3W84%ZD6^-Z1GL@U%V^L^4&[&F)%>&`YU__>X0C_:9E?K9M&]2T(6Y`U`7@$P`C#X-"+N`T`H(6F6ZKF]$D,VJ9HW' M*Z)6&RXEO%8DDEDU]$1I4ED9EZ.W#<)X%=P448?9MA@TQ#PB=@Y$:B"!%.!4 M@8P*I..C83RPLVTZDO,EQ"BRU#A0*$D1FE:S,&H6,_;]PC$Y`(=I8NEQX6;N M>PAZ/P"."0IG4`PL!4[O_6T'&LI%:83MHB9ASP7U[@(=]I+.F9;>#Z#+$$8U MA>,E`/IG5Q6.=[(%?"ZJ]QCH,ID9+@5["X$.#QG7%8_JBG`\2VQO)-#E)/;) MZT"/1R\*YQPJV%L.='C.Z%A!AYN$<#1]P>!#6I$S_47J) M,4$E)7B1NB_RKF0Z.3T)U<2R7;>WA[8C6'6_#)D;V>8_4$L#!!0````(`(R+ M<$<`?HHN"0,``-,,```9````>&PO=V]R:W-H965TF-5-%:_E6\_2O%S[YZJZ/`9!N3_++"X?U$7F^LE1%5E-#$Y2E`48H"K(XR?W-JKGW5&Q6ZEJE22Z?"J^\9EE<_-O*5-W6/OCW M&\_)Z5S5-X+-*NCC#DDF\S)1N5?(X]K_"H\[$+6D4?Q.Y*T^6^7=!BS#ARW[]F_-^5J_)>XE#N5_DD. MU5G3(M\[R&-\3:MG=?LANQIHG7"OTK+Y]?;7LE+9/<3WLOB]O29Y<[VU3SCJ MPMP!N`O`?0"$GP:0+H`8`4%+UM3U+:[BS:I0-Z^\Q/5JPZ.6%W42G;EN-!/5 M)-65E?KNVP9SN@K>ZD2=9MMJ\%CS4;%S*'@O"32`DP+W%+B))Z-X(&@^`>D3 MD"9!.`9@PBBCU;!&D[>#(`94$*.8>=TD4-@#A380CPR@5D-'`WW!B`MB@.\< M.D)(R!<`T1Z(.H",9=Q2:R""`1%SM6=EDSA1CQ,MF)_(KIMAQKF!XY!I&CY* M-\G#>A[FX&$&#[,&`JX7S-P_L[))'-[C\`73P^VZ]3@T-'`<,D`",S;/(WH> MX>`QUF$K[+I1!-3XI/\%1>G)"^]%U7IDVQSWCPJ54F=%#WH$L_Z"Z/OI/)8U4VFVT5[YFX[ ME;K8T"``#6"0``&0```'AL+W=O MJ!J"PB&W>H&MJ*BK4!I\=U^`)76YAK MB$'\KNA=C-J!3G['V+ON_#RL0Z!SH#7=2TU!U.M&M[2N-9-2_MN3#IHZ<-Q^ ML'\WY:KT=T30+:O_5`=Y5MF",#C0([G6\HW=?]"^AD03[EDMS&^POPK)FD=( MDHWM7K7G?NW^2M`]S!Z`^`-D`^'4`[@/P$!";2KO,3%W?B"1EP=D]$!>B M5QNN%)QK$L6L&V:B#*FJ3*C16XER7$0W3=1C-AT&C3#0(B+%[I1`#XD-FH6C MSP);!V+Y7`';(K")CS_%X^<$L26(YP1Y/$FRPV0&TQI,@N(L?2Z36)G$(9-, M9%P8#Y'4BJ0.@FPBTF'R42U@X;&FF17)'"++R;9Q8?+G(DLKLG0L:_R<(+<$ MN<>RYK-EA<`\SX4@&&P$/);6!4HS#YV17:''Q#M`V*L>-.@@!P6'!@X.ABY[3K=4#QHG&V>)UPH, M-H8N'\]VU!R$@<>7#PY.ACY6=H`P\+`B',P,YVYV[*CE;.9PC',?CPRNAW/; M.S;4W/=9'D^%HM$QVE!^,M<+$>S9M97=*6I'[17F!9EC>("7Q86@:Y8]OQH?\=#6FOX*Q69_+ZD>]R_-F\;,X'.N[Y:YI3K>K5?VX MRXNLOBE/^;']RU-9%5G3OJR>5_6IRK-MOU%Q6%&2N%61[8_+S;I_[UNU69!]-%^L3?^_Q<3YXONLD_E.6/[L6?V[METLTA/^2/33=$UCZ\YE_S MPZ$;J:W\[S`HU^PVG#Y_&_WW?G?;Z3]D=?ZU//RSWS:[=K;) MO78##9G[2X8F&34F5NWH8@EZ*W%/T>9D_,<#Z'&.NA_`O)NC^W@`,PY@H@$H M-;.=O&1\GSE>=C+QRJ;ZXT)V+&2%F?I9H3A#%M@;-Q9QPM[,#YF4`8KXL8@7 M]B3,BDB9].,B82P2X@%4,BMRR=CI]10PA']OD*EX"/U_:0^B:I:U9O);$SY>"E$P#7-B.P3L$O!/`>^>0@\3@ MG00>N,!RDZ_H$?`N!F\2:X$+'\?>'>)="&&_.;!WAW@70T@=]NX0[TX\P0.' MR#-XCX#W5X'W#-XCX(40661O&+Q'P(LA`+QG\!X![V/P)C$.^?V)O7O$NX^] MN\0"5^.>N7N)._"C@F?N'N'N8^[.3@W]NM+D9SF$NQ""N'OF[A'N8@BIP]P] MPET,(3\TLO:`:`]7:0^L/2#:A1"D/;#V@&@70X#VP-H#HCW$VJTW&CD^K#T@ MVD/\&WVPT=7\:G+K0Y%7S_T='O7BL7PY-I<['\9WQ[M(OE!_ZP3'-^M3]IS_ ME57/^V.]>"B;IBSZVR2>RK+)V\DD-^TRV>79=GQQR)^:[FG73ZK+G1^7%TUY M>KN19;R;9O,_4$L#!!0````(`(R+<$?>-!J^VP,``(H3```9````>&PO=V]R M:W-H965T=Z>S# M[C/5J$R!N!!K]]\O7Q*:>Y%,^U`AGGOOR4W.$;*XRORM.`FAG(\TR8K'R4FI M\]QUB]U)I%'Q(,\B*[\YR#R-5'F;']WBG(MH7P>EB4L]+W#3*,XFRT4]]I(O M%_*BDC@3+[E37-(TRO^M1"*OCQ,RN0W\BH\G50VXRX7;Q>WC5&1%+#,G%X?' MR1.9;QFO(#7B=RRN1>_:J>U^<:G;1@>0-L`V@5T=?``U@8P'<#O!O`V M@.N`X&Z`WP;XMA6"-B`P`MRF676K-Y&*EHM<7IWB'%4;D,Q+>%XE*3-7%_7: MU4G+9A?EZ/N2T6#AOE>)6LRJP=`>)IA]AFP@A'0(MR2`LJ`W%BL*PNGG`FN( M"#V#PVB2Y_$D6R3)='PFK.LGJ^-YOU=&B14"(<94QB';!C*M(5D-\1X\SZ+K MO./*816C8ZL&XO>JE)[4_!F4K9%;&^0@>[]C[T/VS&#O@TJ$L)D?SL#^M49N M,229EN`>*GX^)!(*9X[D(&6`0$(,5")P^U/;6E37HD@M8DZ>@EI!7 M,!"S\!ZBS8>$-H(*@5(8)J@QV#`A[68$&A$BJ"G8O*&MGK1E$<2/H)YFH!0+ M,3V-XH:?Z+2_4<3?@)Y0D*FG$=`P&>UME$`]V630CD41QP*[&`,QWZ*.MB&* MF0=XTF5PTU"[!=(>0^'C'V.!68E#(016A;0541\VWT+:5%L(M;$0#,1"BSK: M0BAB(;#YX9>;K[V!8MX`FC_]:O.U,U#H#.:#YJ;%].L0SBWJ,"UWYL%%MMCY M3&N4(<\?8)$Q$+-Y0=-*9IA(S?L#T^EQGC<3Y3]L8[`.&\$SSPH]L) M,1X\CU<=$,2?Z`B#W&DH(TC()6L]/C)`M281[(6^GWH$]8-;Y#KVPHJ<3@+W M`[PPAT^$(/:O!$SGHQNXU\!KWW9"!;PB]RRO[@D,O*>#PZ`YNL_!X90JA`;\ M[F'FJ[FCO12>3]5VGA@9-6+S2^0$)]5W+<*K11G>T<./!J=[1.8_ M=HAL$9'F1^L$XR^/!6(K$&N!^,,I;)(L#2;3F,&8A/X*]:E-8FV2'9MH8V,P MR9(A]1"[\0:_N!.V'V![#-8_`=02P,$%`````@`C(MP1^X$F*$7`@`` MQP8``!D```!X;"]W;W)K&ULC551CZ,@$/XKQA^P M(&IM&VNRW$#KWK\_0$N[UD1?9!B^^;Z!D2%OA?Q4 M)8`.OCBKU28LM6[6"*E]"9RJ)]%`;5:.0G*JS52>D&HDT(,+X@P1C!>(TZH. MB]SYWF61B[-F50WO,E!GSJG\MP4FVDT8A5?'1W4JM76@(D<^[E!QJ%4EZD#" M<1,^1^MM1"S$(7Y7T*H[.[#)[X3XM).?ATV(;0[`8*\M!37#!5Z`,8+5C+J.8-)X M6B3"MRN"9U2V!WTK+5[.*FUT=QNC&<4=!S%N=9=G_%>W[.?76=#-WB1-_0$OZ@\5;4*=D*;=N>:TE$(#287 M_&1N3FE>%3]A<-36S(PMNS[;3;1HKL^&?[N*_U!+`P04````"`",BW!'&HK8 MN`@I``"]O```%````'AL+W-H87)E9%-T&UL[7WK M'=1_J=MS6-N>ZN/RB??^39!FB0?OG7LKWVK.G\_.?SJ;GKU^>\+/SH\:"CF" M:A,OA.KF_J_\S_Y]8]NN[M=6'6YG_R^-+USZ21!C?^;\V,OL]DEQL6^^J9/) M(90QIW).0^^F^NW""U.KQ*,\2>B%()U!EW[QO:2Q]OU]M[O?^E<>3/^5F:YG[R;]77SN.V@GZ*0U!!+[F'EH4U;^MGOTMA M4-=QD@71#9]F7I:G7';*>ND76SUEA50)/X).W\2)-9[3E1?B]T5%1_%J[476 M@TI!XM4*IL0TBV<$O\BS-8/+`ZXW#+T=!:L$I?&PU^"^]36_3&-:^ M^]H+O6CF0XM@WJ MI6MOYO_A!W_HL?N:6\LQFB3LH3?^8'M]YU:"G@670+-=<,T''N\T42 MK^#=$,9PSM=>DEE/72;^V@OFW/\5`#'U"_>>ZAXT,2WOO?:B MCSR^]9-YXBVRFE*I@"#*?&A\IDJO/O5 M:C@>]1UWN-5@SS8/JWBPY0$"R&4QG8L'7FKZYAFBF.0D\!/LI/)4:V"^QP/@]P^FA)BS]+`#SL]=L5M`Z M^V2I0/%.@P@*"=#:Q2F)A__?PVOD9K/LWQMT0!I4J(__A(-??6R'HW*TORRM M\:%6D?;'B;Q8SYA#<6P`>]LL/:=9>KDM*CR@J.UG?%L_#@TST#AR*99\L?83 M>JR%0O2VIOT6P3B+9O'*YX6V-.O%>Q\(06X#RU&\``"1/L-XV1UR8JC;1`2/&PF[\R$>G@9Z?KX*(_!`$C/J9&6]LQEOL`YFM M6`^(U1GB"(&0*%:]*TNS!LQ\LH9X"`LJ7[;$":XC!UGXOV*#\R!=JEF.*MW0 M/ZJOH:2UX%3%=RTJ3\\LZ!ES5-"2H&$@D+5XVN'\/_(T$_5D,7+?&%`1C;H4`7Z* MO\^P]#PE/K-=T81@^]<>O@/=1D'7:NAAA?^UPA`-]2ZJWM[V(WZT!-Z*AK;4 MDIK MMLE[)'>ME%%BJG738>/X;U)'%%ZZ26[TJ9[]4*L+8(FHZ<:*CEK=.P./S: MOPFB",M"P5`\HOY!'UESTR/3?+T."44!\1%2`-'R1`R9&GUHAX[:6<--.D(S M$9YIG!_EIS+O5SO6%.U3A89>0KNWTCCE1BHSK(8+/D)HQO%JGUU>G5V<\XM3_OK#].S\9#IU^!_/IE<7[W_AA^?'?/KAW;M#^!T> MF)Z].3\[/3LZ/+_BEQ=OSX[.3J8-#C;V]#(.@=-#-YI9U;&?SI)@C0/"H)77 M>1I$/EBB/P)E`?!E%Q$K'*.)\H#`GJNP&`[#"OK\9Y!OE@1@,`\YX-V!PSV8 M:W?\#CR,\'X_OL/P8)I?I\$\\!*@KB!0C%.`CGH(P:L@7P&&1J0P*;0:NK!` M)R.\9UB%9*[I1T!]L.;Y#+$XO@-%H>D1YPFH!@9#,!09W09`"^#93__+ M,W^VC.(POKD_X(S'*:I))*2AY'LD$50A`GN1*C$)Z3 M\$P=['[F&=TOVG<7A"%,,9["\_PV0*ED=W'R4?8>RCO@5TN?J1+DBQS#CPL8 MP!B5,(7A('+B@5CVO1MLA:X!)+GTPS6H./`?&ILTN(G$XS>J_-00V1(8$C3) MCT`KP8D%"S-G./!4)G3=K`7^@70#PJ^[(%L:8\-]!";T#J$FJ#8`CK=8",^8 ME`B\:G@WIUF'S0KC^*.P-C#,.-:"$MPE0?0Q]%,&\ST/,U$KOP?"MESD(;U% M4H?_ZZ[$.,J5Q@DY&_I0HPN&)C@26K%L%'&^`D>841_%RHA3=,<8SF4P6P+7 MA*K"`*0'X!8!,&#-\WP-\PW5%)3,B`-4-<&;SP6@^-&2G.ML&:3J,49SP$M) M8#,YQVX2M)PH*T`F^)$>\"E(`SN%7B$CC:T`/)+?X\).!_S4"Q)&D9%RA.7,Z"'""BA]&C`&F4<5`L@>.T M#D`4*2(T0`%(2DYC?`>[*P)!_!U0:2`6Q2`?:[(!78[7`$Q2G4X/IZ_YX?3( MH98(J`8;S5>B!"B<'";T[,6([T-S$J/9H%U@`(`F`UB(B;\&ZH.M_D]?S),@ M6H-?J;FP*!G%;=3HH5!#5.17X$XAXG(7/*IK7!TANJO[T5$053 MJ`4WGU;6&&B+-$\$9KC."!Y)OB*R(J8=$_,TQ,^.7RU072%Y&`B`"@(1TE8W56AF-A+7_#8.78'>(P#,D-" M"P5G>OD(1,,,Q_%[V:3N*_Z7:CNL!J#5$8US.(T5#4+-R#K5H>6EH76HG6@K M,K3[Q+A(CCG`*T&G%"PUF=!0MOA>M;?W"JT"-C06HA?6@&PM6E+9+#7 MQ\@K@+,0XP/I2:`P1M*4+6JBJ7]L-P7?(R::?GU?JW22\]_O'7`91V08?H$: MJ:&7TO:BCYGR]_&]%X("BK^.,7@77.>:!H*-IR7%!.E6RL53&(4D/)?%<[7. MQ=[K>`37:YKL31S/D0ZP6I>;%ZM_*?_T/UP]33T7P3L1.&7@__BI^N.*_C!" M0(?<%:.4C=[SO=H0S!D-VCPO2 M/L:!M[9L,-K@,OJX).6,.QT2RX MGB[B_M:J[=G_.3F&)D]/KBR?"<8?BL*`^F7HJ7TOH*OK#3%I6@EF%P,?VD>HJII]@[;[8$I@C4CFBA;NP.[X]Q74__PDYS$$V& MKKCP@W_-R%+B8MFP-U`_21=RF.Y@'8K2B$/%B^P.9=R;.*-N5_Y@;S&BA4X0 M#U;D-@B#[':=P7`B?["WWK51&E;5'[KJ)Q/1X5YWY`P&'?43"D[35ZQQ/7U7 M+J;OX6^TDK['2BOR;-.*_`[O.IU)!W[V\/72J@Y3RJX4.D(Z+HE@JUZ3*M_! M6.^XCCN6*^JNTQF.*EIL10?/?SHY1V^_<0N$P7":E;%^ZT4!.5](/;?3SNDR M6*]5Z.72FY$#AQ0Q`?L"(N*@`9T>*BDPV]%@#.HLG6%.<21DA2[H&2C+/HQN M%``YG1,.IGSD=,9]>'/@PIM#]MZ[X^]TR?V),Q[UN`O\NZ\4;`P%#5P^[CGN M8&#M13D[OSH\?T/;P##:R15A M0E+!'<#.+2GB@DP!D"054X]XAE[9P]T/RL^6#M8L)%H M'X04D'L@>)5@ZXI0E'J%(A7=.B`ND6"<`L@:,_O@1=`!X&L$??B?""5L*%#P M4B@A2#3(8Q/G/K8JP$`=43.@3\93=^#V^/MSH.$L2+43#L]&/A)AE&,3DEB0 M-[VZ./HSOZ#`YY2FW<^'[]\?GMM3[LI?`;/#PM$>9]M!X8_H&A0`%Z#TP7%8 M83$8]5N+U5S)"<$U352$:ANT/V#G.7V`?15KBS^KI<=#L?3(Y+8)A]EL!\%( M[ X9V#SH!="(>&W^!65:03T5PX.OY<;7@I/TA*U/3E#.M%-O7I_\%_ZF,P M:WXR"U+]N6Y@S:2LMA#]\=IQ=8Q'10`\EJU`X))5(O,]X!<10CRX?%(.@W), M1_:]4@KJ:;>\W0?:$1#7,J+N%._R,)`;?/2%QT08AFT7;F*Y6((%HW4\7T-9 MU`0Y%V#B>S"+%E3.@$BMG-(U)9�D`N""P7H53LWNL03-_^=`8T":-E0N^P M@60.XSGXT@(WJ`55LZQ]W5?:#9-M`481I!_Y`IU?O>4-P]CXC'O0&WV+X?=Y M0/'9.;L/_)!6;CK?4@=O8T!S3.2T+:G!'L8I.-O*C M&HTZD+X%L$@4,JZKM\]0_>!3SM$3.26$Z]HV98'+]H')]?24_5FVCRF]->>L MJ[>HP;.CXEDU;8$>3H9.=]RIE%69N<9[VT_=KM/K(Z&2+1WQ0_`QM31+.]X: M65]EZEHDZ.+J9,HO#W\Y!,ID[2S!:7[/<4A>+N2P6D"F^$D505$*F="XG,XS$+!=L"\LXUV4H"4A6 M\P&&A!@>DS9>::::I[*OWZ5`L*,4Q.SKL`?@"[PN""*/Q+SY%_`=NV-GXO9> M\1?%&UB*VL)'L'LBEC#F_,-/^X<<#'*T94H(:>FA9,'#)2J"A#?`2$T1IA<"D(7+FN!,5%/EB,Z?B:X2_4=Y M`9**%6)<@"LLB78F:*_%+`2&&"P"BE2J'AZ1UVQOCQ81FDO:['8%`DZ1/*.7TK+[ITR69)R&^-&M![B/VV$6"V#' MJ$[S6R',11[-*0HF5UWH];D7X+I2L5M<"DKN8&BV_`Y*=^)BI`=/I0+ZRI5B M<_<>'5G`I6MI.H7]5@T":<,#@@RHM\2"J-CYISB%&HAB(RL^F,`[^Y%_$P._ M(.*0VIOTP('Q)7-P.]8@'5V<_W3R_HI"B&WLN#Y"V[C9'SU*M?6'5:.VKRJB M-`DN$ZX`QF%W!EVG/QJR!50JMRJYX`3"E)$SE/IDP(<7:01QQ)?:OQ0!,D5B M%%3$N(EH!=\5.`*MSD.PHGYY^YQT?XT8E+F'1>R:4H=Z0*EPQA!+*A9Y=L&E M=SM[CMPM($M2?I6.YG5)`IT"E-"_E&>80@K\S?V%EX<9]A"*!R@5VQ!F\)#: MJ"`?.<#5@C'*4/_"/A2G+5CY=)=PT"CJK)`;ZRH%9KS2\;,)*)Y"!3$83`RKB-AXBTR$M\',):1NA<&1KV$;-YB:FFW@ M%,,N8J+*+R@Q=`Q_DLGX.8;O`)V7,;;I$MJW@A'):04?1/WV[1%J/(:@P)9" MPWTZMXRS66VC5#%@!RW8$8S\I_\MQ568%6KU]3Z1-)X1"(FVT.8\2*)KK.JZ:&MX-R.*&;+G:!44; M6(M14_5@DPDZRXY$IN1Q$H#*/]H_.`` M#_5@4[MAWHOH'!,+UF)F9%`3'AA1.PO0_A\889MB-EZ4RF>Z?"E&];,%$79[ MSJC;YWM\5YSTY'O;P`.4VADYO?$0VS+N.]WQF%U$0!,!O@`SA.%D=WZ9'GHE MPU4)C?!UGJ2YW%Q1;&*,DR2^P[7W_L@9(!G4YW\*B=67RB*)K.-O":)Q+6+E MB/6EI>GN4FP,-R_(G6/7.19.6[BUV@2I,B:'\&*HAGEH&)6@9)<9;AV!B9L% M*S-HZHX[@&GWJ8$F.'2TOXU8JR<8EPH72&@D\168AJ&?,I#A)F5D1+3=Q)B( M.M@\&&MP@Z:0N92GD`3=AT:IO2CZ':L:8PZ`R"** MICBX@^<_``G(BNN31IS`1NU[DK.OP%$A!P1N18FS6(E9/^JP)70)/G+$GJY5 MH'\H8V%,&#VP`>6](+M^>X@*GP\`YB M"?@NG3Z&A!&MNLYHV+=6P1LY+"^Y()_):$M."C/XK;4K84M^>Q%9X7JWO+)4 M(O<:@U(OA-E<-9+"'<7IZJ_687SO(_/_H'&00H%Z,YR.+Q;\*26,P>V%4))O M!9T[CL9"73_.&I#<+?I:X;U!LLBW+'&N:JR[!(>$8'6K8C+XKTRBF/964AB\8L@2^M6:49I.-V>\C8JARRO>JG9)!NM^\, M^OT6"ED?HQ<]:&TWTPR2;V:09U%IV0DKU6+$F$H9F&A18&?@.OWQ@*F#`GII M@`(@X$;XQ;R0^_2)J8Y<9S#I%;^UV0Z,Q4YZ$^2@O5X/JNL!"24V600=N^5] M)<\`FH7FL1)H$L?52/Y4>,D-O&2_!5[2PCO[BI?_N'@I3@/M=#L39]R95-"0 M/3$:\G9_>C)F3P"&O!4,61D,+XSM=<)CK<,_#]KK3":=$OJU@E^OBSLQNNIG M&_"-@.J.QXA[;J?GC,&;)MPK3)O8:RXM7/?9>2-8KG$7_/L>H^M+S,/J$F6J MMUK1=NS?ECJJ-G,C4OE9\,@:X?&IZ22SX+'&ZZ^!Q]YGPB.K@T>^#3SV/QL> MGRWZ*.%1:HO8AO=L9+$>'AFM3(^<;K?W%%SQ0?"H9I%"@!88PR<&?0%C$Z<[ M&A&,,9.^]3X3NT`+'XIIV_?%D8H]-VV2XF?/39M0-]AO1)L0J=@STJ9)WYG\GIQ*M^^XX\GS.Y55 MI)*32/YL0ZJAZXSZY/R-!LZD-[)C7OWGCWGMN"YN71N:M.DI@:F60K$*,(DF M/0^%8L\;[BKCT$FTZ)\8G)XD%K\5-@W^ MX;`)E*4__!U!T]#I##KMH:;:TY)?%IGD%))SNP67>EVGA]$E#WA$JB15]1Z2LJ;8%*@Y'3[U5]N=\0E8!]C)N"3L^'2G(*R;G= M@DK]L3,&%`54(D&"2T>;VOJXQ\V5F]I&8K];[343?[QX>WSR?LJ/3T[/CLZN MK#1.XEJ)]KLD])TA9KX1&@;:=UR3ED1JJYF^I++OKZR1\[;D)7KIO)*UI'Y+ MX0,O]*G>L85+"W+AMCNL.9&FCY3MR)L?S(W%>)5O<(OZO0X!',4.5(7E$B.* M$R8E;'"=KBB0%=TR#HB(\R&M,J7^#;L#:I7"'R'HXD(!W%](_9&[1LTFU"X+ M?F>'MW;H:#WN94WTMA4E,E=M7#;E.&J58^^+RE%?R*$[\P@I]D:?*\5*E/`S MI"AVA.MK0T9=\AM*JT$'G/O]#KNCTV[ZNCW"=G$[LG@7@$C4B_H@I)3?Y&`.NGWS M>A5U?[!X=DZ,5#121,ODG:Q@@=4I.U(M^\Z5,G09S>V3DJ1L^\;:.X_?O3N[ M>G=R?B5N`CJZ.+\Z.W]SMAX8]_L>Q733N1_1->=;W0U$]]:Q^#H, M;N1113JO[\(8][ND=6S@C-P1?T]7V:M]APXO;J>NI/P(*;>#25F-.W$IX9LS M="#T]^0!P_;C]QPJK%@C9-ONB)DTH_1Z4S)\SL M8?V9$W)>ED$R%P-9.KCVN<=0:O;KJ6,H)@'3#-DX8Z?.G\@_K^1I$GE/JU+` MIO,GY*O(=]@Q^`_R'@@93U,WE^$IBXQ@)@26JBNA%_#$BKK)]:AHZS'Y)@\\ MK$*K_=L=5N%?]K!*<3ARJ\,J_`D.J[#M#JOPAQ]6Z6][6(5)Y#=@P7T<*E#? MWH`3Q-_-CJ!]D7_?9AGE+@]QY10P(5;K;N-0/]C93A^QX8P]Y1Z/Y@4*5%1F M>]M1CFU7.'[Y9S M']!L-W(?[*%F45X0<2P"OY:7DNNK$U=`6D$U]0V[XD)H:$801?$MI7V#PM?B M#G#,1YT"`*RDF5KELSC%FSG$-9(RA=?RO)5K+IU_2]1^IO.(_7ET'E/1G>3]/XO428&A&5$/^ M'5^#SZYNM_3A_51?N[ZA/>*FA23V$!#F@.T)76%$N3'$M7F@O1+=UZ43U@[# M.T[WX8M]\OX1Q4']4E)PG?J%0B%QNL(DE!AGB[S43+B!-YI79AE>O4E"SZC1 M>,>JV6)'7*+$TCC,BYL'/=D'HEQ)3O?OJ4O8[_"8.):\]+TP6^+UJG1%>P06 M%Q5#H`Q=0E&Y"Q0ON9,:B4E1Z<W@3%//&FS$T%-9SZUXF...!MK)@@P,=S]O(A82SI+>B" MW<.K\G@7B4]H].$UM*'OO"B,?1#LM6H>]ML+TUC74B[AE,LCZ_G"=\2AEA0921LK$EYEI;F(Y M&I1]"0A"D*K\*?!AAHMI=(FK(*5XK;A.[VGDW:0I`%^D"W$M%'YM9!YAVMLB M:@+6-Q'7O:J,)'X9#"`Z8>C&E":F)F_ MUOET94X0O/Z4+D47EU.+=`JJ;_/B8BE%F_1U\44V/_(UO8\R9&K9!,-G3#RD MN05WUG4#N8WS&^%[+7*YIB'\!CO,3C['QPA07%Y&1C$D0-<](CSK*[8<[402J:3:P#J'XF;X4)@3B@1D9L-$)F1Q M,8XNBU%"&7V1=^5>-ND=@[QS\R6YI%7(M>@932!`]ULZPH6WPGLSNI1.B-Y( M-L/G<7X-E.`:H*TJ@+*;+ZJGZ&)I2HAF%'G(_'GM_*HX7U`ONFN@][,PQY-H M>,^FF:`7PP7HRLE(IKX(#]J)V59D<:A'&+K&ET`FM/0%C4*!HTY:.%$D3\," MCLSD:74+3YM[I=J?+8W+CRI=57JBL2^@7`%XKM9(ND.NL$)7>=Y.IR\H;I,S M[E'#Z$I$V%YM^P%9&7^;;P7 M?X984P23/D04#J*L#3K)6&H0=T'!`$2*%';Z;F=YZ;=(6T164`4"1.XAE6&M M#+P&R*H+^6606J;/$P'LK/$==<%>IF-YFT6E$+^N;9+),6DZU1J%#OT5B;A$ MS`_S#V2Y%\J9@+B$(:1Y0!?/RGD1IX;([!B_2H)'OYP42?"LA#I?DP)^1E)` M2YI%TKRX(4=@+>A\31GX-67@UY2!7U,&^E]3!F+*0/NJ71$*>5]D$*Q)*/>% M$PHVI/E.>9%?L/$1XRY,ND5O!2I"*+9@P%8!9S!]ELQ'-0.=CC'D:ZZ0(Q*+ ML)_T#RF#E-RR*8:(^()<$)'QW9Z\BT]39S#$=*VFWI)7-35R^T1=JW&3IX\+ MQX*4B"B8C&23VR[UZX"?+4P^IS?Z2>513CXNMZ;0_3#X2+X2+J8@X,K@`ZD> M63V3':)34`0Y&R2"8ZEG),=U#;>65L MJ6RQ<)>VRQ;5W3$L523S0VD21:D"[D#]E^3;.ZQ@NQ24%ZN?#BYY`KER5"]+ M+:GM9=L]SR9=PPUO^*Z2"*,=(WA]'`TI^83H("MYV-&'RAXG]V,: M68;H=MW]0/V";O?NB].STXL7>[BJ0IMU=Z69^02PVEA*JI?F`+SY9IXFY$2M4B7"NJ'-K(N`%?$YHE7&73X M4#N1>#5\-/>2.7\=P_]QNN\B(]R#M^=D::AE@C'V!AW,?+K[Z6^8!U7\]>GO M>P[_]+>V!*Z,$KC:N1XIJ$`I7-M:K[56ADXOKKU5^6^H3IK@MLMM:KWU- M/ONVO5=YF>A>[)@6I1IOWR(N;&^O;\K)F(V+V-'N[CH$>!X`-YS@. M:$+W^#[_,#WFNSM6F]TN?R>BL"=HO.W=8+,#G>C/^E)Z;6?%IBF;R0#0'?"A MP[[Y!K>\U/C5&MN/:9NG944;I5K+K7B)QV2U32K9_'V^I777>,DVYQ3O1@-CE@B%O-,-6YTP;SC?8\'8Z]A!%-C// M*^;:S`C*HUYDA]]BC&M-O3;(->I?L?.VO$QK;P7(3&O_@'SK#Q.>3+#.O5)& M_26)[ZV.71S9;F M??M*C5<>6.F)V'^K*,3&&JO//["Z;158*^!V&OS:OPFBZ$$=J7GE@7W1;7R4 MPK>__=BF;*WR]AN/K?(!:$HN;46AS%N` MLF/FNVZ'[S=2G=P-!1++E`_7DDN\3..;;[#%&TK:JOVT1/A1'MSXKY:IO,/! M!]HHC+58L0B#A24.F8!^0Q%B`0X:8@&T<V[U?60Z:2$M:VA.:.=V:P&GN,K>^D1S_M0'$G6Q%:7D$F_OB9>)>YU7 MOPV'K_J4W%(PZPGERO^+A5?5"S?TS8D;RW3YOWJK]?>\NWWMFQ^UVF<]89>Q M9>!CGS\LQ)&G8.VV&`Y3@L-M):CE\H`!M*9'\Z,6`C8_.MS^T='VCUH! MDY8HV$,F8>,X.F*;E[VFUH*0;J<.(H4%X^]I)X8C0I5T`+)^I0;9G7`ICVNJ M^),'9LE5YJ!CU37+,)>/^-8:B==M-^TTFZ>&(,*XKK.'ZX3,9D,+MHXL;J9H MV\Y`"P80=^M$>R0VXA-V.EQ$;RZW8C\-$XFD>RJD:W+>VFNLV@[3_M<&FNSP M>QX;S0,32]N1,ZF%S?B M:-.+&U&UZ45K7J$6=JWB\--']VHC.#>]:$%UW959#Z1**L`N#\[4HF)WV.3^ MG-,=#J=XL][AJMZ1KGG.;OB_/R;JQL40L^C%JZ@>!:Z.35].) M>ANF7)NF6O*;`[SS9_MJE*P<05JF^F*>SWFWP0"W7NWS,*VZ*-^V(_:_U'6Y MZ4%K&HKK?9H,IG69SF,C$1MIT];,SJFU`<0BFJ?3.[%E_GZ+=Q\-(I-69F,T MZ66:9C_^?U!+`0(4`Q0````(`(R+<$7!E&UL4$L!`A0#%`````@`C(MP1TAU M!>[%````*P(```L``````````````(`!]@$``%]R96QS+RYR96QS4$L!`A0# M%`````@`C(MP1Q.#K'*E`0``]1@``!H``````````````(`!Y`(``'AL+U]R M96QS+W=O&PO=&AE;64O=&AE;64Q+GAM;%!+`0(4`Q0````(`(R+ M<$>Z4-I77@(``-X*```-``````````````"``8D/``!X;"]S='EL97,N>&UL M4$L!`A0#%`````@`C(MP1\IHW>3Z`P``?0T```\``````````````(`!$A(` M`'AL+W=O&PO M=V]R:W-H965T&UL4$L!`A0#%`````@`C(MP1\OU"&XV`@`` M"P<``!@``````````````(`!"!T``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`C(MP1S.=2!N@`0``L0,``!@````````````` M`(`!1B@``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%``` M``@`C(MP1XSK?\J@`0``L0,``!@``````````````(`!R"T``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`C(MP M1VM!Q5"?`0``L0,``!D``````````````(`!^C8``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`C(MP1SME\GR?`0``L0,` M`!D``````````````(`!?SP``'AL+W=O&PO=V]R:W-H965T)```!X;"]W;W)K&UL4$L!`A0#%`````@`C(MP1R&PO=V]R:W-H965T M/X2&UL4$L!`A0# M%`````@`C(MP1Z&@P\"D`0``L0,``!D``````````````(`!6$@``'AL+W=O M&PO=V]R:W-H965T&UL4$L!`A0#%`````@`C(MP1^-6 M2BG)`0``0P0``!D``````````````(`!-$\``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`C(MP1VUR5]1@`@``J@@``!D` M`````````````(`!J54``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`A0#%`````@`C(MP1Y)[=6T+`P``K0T``!D``````````````(`! M/%T``'AL+W=O&PO=V]R:W-H965T`3N1.@`(``)T)```9```````` M``````"``5!B``!X;"]W;W)K&UL4$L!`A0#%``` M``@`C(MP1P!^BBX)`P``TPP``!D``````````````(`!!V4``'AL+W=O8T"``#6"0`` M&0``````````````@`%':```>&PO=V]R:W-H965T&UL4$L!`A0#%`````@`C(MP1]XT&K[; M`P``BA,``!D``````````````(`!B7```'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`C(MP1QJ*V+@(*0``O;P``!0````` M`````````(`!#'D``'AL+W-H87)E9%-T&UL4$L%!@`````Q`#$` *20T``$:B```````` ` end XML 21 R33.htm IDEA: XBRL DOCUMENT v3.3.0.814

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Related Party Transactions [Abstract]

Due to Related Party $ 1,145 $ 1,145

X

- Definition
For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.3)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.10(3))

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

+ Details

Name: us-gaap_DueFromRelatedParties

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_RelatedPartyTransactionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 22 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 23 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814

FIXED ASSETS - Schedule of Property and Plan Equipment (Details) - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Property, Plant and Equipment [Abstract]

Machinery and equipment $ 48,163 $ 48,163

Furniture and fixtures 113,635 113,635

Computers, equipment and software 39,722 39,722

Leasehold improvements 12,569 12,569

Lab equipment 113,461 113,461

Total 327,550 327,550

Less: accumulated depreciation (325,460) (324,275)

Fixed assets, net of accumulated depreciation $ 2,090 $ 3,275

X

- References
No definition available.
+ Details

Name: SKVI_ComputersEquipmentAndSoftwareGross

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_LabEquipmentGross

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.14)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

+ Details

Name: us-gaap_FurnitureAndFixturesGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 4

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6812-107765

+ Details

Name: us-gaap_LeaseholdImprovementsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 4

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6812-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

+ Details

Name: us-gaap_MachineryAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PropertyPlantAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 24 R37.htm IDEA: XBRL DOCUMENT v3.3.0.814

CONVERTIBLE NOTES PAYABLE RELATED PARTY (Details Narrative)
9 Months Ended

Sep. 30, 2015

USD ($)

$ / shares

shares

Convertible Notes Payable Related Party 1

Convertible Notes Payable, Value $ 1,071,593

Due Date 5 years

Interest Rate 10.00%

Common Stock, Fixed Price | $ / shares $ .04

Conversion Feature, number of warrants to purchase for every two shares issued | shares 1

Warrants, Exercise Price | $ / shares $ 0.06

Conversion Date 3 years

Beneficial Conversion Feature $ 1,123,078

Financing Expense 124,544

Cash payments to reduce note balance 51,485

Convertible Notes Payable Related Party 2

Convertible Notes Payable, Value $ 321,032

Due Date 5 years

Interest Rate 10.00%

Common Stock, Fixed Price | $ / shares $ 0.04

Conversion Feature, number of warrants to purchase for every two shares issued | shares 1

Warrants, Exercise Price | $ / shares $ 0.06

Conversion Date 3 years

Beneficial Conversion Feature $ 209,809

Financing Expense 31,098

Cash payments to reduce note balance 3,990

Convertible Notes Payable Related Party 3

Convertible Notes Payable, Value $ 182,083

Due Date 5 years

Interest Rate 10.00%

Common Stock, Fixed Price | $ / shares $ 0.03

Conversion Feature, number of warrants to purchase for every two shares issued | shares 1

Warrants, Exercise Price | $ / shares $ 0.04

Conversion Date 3 years

Beneficial Conversion Feature $ 182,083

Financing Expense 27,223

Convertible Notes Payable Related Party 4

Convertible Notes Payable, Value $ 106,153

Due Date 5 years

Interest Rate 10.00%

Common Stock, Fixed Price | $ / shares $ 0.03

Conversion Feature, number of warrants to purchase for every two shares issued | shares 1

Warrants, Exercise Price | $ / shares $ 0.04

Conversion Date 3 years

Beneficial Conversion Feature $ 70,768

Financing Expense 10,579

Convertible Notes Payable Related Party 5

Convertible Notes Payable, Value $ 142,501

Due Date 5 years

Interest Rate 10.00%

Common Stock, Fixed Price | $ / shares $ 0.03

Conversion Feature, number of warrants to purchase for every two shares issued | shares 1

Warrants, Exercise Price | $ / shares $ .04

Conversion Date 3 years

Beneficial Conversion Feature $ 94,909

Financing Expense 14,189

Convertible Notes Payable Related Party 6

Convertible Notes Payable, Value $ 118,126

Due Date 5 years

Interest Rate 10.00%

Common Stock, Fixed Price | $ / shares $ .025

Conversion Feature, number of warrants to purchase for every two shares issued | shares 1

Warrants, Exercise Price | $ / shares $ .03

Conversion Date 3 years

Beneficial Conversion Feature $ 118,126

Financing Expense 17,661

Convertible Notes Payable Related Party 7

Convertible Notes Payable, Value $ 40,558

Due Date 5 years

Interest Rate 10.00%

Common Stock, Fixed Price | $ / shares $ 0.04

Conversion Feature, number of warrants to purchase for every two shares issued | shares 1

Warrants, Exercise Price | $ / shares $ .05

Conversion Date 3 years

Beneficial Conversion Feature $ 40,466

Financing Expense 6,050

Convertible Notes Payable Related Party 8

Convertible Notes Payable, Value $ 65,295

Due Date 5 years

Interest Rate 10.00%

Common Stock, Fixed Price | $ / shares $ .04

Conversion Feature, number of warrants to purchase for every two shares issued | shares 1

Warrants, Exercise Price | $ / shares $ .05

Conversion Date 3 years

Beneficial Conversion Feature $ 57,439

Financing Expense $ 8,589

X

- References
No definition available.
+ Details

Name: SKVI_ConversionDate

Namespace Prefix: SKVI_

Data Type: us-types:durationStringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_ConversionFeatureNumberOfWarrantsToPurchaseForEveryTwoSharesIssued

Namespace Prefix: SKVI_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_DueDate1

Namespace Prefix: SKVI_

Data Type: us-types:durationStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Beneficial Conversion Feature

-URI http://asc.fasb.org/extlink&oid=6505963

+ Details

Name: us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The price per share of the conversion feature embedded in the debt instrument.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 20

-Section 50

-Paragraph 5

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6928298&loc=SL6031898-161870

+ Details

Name: us-gaap_DebtInstrumentConvertibleConversionPrice1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Price of the entity's common stock which would be required to be attained for the conversion feature embedded in the debt instrument to become effective.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentConvertibleStockPriceTrigger

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The average effective interest rate during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentInterestRateDuringPeriod

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
This element represents interest incurred for borrowed money which was used to produce goods or render services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_FinancingInterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromRepaymentsOfNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_RelatedPartyTransactionAxis=us-gaap_ConvertibleNotesPayableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionAxis=SKVI_ConvertibleNotesPayable1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionAxis=SKVI_ConvertibleNotesPayable2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionAxis=SKVI_ConvertibleNotesPayable3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionAxis=SKVI_ConvertibleNotesPayable4Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionAxis=SKVI_ConvertibleNotesPayable5Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionAxis=SKVI_ConvertibleNotesPayable6Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionAxis=SKVI_ConvertibleNotesPayable8Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 25 R9.htm IDEA: XBRL DOCUMENT v3.3.0.814

INTANGIBLE AND OTHER ASSETS
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements

INTANGIBLE AND OTHER ASSETS
Patents and trademarks are capitalized at their historical cost and are amortized over their estimated useful lives. As of September 30, 2015, patents and trademarks total $646,169, net of $330,215 of accumulated amortization. Amortization expense for the nine months ended September 30, 2015 and 2014 was $42,192 and $26,960 respectively.

License and distributor rights (“agreement”) were acquired by the Company in January 1999 and provide exclusive use distribution of polymers and polymer based products. The Company has a non-expiring term on the license and distribution rights. Accordingly, the Company annually assesses this license and distribution rights for impairment and has determined that no impairment write-down is considered necessary as of September 30, 2015.

X

- References
No definition available.
+ Details

Name: SKVI_NotesToFinancialStatementsAbstract

Namespace Prefix: SKVI_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all or part of the information related to intangible assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275

+ Details

Name: us-gaap_IntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 26 R29.htm IDEA: XBRL DOCUMENT v3.3.0.814

STOCK OPTIONS AND WARRANTS - Summary of Options (Details) - $ / shares
3 Months Ended 12 Months Ended

Sep. 30, 2015

Dec. 31, 2014

Stock Options And Warrants - Summary Of Options Details

Options granted and assumed, number of shares 200,000

Options granted and assumed, weighted average exercise price $ 0.05

Options expired, number of shares 200,000

. $ 0.05

Options cancelled, number of shares

Options cancelled, weighted average exercise price

Options exercised, number of shares

Options exercised, weighted average exercise price

Ending Balance, number of shares 9,750,000 9,750,000

Ending Balance, weighted average exercise price $ 0.05 $ 0.05

X

- References
No definition available.
+ Details

Name: SKVI_OptionCancelledPrice

Namespace Prefix: SKVI_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_OptionExercisedPrice

Namespace Prefix: SKVI_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_OptionExpiredPrice

Namespace Prefix: SKVI_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_OptionGrantedPrice

Namespace Prefix: SKVI_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_OptionIssuedPrice

Namespace Prefix: SKVI_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_OptionsCancelled

Namespace Prefix: SKVI_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_OptionsExercised

Namespace Prefix: SKVI_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_OptionsExpired

Namespace Prefix: SKVI_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_OptionsGranted

Namespace Prefix: SKVI_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_OptionsIssued

Namespace Prefix: SKVI_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_SummaryOfOptionsDetailsAbstract

Namespace Prefix: SKVI_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 27 R28.htm IDEA: XBRL DOCUMENT v3.3.0.814

INTANGIBLE AND OTHER ASSETS (Details Narrative) - USD ($)
9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Dec. 31, 2014

Notes to Financial Statements

Patents and trademarks, Gross $ 646,169

Accumulated Amortization 330,215 $ 288,203

Amortization Expense $ 42,192 $ 26,960

X

- References
No definition available.
+ Details

Name: SKVI_AmortizationExpensePatentsAndTrademarks

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_NotesToFinancialStatementsAbstract

Namespace Prefix: SKVI_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land or leased assets).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.14)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The increase (decrease) during the reporting period in intangible assets (for example patents and licenses).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 28 R30.htm IDEA: XBRL DOCUMENT v3.3.0.814

STOCK OPTIONS AND WARRANTS - Summary of Warrants (Details) - $ / shares
9 Months Ended 12 Months Ended

Sep. 30, 2015

Dec. 31, 2014

Temporary Equity Disclosure [Abstract]

Beginning Balance, number of shares 2,541,030

Beginning Balance, weighted average exercise price $ 0.05

Warrants granted and assumed, number of shares 1,000,000

Warrants granted and assumed, weighted average exercise price $ 0.07

Warrants expired, number of shares 1,196,280

Warrants expired, weighted average exercise price $ 0.05

Warrants cancelled, number of shares

Warrants cancelled, weighted average exercise price

Warrants exercised, number of shares

Warrants exercised, weighted average exercise price

Ending Balance, number of shares 2,334,750 2,541,030

Ending Balance, weighted average exercise price $ 0.07 $ 0.05

X

- References
No definition available.
+ Details

Name: SKVI_WarrantsCancelled

Namespace Prefix: SKVI_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_WarrantsCancelledPrice

Namespace Prefix: SKVI_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_WarrantsExercised

Namespace Prefix: SKVI_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_WarrantsExercisedPrice

Namespace Prefix: SKVI_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_WarrantsExpired

Namespace Prefix: SKVI_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_WarrantsExpiredPrice

Namespace Prefix: SKVI_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_WarrantsGranted

Namespace Prefix: SKVI_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_WarrantsGrantedPrice

Namespace Prefix: SKVI_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_WarrantsIssued

Namespace Prefix: SKVI_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_WarrantsIssuedPrice

Namespace Prefix: SKVI_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_TemporaryEquityDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 29 R31.htm IDEA: XBRL DOCUMENT v3.3.0.814

STOCK OPTIONS AND WARRANTS (Details Narrative)
9 Months Ended

Sep. 30, 2015

USD ($)

$ / shares

shares

Stock Options, exercisable 9,750,000

Stock Options Granted 1

Stock Options, Date Granted Mar. 31, 2015

Stock Options, shares 200,000

Stock Options, strick price | $ / shares $ .05

Stock Options, expected life 5 years

Stock Options, value | $ $ 8,800

Expense | $ $ 8,800

X

- References
No definition available.
+ Details

Name: SKVI_Expense

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_StockOptionsDateGranted

Namespace Prefix: SKVI_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_StockOptionsExpectedLife

Namespace Prefix: SKVI_

Data Type: us-types:durationStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 480

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(1)

-URI http://asc.fasb.org/extlink&oid=6940734&loc=d3e22047-110879

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 40

-Section 50

-Paragraph 5

-Subparagraph (a)(2)

-URI http://asc.fasb.org/extlink&oid=6445032&loc=d3e90205-114008

+ Details

Name: us-gaap_OptionIndexedToIssuersEquityStrikePrice1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Net number of share options (or share units) granted during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Value of stock issued as a result of the exercise of stock options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_ClassOfWarrantOrRightAxis=SKVI_StockOptionsGranted1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 30 R8.htm IDEA: XBRL DOCUMENT v3.3.0.814

INVENTORY
9 Months Ended

Sep. 30, 2015

Inventory Disclosure [Abstract]

INVENTORY
Inventory consist of the following as of September 30, 2015 and December 31, 2014

September 30, 2015 December 31, 2014

Shipping and Packing materials $ 13,033 $ 14,758

Marketing Supplies 19,761 -

Finished Goods 7,084 $ 51,756

Raw Materials 49,873 16,641

Total 89,751 83,155

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a, b, c

-Article 5

+ Details

Name: us-gaap_InventoryDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R32.htm IDEA: XBRL DOCUMENT v3.3.0.814

NOTES PAYABLE (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended

Jun. 30, 2015

Sep. 30, 2015

Sep. 30, 2014

Dec. 31, 2014

May. 20, 2014

Loans payable $ 1,549,900

Payments on notes payable $ (89,500)

Twenty Four Notes Payble

Financing Plan Approved May 22, 2013

Secured Promissory Notes, max amount offered $ 1,000,000

Promissory Notes, Interest Rate 9.00%

Promissory Notes, Proceeds $ 1,000,000

Promissory Notes, Due 2 years

Payments on notes payable $ 89,000

Twenty Seven Notes Payable

Financing Plan Approved May 19, 2014

Secured Promissory Notes, max amount offered $ 1,000,000

Promissory Notes, Interest Rate 9.00%

Promissory Notes, Proceeds $ 1,000,000

Promissory Notes, Due 2 years

Eight Notes Payable

Promissory Notes, Interest Rate 9.00%

Promissory Notes, Proceeds $ 208,000

Promissory Notes, Due 2 years

Five Notes Payable

Promissory Notes, Interest Rate 9.00%

Promissory Notes, Proceeds $ 131,000

Promissory Notes, Due 2 years

X

- References
No definition available.
+ Details

Name: SKVI_PromissoryNotesDueDate

Namespace Prefix: SKVI_

Data Type: us-types:durationStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Date the debt instrument was offered for sale, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

+ Details

Name: us-gaap_DebtInstrumentOfferingDate1

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16(a)(2))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_LoansPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cash inflow from borrowings supported by a written promise to pay an obligation that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromSecuredNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow for a borrowing supported by a written promise to pay an obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

+ Details

Name: us-gaap_RepaymentsOfNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_SecuredLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_DebtInstrumentAxis=SKVI_TwentyFourNotesPayableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=SKVI_TwentySevenNotesPayableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=SKVI_EightNotesPayableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=SKVI_FiveNotesPayableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 32 R40.htm IDEA: XBRL DOCUMENT v3.3.0.814

SUBSEQUENT EVENTS (Details Narrative)
9 Months Ended

Sep. 30, 2015

USD ($)

Convertible Note 4

Convertible Note Payable, Date Oct. 26, 2015

Convertible Notes Payable, Value $ 135,000

Interest Rate 9.00%

Maturity Date Oct. 26, 2017

Convertible Notes Payable Related Party 9

Convertible Note Payable, Date Oct. 01, 2015

Convertible Notes Payable, Value $ 108,000

Interest Rate 10.00%

Due Date 5 years

X

- References
No definition available.
+ Details

Name: SKVI_DueDate1

Namespace Prefix: SKVI_

Data Type: us-types:durationStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The average effective interest rate during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentInterestRateDuringPeriod

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Date the debt instrument was issued, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentIssuanceDate1

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(2))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentMaturityDate

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_DebtInstrumentAxis=SKVI_ConvertibleNote4Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=SKVI_ConvertibleNotesPayable9Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 33 R2.htm IDEA: XBRL DOCUMENT v3.3.0.814

Balance Sheets - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Current assets

Cash $ 196,602

Accounts receivable $ 6,833 9,457

Inventory 89,751 83,155

Due from related party $ 1,145 $ 1,145

Prepaid expense and other current assets

Total current assets $ 97,729 $ 290,359

Fixed assets, net of accumulated depreciation of $325,460 and $324,275, respectively 2,090 3,275

Intangible and other assets:

Patents and trademarks, net of accumulated amortization of $330,215 and $288,203, respectively 315,954 352,420

Total assets 415,773 646,054

Current liabilities

Accounts payable and accrued liabilities 728,582 $ 420,762

Bank overdraft 32,787

Accrued interest payable 497,899 $ 348,111

Loans from related party 1,910 $ 1,910

Loans payable 1,549,900

Convertible notes payable, net of unamortized debt discount of $38,046 and $26,822, respectively 1,149,040 $ 1,112,764

Convertible notes payable related party, net of unamortized discount of $634,320 and $874,163, respectively 1,413,111 1,173,178

Total current liabilities 5,373,229 3,056,725

Loans payable 731,600 1,940,000

Total liabilities 6,104,829 4,996,725

Stockholders' deficit

Common stock; $0.001 par value; 200,000,000 shares authorized; 113,957,969 and 111,813,969 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively 114,158 111,814

Additional paid-in capital $ 21,527,741 $ 21,378,656

Stock payable

Accumulated deficit $ (27,330,955) $ (25,841,141)

Total stockholders' deficit (5,689,056) (4,350,671)

Total liabilities and stockholders' deficit $ 415,773 $ 646,054

X

- References
No definition available.
+ Details

Name: SKVI_StockPayable

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amounts due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer) for goods or services (including trade receivables) that have been delivered or sold in the normal course of business.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 3

-Subparagraph a, b

-Article 5

+ Details

Name: us-gaap_AccountsReceivableGrossCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying value as of the balance sheet date of payments made in excess of existing cash balances, which will be honored by the bank but reflected as a loan to the entity. Overdrafts generally have a very short time frame for correction or repayment and are therefore more similar to short-term bank financing than trade financing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 10

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=28361426&loc=d3e1243-112600

+ Details

Name: us-gaap_BankOverdrafts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Cash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16(a))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20, 22

-Article 5

+ Details

Name: us-gaap_ConvertibleNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.3)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.10(3))

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

+ Details

Name: us-gaap_DueFromRelatedParties

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DueToRelatedPartiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e7018-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

+ Details

Name: us-gaap_InterestPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InventoryGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 25

-Article 7

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16(a)(2))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_LoansPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LoansPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a)(5))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_NotesPayableRelatedPartiesClassifiedCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 8

-Article 5

+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 34 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814

DESCRIPTION OF BUSINESS, HISTORY AND SUMMARY OF SIGNIFICANT POLICIES
9 Months Ended

Sep. 30, 2015

Accounting Policies [Abstract]

DESCRIPTION OF BUSINESS, HISTORY AND SUMMARY OF SIGNIFICANT POLICIES

Description of business – Skinvisible, Inc., (referred to as the “Company”) is focused on the development and manufacture and sales of innovative topical, transdermal and mucosal polymer-based delivery system technologies and formulations incorporating its patent-pending formula/process for combining hydrophilic and hydrophobic polymer emulsions. The technologies and formulations have broad industry applications within the pharmaceutical, over-the-counter, personal skincare and cosmetic arenas. Additionally, the Company’s non-dermatological formulations, offer solutions for a broad spectrum of markets women’s health, pain management, and others. The Company maintains executive and sales offices in Las Vegas, Nevada.

History – Skinvisible, Inc. (referred to as the “Company”) was incorporated in Nevada on March 6, 1998, under the name of Microbial Solutions, Inc. The Company underwent a name change on February 26, 1999, when it changed its name to Skinvisible, Inc. The Company’s subsidiary’s name of Manloe Labs, Inc. was also changed to Skinvisible Pharmaceuticals, Inc.

On September 9, 2014, the Company formed Kinatri USA Inc., a new wholly-owned subsidiary, to market a premium line of scientifically formulated skincare products powered by our patented Invisicare® technology. As part of our strategic focus on revenue generation and creating shareholder value, Kintari USA Inc. products will be sold via network marketing.

The Kintari product portfolio consists of anti-aging products to help fight the signs of aging. These products have been developed using proven anti-aging ingredients with scientific evidence of their effectiveness at reducing the look of fine lines and wrinkles resulting in youthful looking skin. These potent ingredients will be powered by patented Invisicare technology, providing consumers with unique, effective products which we believe cannot be duplicated. Additional products will be added to enhance this product line as the company grows and expands.

Skinvisible, Inc. together with its subsidiary shall herein be collectively referred to as the “Company”.

Going concern – The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred cumulative net losses of $27,330,955 since its inception and requires capital for its contemplated operational and marketing activities to take place. The Company’s ability to raise additional capital through the future issuances of common stock is unknown. The obtainment of additional financing, the successful development of the Company’s contemplated plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability to successfully resolve these factors raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties.

Principles of consolidation – The consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated.

Use of estimates – The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Cash and cash equivalents

For purposes of the statement of cash flows, the Company considers all highly liquid investments and short-term debt instruments with original maturities of three months or less to be cash equivalents. There are $0 and $196,602 in cash and cash equivalents as of September 30, 2015 and December 31, 2014, respectively.

Fair Value of Financial Instruments

The carrying amounts reflected in the balance sheets for cash, accounts payable and accrued expenses approximate the respective fair values due to the short maturities of these items.

As required by the Fair Value Measurements and Disclosures Topic of the FASB ASC, fair value is measured based on a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

The three levels of the fair value hierarchy are described below:

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2: Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability;

Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

Revenue recognition

Product sales – Revenues from the sale of products (Invisicare® polymers) are recognized when title to the products are transferred to the customer and only when no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive reasonably assured payments for products sold and delivered.

Royalty sales – The Company also recognizes royalty revenue from licensing its patented product formulations only when earned, when no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive and retain reasonably assured payments.

Distribution and license rights sales – The Company also recognizes revenue from distribution and license rights only when earned (and are amortized over a five year period), when no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive and retain reasonably assured payments.

Costs of Revenue – Cost of revenue includes raw materials, component parts, and shipping supplies. Shipping and handling costs is not a significant portion of the cost of revenue.

Accounts Receivable – Accounts receivable is comprised of uncollateralized customer obligations due under normal trade terms requiring payment within 30 days from the invoice date. The carrying amount of accounts receivable is reviewed periodically for collectability. If management determines that collection is unlikely, an allowance that reflects management’s best estimate of the amounts that will not be collected is recorded. Management reviews each accounts receivable balance that exceeds 30 days from the invoice date and, based on an assessment of creditworthiness, estimates the portion, if any, of the balance that will not be collected. As of September 30, 2015, the Company had not recorded a reserve for doubtful accounts. The Company has $1,000,000 in convertible notes payable which are secured by the accounts receivable of a license agreement the Company has with Women's Choice Pharmaceuticals, LLC on its proprietary prescription product, ProCort®.

Inventory – Substantially all inventory consists of finished goods and are valued based upon first-in first-out ("FIFO") cost, not in excess of market. The determination of whether the carrying amount of inventory requires a write-down is based on an evaluation of inventory.

Goodwill and intangible assets – The Company follows Financial Accounting Standard Board’s (FASB) Codification Topic 350-10 (“ASC 350-10”), “Intangibles – Goodwill and Other”. According to this statement, goodwill and intangible assets with indefinite lives are no longer subject to amortization, but rather an annual assessment of impairment by applying a fair-value based test. Fair value for goodwill is based on discounted cash flows, market multiples and/or appraised values as appropriate. Under ASC 350-10, the carrying value of assets are calculated at the lowest level for which there are identifiable cash flows.



Income taxes – The Company accounts for its income taxes in accordance with FASB Codification Topic ASC 740-10, “Income Taxes”, which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

Stock-based compensation – The Company follows the guidelines in FASB Codification Topic ASC 718-10 “Compensation-Stock Compensation”, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees and directors including employee stock options and employee stock purchases related to a Employee Stock Purchase Plan based on the estimated fair values.

Stock based compensation expense recognized under ASC 718-10 for the year ended September 30, 2015 and December 31, 2014 totaled $8,800 and $54,450, respectively.

Earnings (loss) per share – The Company reports earnings (loss) per share in accordance with FASB Codification Topic ASC 260-10 “Earnings Per Share”, Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted average number of common shares available. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Diluted earnings (loss) per share has not been presented since the effect of the assumed exercise of options and warrants to purchase common shares (common stock equivalents) would have an anti-dilutive effect.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.
+ References
No definition available.
+ Details

Name: us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R35.htm IDEA: XBRL DOCUMENT v3.3.0.814

CONVERTIBLE NOTES PAYABLE RELATED PARTY - Convertible Notes Payable Related Party Disclouser (Details) - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Notes to Financial Statements

Convertible Note Payable #1 $ 1,071,593 $ 1,071,593

Unamortized Debt Discount (208,939) (333,483)

Convertible Note Payable #2 321,032 321,032

Unamortized Debt Discount (72,788) (103,886)

Convertible Note Payable #3 182,083 182,083

Unamortized Debt Discount (82,054) (109,277)

Convertible Note Payable #4 106,152 106,152

Unamortized Debt Discount (38,912) (49,491)

Convertible Note Payable #5 142,501 142,501

Unamortized Debt Discount (61,748) (75,937)

Convertible Note Payable #6 118,126 118,126

Unamortized Debt Discount (88,562) (106,223)

Convertible Note Payable #7 40,558 40,558

Unamortized Debt Discount (32,377) (38,427)

Convertible Note Payable #8 65,295 65,295

Unamortized Debt Discount (48,850) (57,438)

Convertible Notes Payable $ 1,413,111 $ 1,173,178

X

- References
No definition available.
+ Details

Name: SKVI_ConvertibleNotePayableRelatedParty1

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_ConvertibleNotePayableRelatedParty2

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_ConvertibleNotePayableRelatedParty3

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_ConvertibleNotePayableRelatedParty4

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_ConvertibleNotePayableRelatedParty5

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_ConvertibleNotePayableRelatedParty6

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_ConvertibleNotePayableRelatedParty7

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_ConvertibleNotePayableRelatedParty8

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_DebtInstrumentUnamortizedDiscount2

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_DebtInstrumentUnamortizedDiscount3

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_DebtInstrumentUnamortizedDiscount4

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_DebtInstrumentUnamortizedDiscount5

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_DebtInstrumentUnamortizedDiscount6

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_DebtInstrumentUnamortizedDiscount7

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_DebtInstrumentUnamortizedDiscount8

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_NotesToFinancialStatementsAbstract

Namespace Prefix: SKVI_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

+ Details

Name: us-gaap_DebtInstrumentUnamortizedDiscount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a)(5))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_NotesPayableRelatedPartiesClassifiedCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 36 R22.htm IDEA: XBRL DOCUMENT v3.3.0.814

CONVERTIBLE NOTES PAYABLE (Tables)
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements

Schedule of Conversions of Stock

Convertible Notes Payable at consists of the following: September 30, December 31,

2015 2014

$52,476 face value,10% unsecured note payable to an investor, note interest and principal are due on demand. The note could be converted to option rights for Skinvisible, Inc. shares at ten cents per share ($0.10), these rights expired January 12, 2010. The Note is currently in default, no penalties occur due to default. $ 28,476 $ 28,476

Unamortized debt discount — —

Total, net of unamortized discount 28,476 28,476

$1,000,000 face value 9% unsecured notes payable to investors, due in 2015. At the investor’s option until the repayment date, the note and related interest may be converted to shares of the Company’s common stock a discount of 90% of the current share price after the first anniversary of the note. The Notes are secured by the accounts receivable of a license agreement the Company has with Womens Choice Pharmaceuticals, LLC on its proprietary prescription product, ProCort®. The Company has determined the value associated with the beneficial conversion feature in connection with the notes and interest to be $111,110. The aggregate original issue discount feature has been accreted and charged to interest expenses as a financing expense in the amount of $31,078 during the nine months ended September 30, 2015. The original issue discount feature is valued under the intrinsic value method.

On the Company executed extension agreements with several note holder who's note had reached maturity. The notes were extended for an additional 12 months.
1,000,000 1,000,000

Original issue discount 111,110 111,110

Unamortized debt discount (3,724 ) (26,822 )

Total, net of unamortized discount 1,107,386 1,084,288

On July 28, 2015, we entered into a convertible promissory note pursuant to which we borrowed $47,500. Interest under the convertible promissory note is 8% per annum, and the principal and all accrued but unpaid interest is due on April 30, 2016. The note is convertible at any time following 180 days after the issuance date at noteholders option into shares of our common stock at a variable conversion price of 58% of the lowest average three day market price of our common stock during the 10 trading days prior to the notice of conversion, subject to adjustment as described in the note. The holder’s ability to convert the note, however, is limited in that it will not be permitted to convert any portion of the note if the number of shares of our common stock beneficially owned by the holder and its affiliates, together with the number of shares of our common stock issuable upon any full or partial conversion, would exceed 9.99% of our outstanding shares of common stock.

The Company has determined the value associated with the beneficial conversion feature in connection with the notes negotiated on July 28, 2015 to be $34,397. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $7,947 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method
47,500 —

Unamortized debt discount (34,322 ) —

Total, net of unamortized discount 13,178 —

$ 1,149,040 $ 1,112,764

X

- References
No definition available.
+ Details

Name: SKVI_NotesToFinancialStatementsAbstract

Namespace Prefix: SKVI_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of information related to converting stock into another financial instrument(s) in a noncash (or part noncash) transaction.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

+ Details

Name: us-gaap_ScheduleOfConversionsOfStockTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 37 R36.htm IDEA: XBRL DOCUMENT v3.3.0.814

CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)
9 Months Ended

Sep. 30, 2015

Dec. 31, 2014

Convertible Note 1

Convertible Notes Payable, Value $ 52,476

Interest Rate 10.00%

Option Rights, Price per Share $ 0.10

Expiration Date Jan. 12, 2010

Convertible Note 2

Convertible Notes Payable, Value $ 1,000,000

Interest Rate 9.00%

Expiration Date Oct. 01, 2016

Beneficial conversion feature $ 111,110

Financing expense $ 20,689

Convertible Note 3

Convertible Notes Payable, Value $ 47,500

Interest Rate 8.00%

Expiration Date Apr. 30, 2016

Beneficial conversion feature $ 34,397

Financing expense $ 7,947

X

- References
No definition available.
+ Details

Name: SKVI_OptionRightsPricePerShare

Namespace Prefix: SKVI_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Expiration date of the option.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 12

-Section 13

-Footnote 5

+ Details

Name: invest_InvestmentOptionsExpirationDate

Namespace Prefix: invest_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Beneficial Conversion Feature

-URI http://asc.fasb.org/extlink&oid=6505963

+ Details

Name: us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
This element represents interest incurred for borrowed money which was used to produce goods or render services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_FinancingInterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_StatementScenarioAxis=SKVI_ConvertibleNote1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementScenarioAxis=SKVI_ConvertibleNote2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementScenarioAxis=SKVI_ConvertibleNote3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 38 R24.htm IDEA: XBRL DOCUMENT v3.3.0.814

DESCRIPTION OF BUSINESS, HISTORY AND SUMMARY OF SIGNIFICANT POLICIES (Details Narrative) - USD ($)
9 Months Ended 12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Dec. 31, 2014

Dec. 31, 2013

Accounting Policies [Abstract]

Date of Incorporation Mar. 06, 1998

Accumulated Deficit $ (27,330,955) $ (25,841,141)

Cash $ 258,306 196,602 $ 513,420

Convertible Notes Payable $ 1,000,000

Stock based compenstation $ 8,800 $ 31,050 $ 54,450

X

- Definition
Date when an entity was incorporated
+ References
No definition available.
+ Details

Name: dei_EntityIncorporationDateOfIncorporation

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Cash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_ConvertibleNotesPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 39 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 40 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814

FIXED ASSETS
9 Months Ended

Sep. 30, 2015

Property, Plant and Equipment [Abstract]

FIXED ASSETS
Fixed assets consist of the following as of September 30, 2015 and December 31, 2014:

September 30, 2015 December 31, 2014

Machinery and equipment $ 48,163 $ 48,163

Furniture and fixtures 113,635 113,635

Computers, equipment and software 39,722 39,722

Leasehold improvements 12,569 12,569

Lab equipment 113,461 113,461

Total 327,550 327,550

Less: accumulated depreciation (325,460) (324,275)

Fixed assets, net of accumulated depreciation $ 2,090 $ 3,275

Depreciation expense for the nine months ended September 30, 2015 and 2014 was $1,185 and $1,067, respectively.

X

- References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13-14)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51719941&loc=d3e2921-110230

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

+ Details

Name: us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 41 R3.htm IDEA: XBRL DOCUMENT v3.3.0.814

Balance Sheets (Parenthetical) - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Statement of Financial Position [Abstract]

Common Stock, Par Value $ .001 $ 0.001

Common Stock, Shares Authorized 200,000,000 200,000,000

Common Stock, Issued 113,957,969 111,813,969

Accumulated Depreciation $ 325,460 $ 324,275

Convertible Notes Payable, net of unamortized debt discount 38,046 26,822

Convertible Notes Payable, related party, net of unamortized discount 634,320 874,163

Accumulated Amortization $ 330,215 $ 288,203

X

- References
No definition available.
+ Details

Name: SKVI_DebtInstrumentRelatedPartyUnamortizedDiscountPremiumNet

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.14)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land or leased assets).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.14)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The amount of debt discount (net of debt premium) that was originally recognized at the issuance of the instrument that has yet to be amortized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28567-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28555-108399

+ Details

Name: us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfFinancialPositionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 42 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814

SUBSEQUENT EVENTS
9 Months Ended

Sep. 30, 2015

Subsequent Events [Abstract]

SUBSEQUENT EVENTS
On October 26, 2015, we entered into a convertible promissory note pursuant to which we borrowed $135,000. Interest under the convertible promissory note is 9% per annum, and the principal and all accrued but unpaid interest is due on October 26, 2017. The note is convertible at any time following the third month anniversary after the issuance date at noteholders option into shares of our common stock at a variable conversion price of 90% of the average of the Trading Prices for the common stock during the five Trading Day period ending on the latest complete Trading Day prior to the Conversion Date, subject to adjustment as described in the note. The holder’s ability to convert the note, however, is limited in that it will not be permitted to convert any portion of the note if the number of shares of our common stock beneficially owned by the holder and its affiliates, together with the number of shares of our common stock issuable upon any full or partial conversion, would exceed 4.99% of our outstanding shares of common stock.

On October 1, 2015, we entered into a convertible promissory note with Greg McCartney a director of the Company. The $10,800 face value promissory note is unsecured, due five years from issuance, and bears an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.02 per share along with an additional warrant to purchase one share for every two shares issued at the exercise price of $0.03 per share for three years after the conversion date.

X

- References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 43 R1.htm IDEA: XBRL DOCUMENT v3.3.0.814

Document and Entity Information - shares
9 Months Ended

Sep. 30, 2015

Oct. 25, 2015

Document And Entity Information

Entity Registrant Name SKINVISIBLE INC

Entity Central Index Key 0001085277

Document Type 10-Q

Document Period End Date Sep. 30, 2015

Amendment Flag false

Current Fiscal Year End Date --12-31

Is Entity a Well-known Seasoned Issuer? No

Is Entity a Voluntary Filer? No

Is Entity's Reporting Status Current? Yes

Entity Filer Category Smaller Reporting Company

Entity Common Stock, Shares Outstanding 114,157,969

Document Fiscal Period Focus Q3

Document Fiscal Year Focus 2015

X

- References
No definition available.
+ Details

Name: SKVI_DocumentAndEntityInformationAbstract

Namespace Prefix: SKVI_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
+ References
No definition available.
+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
+ References
No definition available.
+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

XML 44 R18.htm IDEA: XBRL DOCUMENT v3.3.0.814

DESCRIPTION OF BUSINESS, HISTORY AND SUMMARY OF SIGNIFICANT POLICIES (Policies)
9 Months Ended

Sep. 30, 2015

Accounting Policies [Abstract]

Description of Business
Skinvisible, Inc., (referred to as the “Company”) is focused on the development and manufacture and sales of innovative topical, transdermal and mucosal polymer-based delivery system technologies and formulations incorporating its patent-pending formula/process for combining hydrophilic and hydrophobic polymer emulsions. The technologies and formulations have broad industry applications within the pharmaceutical, over-the-counter, personal skincare and cosmetic arenas. Additionally, the Company’s non-dermatological formulations, offer solutions for a broad spectrum of markets women’s health, pain management, and others. The Company maintains executive and sales offices in Las Vegas, Nevada.

History
Skinvisible, Inc. (referred to as the “Company”) was incorporated in Nevada on March 6, 1998, under the name of Microbial Solutions, Inc. The Company underwent a name change on February 26, 1999, when it changed its name to Skinvisible, Inc. The Company’s subsidiary’s name of Manloe Labs, Inc. was also changed to Skinvisible Pharmaceuticals, Inc.

On September 9, 2014, the Company formed Kinatri USA Inc., a new wholly-owned subsidiary, to market a premium line of scientifically formulated skincare products powered by our patented Invisicare® technology. As part of our strategic focus on revenue generation and creating shareholder value, Kintari USA Inc. products will be sold via network marketing.

The Kintari product portfolio consists of anti-aging products to help fight the signs of aging. These products have been developed using proven anti-aging ingredients with scientific evidence of their effectiveness at reducing the look of fine lines and wrinkles resulting in youthful looking skin. These potent ingredients will be powered by patented Invisicare technology, providing consumers with unique, effective products which we believe cannot be duplicated. Additional products will be added to enhance this product line as the company grows and expands.

Skinvisible, Inc. together with its subsidiary shall herein be collectively referred to as the “Company”.

Going Concern
The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred cumulative net losses of $27,330,955 since its inception and requires capital for its contemplated operational and marketing activities to take place. The Company’s ability to raise additional capital through the future issuances of common stock is unknown. The obtainment of additional financing, the successful development of the Company’s contemplated plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability to successfully resolve these factors raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties.

Principles of Consolidation
The consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated.

Use of Estimates
The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

For purposes of the statement of cash flows, the Company considers all highly liquid investments and short-term debt instruments with original maturities of three months or less to be cash equivalents. There are $0 and $196,602 in cash and cash equivalents as of September 30, 2015 and December 31, 2014, respectively.

Fair Value of Financial Instruments

The carrying amounts reflected in the balance sheets for cash, accounts payable and accrued expenses approximate the respective fair values due to the short maturities of these items.

As required by the Fair Value Measurements and Disclosures Topic of the FASB ASC, fair value is measured based on a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

The three levels of the fair value hierarchy are described below:

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2: Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability;

Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

Revenue Recognition

Product sales – Revenues from the sale of products (Invisicare® polymers) are recognized when title to the products are transferred to the customer and only when no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive reasonably assured payments for products sold and delivered.

Royalty sales – The Company also recognizes royalty revenue from licensing its patented product formulations only when earned, when no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive and retain reasonably assured payments.

Distribution and license rights sales – The Company also recognizes revenue from distribution and license rights only when earned (and are amortized over a five year period), when no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive and retain reasonably assured payments.

Costs of Revenue – Cost of revenue includes raw materials, component parts, and shipping supplies. Shipping and handling costs is not a significant portion of the cost of revenue.

Accounts Receivable
Accounts receivable is comprised of uncollateralized customer obligations due under normal trade terms requiring payment within 30 days from the invoice date. The carrying amount of accounts receivable is reviewed periodically for collectability. If management determines that collection is unlikely, an allowance that reflects management’s best estimate of the amounts that will not be collected is recorded. Management reviews each accounts receivable balance that exceeds 30 days from the invoice date and, based on an assessment of creditworthiness, estimates the portion, if any, of the balance that will not be collected. As of September 30, 2015, the Company had not recorded a reserve for doubtful accounts. The Company has $1,000,000 in convertible notes payable which are secured by the accounts receivable of a license agreement the Company has with Women's Choice Pharmaceuticals, LLC on its proprietary prescription product, ProCort®.

Inventory
Substantially all inventory consists of finished goods and are valued based upon first-in first-out ("FIFO") cost, not in excess of market. The determination of whether the carrying amount of inventory requires a write-down is based on an evaluation of inventory.

Goodwill and Intangible Assets
The Company follows Financial Accounting Standard Board’s (FASB) Codification Topic 350-10 (“ASC 350-10”), “Intangibles – Goodwill and Other”. According to this statement, goodwill and intangible assets with indefinite lives are no longer subject to amortization, but rather an annual assessment of impairment by applying a fair-value based test. Fair value for goodwill is based on discounted cash flows, market multiples and/or appraised values as appropriate. Under ASC 350-10, the carrying value of assets are calculated at the lowest level for which there are identifiable cash flows.

Income Taxes
The Company accounts for its income taxes in accordance with FASB Codification Topic ASC 740-10, “Income Taxes”, which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

Stock-based Compensation
The Company follows the guidelines in FASB Codification Topic ASC 718-10 “Compensation-Stock Compensation”, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees and directors including employee stock options and employee stock purchases related to a Employee Stock Purchase Plan based on the estimated fair values.

Stock based compensation expense recognized under ASC 718-10 for the year ended September 30, 2015 and December 31, 2014 totaled $8,800 and $54,450, respectively.

Earnings (loss) Per Share
The Company reports earnings (loss) per share in accordance with FASB Codification Topic ASC 260-10 “Earnings Per Share”, Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted average number of common shares available. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Diluted earnings (loss) per share has not been presented since the effect of the assumed exercise of options and warrants to purchase common shares (common stock equivalents) would have an anti-dilutive effect.

X

- References
No definition available.
+ Details

Name: SKVI_BusinessHistoryPolicyTextBlock

Namespace Prefix: SKVI_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_SubstantialDoubtAboutGoingConcernPolicyTextBlock

Namespace Prefix: SKVI_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 305

-SubTopic 10

-Section 05

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6375392&loc=d3e26790-107797

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Financial Reporting Release (FRR)

-Number 203

-Paragraph 02-03

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_CashAndCashEquivalentsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.3A-02)

-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355033-122828

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph k

-Article 1

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02, 03

-Article 3A

+ Details

Name: us-gaap_ConsolidationPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for determining the fair value of financial instruments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13279-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 60

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260

+ Details

Name: us-gaap_FairValueOfFinancialInstrumentsPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32840-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 30

-Section 05

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6423966&loc=d3e40913-109327

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 740

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 17

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32809-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e32247-109318

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e32280-109318

+ Details

Name: us-gaap_IncomeTaxPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for major classes of inventories, bases of stating inventories (for example, lower of cost or market), methods by which amounts are added and removed from inventory classes (for example, FIFO, LIFO, or average cost), loss recognition on impairment of inventories, and situations in which inventories are stated above cost. If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28360613&loc=d3e4492-108314

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=28360613&loc=d3e4556-108314

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Financial Reporting Release (FRR)

-Number 206

-Paragraph b

-Subparagraph i, ii

-Chapter 2

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a

-Article 5

+ Details

Name: us-gaap_InventoryPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for trade and other accounts receivable, and finance, loan and lease receivables, including those classified as held for investment and held for sale. This disclosure may include (1) the basis at which such receivables are carried in the entity's statements of financial position (2) how the level of the valuation allowance for receivables is determined (3) when impairments, charge-offs or recoveries are recognized for such receivables (4) the treatment of origination fees and costs, including the amortization method for net deferred fees or costs (5) the treatment of any premiums or discounts or unearned income (6) the entity's income recognition policies for such receivables, including those that are impaired, past due or placed on nonaccrual status and (7) the treatment of foreclosures or repossessions (8) the nature and amount of any guarantees to repurchase receivables.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6378556&loc=d3e10133-111534

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=49124121&loc=d3e4975-111524

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3-5

-Article 5

+ Details

Name: us-gaap_ReceivablesPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18823-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.B.Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section B

-Paragraph Question 1

+ Details

Name: us-gaap_RevenueRecognitionPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b),(f)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6061-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6143-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6132-108592

+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 45 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814

Statements of Operations - USD ($)
3 Months Ended 9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

Income Statement [Abstract]

Revenues $ 30,377 $ 22,303 $ 158,428 $ 41,276

Cost of revenues 9,859 674 56,047 3,907

Gross profit 20,518 21,629 102,381 37,369

Operating expenses

Depreciation and amortization 14,631 9,680 43,377 28,027

Selling general and administrative 255,436 373,101 900,605 758,997

Total operating expenses 270,067 382,781 943,982 787,024

Loss from operations $ (249,549) (361,152) (841,601) (749,655)

Other income and (expense)

Other income 70 26 258

Interest expense $ (232,107) (200,944) (650,079) (551,872)

Gain on extinguishment of debt 400 (4,054) 1,840 (5,044)

Total other expense (231,707) (204,928) (648,213) (556,658)

Net loss $ (481,256) $ (566,080) $ (1,489,814) $ (1,306,313)

Basic loss per common share $ (0.00) $ (0.01) $ (0.01) $ (0.01)

Basic weighted average common shares outstanding 113,957,969 111,609,529 113,957,969 111,317,222

X

- Definition
The aggregate cost of goods produced and sold and services rendered during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_CostOfRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12317-112629

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12355-112629

+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1,2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.23)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsPerBasicShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.9)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This element represents a sum total of expenses not separately reflected on the income statement for the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.7)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4,6)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Reflects the sum of all other revenue and income recognized by the entity in the period not otherwise specified in the income statement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.4)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

+ Details

Name: us-gaap_OtherIncome

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 30

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51677171&loc=d3e3636-108311

+ Details

Name: us-gaap_SellingGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Weighted-Average Number of Common Shares Outstanding

-URI http://asc.fasb.org/extlink&oid=6528421

+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 46 R12.htm IDEA: XBRL DOCUMENT v3.3.0.814

RELATED PARTY TRANSACTIONS
9 Months Ended

Sep. 30, 2015

Related Party Transactions [Abstract]

RELATED PARTY TRANSACTIONS
During the year ended 2013 various officers advanced funds to support the daily operations of the company. As of September 30, 2015, $1,910 remained due to related parties as repayment for advanced monies, all related other party notes have been extinguished or re-negotiated as convertible notes. See note 10.

X

- References
No definition available.
+ Details

Name: us-gaap_RelatedPartyTransactionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph b

-Article 3A

+ Details

Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 47 R11.htm IDEA: XBRL DOCUMENT v3.3.0.814

NOTES PAYABLE
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements

NOTES PAYABLE
On May 22, 2013 the Company approved a financing plan to offer accredited investors up to $1,000,000 in secured promissory notes. During the year ended December 31, 2013 the Company entered into twenty-four 9% notes payable to investors and received total proceeds of $1,000,000. The notes are due two years from the anniversary date of execution. The Notes are secured by the US Patent rights granted for the Company's Sunscreen Products: US patent number #8,128,913: "Sunscreen Composition with Enhanced UV-A Absorber Stability and Methods". As of September 30, 2015 several notes had reached their initial maturity date, all note holders executed agreements extending the note for an additional 12 months upon the same terms. During the nine months ending September 30, 2015 the Company made principal payments of $89,000.

On May 19, 2014 the Company approved a financing plan to offer accredited investors up to an additional $1,000,000 in secured promissory notes. For the period from May 19, 2014 to March 31, 2015 the Company entered into twenty-seven 9% notes payable to investors and received total proceeds of $1,000,000. The notes are due two years from the anniversary date of execution. The Notes are secured by the US Patent rights granted for the Company's Sunscreen Products: US patent number #8,128,913: "Sunscreen Composition with Enhanced UV-A Absorber Stability and Methods".

During the three months ended June 30, 2015 the Company entered into eight additional 9% notes payable to investors and received total proceeds of $208,000. The notes are due two years from the anniversary date of execution. The Notes are secured by the US Patent rights granted for the Company's Sunscreen Products: US patent number #8,128,913: "Sunscreen Composition with Enhanced UV-A Absorber Stability and Methods".

During the three months ended June 30, 2015 the Company entered into five additional 9% notes payable to investors and received total proceeds of $131,000. The notes are due two years from the anniversary date of execution. The Notes are secured by the US Patent rights granted for the Company's Sunscreen Products: US patent number #8,128,913: "Sunscreen Composition with Enhanced UV-A Absorber Stability and Methods".

As of September 30, 2015 $1,549,900 of the Notes were due in less than 12 months and have been classified as Current notes payable.

X

- References
No definition available.
+ Details

Name: SKVI_NotesPayableDisclosureTextBlock

Namespace Prefix: SKVI_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_NotesToFinancialStatementsAbstract

Namespace Prefix: SKVI_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 48 R23.htm IDEA: XBRL DOCUMENT v3.3.0.814

CONVERTIBLE NOTES PAYABLE RELATED PARTY (Tables)
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements

Convertible Notes Payable Related Party Disclosure

Convertible Notes Payable Related Party at consists of the following: September 30, December 31,

2015 2014

On December 31, 2011, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, the notes dated before December 31, 2010, and all salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.06 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes negotiated on December 31, 2011 to be $1,123,078. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $124,544 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method. In the year ending December 2013, the Company made $51,485 in cash payments to reduce the note balance. 1,071,593 1,071,593

Unamortized debt discount (208,939 ) (333,483 )

On June 30, 2012, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, the notes dated before July 1, 2011, and all salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.06 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $209,809. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $31,098 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method. On January 18, 2013, the Company made a $3,990 cash payment to reduce the note balance. 321,032 321,032

Unamortized debt discount (72,788 ) (103,886 )

On December 30 and 31, 2012, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, $182,083 of related party notes accrued interest and salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $182,083 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.03 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.04 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $182,083. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $27,223 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method. 182,083 182,083

Unamortized debt discount (82,054 ) (109,277 )

On June 30, 2013, the Company re-negotiated accrued salaries and interest for two employees. Under the terms of the agreements, $106,153 of accrued interest and salaries were converted to promissory notes convertible into common stock with a warrant feature. The $106,153 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.03 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.04 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $70,768. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $10,579 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method. 106,152 106,152

Unamortized debt discount (38,912 ) (49,491 )

On December 31, 2013, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, $142,501 of accrued interest and salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $142,501 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.03 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.04 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $94,909. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $14,189 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method. 142,501 142,501

Unamortized debt discount (61,748 ) (75,937 )

On June 30, 2014, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, $118,126 of accrued salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $118,126 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.025 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.03 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $118,126. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $17,661 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method. 118,126 118,126

Unamortized debt discount (88,562 ) (106,223 )

On September 30, 2014, the Company re-negotiated accrued salaries and interest for two employees. Under the terms of the agreements, $40,558 of accrued salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $40,558 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.05 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $40,466. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $6,050 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method. 40,558 40,558

Unamortized debt discount (32,377 ) (38,427 )

On December 31, 2014, the Company re-negotiated accrued salaries and interest for two employees. Under the terms of the agreements, $65,295 of accrued salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $65,295 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.05 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $57,439. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $8,589 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method. 65,295 65,295

Unamortized debt discount (48,850 ) (57,438 )

$ 1,413,110 $ 1,173,178

X

- References
No definition available.
+ Details

Name: SKVI_ConvertibleNotesPayableRelatedPartyTableTextBlock

Namespace Prefix: SKVI_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_NotesToFinancialStatementsAbstract

Namespace Prefix: SKVI_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 49 R19.htm IDEA: XBRL DOCUMENT v3.3.0.814

FIXED ASSETS (Tables)
9 Months Ended

Sep. 30, 2015

Property, Plant and Equipment [Abstract]

Schedule of Property and Plan Equipment

September 30, 2015 December 31, 2014

Machinery and equipment $ 48,163 $ 48,163

Furniture and fixtures 113,635 113,635

Computers, equipment and software 39,722 39,722

Leasehold improvements 12,569 12,569

Lab equipment 113,461 113,461

Total 327,550 327,550

Less: accumulated depreciation (325,460) (324,275)

Fixed assets, net of accumulated depreciation $ 2,090 $ 3,275

X

- References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph b

-Article 5

+ Details

Name: us-gaap_PropertyPlantAndEquipmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 50 R15.htm IDEA: XBRL DOCUMENT v3.3.0.814

STOCKHOLDERS DEFICIT
9 Months Ended

Sep. 30, 2015

Equity [Abstract]

STOCKHOLDERS DEFICIT
The Company is authorized to issue 200,000,000 shares of $0.001 par value common stock. The Company had 113,957,969 and 111,813,969 issued and outstanding shares of common stock as of September 30, 2015 and December 31, 2014, respectively.

On January 26, 2015 the Company received $50,000 pursuant to a private placement agreement with an investor to purchase 1,250,000 shares of Skinvisible Inc. $0.001 par value common stock and 625,000 warrants. The warrants allow the holder to purchase shares of the Company's common stock at $0.07 on or before January 21, 2016.

On January 27, 2015 the Company received $30,000 pursuant to a private placement agreement with an investor to purchase 750,000 shares of Skinvisible Inc. $0.001 par value common stock and 375,000 warrants. The warrants allow the holder to purchase shares of the Company's common stock at $0.07 on or before January 21, 2016.

On April 1, 2015, 72,000 shares were issued to settle $3,600 of accrued expenses due to a director of the Company.

On June 30, 2015, 72,000 shares were issued to settle $3,600 of accrued expenses due to a director of the Company. A gain of $1,440 was recognized as a result of this settlement.

On August 24, 2015, the company settled $6,000 of debt due to two parties with 200,000 shares of common stock. A gain of $400 was recognized as a result of this settlement.

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 51 R13.htm IDEA: XBRL DOCUMENT v3.3.0.814

CONVERTIBLE NOTES PAYABLE
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements

CONVERTIBLE NOTES PAYABLE

Convertible Notes Payable at consists of the following: September 30, December 31,

2015 2014

$52,476 face value,10% unsecured note payable to an investor, note interest and principal are due on demand. The note could be converted to option rights for Skinvisible, Inc. shares at ten cents per share ($0.10), these rights expired January 12, 2010. The Note is currently in default, no penalties occur due to default. $ 28,476 $ 28,476

Unamortized debt discount — —

Total, net of unamortized discount 28,476 28,476

$1,000,000 face value 9% unsecured notes payable to investors, due in 2015. At the investor’s option until the repayment date, the note and related interest may be converted to shares of the Company’s common stock a discount of 90% of the current share price after the first anniversary of the note. The Notes are secured by the accounts receivable of a license agreement the Company has with Womens Choice Pharmaceuticals, LLC on its proprietary prescription product, ProCort®. The Company has determined the value associated with the beneficial conversion feature in connection with the notes and interest to be $111,110. The aggregate original issue discount feature has been accreted and charged to interest expenses as a financing expense in the amount of $31,078 during the nine months ended September 30, 2015. The original issue discount feature is valued under the intrinsic value method.

On the Company executed extension agreements with several note holder who's note had reached maturity. The notes were extended for an additional 12 months.
1,000,000 1,000,000

Original issue discount 111,110 111,110

Unamortized debt discount (3,724 ) (26,822 )

Total, net of unamortized discount 1,107,386 1,084,288

On July 28, 2015, we entered into a convertible promissory note pursuant to which we borrowed $47,500. Interest under the convertible promissory note is 8% per annum, and the principal and all accrued but unpaid interest is due on April 30, 2016. The note is convertible at any time following 180 days after the issuance date at noteholders option into shares of our common stock at a variable conversion price of 58% of the lowest average three day market price of our common stock during the 10 trading days prior to the notice of conversion, subject to adjustment as described in the note. The holder’s ability to convert the note, however, is limited in that it will not be permitted to convert any portion of the note if the number of shares of our common stock beneficially owned by the holder and its affiliates, together with the number of shares of our common stock issuable upon any full or partial conversion, would exceed 9.99% of our outstanding shares of common stock.

The Company has determined the value associated with the beneficial conversion feature in connection with the notes negotiated on July 28, 2015 to be $34,397. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $7,947 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method
47,500 —

Unamortized debt discount (34,322 ) —

Total, net of unamortized discount 13,178 —

$ 1,149,040 $ 1,112,764

X

- References
No definition available.
+ Details

Name: SKVI_ConvertibleNotesPayableTextBlock

Namespace Prefix: SKVI_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_NotesToFinancialStatementsAbstract

Namespace Prefix: SKVI_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 52 R14.htm IDEA: XBRL DOCUMENT v3.3.0.814

CONVERTIBLE NOTES PAYABLE RELATED PARTY
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements

CONVERTIBLE NOTES PAYABLE RELATED PARTY

Convertible Notes Payable Related Party at consists of the following: September 30, December 31,

2015 2014

On December 31, 2011, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, the notes dated before December 31, 2010, and all salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.06 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes negotiated on December 31, 2011 to be $1,123,078. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $124,544 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method. In the year ending December 2013, the Company made $51,485 in cash payments to reduce the note balance. 1,071,593 1,071,593

Unamortized debt discount (208,939 ) (333,483 )

On June 30, 2012, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, the notes dated before July 1, 2011, and all salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.06 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $209,809. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $31,098 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method. On January 18, 2013, the Company made a $3,990 cash payment to reduce the note balance. 321,032 321,032

Unamortized debt discount (72,788 ) (103,886 )

On December 30 and 31, 2012, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, $182,083 of related party notes accrued interest and salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $182,083 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.03 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.04 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $182,083. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $27,223 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method. 182,083 182,083

Unamortized debt discount (82,054 ) (109,277 )

On June 30, 2013, the Company re-negotiated accrued salaries and interest for two employees. Under the terms of the agreements, $106,153 of accrued interest and salaries were converted to promissory notes convertible into common stock with a warrant feature. The $106,153 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.03 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.04 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $70,768. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $10,579 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method. 106,152 106,152

Unamortized debt discount (38,912 ) (49,491 )

On December 31, 2013, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, $142,501 of accrued interest and salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $142,501 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.03 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.04 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $94,909. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $14,189 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method. 142,501 142,501

Unamortized debt discount (61,748 ) (75,937 )

On June 30, 2014, the Company re-negotiated accrued salaries and interest for three employees. Under the terms of the agreements, $118,126 of accrued salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $118,126 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.025 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.03 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $118,126. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $17,661 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method. 118,126 118,126

Unamortized debt discount (88,562 ) (106,223 )

On September 30, 2014, the Company re-negotiated accrued salaries and interest for two employees. Under the terms of the agreements, $40,558 of accrued salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $40,558 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.05 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $40,466. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $6,050 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method. 40,558 40,558

Unamortized debt discount (32,377 ) (38,427 )

On December 31, 2014, the Company re-negotiated accrued salaries and interest for two employees. Under the terms of the agreements, $65,295 of accrued salaries not previously converted were converted to promissory notes convertible into common stock with a warrant feature. The $65,295 face value promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.04 per share along with additional warrants to purchase one share for every two shares issued at the exercise price of $0.05 per share for three years after the conversion date. The Company has determined the value associated with the beneficial conversion feature in connection with the notes to be $57,439. The aggregate beneficial conversion feature has been accreted and charged to interest expenses as a financing expense in the amount of $8,589 during the nine months ending September 30, 2015. The beneficial conversion feature is valued under the intrinsic value method. 65,295 65,295

Unamortized debt discount (48,850 ) (57,438 )

$ 1,413,110 $ 1,173,178

X

- References
No definition available.
+ Details

Name: SKVI_ConvertibleNotesPayableRelatedPartyTextBlock

Namespace Prefix: SKVI_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_NotesToFinancialStatementsAbstract

Namespace Prefix: SKVI_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 53 R16.htm IDEA: XBRL DOCUMENT v3.3.0.814

COMMITMENTS AND CONTINGENCIES
9 Months Ended

Sep. 30, 2015

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES
Lease obligations – The Company has operating leases for its offices. Future minimum lease payments under the operating leases for the facilities as of September 30, 2015, are as follows:

2015 12,042

2016 5,717

Rental expense, resulting from operating lease agreements, approximated $32,619 and $31,368 for the nine months ended September 30, 2015 and 2014, respectively.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51674963&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 54 R34.htm IDEA: XBRL DOCUMENT v3.3.0.814

CONVERTIBLE NOTES PAYABLE - Schedule of Conversions of Stock (Details) - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Convertible Notes Payable $ 1,149,040 $ 1,112,764

Convertible Note 3

Convertible Note Payable #1

Unamortized debt discount

Convertible Note 1 & 2

Convertible Note Payable #2 111,110 $ 111,110

Unamortized debt discount (3,724) (26,822)

Convertible Notes Payable 1,107,386 1,112,764

Convertible Note 1

Convertible Note Payable #1 28,476 28,476

Convertible Note 2

Convertible Note Payable #1 1,000,000 $ 1,000,000

Convertible Note 3

Convertible Note Payable #1 47,500

Unamortized debt discount (34,322)

Convertible Notes Payable $ 13,178

X

- References
No definition available.
+ Details

Name: SKVI_ConvertibleNotePayable1

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_ConvertibleNotePayable2

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: SKVI_UnamortizedDebtDiscount

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16(a))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20, 22

-Article 5

+ Details

Name: us-gaap_ConvertibleNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_StatementScenarioAxis=SKVI_ConvertibleNote3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementScenarioAxis=SKVI_ConvertibleNote1and2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionAxis=SKVI_ConvertibleNote1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionAxis=SKVI_ConvertibleNote2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionAxis=SKVI_ConvertibleNote3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 55 R21.htm IDEA: XBRL DOCUMENT v3.3.0.814

STOCK OPTIONS AND WARRANTS (Tables)
9 Months Ended

Sep. 30, 2015

Temporary Equity Disclosure [Abstract]

Summary of Options

Number of Shares Weighted Average
Exercise Price

Balance, December 31, 2014 9,750,000 $ 0.05

Options granted and assumed 200,000 0.05

Options expired 200,000 0.05

Options canceled — —

Options exercised — —

Balance, September 30, 2015 9,750,000 $ 0.05

Summary of Warrants

Number of Shares Weighted Average Exercise Price

Balance, December 31, 2014 2,541,030 $ 0.05

Warrants granted and assumed 1,000,000 0.07

Warrants expired 1,196,280 0.05

Warrants canceled — —

Warrants exercised — —

Balance, September 30, 2015 2,344,750 $ 0.07

X

- References
No definition available.
+ Details

Name: SKVI_ScheduleOfOptionsTableTextBlock

Namespace Prefix: SKVI_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_ScheduleOfWarrantsTableTextBlock

Namespace Prefix: SKVI_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TemporaryEquityDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 56 R26.htm IDEA: XBRL DOCUMENT v3.3.0.814

FIXED ASSETS (Details Narrative) - USD ($)
9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Property, Plant and Equipment [Abstract]

Depreciation expense $ 1,185 $ 1,067

X

- Definition
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 57 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814

Statements of Cash Flows - USD ($)
9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Cash flows from operating activities:

Net loss $ (1,489,814) $ (1,306,313)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization 43,377 28,027

Stock-based compensation 8,800 31,050

Amortization of debt discount 327,478 250,558

Gain (Loss) on extinguishment of debt (1,840) $ 5,044

Bank overdraft 32,787

Changes in operating assets and liabilities:

Increase in inventory (6,596) $ (59,393)

Decrease (increase) in accounts receivable $ 2,624 (9,030)

Increase (decrease) in prepaid assets 1

Increase in accounts payable and accrued liabilities $ 321,020 105,803

Increase in accrued interest 149,788 133,516

Net cash used in operating activities (612,376) (820,737)

Cash flows from investing activities:

Purchase of fixed and intangible assets (5,726) (15,855)

Net cash used in investing activities (5,726) $ (15,855)

Cash flows from financing activities:

Proceeds from sale of common stock $ 80,000

Proceeds from related party loans, net of payments $ 78

Payments on notes payable $ (89,500)

Proceeds from notes payable $ 431,000 $ 594,400

Payments on convertible notes payable (13,000)

Net cash provided by (used in) financing activities $ 421,500 581,478

Net change in cash (196,602) (255,114)

Cash, beginning of period $ 196,602 513,420

Cash, end of period 258,306

Supplemental disclosure of cash flow information:

Cash paid for interest $ 211,564 $ 144,708

Cash paid for tax

Non-cash investing and financing activities:

Accrued expenses converted to notes $ 118,126 $ 156,684

Common stock issued on extiguishment of debts $ 5,760 $ 20,644

X

- References
No definition available.
+ Details

Name: SKVI_PurchaseOfFixedAssetsAndIntangibleAssets

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: SKVI_RepaymentsOfConvertibleNotesPayable

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of noncash expense included in interest expense to allocate debt discount and premium, and the costs to issue debt and obtain financing over the related debt instruments. Alternate captions include noncash interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_AmortizationOfFinancingCostsAndDiscounts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Cash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in cash. Cash is the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Includes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906

+ Details

Name: us-gaap_CashPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Increase for accrued, but unpaid interest on the debt instrument for the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(f))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_DebtInstrumentIncreaseAccruedInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Gross amount of debt extinguished.
+ References
No definition available.
+ Details

Name: us-gaap_ExtinguishmentOfDebtAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12317-112629

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12355-112629

+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_IncomeTaxesPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in other expenses incurred but not yet paid.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInOtherAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of cash paid for interest during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_InterestPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NoncashInvestingAndFinancingItemsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash inflow from the additional capital contribution to the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from a borrowing supported by a written promise to pay an obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow or outflow associated with long-term loans for related parties where one party can exercise control or significant influence over another party, including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from (Payments for) Advances to Affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3179-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_ProceedsFromPaymentsForLongTermLoansForRelatedParties

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net cash inflow or outflow from the excess drawing from an existing cash balance, which will be honored by the bank but reflected as a loan to the drawer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3095-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 9

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3098-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromRepaymentsOfBankOverdrafts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow for a borrowing supported by a written promise to pay an obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

+ Details

Name: us-gaap_RepaymentsOfNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 58 R10.htm IDEA: XBRL DOCUMENT v3.3.0.814

STOCK OPTIONS AND WARRANTS
9 Months Ended

Sep. 30, 2015

Temporary Equity Disclosure [Abstract]

STOCK OPTIONS AND WARRANTS
The following is a summary of option activity during the nine months ended September 30, 2015.

Number of Shares Weighted Average
Exercise Price

Balance, December 31, 2014 9,750,000 $ 0.05

Options granted and assumed 200,000 0.05

Options expired 200,000 0.05

Options canceled — —

Options exercised — —

Balance, September 30, 2015 9,750,000 $ 0.05

As of September 30, 2015, 9,750,000 stock options are exercisable.

On March 31, 2015, the Company granted stock options for 200,000 shares of its common stock with a strike price of $0.05. The stock options were exercisable upon grant and have a life of 5 years. The stock options were valued at $8,800 using the Black-Scholes option pricing model based upon the following assumptions: term of 5 years, risk free interest rate of 1.37%, a dividend yield of 0% and volatility rates of 483%. The Company recorded an expense of $8,800 for the nine months ended September 30, 2015.

Stock warrants -

The following is a summary of warrants activity during the nine months ended September 30, 2015.

Number of Shares Weighted Average Exercise Price

Balance, December 31, 2014 2,541,030 $ 0.05

Warrants granted and assumed 1,000,000 0.07

Warrants expired 1,196,280 0.05

Warrants canceled — —

Warrants exercised — —

Balance, September 30, 2015 2,344,750 $ 0.07

All warrants outstanding as of September 30, 2015 are exercisable.

X

- References
No definition available.
+ Details

Name: us-gaap_TemporaryEquityDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 480

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=27011957&loc=d3e177068-122764

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (27)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_TemporaryEquityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

ZIP 59 0001647488-15-000172-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001647488-15-000172-xbrl.zip M4$L#!!0````(`-B(<$?S(^$.9F```!A5!0`1`!P`J8 MZ'&+)/++1`)()#(3G_[^.AKVGDF\L&O0OPX?H;[WOWH@<][Z1D,3>)(K_ MUOOA#:?LE^@B&)*X=QJ-QD,R(?1!1NFXAP_=G[U^']#L#Q+Z4?S'[>6\V:?) M9'Q\=/3R\G(81L_>2Q3_2@X'$:RYNV@:#\B\K7]^O;WJW?WVX[*GN89V^/I` MT9]Y$_I$UY#YO_H90NQ?UKV.CK%+__=_0#(3;S)-YF2T5VWV3_;YI]>?\3`X M9O_NT1X(D^/7)/A\P''V8AQ&\>.1KFGHZ)^_7]T-GLC(ZP=A,O'"`3G(OQH& MX:^R[Y#KND?IT_S5I3<9\9R&<<0>__22]Y89P)KWEY#0I_YD_@'_LGF4/2R\ M&I2^:F6O!OFK/EEX+R&#P\?H^8@^H.\CW-=0WT#YZS%YJ(1L'=&G^8M!$F$= MV77\96_D'TR3_J/GC>(]DS]I%1 M_(B-KODG[#_2AMEP.\@'$E.^XR15\5ORT$OU]O@I[ MYK_.?P]\]N0AH'-9BI(49)U+X/3RMX,O=(@CS3%UV_YTM/CQ.[FC4GHS:F/: M3Y&_C((.N'C")J92*OE?))< M/^RL;+/I;%(BI/R)4B'A71<27J60JD?LOP;39!*-_G4:T=DFG@0_A^1[-"'H M=S+Z2>*-B?-]B)+'$>'D,'_D4S"OXV$P""89UIX?T#@^3@"YLSC\LY_G14VC@/[*@<62>G(&'%T3^V'B#2;TA4QU\I=J);!N)5KS(ET_=>2B MZ,C:4ZL-91/)`O][7:!_=V0YD=:%#2TN6ZD+Q@?7!:/;NC`S-3%G:N[FIJY@ MF6$9RPROT3*K'W/X@X\YW.TQ)Z0+Y@?7!?-#Z`+N([UOH+U?:+-^H8)G,.V1 M#?9Z1ZSP[7?JK*O7F]UZ]R\4^=M%-(V[YZ\90UPBE!'=-[_Q[` M+_=0BHTYWDVCPZWK,A)Q\HP*GPN_(#O]T MZ"5T9OW3BQE;U_%M\/C$NQ^K.=\KD:`272;)E.5C=D1S[IZ\F#Q%0Y_$R?F_ MIQ1ZJDN<[BPPO%<8287IB/<'KC![=X]2J\?IAOY(6SW.7IW:;JCV*M3I#=5, M%XPL1&S'PN,Y(1EKB&S<6W4;M>HV&\F^-\FZV=NEN4*[.!FJR!4JS*$K,CJ0 MUM?-'9-M01E3!E;MWK2[50['WBX+^'W0V_U.)0B*RWD="8*[.:&N/X," MXFR/<^::[5[08F7D:P6_F][&8YE)S%KS-GZO*Q_!7*UQ!5X$SQT,<*[L_W)V M-SU5[(3';Z\I'9XH0$[>CKBNA)V[']*#UO-UC]7NAW MQ/H3J;[TSO7'7O_WO=_-L2\<);B?_??>0;%XY*YH##CX9:\P[12F(PG"<(79 M9P2W4YB.I`##%6:?\ZO$ENG(1%-Y>%7.[EYKU.3)N!]+>Q;8WFN1N`]E/]]T MT'&RGRRV;[)8I0I,PR#K_S_NSI:ZJ1XMRY9]^YU=/D;" M:!2$362;Y;)(MZSA_'E!"@"!WI!X0'6UH=?&]$]XG_DD.#Y/]?^6/`9T\%$% M9I=2]V;Z>G? M?R-O8)+\I%39&D_N+!JD<\K]VQC.&-+Z_\C:YS\O:_8F'=_GV9H/;I^?/RI; MX\F=T*<^>^-BZ#V"R3QXPX1D%`H-\"V?3N.8_1PD`V_X%_%B45[ZN1NYKK5E M!?B3#(>_A=%+>$?U-`J)S_:@='&`DOT>\0I0T=HRV1_1F=RN"7CB"Y>X>-=>LL[F-I?;(II:FV9:HKFE(K[,8KA0^INY`WI=[UY M\[W3:#3VPC<>0J'ILH&0=7FFP!?T-SBS_S"*@V"II6IR3,/$B+&_R\C-6\J) MO=,,IH1#3-:Y`?.%RZQZ;<-,'W)+8\\D@H%)/ M/A]]HV'KG4H"B8K"@/K$<75\!6,X']I6$Y"&@G3O,?F1> MM`M"=P,Q=,/6D(!1QQ]B_VA5#,)0KI-3V&4K]1SKAF8[N\,R[#J06B767$=S MN\(Q2*WI3.H87>'8`'!L:[;5&:7&`(9=['9'ITW0Q.4@O7+AW#6.+0#'F!H* MG6'8`3!LVMC8>9V&S%8&Y=-6P^B[/_,R'$3Q.(HS*YF:S=&5_):V$@I!A&=RNLI)`*R00F0@CF9V&C\;3R2R,+Y4;??TN>IB\ M>#%I)1DZQ-C>!4A%`2B0(T0*5"[2=.O*PAXO1^,X>DZC\ENJCV[R;K-J`NV@ M@/1'%$HJQ"OOIYK9A:HOMM"L:Y9:%:<)'#(`FKE$*CT<[8:);ILFMP6NI](> M$\Q=V`83[RV"+GH-EJ?)+];OK8M2+E;!!%#6++N>XL::+F+"W!R M)V<1SM>%"L*RX&`IR@O@7I/@.`R&GP^H44H.>D>KD0R?*UDK'5O'FQ`.%-_, M30H!F`_FZS$+X`K"QW2=2VY31W6JF(ON6LF1:N@6XI;36GJMP8F.38/:BHX: M\(&7AKK8-?O,L3UBTGW7-1(XBCL5&-+)T&,=W M9#BDB]PW$M+E;LC"!OP17>18+/"8S2T-%_[N:9FG<7A%&61U>4:VQ3E8-0IAM;*U@J-%F2S$E,71;7[Q@*-@YS`CO8-7'9AEJ%5(04I6]8")EE8[<&RN2)Q-EC)3K"G\1S M;0N2%=8'W714T`5T?I4##,Z96)_:&IPQE>M`W\*.CHP%XI533A-YX1XU32#<$I'_6SX1V%R0^*O7A(, MEM,TH-I1E;+1UP[Y)4$0R@HX:52TG>&D46?K.-&VB9-&]5]/G_Q)V)TEQ#]Y MIJ\_DN]3YK^_?LAH7T\G+*V=Q8.G+8B/$GA*C!`0Y5S4CY#J5!HZ(^I\T/=F MN:@?'3O4%S4CH[HO+,TU=55?EF1CUD0)%]$&TF?1FDV,EUC'D342$@%,)!09(&5 MQT&6I)=(GRKIFN-6AY:64%("#73D9!@&KH[5KX$&E+(N'QB$-$,']Z:N`A5($*J%QN6K9&!E:S<+'\"FFE_C$H'16X8`MD"UR-XI46 M5]]P7*1#>U$%*E@LAHM=)(>J6;:FM&YAW=00N`]-%;A`NM4&5Z-XI<75MY"- MP:NB"E0@W;*IG0J>M\KZD,O$R3=A?WHQ*PZ6W$/POIP(_'%X7\X)_CB\ M+V<'?QS>EQ.%U\9[[H(Y&:3K/A?[G$:7S6H6RII"EF,4J]O4T&B/"&(&N=BT M91&=30GS;7,V94!:Y-YA/L.JK&EI^K`\/&'Z-S$9>X$_.ZL]"?WTZ#:K*B2N M*$V^=DEJ%;PW49/EHJA9NL>?I2-Z<:FFG9NBE)7'K/A33L5+`L2`ZT<+AN)9/+66_S"L5IJ>L6>R?$ M!]`NMBM#%Z;CR$$83O?$]P,6N^<-;^A.YC*<56.5-K81NS$#P6-$D9?GGBU9Y$QT5N&0L>5%"Q##?[%#;S"//B^96J:7>*HJ,AP!D"02"Q#CJVKA""17*8C/KE, MB11$$\PTEU_O&B$\4U6*XK=6)04=US8+'B*^47&2H(%A(-[>!9)D_M[DB?C? MHLB7YM;6'%Q"N="V/`((\R:R^0V(((1;[^5W.G/$`6U.WC'I\%9S:=O2`$"[ M4OE26P>K/(WC^N&!ZF#XR.IF(T'S\/Z%-O#&:J^51`)^21.B-+-??4U+@?:J M8=ZQ.DL5.#'#B2JS<&IQWI'!-";^510^WI-XM&1EEX>8U(I.R*0MH2\),96" M#A2;:HQ%B>?&P"V5>';IWNQ.7N^QSBU8$<"S'*"9W_"[&+FC':(J):B#M$YF MEB,NJYFIOH=C?=S(*?YV\R0Y4K:;J86..F?YO-UAYR)XKH]7WVYN1$LEUW!3 M>1F1"#M=/FED@=FQBO M'WG[RQ[I!.,ZVP8;3MK\]5@U;4/UQRDJEC M>Z,@08-JT8VPN9Z'72-LFI7>J'6"A:RTEJF[YEK!YM%7(/5<>[_GZ$"WI*T> MG=1=5\\[ M>J7]LPNX$EK##C7(.KT%7`DN6MO&5:U_ MI)H->TO9$)J]V[&1ABA^] M&+R-,`>N^VSO'F_@NLZVOFNL@!7E3!SB"K/+ZL@ MKI8Q4<]F1QB#ISWN&&/PW*T=8VS9UN@(8\LNSHXPMNSE[`ACRX[.'6<,/K:@ MZ:N;YJ@ZK*@F5U^ZKQ:NYQ!Q>T'W)\9?2[>`5#BY1!%`]RJ;0J!O'(&Q<01X MXPC,C2.P-H[`@2(HR_J])6/OC4TFR?6#3"YR^P04$V&G>%-&([A5,J0@1<5U M*U*LH?Q`DY(]G_7X:+UV&4E8R4+!9H80M9A5J!0.(%Q<[B>(2+Z5?5 MM@>U*5@O/VOS*1B/Z4IY$OHWWN`7_:MU\35D:$9>J*JF^38P8#>0VO.3%0", MN=.3>3>_TG[V3Z,1RTM+3ZI.V-5=CX3IZM>W]U=N,O4]>?%B?W:Z]2V]X^LR ME#*/TA[F&R(^^$!!7RR_I)2113%E+UV&/GDE_GV4>H/S8L]WDSCX14J.PA4) M`!JO`,6X/,C>3RK)8,+N57D0G2]K&.&\8E7$@,<$:6'[8AO4;`X2LA*]*\E# M=0#'!=4@"W*72T9M!9RG6ZD#S&"8M:Q0!;*W#3J'E6@"1[)A4S8[X)%QW2X> M6'[)7Z_.RBN06STR?0E99?3+FI$9162X7YUWN69DN(C,2@,QM@*9643F]/7* MV,8U(:OPKF0`D;;Y@=!TNI(#E=0^WA+/7[Q^X.Y-46%-.]45KDII*@$)*,Y= M:Q0W!^(XLL;Q+*$42D8%+-!]'BU@-4;B2`NKCQW'+"^/7T9&`2I0&))I8\,1 M1I5K]'="/QA$(W*U6%]<^IH3[+B%NX\*)(3I"Y>VIQL^RT"&*OJF\.TD#M+Y M@N.MV1>K:6]:EN9H0/)G9!S3K[.]6.B?9.J2_J<*7X6GP.? M^%_?_DC8R]=CPC)-PL>3P21X5J;O?0OIAEVT.('DU0(7GF4<7;,-NPWPK-#M M-!X\T5YAR^4K\;-C,#H(%D_&E`C;M.>WQ$#I*@,KOA&YP:Q6+;&. M"I6YX-35XA:6KH,*.R)YW.EGZ1':HOVAQFOD6I;&50ZM)M<.F/#`UDT3%6[R M!@/+K0-VT;62[0-"IE5R6R%K7Y2VL%F$L%XSZF32BVD%-"'-M<`"W>V(L#H>W,6:Q M1LG%_[?WM4]J(TG>WR_B_H<*7WO7CE"W)=YQSTZ$QQ[?>7=F[&?:L_/Q0H!H MM!82JY?&W%__9&952240($"`H&MW9[:;1JJLJJRL?/EE9A#*WG"TV_"[$F3: M7XW8)F$JHV77C535@KV(6`%AQ1,G3'N+/B2SF;=,ZBZXO7Y7+>-?_/+]2=@' MG?BG'7(4&J&*RDUL'3RNV<1:K\(TR[]XQS%79[)NS';+(K?>;F,2*JWT+FZH MB=4M')E>O\_PA3NX8?CV]N&W8,?XNP]!N&W?I/Y.Q0JV`]GRLSVLI-$:DCL- M7@^X:+R*:"E=ZJ'9W4[+R''?_NS';KQ0@!O\?9^3.(IM?P3+7$P=`G':)TC<+O<:,L<>"!.?K,^T<^9LF5A[[N05('F75&FP-YM_6Y[?7.792*. M4[^T!B]5L1IQR+"[^\:SLU5BR.T1E"\AO,4=?7#&#NC4(P%^?>>/Z!X_R&E; MPGRLB)B=5W%3)*<,$=NGPK]\E.#:,TH-72O7.:][N='H;8Z];J,[=)[L! ML$O<%K)E1M$HFRA8U8W*[NH.:IHZ5B$Q5$&MRN6P^IU&;WDYQ"B;*#C*I8A<2\1X7%\PY9D%)6R,9Q-IO1^XU3P?)6-.!6)\%N`U:@Q1\^3H4[EHYS MJAW;/F!%.Y;/7]D=<+:M9AR*YR_]4 M0NI6M`YK9:Z@\=BBL,PPY1:\Q#`G$W]EARN_CV46\=A"L*1GIIJ].K'@*R78 M*]RK"AR=J3]K];V[C5C:S;G;B!7[./-R:YV'L]30^_HWUPXMC9^?;/_;9S#8 M1Z$]CO?VSS<;W9X"W[_S9FS MWX.I[1O\`X,].*$[OF?I"/<,R;NU/?<1?OU7$L7N>)$.BN]='6/SR].'$_Q! M62DB.QBS@5A$FA5]B?W%GL[N_\MJ`SD/WUS_R8W0$V:P3_[PSF"O0N'+87'` M[(C%$T<^T>K>8Y32]A?R@][]:^9&;!P,$[RZ`I^^/G*>'"^8(:\PVQ_!_/UD M;`_C)'2(+/PLLCV8%1#H^G[P9,?NDP,#SMRA[1DL!CTR&CFTMO2"9!C``VP6 M>,"!X>T``Z8PC`=/A0L6+:+8F<+:#B=^X`6/Z(3!Q\:P.XE'$=4(QAD&X2S@ MP$PBPP7.G=DQ4'D[<[@/73SQ9H9\'^'$L-?1=.#Z^-?)8A0&LXD+;$?O%[\' M`_A=D,8<>!XKY41W["LLQ4::B(J)#3,?A($]`A)'P!(P(1OC@$-!^-R-)RY? MV!D(TZD]=)*8KU,`T[^%/]S2D7!"@\V<,`I\6*H(=G:(C0EP4%B]J1,CU:'C MVT#:N]'(Q;?;GK`%NH(TP,ZS:+\#!_W0>;:#T-^?)'MEW=!#P>%WH M6>=+US'O+WTB4FC]CQMA\#LEF4NI34)J=QDUMU4!X.!1$_R`,NM7.QQ.6,=@ M5K_?,^"6`H['=Q))OCUUD(%_=8@,PL2&T]W@(_4--I\X/G-C\26@"@X(/0734F=-A"R/I1ZB*!E$[LB%M^<. MKR3=]KW`@;,PD"3C>H"B$*0CYP=D7W*"1CQUZ0QWZI/3!+),UIG%1YK09RXO M'YQ93.%!!AR%VI;!%&%.XAHV^!^N;\>AR_YX>"F!0>/E\$L`=A,79#C'J@2R%`1J%V@@HV1.3Q^G"[Y^(X?"[8G.ZK?OLRES`/84W=!CCF/@@7([P*%Q#7./` M4Q6"KN$G#GMT?(>W14E5#`R5X&7/(K1!8)YXK)^PGHZ!RQ';RG)DM,Y=SV,# M!Z^T$7MR<97B>1!^$ZL![SO503@V_WP5$DZNA5@"V*TP'H-N':`^'8%T)CW- MA@V_M1]Q/=.U`AZ9.-Z,C;$;$7%=!"3RK^,W25Y%"B-P9<(C^'(E`SCD*MQ=PNL+?!LW8E>B-*`$%DM-!RYEH1'$"2PA_=8!)!K@VGL$B\V1M!)2M'-N!IY!D+OPA M0OM:_-E3L`C"N3&W'.EKRAQA06;BWI:V MOKQFF9UE%L4!-U+M;R`$/5!,UVK"?.H+/'ZA[48DYZ0,E'3$DS!('B>T,N,$ MW1+,%<`]FMR0@&^PD>A3`J&8^-]\4)!H3.Y7&:#Q2?X-W(YLA+',2^(Z6)0, MT8V`=XCJ$^$75A'UN96!_Z/]3%K#,G)%!F2C(0 ME"?TY]!-B9P9A)'8#I2C,=[PL%JC(!F`>CF`>W;=@BC;F9*"MDO^"-T1&5_I MGO)A;'=$"UAX)O.+#S0PO#B!<[UDA$Z$!>PGBA7^[7@":L34ICG!&K-Q&$SI M>:`9\WG$ZR+AV((5I&%@G6#\!(G#34`>UJ*^+A.1HOX+:'Y#=R9U/SKXDGO0 MCBCTF)9C,LE.L;@FD@+.$T3 M0(8$U229\A`FEYTV&2_T3I@*6);P5GN:'@BNRJ0FNZJZX.\C-QJ"TH$W-)\] MSH*\:YD*E'N&CX3K(X_;]B43>I30M%9IE"X&8?4@P#4",RN4AB5_AI:74AW@ M$`_C!,;@=P;>ZHF'4HQ:SIS),$O#(_`D^TAQRBG M];*G^S$(B(H0NSA56!,P&GBPXT$10Z M#@.%/)[`[R'ST+D#T@HZR-$V'=AB20T)>8*$S]J@ROKS:A0()9]+!*Y1"W'`>C$Q1G8D4'+K0 M>8I!=O'9,S`EO].])6X_>0S`TA-K3DYVO",=:8R2`%@YV&@>@IXQU1=@72;R M3OK!2>$C'S9N'YXFQD_2KXZ-^E@FVS^D.EK$OB*"0]XB']\]_,3>/;PWB#%X MY`7=*5/^AA'C,`[RB)&0OP7.")>X""X64%/#X60A/62@PP;(1/_''63`UK,$ M2"$`"K`X?SNYY+)1;>1S#^^PM^S5+^B*8=9K%@PB)^0U",5+H@0&@"__.PEB M$9J8A1)+8',N%TB&>_FBQFOQM,&A"JCW\I/&W\+6O<$0&C(JMQDECDLO&<'R M#V.AG:/?S)>?W-.JB\&;KUGBK\X#QN*+%=-]"(L."G*,OI^0^6E@#W1B6ZZJ MV/$EA=:A1%#IY!$^++):@[FO*OOZ`-=D(O(>X%J3ASN6JG7*@4A/%;'?B'!C M`SR2L,'SMQ>^!J??3/[?N[;K'VE*=-J)8NLM&.?<10G[M47$9!+&)O\L@3N$ MD3S-!#DWF,D]/\(C3^"RQ,>"2?!B,H>YO2WL!<7DOIXEOFJN:;QE_V^9559X M!!WAG'\,1E<.W24%EY2Q?$NQW`UE$"LIGGYQC?%X"QB+9`@*H42<17:=8*K% M]:S_5;-4\RW[PGDIX+<*]U(2O`&!"X)SI&*QS$V#`.$G@X"FH,I[J4&> MOLD6H'P*)678%7*=4TD2$/,$P_9!S--[X'2-DY#D?^J1'[I<#DQ%8TATA6,0 M@CP-P0`65(DXSWD:KC,RI.\]=`:+#`WOV"&&3\D4XT)RW/#25'!*X1G3GD^8B%_11J^H6X9_,OC$"=)CQMQ"RVG-9.GCH,#>+0[1]/%7WER5V3'$*(Y:^)2O#'RRX*Y MN6,THGT(*<4>%BCQ$;:+FX302H(["F5'/548P>#I0&(]0$M"6`_8KZJCG&+_ M_(C(=+VFR4;V0E'A7/\IP,QI=+5P"-U2J(;@$,64PVZZSAS/(0D,GG:!EY4` MJA+^6%C/=^S36,5IC!RDEN#N9'M)M#+P#$$;/?<;H09M'^.XP5Q@PAU*TWGBB#"7<0*YK)XK2$#=B^#'+`[<./C<45`LI MR_R0&(_7&`0%DB6NL-W.UEPC[O]\=J(G&&BQ'J*EAU9,[WU M[,?0$1B@I?$);O0G9GC^E>_&^PGMP4HZV2^_O,>-(!TL#.!4PLT3+A#ME"8P M2YW,8&`UO8<-R.RTS5HI(<1OH.B(HJR M1&1^=J1L3/%UH(>)$%ZA>,XH3A%Q-B80Q<[M"`-B(-94(>.D7C$I'M,7:!:N MRT2\-/$C&*4BG+"Y:9\AB5+<:D6(&+,"-"5$_BA M)4?R+7^:(D&QA"&)F.+.1Y8>I3F1]O=U MR&V=6R*-VZ3+1&V39LM@&>XJS4DX=:(2*LM+(8%F0>4G M1,TJZ26R24@0/5/R*`4,\SZ#A9-FOB"6(@AE+AF)!O$-D9D:B#P;RDO)_VDF M>F?B.>,*!,H.]K/\%JT&DQTVB8POF&V::D!TVH0/9*3$Y*])B[CLB60,S3>M MD`45*9ND^J/]#2N**U/[)CK`JS'JB>`0@$6BAD2LJKPC=0WS??K)=3RB:HA``#T)G M-80BZ2F=.QB20NL,-"8;E!P_H6.BE!"@ZJ?92T$K=#VBH!R=D3N%!T,)P!YL MF2)ZN68Q5YQX(48_(/<6V@ATDU#W"+H-U!3EC&ZU6H(Z!8'?0S5WD(.;GG%YU5QR&HB8P9IQ&9;2@;WRJ,8?S_/?OH3HB^9> M>%YZ(^)1?EZH(E9TV12"F$PIQX67*^9%%[++5<15*>MLIMZ9>5)?Y>I&*.EE MK]5%LT6!(SDG04L)*5DL9M:7+U6*W>Y:2;5<*58\<='G\1>^P'2J#ZS%>@R9 MN;W&:0I.K:[.::X:Y2XU3GG.255U3MDA-4[3:_W0.J?L@!JGW'->29W3=35& MRM4XY;=`-75.E8CJSC5.,TA4B3JGI>3`IF.<*P,N'Q<5.TEJ+"[AQ!<5#%U2 M-RHK&LKV+!C*3UN%14-7QBI7,%2&JJHL&GI9:K*N$ZKKA.HZH;I.J*X3JNN$ MUKQ.J&BALEDQR^EP"@SG`P+*WF'U/2IZ^9[7TJNM5E>JY&:61')8V4VV=\E- MB;P[O.PFV[_DI@C]'UYVDQU6.H!93?9X24WN=9Q:-E- M=E#)34Y#!64W2U9#+"RY*2/7AY7=9-M+;JJ"Z\6B*RMI*Q$VSMR MD4NVM_Q'Y'P>_YSBOZ]K5T]03Y)MK"6I9$TX1ZLG M68CFR6I)RMO@N/4D"^D+E:3GT]>3S`Y$GLE7Q)P=3=[Y(_R_G[,P1JWEW659 M$[KPXI$++RJBOPPO+Q\`!`E3N;//XQ3+K50-Y$_K`Z#+%5[FZE\-I$67*]3E M"G6YP@N>B"Y7>([-U.4*+W^)KYIK=+E"S5*Z7.%&N[:4B;ILUXIZ-K]GV2O: MJ:/+_.DR?[5BHSJ7^=,E_G2)OU,QB"[OI\O[5\ MWCO7]B-"]JSOMS+;?6O[B6R/O>O[L/L5N(X=EME&%D1[YX^RDFGOR(E< M6T8J6WB.)__L77R.':OP'-%U:/$Y5GWA.:)KI^)S[`B%YX0&L4/Q.7:,PG-< MQNQ1?(XM%YZ[+!_,-L%27F"LWE`(8/YJ?[\(P;*FS!QW)1ZEU!S;M\PK\,9*5G?+P]"/ M5^&-;:GNIF3!'+/"&]M0W8VG9>L*;[6;R,57>,M$Y1XB<%F*RC)@7YR0WE:) M^E14/.EP/W/F4RXHF\;=3]663BN2C3N53=M&U+ZET]@.9=.RK)PJ2Z>QW(&B*@;9A4DEE&.\GRCBE@9='7][@5+0"5^PH>-YT,;H>!%X1O47>*G1?9XN($0DG.ZM<);(() M^'ZL(!A;`:$5XRW^%CSW88V8!K90#N65"I?0HKNI(M20E7ZHG1]Z8.)CI75DW M+ZD59ILBM,.UTZ0?PS7R8>UL5N1&^#AXU3!;,%BSAR.V7F\2'[LKW^67X%=[ MB&'#D&>R.U+6[[C/QZ3PY@!:"'-1&26%#3I.\%.K9UB=9FV606_(E@VI2$@L MZ2*G/74?$U`:TT*O8_<[_AP=72P<\S(Z'A]:5M/H-'>]RG>EYSK7YNINU/?< M0`^QR::\3CEL+AC'<^FFT(=HF:1FW^@V&OH,[;XTUW#?_(+.)_2C(>P`RU_R M:G?ZJ!3*U(;1[O3U4=E]::[NMOG%'IS0:CLI3YS,#8`J2JMC7=-YJLW:G?%N MNF?"I9PN@G77WAH'V\?Z_(JQQ.LZ?-7I+HVNT6Z;UW2X3K8V=;FMCGV2?G&B MZ&U*CCT4)8*I-]?O5J M=<,U*SR5']WO::49(R4*:W;S1*_S'-(3^JE3)HN#V0J'K>-`%(R4ZN0YE(G2"(NL=%\-4?,'27Z2)1QDQS'. M(I$K+85&P%F.(2].-RR&\9VW-)KX$/-P\+U4Y^?D^$X-L-$`&PWET`";.NZ* M!MAH@,WEXSDN3L&^]@TYH\FM`3;GX$,-L-$`&PVP.=3;H0$V&F"C`38:8*,! M-AI@4RN0R`6>I]JLW1GO)@VPJ8-`U@`;#;#1`!L-L+G5T<1N-O:D[P75%>6CL31UW16-O M[G-=:;X`H?ASVMWFFC3IZMR-3<-L:BA,P<*TC&Z[5TP)3W M3A<=J#*2J#4(N^FT.H;5Z1LR(GO3A*<;5GLY.JLVUX,1E=_8AI@)CZF4BYNT M&H;5;_#`2:-C]#MFJ<#)I82:KB9F]@MO,)NR>=IX';9?]%I7FDVF;6B57I.\ MIX4]I+Y-:5=;V6'%]=G?;3_!]F-6O]\GAD`LMSNB'A]>$F'3"#@!N9;O1`[P M["SP%E-L4T*/\5]$RR31KK:@(Z^-,:9;X&/>*!J[H,H&2VD[776FR/5\JDJ# M2V_!3YTZ%]YRDO=H=_!_O`7FEI?R-GU98TK>;CS*&D6+5F=^H'XK:[Q*9+BB M_,"(>K/Y#C9]Q35=5WJ@3!O6K9)\;2/?ZY7ZZ11IU2NJ^'!6$5$+S(`..NN@ MLPYOZJ!S'7=%!YUUT%D'G77060>===!9!YUUT/DYA#MUT+D.NZ"#SI=\]'70 MN?Y+IX/..NBL@\[G#3I?0!!LJS=;#9NLCX'(>,G#/_[Y28FP?^:]UP_.V5KV MCR_[SY?$I)'`+Z$[7%\@K^(['*_P;3>X/#>M=?[WE=L M/]F>[0^=+!>_1/2Q;&QA24G[:3DI6YT[SNHDQ[>(6`HM[$)M13F2Q5(56E&ELHC0V5KN:+GS7'?]>5H& M*22TK6+$0JWY5(LFS0PU4I8V^/RK%%\I:8X(E^PJQ^KOW#^##[4*UJ^52W4C M66?T<&KN>P[<=ZTJI-87+M&_JQ7%9[KQ]5$*&PCK/!D49#4_O8I;NJ%4W:_M M1;V>R/-`/]8PPOE7KY"PNBF&QV:YD@"/\W!:>4]AS9AL4QVJ,A#9-7#:/^T0 M`YF'XVE/58YB`P(W?5F)2A4OM_PZ'A.6NRS/3Y9-57D%D-,F@S6,=LLRS.:N M7;,V+OWN;K73K?<:@&>MZ#L;,^^:=%P/'MZH#%X>^U9T71S6)_$H%\"I/$4G MINAHZ?:7NDAZ*32_G#0.4D&2>=E(R`YF@[#)4VH$UOAT&..+YFL+'8D;G8EU M7Z-:;EG-:SAW'V+T".7=9 MBMYI4-07S<9[PKKJOG"UVC'-0Q>R<+50!@_":!^D(>Z'U;Z\B,_Y/.1'/2EG M=Y@7DUE+HC33:J9]/HKQ15[&VG^OM5[-+_64=M5HN/L#S@_`.AV,.R^I.JC0 MVWKQW";MX2A4-XQF"QNO'.I97<-!YU_=FI)U3DX]N&W"*8FM(&95`]XLD.T; M4.W%2/7EKII?G>DL".UP\?._$S=>'`!KKV^![:\3CB3..FBZV*? MZ*+6M,(V(L3^?3"=V?XB+=N7W]!Q M$&:+($).+"(H,H*2W3ABPV`Z#7SQW-R-)XCNCT/WF\-F",'%[]V@-+IC,A<@ M/\;(*'XI6DPYB(-VHIB%=DS3L.Z:W9<&S&OD/KDCQ^<`BX7K>"/\ ML_F2YOX4>';L>I@6@0_2HK=ZS9=WA:9^^M-796-#9X@7$!9DQ/BIXT=\2_CB MP`879UH0.?7,MM!'&AY^0,XG.NBV M+:>B2)=EJHUB6+NET/Q2'Y7XW-6\==L6W;;EV9SP4[.+;MM22YFGV[9LEW.Z M;8N6<[IMRQ4I>KIM2UF2+K_EAA:%FH=J(B1UVY9Z1WS.YR&_[@X8Q636DBC- MM)IIGX]B?)&7L?;?:ZU7\TL]I9UNV[)5==!M6Q1LDV[; MS<+@";$@;.SZH"G@=LQ`96!Q`'LRALVPA\/0&;D(&''])R>*@S!BR0R_<)-B M(^!/+'*&L((C!F^6+.?XW80^)'L.2.S[Z$P2@9QM%;?,6,7L%\GB/Q M7SW#:O2,OM5\RUYD3^!;@LBE3$=*T/S9GZ#^-V)__//V'7LW@&V!QWG&'PA' MGF^("_:K$T^"4?3BCKU;=QHC!_,./+%8$QM7V<8^6#@!-X0=@('A[U,[ALV. M^4(9S/;X(VP2>'"A16+=1-ZA_0B$3QT4"7``'"X08K$EM#K`C'BUX)S@Y59# MYDNE69N1/74H1S.Z8Q_6YE;AQP7*+]*@\MS4'E$V*QR%&0P'#,:)HSS*/G', MA8OBJ[E3%.%F]7GB1H7"+<]VVT0=4<+%'?LHCO0,*`U&7(;DB0Q8/C][J]3# MH^=O%GO\-*V(/G9RL4>$+(L^=E*Q1R04BSZV1NQ=^%FXFD/-!7@JEN,)IM3G M,F3_GH!<3R^EM2>'DN74(WRXTM`P>UIE*#H[U\)\5S.1RD[1V,6*'%4>(JMI MZ4.D+Z#:3F13.214H-JMOM$'-1"^$*?<1^5HD(5!.?2<*((_@?Z8V2II<9L! M)#X((I%:4S&9! M&-,K1K;K+5@`"KO-RPN)S1URX;#>)C:0(_J6"5)O:H.]R95?DF4!?$:K#EL: MQBZ*J`@^$@8EMVPE4<`E+LX/367Y5``$A/3L(K6X)0/!_L#L$S="XQM>%#JW MOO,8@/6=FM58KQ M<>^*&ALKRRZ$DEAXK(\%2QZYD8)V$PR>EJUY6];_?Z(NP+FCMLGE?Y::O2=: M!-4[6F5(NX@WZ[&*^-3M7-3K&03>4AEUOK#;FJ<>OO`;P^*YHUQ`<$WJZ-=Z M===76*D(H;%'M^[NUA(U'*'1OFM5L:,W[8;1ZG92FL;V4%0T-"SS)0/30E@S M=&$KYA8HEM+B,O@?TXJ#J&9FOFMI5H%-,@+UQ!\5EA*49A@P3.)EO1\'CE0@ MR)03A1>E&P^UEX=O0(8;X85CL$_^\$Y6BX3[)D8ME_SFH%/QS]FK&_/.,E]3 M+N4 MM*Q@"%]B0@437RE0=O8MRU'!QI>3+)*&PIHF%1S"'G'?3J0<93EVK4>=$G,. MH:KYHZ;\49\*_H7URRH!@_SAVU.P6-W_4UKTCIQ!S$9@D<%$XAVY6+?8J0[M M[VW"P^D&3YK[GBGWU:K!T_%%]%>,>60*K._$Z&E),L&M9?69=)1:G0HMDS67 M78;L/9I.7)47)2O/M>I(P6AUWH]2'+Z;]CI18)/],V7 M:TA20KCOA;?GL,
'-&XD(OVTFO`TMNT8 M4LN)%-*96PT)+YC8$0^1_QG`=R+V?A(@;5^`SBGL7$*,"5ORRR_OT7.%?4=F M80`3<&*D(:.4;%>&08P?1K<0M\*GO#+.8?YP!&GQELV%O M!UFM[AO+L@Q+^K7L1UBK1\(U@+1R$6'A1A$0E.ZN'`])I]@?019E^;XAK-HC MYY]T/-'Y@^*-"O)1+85%V^1R]"RH)H*+;A"9T>WMW)^`9K*-?C<2[5I2.D#* M"&X$TF'$R!V*W9@2)N*.),T@9&_R(B_W\6<_CUT1T&*.):8-4P#&M$LJBEE` MDME\$OPUBXWQORCP9@EH5C$KHI5-S%=E`TYY:1KZ0CZ8Q.T5&>M[)VO-3S/: MQ2A_%7=6KLC&_IR[:3)/Z'Z&]?D9^QB,RW6,WW\BFVE$E:;5E61H&UJO?$7(7TJ=O=5%.'][+._)]Z"-7HB MY2ZE:.[D*WYL-%;L1Z+PGL;OM^,C4H.D=%0#(X/K;;\CP*X"483DUPD)GM*K%" M>(U`[+^#!ST98^MDD2="P6<$I538&,Y=L!B6+\OJ8E;/9"-[$2FA7_2:8M8A M3Z>V>=ZI+,TCXMNTG%E`&DLNY://,!CE6-HJ"4J4E,>;X=%V+XU,`TF4H\"; M%XN<="`.,WJ_@0*?/K,RG!*0M$P6AS85\Z%YP4-!F,69`QF$%:_*2#)8E`S^ MY0QI_WE#;PK;4T08(\H#8J.E(#A?%S4*+W.WX2UB&])',LZS0+X(?E*P&OO3C\$ME":K1 MA+,9)S#E@.>SYB/J!IMCX@ESOF.-`-:_Z_=?RI>K1>*R8=4A2P6)SPD%R/)R M\52C),O26WJR^@(B!-A-LV4T^]UE8,#FL?>"!61"0RF,M!X6T#7ZK>X&5$!Q M92T^CXW4IW2DX("MH(!#@NE7J:#P>ZO>RHG62FL($[]D3;6:`-":^MN7$P)2 MBP'7UF.TGLC*`D%P;^[KJQ<\4)M84)FJR2=W2VH^JTKHGHS]+M!K<`JQ?-JX MD3XWY-1O&E9W3X_^F<^'EM,7R&]:3NO8T@4:<[4WW+05_TPW_M1:8BF%L*+H MTF5=P"5+PYQ)SS.L5M\P6WMF2VA53W-:>4ZS&D:WLR?ZMV;*W'*3JI42R;SB M\6TO_+*YPQHM-S%SS)R11ER MU>E3^%MD>W;H+A?+X&TY$!GF3&=>L'"P;/T?*2B$NKS)&R&K[+!:=R4B>-N( M#1QXH[-"H6FD<+R4#@1DS4+G"1L'>`NE.`N5>LC5:EEN<5B(R",070X>1=`@ MFXD>F!(%PX$R*Z_$RBMI\1I>H8::L2@-4B24CT]F@&T5J3@P7\N4D%#T3;', MEP<5M\EP:/O4KU%@@LM(PK'[G9JI"=#>C7EGMI3"P;87^(]B\;("&VDG4=R/ M)!Q.[`B!DXYX"!D),7@+ZBK#B5/P1A&RH,W70G08=?(4=!0*,J[DJY^A*150 M$ZY1KNQ,`<8LI>`$6+.54[E2B<:P&DVL^'("R-F.E6BL1LMHMUJ[@\[65;BN M&H=6.-`G/]??%$E,-P';DA@%1R/W`FH^>=.VC%:OK<@1-K2C2=:*DEJ+C)*A MDQW(`6_S?D"=Z_KG(ZD%C\^3F]2UC':_N1NU+]?VW!FC:;H)R5E+9U8*]:0?RJ3PS, MFI@V\DZ`$SH?,@LLD^NJ\X'2%U//R+'\#JJ_82D%[+1^!_(WI!1HO\,5^QV* M;%C.12*EK6'VC9[97W(P*$VFCNIHV%+JMM_+SNM)_`R;_0M+>[3!SX"23[;+ MXCF$)5T+-DSSQMYN M'FAO9UU_"NSN4O9VZV![^^0U981Q+;B+:,DXXU11_&+C6N6+FT;7:#2:>U2. M.;9-K>V;>RE>:VW?:*OV.>ZZMFJU55N-W8'R2KMF\TNMW+8:^3 M9IY=;'+4J6SY="[=]LM*X?AJ5+QYH#$/ME0%IKS9,:QVSI3?;+;O'_G>;)6G M%'#KG)-5F75>RBK/@11.'PW/+5.N>/`QK/,25KD"!C^.=5[&*L]*2E=GG7=- MH]O9#5J?[<0+CO%*C/)6F5@7"]&!++:/&K(`<+JCV MC$6>=6%..[3FE$OC%&WJ:U._(F!NS^A;%]2P39OZE\1=K;[1ZEN7PUW7&[_. MH2!E)#NE2H2P#[5Z#TA`O[%:#:-M6MN-W//BOE,Z*[=^E2#U>6+38GM2.LX5 MFT9>R@RJ\\2FT914M(Z3Q:;[+:-?1]RWU3*L7G]_W/?VIB8GM'EK8+Y48+)P M.53OD*0.1#_'7=?6J;9.J[$?.I;1;6EXM;9.CP/>;QO]Y@7'H:_'.EW*26Z= M+2>Y.`YK]0RKT2F*PQ[3*BVT1C/@;MXJY22>)B:;TG#>#.5BXWV=5=IH'S$H MJT:$UYNES8L-R@KVJF%4MFMT.E8E4=EZQF>OPVH1`K365HNV59_CKI_?5CV6 M64KF:&:;[F>67B5CONKUC';G;#GJ6RQ(+86JAAMW,)VJEKM]U19=OL"_)(C, MNQJ`:UNFT6[WZFS3<0JU27?:HE,[673MB[7H@+E:G1H:=!W#;)N;XXLI':>I M+Z7-N642A.BLM5ZO]:AGN.G:F'M^?/FJV3":9;,)M3%WZ9O=,UJ->F[V5=MR MN3YE=3/E.FVCT6_7V93C%&I33IMR1S#EVEVCU5S&C-;`E.L9[=ZZA$EMRM7C M0A6BL]9:O=:BGN&F:U/N^?'EJU;/Z+7-6FKW6@A5O=FDMIS-H50K4^[(&7^: MW0XC02L[>N.O0^%91K$W[MI':W1=;;("4.M%76K;)E M-0W+*JD:K=GE\Q_O0L(TI]6*TZPN<%IWSYRK,W/:MD*-WJXU&O.C4K7&']X\ M_..?G]Z^SYS"OZ$S[HN]P+%^YZ7VOV"E_:^P"C]YP?#;C__Y'\A[/R31[:-M MS]X^#"?.*/&:PC&_+ M"AA80UAY6.SFBZ+IB"TX>#9YB%W=U,H3+4(N-E6AAE7$F_5817SJ=NZ@R$=B MO:7\2+ZPV_IJ'[[P*(7*W1,%!-IG119U=W\>APW]GS3;ABM M;I9[F850#:!R)F1Y'/#(*`]Z&OR/N7)"L]#UA^[,]BCPBM%6#.DY M0$1Q[\BO,A8Z#!(O"^,M1T5%3)6TL8CBB`_?@`PWP@O'8)_\X9T,3F(TTO&) MG2(E]OCJQKRSS-<4?8T<^2;G^\S%6:;]*QNY,+S)HW^_T30C!BL2PFN]!4;E M1L[83KP8%P&&\6TOQH!X,(0OT;R!:O&572-B:=G#,ZK)617(H^C#C1YQWTZD M'&4Y+K&"J.:/NO''^:-JNC)+]6?]#+4S!(EMZ[[HLMS/>7"DDAH5D%4W%Y7F MOBOCOEIA1X\OHK\&L>UE"JSO$&`L43$26E:?14>IU:G0,EESV67(WJ/IQ%5Y M42S#-$W\I\"1POK+?I1(=:1(+TK$0>FN+RKG'(`LSU7W(J\*NF1DF^+43W-P MHQYFIQ<)/M$W7\H'A83[X4#PC.T]]@-R5WDNQBE0;^+>!QISEPN'+PO M%W"PX$#H(8T;P;2&COM$JXF9"QN`[3#2NA+(V^A/X>LI'5MA["1I!B%[DQ=YN8\_^SGF+69#DV?)OQCB7HMA6*F&U:76)N9;: MIGZF&U\K_:_Z#DK>@C5Z/-R4:7USAU'&`H^L!LS.%31;JD.&I;6PR!C%X^83 M=SC!Y^&."X,YO."FU37:IGG'/LDP6A:>*GYK/ESD1JSWDL#NMN\G4U[(#!]6 MX/CPB>UY:0FW08*#S&Q7B17":P1B_QT\Z,D86R>+/!$*/B-(+0&&`;`8EB_+ MZF)6SV0C>Z$6^I*UUBA@C8_A6WD<+(UOTW)F`>D@"0L:Y#[9H6NK)"A1TK0` M6;N71J:!),I1P/#;HR/*D`%QF*'XS8FS9U:&4P*2ELGBT*:F-S0O>$CIJ0M4 MBR"L>%5&DL&B9/`O9TC[;X^09REL3Q%AC"@/B(V6@N!\7=0HO#UP/3=>,*J6 M1]N0/I)QY@2F"G\R<+,\=^K&\MVP<&[,YJY'\4?$`,PP&!T+#(!\(^[D#"T9 M6`(E,,]<\7-"`5CX2]$>+16FR\+8<(B"N9\%\D7PDX+5,;+(&*8&3`''+PX> M'?A*J`2V-XXIQB+>4EDBF6$$%F8S3F#*00@B`F:5BZ@;;(Z))\SY/G2`MOY= MO_]2OCQ(XBBV>8^C;%AUR%)!XG-"`92JD0&79%EZBY!HLMQ=LV4T^]V=RMWM M!PO(A$:IO[/$*[\U]??5'J^NQ9RSH61:.N0P^.T9N3LW*RM0B M:G1,L7S:N)$^-^34O]RR2UI.7R"_:3FM8TL7:,S5WG#35OPSW?AS%8W6M5R7 MJ:U[AKA1Y2# M=6"74,)`[=8G=+G"2$1`+NR:"6]T5B@TC11X5G7/T`R^L:5W:+YG:/4-0E-" M1*-0=MX&H0H@;ADS=ZH&H0JR!AN%;FX0VCE&@]"4@A.@JE9.Y4K-%<-J-+&V MR0G`53O67+$:+:/=:NT.K]JKB^@>B*O"@3[Q>2"/2!+330#JFD;!T;NU'[=UY/X&3;[%Y;V:(.?`26?;`S%L^5*NA9LF+C1[YLYAT*%_H3S MZP1'N/.;#>"59LE,"@U#T[NNS69M-E^:7=-M&-V:%1C25O/5<)=E-HU>S0JE M/5^K.0L,9NU!4+,6<<+&Z:/W!?KJC=5K&&:OJ1J2LF,(ELM(S55!4*[;:TUB M^G(.:O.5@^SMW'85VMVGLK?5;2G5F66-O=T\T-[.^ML4V-VE[.W6P?;VR:NG M".-:%4^NSCKOFD:WLQNT/N=(.%;DVS*-=K>_QBC/=N,$QGFE1GDJ3:T*A.G! MEEI&C5D!.5Q0[1F+/.O"G'9HS2F7QBG:U->F?D7`W)[1MRZH-9DV]2^)NUI] MH]6W+H>[KC=^G4-!RDAV2I4(81]J]1Z0@'YCM1I&V[2V&[GGQ7VG=%9N_2I! MZO/$IL7VI'2<*S:-O)095.>)3:,IJ6@=)XM-]UM&OXZX;ZME6+W^_KCO[>T[ M3FCSUL!\JV3*/=[M79IN,4:I/NM$6G=K+HVA=KT0%SM3HU-.@Z MAMDV-\<74SI.4U]*FW/+)`C166N]7NM1SW#3M3'W_/CR5;-A-,MF$VIC[M(W MNV>T&O7<[*NVY7)]RNIFRG7:1J/?KK,IQRG4IIPVY8Y@RK6[1JNYC!FM@2G7 M,]J]=0F3VI2KQX4J1&>MM7JM13W#3=>FW//CRU>MGM%KE^SXKDVY"]]L4EO. MYE"JE2EWY(P_S6Z'D:"5';WQUZ'P+*/8&W?MHS6ZKC99@2AEHR`9>,XQ@/;'+T\[\3-U[@>SZ`.>@%41)F#Z*7"Q?T M=V?\MQMKIO_"",4.'[9/C+0J&TH$B'[7YZVIA M#Z2DR^`3F(ILQRF7CC-Z1[-V32:RS-K=C:S=K)2UNVU55$O>VH.QF]U#&5LM M7Z,9^XH8^QUPIR<:`;<-UFVHR@'%[\5]CE%I)XZ!Z6Z:1@>^HR`!TO`E!M:) MYT$[P>//FFK M%`*'\1,OYL^#,LO'1HFI.:@F$Y'R(WF$-[)&2_(0!W+PBY%OVXB`YYQG>!47 MSB>()<&N:51<'>_!QHIIDK=$%.YIT6W&[\2#>>>'-SO;C)B)WT)M$8?HV$+(,Z0EF M3FCC8C$/7Q(1/,B-S8+@^_N ME-"Z-\V&T;&XP^RF:1G-3H])V;2$W(-OKPHGH@(?+N\%RVZUW2ZG%5]J,HB< M?R?P],]/^(IKN\6$(O,9%%9<<>F\,D#_9=0!B!?+1;U6!2LO88QS-O]\X@XG M^/P@",-@COMO-F_)`2M[?O)E".4\4&PW6`7 M9["&^`F8\:E./DAP@)GM*IAPEVOHH$\MS;7+_0%B+")!G2G"BN&VCF'AQ-TH M,:>@7X4CSKI(FHMX433V,TBO1%43H!??A(,(!4MBI&EQ,YTO2$)!PG(YW"<[ M='D#IPR:FL*,^^;+%-(.?[0?'?GKU]`F#_07_&J4'KO<^Q4@+0'#Q3-$R`=[ M@8OO!B-9ZR;@<%R,1L"ZHK;K.7$V$#T`WR='"K=_4GH_$/@[2@;_@O-+UM(( M.9F[A1#A'`U#=T`LEX*1>8N@KZE_1@6"VP/4:Q:,D/.T9^EC!GQ]CK!M`[?> M`IW3D*)#JA83J2RP$PN^\0O2$#9NV/7]J)PBCE8)O=DNZM@ MG5HD]:>B2+8(9%LYU>E=]'F/KR` M^V((&J878=_"'QN]5K=3'$*7`Q^'N$8)XBR3_G,.\IHER&MUV\WWS7%N\F=;,W$[IFL[]'[EO?]?[V(@;]^`5[4V+P MQAZG%,1VJ<.`_]F\/(U]*=S";D>@,+,S"V$[&Y9Q"PFMOMDR53NV\/T'D"'6 M:MM*-+J=UC').%Q\64TXE.H<4VK58DH/I%A^ M)J-SOWFT5^;!WZE.Y=-O'^$>%_=C>8IVV99JI["Z%9TRM&>4+)/^P1G$G_P( M;F*T1G[%W&(W7J!G9$>:EPZEY*(?T:=U:YFW#472K!\4R/OAS?=!Z+EO\=_P MZ_\'4$L#!!0````(`-B(<$=)E`B3Z@P``.^0```5`!P`&UL550)``-W4TI6=U-*5G5X"P`!!"4.```$.0$``-5=:V_;.!;] MOL#^!XX'"W2`=1PG:6>3:7?@^)$*=6ROY73:_3*@)3HA(HL>4T?O_WW_\&V+^//[7;8(218U^``;':AKLBOX$) M7*,+<(5+^!K]`)^"=DA!WD@3Y9;QSD(_;%MN$+<'9TO@3MMD*U7Y%K M$^]F;NRKO?/]S46G\_CX>.22!_A(O'MZ9!&UZDP2>!;:U_7MO!C@^ M/ST^>EHQ]`/HLV].CKOO_W$RZ';YGP^+D^[%V3G[[[^*S?C0#^B^F>.GX^C? M5ORC@]W["_YG"2D"C!.77CQ1_*D54^[Q](AXMYV3X^-NY]OUV+3NT!JVLWP M#SN,F&"-7+_GVD/7Q_XS9\E;AR`9\+"6.P^M/K7H_0-N<]:W/8':/ZO(^L\; M-D0HYCV\!3HET5U"AUO0O$/(IT5P,@M7V/X,>DS9.^1C"SJEP&1*'H:,#R#$ MC4^GJ^F&.Q9F]$(3Y4M5AZ@/Z=W((8^E`*6$#L,S0-3R$9K.%U=!A2[B-+/ MF#(/_,QZK!FLU]![GJY,?.OB%6/&]6?$P19&A:@KJ/HPW4;X"=D]2A5&14;1 MP]HVW`?&%].TJ.54P4/;9=[T%B\=Q$P\9:/)4S-`D=RAO9Y8]].P*U!6_Q_0 M\QC;"OT^5^PP3!/B(^9SGN&22^<#R2I[6.MSY+`Q;3.?YS\OF%846DJ^J4CN M,%1]PGJCY_-N4,8\!6*U8(H;XI7XLJJHH)_?$<=F,]0!8CX-^TI]/%OD4+NM MU]@/HP8;.\P$/IN=LUFZ@N=6$#W03L&2HK\"UL"0>[]B1R`IKRWVO4$,K"T6 M+GC?+Q,118&*XJ(:"DGQ6J*1&B(EX5H\GAH^)>':/?)!6.45:1OO`^1#[-`) M9]O'#X41L8:F*AO_;;X'8`<.FJYF'F'K&Y]#FK&5V/"O`&^XVX\PE/`1Y2NM M3)^RW"B(5N3C8D;9?Z9HVC)UU+-B*&O6LO74XL/;^Y$5?:=H[E=65[,.NT^J M4D)27RU:E.T^):NI;NU7%JB*;#UKP[)(R]93RZP@YK^V)?C6/661C_.MV+$K MJ+KV&4];H88I7UFXM5BG;34M64SN3%>%7J;+RW897>5VU*FK; MC2AO[])55;M;4=K(BO)Y*"WH6($3GD2,V7M!`CWYR+61O:N'@W[E(1;[F,M& MQXQ=T`8[J?A+Z-I@6P40ZJ@<R&`$(SQ.7$&Z#,\4`]J^A7#3X^>'X#0:N6=9 M)&`^8(XLA!]XG+CR"%7H)@5R:L2<:"5&3??&438(T(BI&XOGL5W9-%.2XFH$ MG6HE*%?3QO$R\]`&8GOXM$$N36PZ%(XG)6$USLZT6'Z.V[?7&^*1Y.PG<;XQ.4ZZCRI)H1 M]J6NJ5CAQK$TPB[3>,R6979L1SM4,Y>G(KEFQ'$4VI*-XZK,89+[&`^2RD, M^%EE&[`.B#:+V.A@GW@!LLOH5*H2W1Y=W^79FT?(4;Q\^80#>9II;A,X12NCVX,A=9RC6.@8*C.YEFS)1Q8HWCBO)R1-'[D!*\0HCNY"\4I6HL?E! M/YNO,$WCZ+V$[OV4.0_;@ZN\Y7JRG!I)O^HG*5O!QO$0TT=IJ=&H:;=LNO#C M3*OC,YOB%5]6X09-J!5F;TWG(YX^P'=W7GY'D:8CJZS6^>=Z3=P05/CSVKR) M9[*D[C$M-WMJQIFM9.,Z4L^V,=<;.C.(;S;%(34N=/>]A4):(]`#Q+"=W>*,.PJ3`B:M.X8-$GU)^N M(IAY:PVAF&XW66SX3+TRK-_6:_[(/[BW49Y43K?/**IS#QYM/&3A+>6NW5L3 MS\?_$W*V,S;A\X1T#V8I%2P.F^WEY@Y'+6]QBZF_C;1/](X M9X]$45ZW7U#EL)P]&D=GF$JIX#'$8KH!&ZY%UCF=3"BDW1MDF3C1BS*T:EZ$ MV25`%([Q5$'M@UF!`HEVC1NQ5Q"[=,PF+8A.W>$3=U$!IG=\G3!=#=`R;V)> M+*I[`TR%*64+%`RAMUFRYM]L)RP`W^4(E3P6GG(B>Q:)>P>%AF3JJW`V>!9YU!RF:KF+W8["(GP4JXOKCCCE M28KO+IF+BW"^2MPQ-T]E[U%WNOK$[WO*W2 M#E#:C(WN%&H9I7()W1.]2JG](7)-YV@3]<#I2HT]N83NP\^#V2LR1I6K7\ET M,`Y!/56;BRI)ZDX%?CU%RBHV:)55Q4WXF^&9G]NS!;& M=`*F(W!Y8QJ3H6G^$WPVS,5T_AWT)@-@WEQ?]]AK5L`TKB;&R.CW)@LPFXZ- MOC$T:SA@S+K66U#DUZ0B(^/;<`!ZICEY,JX'`]#+S\-Y?88KN@H\CK5[G,3*^F#_"YB&_=,,X?[1 MF\]9YZL#:J8;$/!UD_@FT\70!+/>]QXS9PV0"F\-%^"=).'-A^/>@@V+66^^ M^`X6S'!FKQ_:L@:L10Y5@'J:A-J?LA$S7X3=LFZKEKE67$!]IHQ:-'U=XTIR M_;B`^7WFF/H\'0^&GUM;&X9GYT._29L1?& MY&HXJ2GH2"\K%V"F(H]Y@"T%3(DX?D.I&K MW8XN($]%0[FS?GO@.5>E"TJHQ\E$L*]1I3KN2!>43H79:IQ2U#C8MUZS=WK% MU>J"&5*16_!@;"1&U?-CM%T#X16/O`FP;V.O^"\:3]BD5\H4W"!5)*=QY^L: M6G>LZX=]7E6=/!G=YQ)J%"5VO(J-T+@=RU'@N=AG(XI!9J.5OZ(%M.6(Z#Y, M>!5KA2:H_T=,_*F@@1^EXV^BZVU-LO(?H8=D='!)%4'=QP#E2%'5JJ'C:8P@ M17PE:JPW'GG8IG84#*@\&=VG`*\:4<5&J'](C>&R,`[Q@AGE=&_KEQ\P4F4; M-S[T71^H8:X0OW5.\5+!9K,G_*[Q);&=O7901H:[5$LYT]6UT-BYB+Q75&W> M1AS;J3RH2ECII;8^Q;VJ-UFXEGIPE8`^M2/ZLIOKME0\#!T9,$[5T)W6)#\]DI`-]0;O9(^4VXE+F:*T)LE<&<**][Q:C$3;ZRS>5F#A_SW%I2 M.[&X[N5@.6:R5&W"%0.E'_(H1/B,]!9I#LD;35=>^^!'0:_4&6'.X1;[%.R2 M.J%4/9UN@Q@($*(`$0P0X0`A$/""1(?=U$9`1N:2---`YP!0>K*EH%EJ::^< M?O!VDP#%IV`*>J4F-%E)<6]&5OG'8@K*I&8QN8ES;T6-ZK,SXZJ0Z M.?QH(LW_+"%%[)/_`U!+`P04````"`#8B'!'&]T;*@42```F``$`%0`<`'-K M=FDM,C`Q-3`Y,S!?9&5F+GAM;%54"0`#=U-*5G=32E9U>`L``00E#@``!#D! M``#M76USXC@2_GY5]Q]\;%W57M41`DEF)]G);1$P&=^I!P0Q#7& MREAV$N[7GV1LXC?)LI&QV&%J:B8!M?1T/WIS=TO^],O;TE)>@(-,:%\VVD?' M#0784S@S[<5EXUYO=O6>IC44Y!KVS+"@#2X;-FS\\I^__TW!?S[]H]E4!B:P M9A=*'TZ;FCV'/RM#8PDNE&M@`\=PH?.S\L6P//()')@6<)0>7#Y;P`7XBW7# M%\KIT?FCTFQR5/L%V#/HW(^U3;5/KOM\T6J]OKX>V?#%>(7.5W0TA7S5Z=!S MIF!3UQ]7XQM%__6+IAR?GQP?O-B'*O)T?06;0Z MQ\?MUA^W-_KT"2R-IFD3;J:@$4J16K+DVN?GYRW_V[!HJN3;HV.%;9RT0CB; MFO&W,W7+`_+*!OKZ83=)!UIT&S7[@D757SW@T(9,,AH;2*HCNRK"(!?4G M`%R4!R>SL,#V[PP'*_L$7'-J6(7`9$INAXR,-4",CT;ST3.9@[#1@IX$%7PL!2@EMAZJWO+I>&L1G/= M7-CF'#-CNW?0,JW;:^'TZ\CORL@7/_OAN-@MCGZ/5-L.TQ#Z`(\ MYZR,1R+-!I)5=KO6Q\#"8WJ&YSQW-<%:(6/*-3?ER6V'J@=Q;W1TTR7JX]GBVQKM^72=/U5`X\=;`(7;^3Q MAIYCYN80W=).WB,"WSS<@$IFO_R)@%*^MK5O!VM@96OAA/3](BMB7$#0NLB' M@E*\DM6(#Q&7<"4S'A\^+N'*9^2ML-(KJFV\]X%KF!8:$K9=\R5W1:R@*6'C MOTGJ3!]BG+#(2IHCHL8 M9?,9IVF+U%'-$T-1LQ:MIY(YO+D96<%WG.8N65W%.H2?B%*"4E\E6A3M/@6K M$??L5Q0HCVPUSX9%D1:MIY)=063^6I<@7GZ$5S["-V?'%E!UY3N>)D>9OHFF M%O00<+937%B[E5BE:#BL)& MYI1GH32<:0@TJW`4`"4B%@;F2"CLS,?UA*MPIMXC:,Y,;$[D!Z2"AJ*6V-1B MVFX+%VT%95J9%52/>]-8./B6R0D-!6FDHH%?W1L&?*N@HE5H=HQ-FAZAC$#L:UB8[BGP,1)92I M%%)VP#J&[X2)3_DQ5L6_Q./-"67'L)XFL+[+*G"N1*6K1)F.;\=`GC%!$F$E MD!8^?@2$LV.J?"!CRM^9(\\!Y!=5[XVUNXDV&BJC@7)UKVM#5=?_K7S6],EH M_*?2'?85_?[VMHM_Q@5T[7JH#;1>=SA1[D8W6D]3=?%Z9X7&8WK\E-1CH/VA M]I6NKJN3"O"D`^8Q-!^3:+3A%W5(S%<%E)R@>0S9>1K9I#N\UJYN5)_9T>2S M.J[,;'FQ]"C4]G$2*NY_O5^5D=\W=1_M[]WQ&'>\"I!FAI!C\-I)>,/11-65 MN^Z?76Q,\8AR@^XQ=)TDNK%ZTYW@$7'7'4_^5";8;'JWYUM2/-2\4'P,Z4D2 M:6^$!\MXXG?)BFU:)"8?`WW*#3IN^(J&%"5T'X-\ECFZ/96F]SB^7,]Z+&I)]KP6AU6L]10P_PQE*GU1K^_TM7? M[C%*125S?07(1,;Q8\JDEBL1FP"\KPP:K6!+24\,B"F66NVBNP+EQ[5H!?!H M&0-1<)W4^K;9)%2(C"]S((8SM=#1U^$*@?.E%,2`I]9`^B2]<]R,](*8#ORK M8V*%KTZC*M(*8CJG%E!<,%, M!U3J8^!N>"F;_!!3*[7>,Y8J_.6ZZK5CR:^\2L)*)T9$-3PI\%`O3=XAYJ+@SCN47"9RU@ MN2C\Q`^H-8_;P?FM'X*/'S;N/VPWH.$?-]Q9QB.P_+8?@L)995L20)]$']`9 ML(-R2E(,X6=?,-S$!77 M.TU5Y_@OQ=5#.T,?472%,=B2,Z-`/GTU:92>E*4T(T<%[R0>HIN(:P(%S-JW M0>)!BB(B01>H@)YX(D01TR>&!N16@#KME9WW.`Q/[A@(H'!8/5+Z(:L[[,#D M^?N`/-`T,]<[8_F(-80\,.M[CFDO[H!CPIG^9#@`1=51W_`Z;*),OC8V*EJ7 MO&QNIY*<.PD?]96!09(;2?`R8*R-C#OIPK?&U>J]R)VQ\A-I7@UG%IT[D&:O M;<#H!T+;D;^/B%>7NKVIM?^L\6KX0?T-S";0'Q8.(IY`=Z6[COD5W#GF%+3I M/8.W!NDY+Z0(=6=3W?JJOCV#*5YY;LQYUE-WWC'X5DDDY"]!4B5D]NLV7!Y_'^?6@E-<#M?*TR)Y@OIIA*P M$DE7ARCN(8K[_41Q^^#1U6R$)F;X-JNLW'%;NG:RN5GC2,E]R'D10+I$ M/:%:AJU9I*15E2Y`*XX;F4.S6_.WTX#LY!6WO1I`SXGN`)@A69;(0ST[L-RA M`/GABY[7F(;7P0NP"UJ>(O.0-;JEM#U+`>K4)=C\JN]/X#4\I?3#J?PF9T&G MNNP%&WN`=__!I3-6>*$(\GF-U`>S$!SI)HP7@23!>6GQ@JZ'UXSM#P%M$!R!UC97V-9W?X M`0Q_82P83^S\=.7`*P`P-L!V"#IEUQCU-98Z@_/QQ*4!] M*!&[7(/,S9;N075AB@^>!IF[*:AT9-]"P\X=!M)3$%%#1 MTFQ?-K5!C.W'X'F=N(9&<[[IB"8A/R=LY#1^/NPV6%+XVMM8X"1UZIM^>\MN M3F>*N/PVIF&!"U3BAVLC[9!?_98B9QHE",*D^N\A?G2('PF9XS.G%'8@B2DD M=T2)0U_9'ODHD/-B&#EB]029>,S/19CD(:QL]@ZDY-\$L;]%FB-2SR6(; M'/*"EW1K)9(AF;=40EBL/PSREYE*XNV<>U;#GA7:2$4$'C[N MG\F3\&EF_UBMV0.'95;.0@;HL/1#NZ8;1+C/"]!1TPQ=[4P28.@4LG-G+^W< M8=M9<'\>.>;"M`W+/XM+/.?0L[,2/$CAS+*2VYB!6?3VDV+A>]M80LSR__#L M!A[='!M32DMN929JZN:CWL.0[)<)9!QWS!:0F!D>X%0GQ&[CFI6_##(6)4S= M@8WXX4G<(B7X_ M(=TZR`.C!)W?PR1U\7GMGP];M&\VJAD"TZ,%?,':O6"ZR>@Y M"7XF;)Q$QLWZTP?-_\\_M;FY@=1Z\,AGL,A'J%NTL,AGL,A M'DD/\52:_T%U);*3*6KUDQ\Q!'H2A%0FA?CV)EJ5&31SV$4BB( MD1#:UR-:66H(][87HZ%0@",AM*]'M[+4H-%0^@A7,1I.R]!P6F^.O2@:HFK0 M:*@XUSZ$8'O0GU-TP\:$,$Q]"#?9\F8[I065B1POUQS), M?`PUV/.5.J8'E8F_3F2\+;N+FHV+'D>/ MOMNO3$I!5%YBHDKH07VPDXC)R'3KWX?FA^DGCKE8L#PD_'7L&Z/YNE!]755L M`B*1V?#U=.&+R2;PSG.F3P8"`^BHN.QJ\@K7;Z]>OW23N5'8IF*).16I(-4A M(.?P?5<[[U7-W%5(3'0Y56B4"GZY['OCC*N%XX4D-C4-+-53(^?XV%U>D+Q4 M;JT5C?-ZWX,K,#-(>N[8R*EN.VDNOB]^W32/M/R\\6M!XS#RCME=Y'?YV]\G M:.&V4=^?%5R^?*Z/R7PN?3+J_?IY=--7Q[K25P=:3YLZ*_\EU#F'CEE"@KFXLK@`F7S]#&VN4E`%&*UW3PF,/BN;D\21*U96XP^[ND(V7.B@$!_["MMDI M.8E2=>7@%+9H'P%]'^P0=^C0E$5';99KM%T5)Y-0GB9J=LGC4 MK\=[-"\H.@\,H*,#Y\6<`J:ON4@]\G-91A\:PX*#]F%VR!H%+:4P44IBBU/1 M4I\4)9K1JLYKD9:UM=S^=NUQ1^;GC5('*7<3_L9M[DI9+T[]B#77M&5Z_"6!@3TW` M^4;W\_3]2+>WVN16'4YTI3OLD_N2)MKP6AWV-'5'+W77O4<$OGE8*?6%:,:E MR>EQ*C/H_DI7?[O'FBCJ%U^?0UK0(2WH.TH+BN_SV=E`667E3@*B:R>;5SJ. M=&@L05Z*"5VBG@P@AJU9I*15E2[W1QPW,F<`;;F=O] MZ6?1(\!%SV+%;@(X+W,3P/DF#K]O=L_2@&=W7_M<)2"`=B;YPU@>=AI/,BTI M6X7/]HN@!/!]V(Q5=M?`?C''5(.Z`L``00E#@``!#D!``#=?6MSXSBRY?>-V/^`K;F[W1UA5_E5KD?/W`G9EJL5 M[;*\EJIZ>CLF.F@1LKE%D6J2&$?X M'Z^B^-4___.__S=$_N_O_V-_'UT&./0_HHMXMC^*YO'/Z-I;X(_H$XYPXF5Q M\C/ZZH4K^DE\&80X0>?Q8AGB#),O\A_^B$Y>?[A#^_L&S7[%D1\G7VY'5;,/ M6;;\^.;-]^_?7T?QH_<]3KZEKV>Q67.3>)7,<-76O\YNK]#DUZ\C=/#A^.#U MTYR@O_`R\LW1P>';_WET<7A(_^=T>G3X\>0#^7__Q_!G,B];I=7/'#P=%/^7 MJ_\]#*)O'^G_W'DI1F1,HO3C4QK\XU6M<]^/7\?)_9NC@X/#-__Z?#69/>"% MMQ]$=&QF^%6I15L1Z1U^^/#A#?NV%.4DG^Z2L/R-XS$KJF`67;J^*SAP3/Q6#")'E#]=]$^)Z,N$]_Z`/]H<-3^D-_*SZ^\NYP M^`I124)":;\^--HJE-[8!GN#DR#VAU$_U&UM1_#)NY-D&W2@KF^]"],X\\)> MX.N:UF%?XWY/?*UG_TF3N03W>](US9W`SGC(G1^O^+F&],,K\E<#(G[*R"R) M_1(D;4)A@=DOL(FA:+MJ/9XUV@VI-8^39M_3;X_!/IT=\QF3]([.GW^>QQ%Q M*[+@+L37<88//^/%':Y4&>Y_O%)*OFFCH3J#I(3D)3--OPJ)-[.8S$K+;#_, MGV"N/D_BA09`T?58*?9G>%>UF3\E\K,2\`VQ!*?,]^@T2/4>Z)]A@6T1$EGJ MS^%H_\ODU7_6A!&51H=_?[-NL0\'"M0,\=Q+[QCL5;I_[WG+-Y0;;W"8I>4G MC"W[!X?%%/ZWXN,_J9.$%SC*)C,<><1T#YZ"M-5;C:P-SAC!I:Q1"CKGC0FZ M-G-*$?0'%?KWIK0Q,QU'QJ;CR+7I.#(S'4>`3<=1-]-Q!,-TM#J1WGC/'OE; MR!Q#'9NFQ`A^W:0H%9SSJ@M*'<-25&BA6QQ2;XW\.\F>HK- MZ'I7,7,I-6R2S@!ZG7(*<3"$TV-LTVWXURH@;*(AJ3@BDV!J=6HKWPAS[YC3 M<#752:#+IKR6N'/&F&/L:Z`VGAF[4U&H;.BBK6\2-#F$EX.M+YRYZ6<\T8+ MK4T8*HC6DKM=I5-:9AA'9D9%)6W-I.@A5P9%+NJ<%F;XVMQH*&S)D"@GG`E^ M-"6'1L'RE*,!WIIS)-(P6&("43+K,*6FO[(CNDR")W,[HA"V1A,MX(HB4DD8 M]-#!XZD1`W1$)JN[%/^U(JP=$LIF4_)[JCUQF;3577$UY,:^N%C4.8',\'%[ MXY4T8N*(RCO933CMO((^A;*"/NVV@CZ%9'*,,/9=0;_;U0R5Q;-OXR7=)4L_ M)5Y$?E&Q&:62MC=':2&O)RFI*`S*:/%Q1H8JH$(#%2I0]L+/0R]-Q_/?O(3B M&B>WP?V#:O6LD+>:?*&#W4B\D`D[)Y0I0LX"47D4SU&A@>($,9W=SET"ZBNV M,%72+@V/;.M2+NJ<)V;XS`S/KO:X1VFZHD=)%%,1)V*-!A)PU=BWOHCC),TS=9BU4JV!5!I6UT%ZZ(VUD%S<.8',,7)6HZ;Q M`RISK=B$L]/)I>2Q8D;A1*S;#]G^?`K0$GMA^7DI_>=5[SOH:QXWW=; M\;Z'1`HCC'U7O.]W1*$A]6W-(K)246NDT8"MV"*1@T$3-3@N(Y>M/6Q$YR^# M1_UI`:6DO>T])=3UUIY0#`8+E-BX+3TB;(4#+1-FG@+I//71,.414A2X^MKD5!O'+'U!D+7,BU@=6EI?<^A[6P*HSCZN!W55V>OD#BEQB M3L3ZP,JRA5O?PQI8=3YP-;"6+P`U-NLQ*:=EBT?/?G0.0;T MP34G)-!U,:`/@#DBQM@W!O1A1Q2ZB&=YPG'D#Z,LR)YIK;9DP4J5#>[2+/%F MF:BS9GK6Z-2E&Q6I3)1@4*L#4BY=O%!%1!?ERJBFO2,D@FXYPP&F!1CY]^Q<_2SG%R=HDA@=ED1DL($#7$R"3<*(01DT9$ MW`4[2CM&K?@1AY`2#I9$%E7(YR57"3EIQ5]*4E9WO< MA3#;!&@(@6*"")F4$KDP<2%\5@?8!3L&!(A/P5R&WKV@7ZWO;;%!"*MD0>-+ M$*,O0M0>]4H&42$78WV^2A**,4AG7O@[]A*Y,9"+VF*`#FQ)!ID<"%YHP'$K MUUP=U,!NNI4281`D M,D'(QTK+A:F'J.;^-ZJ*2EV4*__3':F^QN$JRKSDF57M;R=<*N3LDD@"LTF> MEA`@THB1J6LD)90.Q1 M`I22Z(<451K%U12H:,DAFQB;S\D\>A\G\@A(2\HN=X00FY1IB`!BB@B7)/)1 MW-)2R+HCQ,WJ+@QFEV'LM8/Q$AF[9!#`:U*A)@"("#PJ"0UR0<0D';PPZT)IU%!J`B&0`4Q9:99J(J>ZA7!G5 MM%W&X/*%71[VN22?B=P9A:SM6)P4;CL>QPF"8)(.G30N5ZR_B_`<4W'/&AH- M,.-,3=(-8SBH8KY48@#9TL:FXPJ+U6R=*5NX[F0\OPPB+YH%Y`V(TT"1A-!- MU8/GSTX4J/6E?*:-2&_U1ZF]\)'([Y!RD*:LODIB=.2IS(N:Y2LF@>C#C3LA%(##'V,8'+S3*&$DDH+!L]&$:VA%R?/ MK!.2+K>%;/)(#+#.FZ8$&)X(87%;!:40##9?JUZYT"+*W)+9:U6I9; M!;=1F5LD"(8I*G3<8GN%$7T(Q)#D"?Q+FL`/@STW"5YZ@3]\6N(HQ8/('V;K1:K?'[T\9+XW`$[CD2_^X_C MH[=[)Z<'S&J1?YSL';U[NT>FTW2)9UGPB$,@L^EE$`49OB*(_%&4D3[34WSY M&T<>AR8^9*ILD[+=.E0GKYDF&!IW@LNO"$J-VKR:\_OC2R!FKV<"B8C="?A" MB"?SYHB9I)$)RC9"3!\OO.2;V)9Z"YK+]E\U6WI\L'=T^#:WI4?OW^\='1Q# MM*7Y,U!Z,2Z\/KF[!]'/4SIXD!R[J\"["\*`KJ*)$\&R7QK55#5SI[FZ3<9T M[52=4Z:Z8`Q91\!M2EZ-!F>CJ]%T-)R@P?4%FDS'Y[_^,KZZ&-Y.?D`7P\O1 M^6@*CJMF.W\J!4=\--@#E$M#Y%RWWB::(O)0!T,+[MCEFX^+8OB+]1=\_)&X+'WS(N^C1]QXB?>7.JS MM85LVNJ42(,AE18B MY\_'7I2"W?9DZ(H71.9;-D2LNND"<`W'O/8]&(((0(DI`&W$CA$XN"X8P:GZHP8L0*(Q94JN*>JZB(=K(]I+L,^4'*W.@\\/E^[^#D MM(A[GNZ]/SJ"&/:L/XB6O:5W`P7S`/OJ.;!3"S:9VZ-K=39W4`?#\.Z8C5G? MG%;%[T"=_J?')WO'1\4>ZOMW)WN'IR#C_L8!#]=Q#;/PA>,HA7:?P#@BT4P* M`1>"J/L?&MZ()%WY=RKF\&)6J4/,SEV<8B5YI!!?@.]78[[^W7!F6C0V!:PQ M45H1<-:C\X8CE"W&;IN*+V`;L?/&85WA!^+VSX-9`"0&6JL"\=4+5_)E95O, M[GI2#+*YD&S*@&&+!!CO1+.B&BF5^QG]Q\'K@X-#ZC>C1ZKT,R(_MG>0_W^4 MYB4WO%7V$"?4C?X9'1X>[WUX^V[OP^D'YCX?'A[NO:>?D7\7X@&M2.?GZ5_K M8AW(R]"$/']6[Q\='^PARA0F=8%GQ:>'[-,3B+[XP/?9$6POO/$"?Q2=>\N` MV&_9KI=,VNINHQIR8V=1+`J&W&I\7"2_DD8TTW\_B-`L5]CE+?7B@)G@>[LW MT0N"8MR7SL=9ADA\OSPHW_D69UX087_H)1&Q<^E@G7%XD<_`$DZ;*-HT%^8= MJ5L.O99S`_1V)5T[9N;^>2PUG12?.*E70K7'==E*.H7 MM1(U2#FEFGB!4`<6X0S1:B,+S,T&3,?:VN7&2\8)*X/DLV7,#4Y8Y3_]JD>N MZ6@-J>N*9%DI4P,SCYICE2P^BXJ.1!DQ+7`DS&M-#JIUK_Y!\!J.2">#+B%; M6QPBR208U>0JRH6NM8"2C-7O-R98*>V47$W(2F+EHG!)U<"G)E0N"H-%C97+ M^H`P^3O$K,I@Y`]JA]VD!Y-ET9:M-6\YN7ZK#Z65>;^5ML&\"5OND&K%7&\? MQNMS@>^R491F"2O\^F6=)G)19(G<)'@1K!;R\\"=6K":;=N]:XWT6W-U,%3N MCMGXGF%].MVN;AYN]*F6+O7["?U+]KO/WV$%G57Y7 M_3=@O,JC:!8O<%7C7)-7))6V>Q1.";EY%DXH"H:6:GQ$1\JC=8%Z:&5GK_% MCSA:21,6UU_;W4-M@FKNE.;?@2%$"U";`>77,(;[/$ZS\;S`)`WO-&3L!LD$ M$JAL9H`&`J(4/&^9,IODT0LJBT*PNKM(%/(V*:*%72>,5!B,&=$A;/.HDB^+\`(Q M*G5WO>6E2X-/"@V[@3\M]&:@3RH.AE5ZC%QY\7JU5%8F!MP::()#TN;])QR1 M5R"DW?(70130UX6F.Q/XWF35CNE@R>.)LK!CIE5KW(`P97\FM8A)).2,-#%=)F M+0;&!LFQ\:=,TZ+F3,&<.(+"&%H3VM1=%\M:98T*;H,W(D$XS%&@X]QS5K4[ MR".`=*;ZL;`Y/P%B4/X&J'I;2EAG2Q,:QY'\:SO,^)`S(\+W=$]`.1UQT%2T M@$&$LKZ;VFOFI%S4TE/XP2T1,"9#C$M0\3\OEU?8"!C,^.0%44KG0)R.H^$3 MG3)70?J0W\I+]]IE,3"]GM50HFDW&@%&G1(TTV,*F`M'$CU$5OJXH4)CU31' M!P81&_.NR=SLT+O1>C7`%E`":)+%$YNY0!FH:YQI5TPM&:L%RD3P&B7(Z@)@ MIBP1JC8EB`P*R=
+"&2R]1/(\C8LI6Q)J-JU7;#4[.O#28J8Y!=6[%?@Y% MYR[RN17&38#A8S_7[&8KPN`L(Z(GE4'=NP2>!>W:O3MU,#8,C;![68NM^+EI"7-]6@<%HO M$P.#SU76TWA.[U2_#./ONDB56L7N67L]^.:I>[D\&"X:@.1KA92I:V1!0)40 MTP*7R$;\$8KN)HD?`Q_[9\]?4GH!6A7J'=`Z2/D9<#4%^S1DV:?LV=&6X]FQ M%3`D[@V=2\FB;)XS-M=#_+3*5M4$D.L6!_[_7:49?0W3:T(1`GQ$WLJ45M"G ME`E"W/#9I_%VWH7=_ZS=2EYV'F*S)-AN?Q/,6VFIHWR1LNIG41:CI/PQ=B*' M^?KD4_HW1816*;N9!/*;SOS",WI$X3Q>T$B+*F]*)FS545(";KA(0DDP#%;" M$Y90V[^CTM0-K\1AD*B>Y#6>7P:11UZ*Z)[F(-,2..4!..F)+6-UJ^:[8Z<: M9MA0%PP9.P+FS&+KDE[CT[8O;Q?F",R8F6,5;L'\2%5_@KX30Z;L&<8^B\3= MXJ7WS.;>\=SHQCY399MFI5N'ZMPTTX168K\3ZI=Q,>`LH6M:J!0-85_',818_DS8\3^745&AVW#!?`5_.WI@"8G3Q*P9EB)DO) M%Q320,J[\]TIKQV^Q3,6?4S./U`!-0"I8_)E3P\,>@:.0G M2DFOO&@ZJ1J`2LZ;!-/*]A=XCI,$^T42#)D+V!2A+&K2MS&W!.[2836E35H" M3/(.\*7F]TY1[ZSI5`W!L-DFW38S(BK6@+,^`[P50Y' M9=W+2R/9$;SBSF]PMW`URX&5_2@Z7J9<2QZAH:Z[LH2:[L@+$DH4P9"W"UH- M5QM7T8ERW` M2\"K[X_3VTH(3C(AU>X\,=A7E^BY2FM0=D.6T2!4`L-,4Z2S75ADE"1K5"5^[ M^D7!%G,U:Z&B#IVHHD0&.E",4T>\*B,UJ]WN`]!@F:^]-EZ\05U5;[::?A$! M(CEN:8!H632![I[1CT6TZ"?ABAH&D5FW<1+$?CLK0?*H5`I6;Z/0`F]<32&5 M!C,#:R$*.<=2G6E$DK+/T=DABESVT"V?`%JR!SC)R$)*];XWD(G"87OH#M\' M441?6;H(8\U"?+S'#A[O,%(N31JXQ`\71[[98[5K"&GQC/)\=+4W$/F":8`> M\0OC=)5@311]\V9M&]5M/(0V33=I$Y2!WD)'N,/*J^4R9$5MUX@>QJ]Z:(BXJT=7"BS#\$H`2[M2P3&9" M!V"I,@\E7X*A%`Y!#A4O,C\YY@4$-E,5DA$MU6 MM+F^U;5RUVXUELJFRF`HV!4QMUZ)HWTVH]62)X@?"'BW67(\=8-3&5)]``>2 M^YZ]D"B#X6U7Q((+AUFF>GDI31F;)!_1\D4T.`F#KJ*J%H,%/1$B>3(J!9N$ MU`.O,U`N#89R6HC\!:3K'`<4I"GE6U%KA"LU`H1MQ9DETL^;.`QF!O7J%`J6 M+XC7`&]=ZRZ1!L,V+42!12L44*D!KF3HV2H-(IRF%SB=)<&RO""1Z^J4O"-G MH3SSJT<[-LG8NYMUCG9N!`QU^R+GCKL/)^>WHYOI:'R-QI?H[,MD=#V<3/;0 M+Z/)='S[.QI<7Z#)E\^?!^1O(C`9?;H>78[.!]=3=#.^&IV/AA,8O+])Z#FC M[/F&]"\CSV+XURI8UB^SEV_@Z_0L)T>8=:.5):%6`L-;4Z2"O`FFMX>8)EL` M5;K@;+"TE^O@IL[\=FL"!$,5G3,BJT`?/F_EH-L4OAS]:WB!!I/)<`K$9)95 M>9Z-=V64&G:7XEKHS<6W5!P,Q?08^6/AA09:JX"SA8)NZ6R?6L4QS92V324/ MF6@ZVS6Z_CJ\IO[@CI(469+;-"["HEY8W<\@6QL;:UE+433O0I6AJ%=QSIEN M./G(-4U`S&)4J:*U+A3SU#R%V\5*&6A:WKPU[4IK3U>GYIR&W;'R%FPZN/XT M.KL:LB7M>/K+\!:4,S;%BV6<>,DS=2TS@5@D,`4V1W.:I_+CBL()^)C53L>O!Z<$WW3>YO'/F=`#).6[CZ7"";@:_#\B$ M"<,JU8Z'/D\3+TIIUD,$$,Y>WT=S0E,^MD<,XFVQW- MKY)S@3MF:=*L3;C?R-%Z#'D22 MZ+LFE;);.H()E4&33878F'BH8=!@S+GY03FTV3LG`TZW0$LEL;5L\[]NE>XW!C MEP;`\+4/:E'&9W=[=H(.%(K+7"W%EX6K?5.Y>?/H^GG MX?4TCS03)W,ZNOXTO(:3(CI9W:7XKQ7IY_!1D5N@%[?J$FA`-SP`B2P8IFD` M\D>\2W&4RX,SBNT.:?U.N;Q+4JG]2IDP6%II_<8O9Y/A__Y";!4:TL0F(/9) MG-1_YJ5!.I[?D(=&:QW03_N=W5`WY/[PADE']:Z.(HAE\[\$*]J@??7)W*Y9T3K0-(_FQ80-:JRQ"G=`IL-`"# M95_HY3_#-`L67B:M>=$6LLDD,<`Z=YH28-@BA-7FQY?\\J1*#`8I:,DA&FTA M_Z&A[TBZ&N34)VZDZ=D$:*8`C9!2UW(I7H(J9,[>/ZC$Y- M'P8U;_$CCE;X%L_B^R@P]]4,].SFV!EVHYE9IU$"0T53I'P"*--#-44HM)MA M8J/OB&=IRC>Y@EVBZ8`W&2:3!D0M#41)I9X4K35A<*HZ?&O&*+FXDV/0!FR2 MR5KETB-.[N(47RDHI<$I/6L/@T:?XMC_'H2AX!Y9,V)U:<`FU;IWK$X^4ZLG$W=2]=C(ZHEEP=!,`Y`W=U0?`2?.:EV#^/%[2@*`OPCK%:J^6K.[.]^]J8]^^ M>S-@Z-H?.[?73W-,]^]H4ZC>%@Q6#[V$WI62WN"$==G,/FJUK.:_FW6AD1"O M5@'#0C.<7,I\H85^#.,T_0D1;<3485!.6LJL=TDZ:(7H^I6?@T<_8ZB-H1L(JM6UMFRQ)4*JBY+Y$J.6:F8B_]Q`S\.MM$+>^4GBT>32#HR1Z3B@C!J^@#-B!6BD4:)4L*;4@S8'YL=[4\KH\9RM M7U^\L6D+-0CWKDV';-*$IGKV^CQ_?^#B@UO.$_D%I?%(S MFN2C/X=1%F3/-$J9T*IHU`.X(."H!UK[J/6A4[*<[6W0@5:^MT+#N7'H!--XEG)D',3[%>:[ M,O",@`:G<)L%Y=LLLUPA`[3/\MF;/1"3ECS7PZB?DCB5I>.K%&R^]GK@=7+) MI<&\[EJ(;695"BR"C6$%KR]79(K,:-4/>JGK$_TK5=%*(6\U.5H'NY$0+1,& MPRD=0B[QN90O+M+--7:VY%XL5UE1X2B_ZRKR)_$\^TX,K(@KQEH6%]6F7:BM MHG4JSMG3#:>@CD^NN+>V28Q.::$,PT!=T9M[:8FMT6*9Q(_YU1LJ"Z52L&FB M],#K-DHN[9QFQA#;#*L44%#3V)&5(JZ@TB^2"5FS05*`E M'33O1IJ`H#(@.B40*2)20Z+6L,JH+,Z\4+5$,\+*W41"6W6T2FX$DI8)G@5Y M/!`O0UQ>8;N(R;+^O_+CW[+^B09N6VW;6HE_R`R^K?0Q%F]]KW&31[ M\T>=KI)'T12Q.3>(P-4)5?_>N2>A`,67A%J+(/Q$(W$;KT5DR3$/P7(91/>$ MPC?>[!OYZS-A8A)XH=!]5(K;2XG1@UYGP\AEG5/"$"`7J"TT\GS07`=52C#L MQCA[P$F5"CA9+9=A("V<(A.V:4O4@.M612SIG$Q&\/C(;/(-TUJQJ!2$09\* M_V40!>D#]ND1.1E]9,).SM<*`0M/US8DP=!'"8]W:'(9Q(2`4>?6^RZ;RS2R M3H@C@BOD35T0'FT$Z+AJ$=YWL^G*QF.7AA&:$M#6'Q)TG4,%5@\0)S0<>H'S M_XZB]F%I=29'!WW+1XR[=:MUYMA,&=![W@TQ5^F/O/?EO0E9XOEX03P0LAAF M--[1&J<>6AGFJZD"!O&YIQ4(D7-NK&IM[=.Q,]4ZR%#/.=%Z@.4RV&K::+C; MY7-^'*$Z^7)!\^Y"V;4$9BH6:^$:@:^5OE7*PZ".&4AQ[E.A@@C)JM,E:!^5 M9T[&U4DE5+2Z(U85OS)*TQ7V19UL"5ACC!!8Q8_&MU;9L"2^9.Q/,B_)1$Z3 M%%V;!F?X/HAHPBPZ\\@7,[R'HM7B#B(TZ\>XSP$TYF08K1DC:T6T/PB5HBI26H M)&R;@A:TMBTHOH8Q-0@QM<>^M/#WN11S5#W"F`7V+1N#`J?&&C2E+`^_"&*+ M`G412#00X.I$!:<&@3BU0:(T")6$;8/0@M8V",77D)C0PB1C`@*L]_*]W^R:?4_Z5DI9_FMKO!IWNNVG.7A%\-L4:`I!(D&0F0&5'`\M>>_I9[<*QG[TWL+ M'C_!%P*0F,"ADD_RA9SU:;[X7>U$WY2S/M6+8'*3?5T($@V$R`RHL(%!@!") ML[MUF0=BAI$P(5:!CJO!&/F]`W&0@F`PG[X(H6X$W,R+92!>'@UO2U@SBF)H M%1>:7X.+A@KAP8F(-^%)YT6AF",&B$V"0`8X%UY$;+R$K`B.2$+C[>^ MA^$DB4&U"5!MC+J,D+>@:JV#HRBY"J:,"X"\9@6R;JQP:R$4T7).Q#HU9/'R MUO>P"*&.F%=;R= MDX!%!EW$O6*"_9`[!U%K%YR%W=50Y5P`:!V,@N\B5KCV%13A=X&0@TE#%H#G M)&`10A>"K\T5MF/P'$0#S\%1'%X-5`E!Q^2W=CY!Y&2M_Q4J8MQZ!3,CJC0="@(VZKPT)Y\94"8L_X%`( MH3^8V+^!L>(JB/"(_"D[J2L2=,(.#JB0(944/):TH2F80D41D]V8+K+S4_3< M37E2A_RN(I@O%;5W7DH-=GU.2BSGG`H&X)3GHO80*^9?:$`Q(`1@/FE>K!(R M+=[DNUW,(:GW5;:PVZ0ANP:H;T>;!JIK*\Y9NS%T#:<+9TE7>=[U- M,\-\]KP6N?&>6<7;[U[BU\^WI*,H?SZRI[GE'W%_N?*F#TA?X;_O+\!YA7;1 M+-SIXG61)\PVSA=2AY?.;J5@M7=>Q4 MHY25H2X8!G<$K.,FT2#_WF5N"SIEB M@D[K$>0:*"0J,"R7Q/GYZH4KO`4O5]4.`"=7WTT#'U?>B'/.;HI$8,51;@ M]-RCV_=GS^5&1B$HB^=NW*K5B_NV\P@:-_MMUB2TJ^:VTQW!!3V+.,IO4]Y# M^<0(^*4HIV6V!%G?:UYV4K:L[-F6\Q?`M+M:VNL:G^B+/=J;W60C';*2W*Y:9`QCDK-,`DF2Q;7E[*+XE/5R$M[*UPT`5"-B]Y%P.L7^+> ME(`QX#)8@NMM"[EME:#=]DH2K-D1:.[X_D\RNW]]#">T+>(EY%]"XBPCXH M3&J^&*,H(]#2[):\&"P_Q;\AWA/YPKN7I9)U:<"=$3/IF-RFJ;3!L+0S9*YD M.$?:LA%$6X'!5P)RAK&?7A*PQ=O&P!9WVDN>C5;+\DV+)EUHW=BF4@'#03.< M>N*5[>S(:U__(/N]BQ6FGH#("Y5)6O/?U5`K)UXLYIP7>FQZ+ERH]U1V.86L M,"7R+6:7!MYX22:YJ4HH:#GUW2!XJ(;)1GLY MJQ:U&?A0@:V'/T1R,$RG&IP@%%)*,^.)"GGTMT.KC#@R[\J144=D0C:*[2H`KHN,R>2@L$$%32N MUF(ABP(JC/Q">D<<^!)Y^BU[A+D+0=1LFGC@ZZ+D+."NZ(8\S"Y2<^QI=D:IF&=H&NMBM\Z%_ M43HL3UIJ@"R:Z;*EH?/"+!J<58V6_$).F6C9R_0U[L(Z[5>K`HI0QG#AFZCC M?B_,,2@3==S#1!T[G^\Z`C6W3<>N;).03"9:<&P33R6]RLNR33(^P;--)_U> MF!-0MNFDAVTZ>2FVZ:2S;3IQ99N$9#+1@F.;>"KI55Z6;9+Q"9YM>MOOA7D+ MRC:][6&;WKX4V_2VLVUZZ\HV"V24@F$RTXMHFGDE[E9=DF&9_@V:9W_5Z8=Z!LT[L> MMNG=2[%-[SK;IG>N;).03"9:<&P33R6]RLNR33(^P;--[_N],.]!V:;W/6S3 M^Y=BF]YWMDWO7=DF(9E,M.#8)IY*>I6799MD?.IEFW:8\5'/Z&H>JF`%+()Y M@/WS59)@<>Y'!W5XB6U]P%M+=MM%7M*E-\.#A7$Z4EW<7182#UJ>?+26=3[O M&`(TYM,>^JHKS6=M2'9X$AFB!O3VF6SV"+#NSP`HXYF6$6)4@@HO59Q;- M7@IA>V<7=(#7YQ=DDL[?<2-XW#D&)H]RA;V\I!-:X@0QI6U.&RF>O;Z/']\$ MQ*2D&9TTCHN_*8&.:]-%_NF?(_8?5EVDJH<;)*SPM^!PL:F2#4IUZP"EEIF& MF6V?E M,ZA9.\ZYNP7P;4:O-="L4D'S7`<&OZNB2^6T+ZZJIA>WR5,=Z#H79;)@^*8! M**^2A7=;4#DO&B$\C+3^SEZ0I@5G'8HIOG`^GB(TH@H/4.>V^F*A7J.]\TJC MJ0RC`I6H0V9KOKJF3-M&X^@M=>V29/.&;W=?H@CIVP]4+1WDW>!:C M9=$^FL<)PO074/8]+FX?R\M+@*QL67OWUYU5WD+601^$#9=UR\B$MY6=\[TO M8MF]]GO(2B'X-2I91<&VA`.[*JP@V/S:^?C+,2ELEVXQ\_]KL`KXQD_'7BCB M5OP\Y6BXMQ+S`3=L6J3R\`^HVOOU,K2W>)E?L)J.YQTK!/F5\)T=)P&,L2 M05<$L.KB8"BGQRB[/\[DWCCH*3[@YAXMTO9H4-.PAZ@@RB5AO.22NT7KBW"R M-I_@Y)&L0F2W]G5M!,#=L9H.&EP<*VD!C,'H!5L=4,QUMW3CGOINL@*A<`>- M$[%])UD;7/L^LO)[YUQ0@))''B!=J*BZ^GA#ZR1K`X!Q4G?/]%+K%V>:E*@- M+),^;=8Y<7,+.LX>I)MQ)HH`*"KHB/&FQZ]C:)7VL/,N^Y;F]"^ZJQ%\OZ=@],2;]Q^9>= MD/X61^7&S366G5;4Z#@DKQB^@J!-!:@D%*+D+_:*,B\TR:5^&;%^X%%F,5C3 M,@9[8).G/].M\2![%N2@F"BXVU@2`9=SK2X-YK770FS3JQ1QF;TR2%./"\&Z=$KT''/GLJN9WO'3W]-!`W?(3UM`2H% MPQT]6A;@>XA#'R?I\*\5F8NE\?* M8GJS,`BJ#R+?;'1T.H#&RABJXDU!7N078^=HD#XE<9K>)/$\$,X"M:\!/7H1 MJO939C(H%W+T;*O001$P4(?I2B%`SUF.31Y:*T5=/7.Z$32*9O%"N/*L?0WI M.0M0<4^8RJ!HYS)ZP8_[*,JC/O.C;^!$G?N+-Q:M/,TU` MH](1<'NX2G5$'R#Z<=T"BN<_(=H(6K?BJK0DSFA>.X'Z&/C8/WO^DF)_%.6E MC(BU',RRX%&Z&##7!C2J/4!S*<$X0^PX0-D(NGM&/])V4!#]A*JFT+HM1^/; MY2"']#P$G+'30N0W.FHOG7GQSQV,",OHK.-OU3L6C8RI#H`1Z@Q5/E)275@V MLCJ3ULM&"K0!C.(&H#O:R/6)/NRA707\4_Z6ZB"G_VYVW219NV?,-09P-(I^&(I;42K#5L\3+ M5&@`&B=#H`*ODJF1P:**58!FF6<',F474UM1\U)2&:7Q[9]`;M\5@Q+7@DWU MARMV^V3SWVA@>(DKR6^AZZK:E?K]E'^`]1!+G^BTG`RE]?O M2L%W67G]"?>V2N0`C+`1/,6]+W5Y%R.@OPR)/\-JH`-E9+I`5:1)RG1ACMA1 MCQ$[>CDC=K3!B!VY&#'M_5#\@.E5H(Q7!Z1<^1&M*LC1.NX^6L^5=C9:O6Y%?2FC];[_:(ENVJU_=$7^(A^7'Y'_ MN?-23#[Y?U!+`P04````"`#8B'!'6-S\((DE```*<`(`%0`<`'-K=FDM,C`Q M-3`Y,S!?<')E+GAM;%54"0`#=U-*5G=32E9U>`L``00E#@``!#D!``#M7>MS MVSB2_WY5]S_PLG55NU7G.'XDDV1G[DJVY(QJ'$DK*9F=^S)%2Y#,"T5Z^'#L M_>L/("69#SP:?*A!C[>V)HF-!M']0^/1W>C^\7\>-JYU3X+0\;V?7IV\?O/* M(M["7SK>^J=77V9'O=GEO/]Q81T>`;K\2;^D'7Z;#?;>W473W\?CX^_?OKSW_WO[N!]_" MUPL?UMW,CX,%V??USXOIM37[Y>O0>O/A[,WKAQ4=?=^.Z&].WYR\_<_3_LD) M^\^[^>G)Q_,/]/__"_Q,9$=QN/_,FXG5QGFOI^]]H/U\>F;-R?'__Q\/5OA\#)/A7?L+.TJFEO(SEK`%^]?1 MKMD1^]'1R>G1V MMQQXD1,],I2"33)(.O"DE]N`K'YZ%7Z[=XX8ZNE,")=_@=!&CW=414*'S?!7 MUK'FZ"YLETEP=DM(%*J&PVWN-C"D08<(/QZOQ M'5M8J-"5(I)3-3>B2SN\O7+][UH#*A'5&T^?A(O`N6,AX)`Q_=D*Z M`C_2&3N+-QL[>!RO9L[:!+'MA"-`*3M-Z MWQYZ]Q0ORJGJRZ6&=;]+5].U<^,2*N(QU:8`)@`57=U9[R^^C9.I$-+^?[6# M@*(-F/=2LGIC&OD1H6O.HWW#J.4#X;6M]_4I<:E.+^F:%SW.*5>AO0"M32JZ M>J.Z].EL#"(V#73$HR!K94Q9050<'Z^+!N;YK>\NZ0FU3^B:YD2@.#4)?'J_B=B0)O0F-O@C=N[8LK\=@\8: MH=]I8_SH8@,@;6B-RPAE_S.@:'7Z:.?&H"M6W7Y:6<./]IJU_1U0W!6[:YF' MW4^:8D+07RMDNOVTV'=;D8KN--7LIG4D&QH_I,O&K0V55EU8 M%ZU9(_3EK=U5L]8*;2$#Z66CO`M(2&D35\0U_4&.A#Q$Q%N2Y:XC-NJ*7BSZ M8T:[]3.>6$?6CBK[5]M;6FD75K:/[8AW8W;]16Z8+G/K^8%27'3`O\O&VKL) MHX#N9;N.7/N&N$GWOS-:&.EQE<%N19HX&D.R>+WV[X^7Q#FFXS]G?V&,G!^] M.=FZ&?]"?_1[.H8I63OLTU[$7+NT6V+X[O$X7:TN'7<_=19!?Y&5Y1;L?D*1K+2I4,X.`27E)'`=H=44QY^ M(8\R#$I-@2""@&L,&'9\S&FW?.GG6P"%?FJ2T'D\8LIZ0@+'IQPL63R* M7.B%ID#IGYDH?2[7&##TZ&B6;$17KKWFB[_0!"CV&L2""K>\3;>7XGK_N+YW[T9L4/?(\MA&,8DD&W`0A(@ M,N],0@8D!3QXOOIN3"48/"9QEJ$,EE)3(!P_F`>'@&O$XVFJOU-RYP?L1IL& M?TI/J0(*("COS0-%+@,\;)(YW>;?^_:ASS%SB[IK^H'%#./\-1,[R?6H=6?NP>_KW+8FUI:D[?59V>)-`$8=':]N^ M8W/H[3%QHW#WD\0FGIE,VQ__OA_4>'7E>'1,#IWK?N@H#.-;VHSEX: M,Z)FI-@.RTJN)=>\B@@X:7ZMJHO&]E0.!:74',UX+I4-\E1U&(7PZ]A6A MOUQ>IUP+1Y@,+_(CVTU:(FM=^NJ!/7E(;LJ[9P\C(E4W&16:(;^2GJGY-T/! MZ`7-BS?BO<^W1$T87`*P*'*;#H!H8.DB:A6`^ MMX!H<\-T$C2!""^#0G\!S_]0WYZG M*R,)`!J^14M#1F:`>V%[W\;W)%@&]DJV71;;02%JS:*B#1&?4S-0H!L_H0*, MMM-'J4VB]E!46C.;:*,BY]P,=/HQF?MY/2#/DKLG1Q/(HB`B@JK9DVM%$!92C#!DCP>I@Q MZ=IAZ*P:@I,NR3=^2`P`]$D:(*V$`W@(^X:V.CX7/:QBA&S`['AZ M"--&%:-55XR-F0#Z)+6][`A:;`G%J#7;AC8J(F[-P**W7"96;=N=V,YRZ%W: M=T[TE'^=8RP4$4"1:Z``E2FR3#%%^^6)M\$ZA@6S-)P`5;'KQ) M+D][""T4J-:L%=H:`)>(&0B6&=39 MZ>$(M6:Y:&!/?RZG-]5AI[HC62/@VABQ'0'VT[`FTLK=A>4W^E?Q<&#`MC=-IZ`O8#]+JO)=M6,QF3)X^N8F&'F4\>3+_ MQ;-3%BB/3IA$+TT"LG'BC33`6:L3[#=P-:9`!6&U9,O)CR2;\ED7PB310M7> ML%_05<&R%L,FJ6Y3"]+@8>'&+(?,U@QY3>RP6)2PO3U!_G7L%W\&[!<0>!!S MFBB*EN:NU^>%Z_43K>6OK`PU9M#EPM^0_<#4=VDA`:J]^9YXLPU_73?#;I=Y;;Y_'`Q(O24BP+Y5Z<"IY-T.KLF>6PE%%=A&4$&%?_-2" M+][VE!(P`ZH9<6F?ZT_$HPRZ;*C+C>,E-3!8F9^[:G"Z">7,S` MLL2CQHJ(?UW214C([;/9X-*]X5J:)8K;&#NQ2F4HRQP;HEDL_X[&>8/?'#LU MBN990\:S0;"D7"G`V#7"SF\B%RH'@#QW^DO;AW1I\\B:&9/P%[?=\TSEP:+4 M$#W3B0YV`C;-4)M/MN.%;)$EX=@;/+"%-W;"V]14RYH;$"3P+]W*)07CU]"EJIN;P7H+2+G/HTJ5S)9I2]SXG>%:)8WR(H2 M,V.%;?<,TQ90-:3>F?--;_E_<9@6IA_YWH*R.Z23,V3)>1;TWXY+L-"T2W_#SJ,*L$7ML;W$ M2#C+Q6<&Q-G)MX^']-8L-(B]'=S%R\J"1L$]8/N:D::!KHC-F!A&&*/;J_J! M,Q6JF+5QZU`L"%F&:96:._MQ>W.'YI*%TF/[Q9%F@YYXNY\9BTHP8('N?9+^ M267&3%U/@DN+3'C97,J@*AJU.\:.`*A@>FA(F&8L-&5F=I7*I%G4%&38005- M0:0"GB,K4V$M%P3409='C1Y^<"B4Q:(S%>QMN;3^=K/BEDW3@1_6'WJ7_HP1.'7C,@XC5CBN1?\>XXVHYZ%[TE,S>"R-&C,-J9 M`%K",P-ON"V^"5^C`=$;[2"O+T:CX6[`MG""2U=VNL&K M\3%2$"5Z3:+Z^(!Y?2[Z"1=9$Z=M`TH<-:;#^I+K^@TM89<$CK\L&B3%OS M4\%[1U)A(=\*O:148Q#PTZYD96$*2BRJ=VX_L/N`'*A"0_2R4*UAQ96(&7#) M>$UBM@'^!'@74(@/490&[$;0E9`9P`K"(NI%@PF[@`+;GO5)&R50]+?IT5V\ M)R^]#0M1$\,JHX'BV)Z5JB:.:H$@)NOHDW`1.'?IN[6+.'0\$H8_.R&='(^L MKF"\V=C!XW@U<]:>LW(6MA=-?-=99*==+J7'.^O(>MJ'V#\&L\OI<#(?CD?6 M^,JZ^#(;C@:SV7]9/P]G\_'T-ZLWZENS+Y\_]^C?:8/9\--H>#6\[(WFUF1\ M/;P<#F:(^3^VX944P1W?@.?U$AI$S=S!F\$\C18M#'9.Y\Z%*_7F5N@*.?.' M&L>"VE:6%J(V9V*-^-KY0U$[KX;_'/2MWFPVF&-JF;"*BEK9`*2X_C3^Z)Y0 M`*B;7B_(F@;&LNQDTQ85HJ[M7F0]\C7M?5'3AJ.O@Q';\%"KY&S'K&.HDA*A M7B=*XP*HDIP*O:J.$I_2)4$M!%0EV8>[\M\LY73F0UEGYKW1I^'%]2`Y)8[G M/P^F=38K@9\]<17/_7VEL*._VD%@>P+-.7E3U!QZM;K\Q1HGUZY9HCR_]J93>J?"/.7- MR>;.#^A],BU1K[,)`4@1%:TPNCF+.0&HF((,>3,"HU50+Y`P$!6+&QB4TZ:3 MHC:-QO/!S)KT?NO1K>AY[SRR@6Z%!MM&]J.4475K_P"QA#Z_LV5QYW3/""DG MPMJ>)Z?%N3X=7/?F@SZ=[=/Y;]:<[AFSWF6RC2#N'"*>U!N'FA(URIH_.*V# MFE8GR'L*%,=2W+6VG!`54!6$FM._LZ+^78Y'7P?3>7+I>=EW!+)4;3QJLN[M M/%!1F#?SL^K+UX)SL!;D]Z<7G>!+N:)^"+IX-KHB%1'V7?_6=ZD8PSY9.8M, MR>"O9\Y9I\9LU\83Q"2>E^(3+\>?/P_GGP6B> MVLGHSC,?CCX-1LB!!Q+.M,*,];K!#+6&C!2@C;K](*MD)9R+4=651(>YX<4W M(?DCIMT,F/]*H*NE:(79EXO9X!]?J*Y:`^9-Q=3/(@N`HD!""LSMKS`HR'8G M)L$N[Z/`I+C1J7CO9F">-$#OI!28T$2`GO77W4?_]A*KUUZL'BOQ%HY7D\S\ MJARL)^_K>43K0>35TMO]@LHF;"BOY2HB[*I<<%@@W+0J?[:V1W11=&RW[\_&CZ-/?E*4PUN0P(,AHM\-=N4K/8RJBLF,MP9TC"$=WS(1KAK0_6E91H5> ML$IWZ8,(P0RXOK!\B(,PO`Z6M13IB,0/)*]L)OMIN3/85IVSW*37T=NQB)('DZ&6<=)'4 M$HL92$X)O7_&A)4BHK>DD70;`X3$%O5ZT#OHS*:+`K%57`2R4` M,X#:!\N#81)38!<>T@9)Q7SW:X]]\OWE=\=U.6FVP8#K](%>EDA[#NA+R!3% MW>:KT%!<$05Z[:`*FBOGW@R,^)5PQSM3'&6"BL:Y)^QYG_)L6JDS])(_VLC6 MD)D9H`_LP*/LAA,2)+R`]5-)B%Z^1QM,H"S,>!Z>O,H0>(A*S_"RC\2MOZ:D MF'Z>/]]K\3IOQ,WQZC3^,MPDY=J?KR6J=5IZI[=_%6Z"7CVKY^&SQ2U9QBX9 MK_8CO(P#-DNAS_/@/73NV;BN<+!C8\OO8&5:5GJ_)WX-:X+:&?@L5N14W4^; M+2!*54I\C"JJKCUT!3'5KG=[__6QLA6L=++3/&; MF%J+6&>>PS1]+D@Q"9GRCE?)-J-U*)"2=^O)C!YOIBI3[G6/1+'@3RX+CZ'_ M'&I6X]59C:>9LGZZI4P5F437JAH1QWT2V8X;CMCNR^R5?+TK/?)L)O)X^W%K M__67$.0,*R%9O%[[]\=+XC`NSME?V.#/,X.G/_I]0`<0/3)70\`.8&P6].E< M91?$S(\X3%!B*&UG@HHU>#+)&C]EFN"1YE?("$M2TV)># M"H$)4(%TW_O=9*T@8P`4E`3"#3GF[>Q;ZYD$``5=%\..`8(P`S2^GU77_=S! M0&0YXPTO>@ANS*.G*^O.242/JLQ/])0].#T>\H^DI7P*.5?GD;7KWO)7UNX# MENTM+?8):_^-_2'TQ2O:`F.?;:H5'DEN(?N1?0K\4/*$0$;342^H6@QF++97 M,3UL1J:R:$-E\Q`D;E9K72@G@6.[HHN*E*([L*[.U=:V5C4'MO^I1];+N?< M#'3VP[MR/">DZQ![&2NM.\UOCVT0JU$PCLNY8>A,[>^RM:W(4KXYMMVK!C8\ MO@V#1F%\*;;#-HS5`*,]LPIV%4;8[8=3R518E;&QRU!GHF4;2W`0,'-WGZ1_ M#KUB?@9E@(E&%]V*I]7GSZ0%LRD;V^!AX<9+EI?1OG/84L)D4*CUW9Z-4_YU MM#-JK0EU2&1:\E1EQS=X8/$]9$+Y2=/`SP-[239V\$UT+013HYURJP?@:TK& MO/>M1_MX^^WOI(:64LH&R8M7^LNT:V9XV79>T^PBS,'+94&Q52NIFM2@[3>& M81@_(5484*$-YNX)E&A6$[@<5C[&TB70\9=4!X.HCK=&BD8ZU$G@+(@4D5P[ MU#VH,BP<5HV&)OS$%B>5INP;H6XVWU+,]WQ#-N%%+LCQF M6Y5N2/=^)U#-UWTC-"M%O?E:8+)5B6Z_I9ZO^89HP3:U),MCMMWY>DD/N<1U M53,VTPPM^*3>G"TQVJI<]U]3S]MB4[3PC5KRY3/<]EI+@H43JE?;?3.T3,=U MU]L"HRVON-NO0=;P^W.7?@%\/=3S,R_35P"&0>-W#4&7JV0 MO:8O@3K(F'L/;!$=8TQ:NY_(;%IGI5R)4)O6KG:Q4BOL\*%:Z!S&2E;X&D0!#+&4 M-2CC0QR$=Y^46\Q*K;`#>VJ)]S"&L\+7(%/8$.-9@S(^Y!16&=$X[;"?<-42 M\:%L::7O0::R,?:T1B5]V!59;E?CM,,N(59SQ3B,>:WT/=C*;(B)K5%)'W(Z M:]PO<6UMS5UA#+>XU;ICXEK=&KYF/E_C&RC6^TRK1/`H-I)AO2ODMAK7ELS0.%/*1$"F>'O[5&X M*%RZ=ACNO0CC8.JL;Z/>@R,!0T+2(4PD7&0,N:8AT_A2MY;ZL.3^;#+#VX MW/XO;(WL11/O:B(A26`-.Q-,"W@.V_Q$,N*Y0 M#K"ELI=["Y88SEF)+%+BYMB>2?U=E<>N&0HCV"V^VFY,FME595UA^S_K;JIJ M,;6D2]N7KP+5V?\6V_D)TY0",RV)+"WRL[UX,"B9QT\@0$%;;`\G3)Q21LU8 M=;BWP%',[G7CU8PLJ(I%#@DO;>:1O7C8-5%SM.I`!AT)N2W1',FQ=EG#96LD( M+XQ=5E5(?E[@M$-W_,)D*N00,>]'MF@6S#E;*@A=*`+]DGKK3^1?K97ZZ,6[ MBNW),]B[VBT-47E0QA1F`B*>5 M%)0L(^TX3N??Z6<>K_PXR&[)4M>IG`3;!Z2:.]F3$83YEHZ=Z:=GY)YXFH(7 MTF#;VO4EKV"_+;M@8@6`"EW8&MLNJR-N!RIDQ)4D>_8D=1(_S@,XX>Y%-@*5P;)P5'1O3P75O/NA;D]YT_ILUG_9& ML]YE^@3-K%=G(K[5C\[4E)A'OIBPG3$S1FGM,D%SY%L1%)OBJ4[&>\-Q$(=2 MSTO?HP.(6*F4[**3J>>8M@B9?,:K)%1-FIOMO*BQE^/1U\%TGA0%RKLE\X4> M,]]A_TR^U$[Q@1=_Y8N_\L5?^2?P5PK6>;GC4DK4(5RD?)CARA0,4>7/5)"9 M@1%@[L$`:]?%6=C_Y>]"18VQC3N@>52(^I)PW5XP7?:CISJB/C7%L597U*<8 MHC[3$?69IJA;"]:O*^HS$SUL^ZUKMB">'3B^?#,6-#=CB=<['N4YR+@J,-'8 MCNF+%]Z1A;-RR%*U^4I(#$.%-\.*X(B9.7F"-!?9]00.(?SPXA\:TOBA4YPAOG4VOB8">GH$21\JB5AGX=E*B@]_6_#@%R>!;%>X7ST[+[[+*RC>1 M0KS"UM@73IB`%#G)=QZ(#X]"`O-#%E0@1HD_I]XI`$ M4A?16[B+*._N/;(R@["245C;85C;<5C)0*RGD?Q97$A:!X8L:'K'LP(EUE&M MFL\(S%8KRHP>H)G=C\0;+S>$D4N*=HJLY3$$R^2@1_CL!-0[SA;:ID M_=S;#:BD*"V,:CZ)X(00HAUTJZ,)EX>!8*JGXEEEY3Q#/.:VJ9QG+2^8R@DE M@@1"B.9/:U'!>(!T1\'.*RO8.6*T;YL*=HZM8")(((1H7M06%8P'2'<4[&UE M!7N+Z'EJ4\'>8BN8"!(((9IKJD4%XP'2'05[5UG!WF'F(FM3P]YA:Y@($P@A M7BJS%E6,ATAW5.R'RBKV`QS/;ME(?L!6,1$F$$(H))TR=/`0Z8Z*O:^L8N_A M>';+TO$>6\5$F$`(H9!TRM3!0Z2COAJ!4Y6E8&89=Y.8K\LX8((6>VVT.H'. M"%.L)55X?(YN>=C3Z7=P+_M+?MB7]Y8O[RT1(7DF[RU?'G>8]+KRY7$'[N.. M5M]2MA>:7>>EP;-[1]E>!'$-,3^_-Y3M)<.J_U"I*3&W$=%W92](;Z,3R)>E M,/Z=C9(#V_3N#XBRC;>E/?Q\F?R2IBO<%,IT@$:$@869* MJ*1#/QG'QL"V)F`+]``F%3<4T!QJ#7G?!3,H_5'VX]6)@?C$POQB8#3*? M==3`_)+0[R6AWTM"OP,\X1<:^^3/X$TQ8FNE3H.Q=$A;Z^[;6AZ$$A'V5;9N M_CJ!%`X+@99WH42$?7MI"@(4C\/NXUJ>AQ)1U[,X"J1P6`C.JT!P;DKRM*8@ M.,>$X&T5"-[J;LAF[,@0CC`P>%<%@W>Z&!B_(;_#Q.!]%0S>ZV)@_([\_L4Y M_>=P3HN>"J3ETD3)FYY^C7T5@WD;B^R8.)^SGNM^S,JC3DC@^$OH[!;3F^\1 MUF3(7!`SRVE282AQ;<\#9[V6F3MT^L"^=M=W-`H%T^I.GW%GCF*VMXU7OS)O MD1>%B)KW$T=2(HVG-GG;H.)J.OB9% MB,%IK]I$"S$X'84U6YU1#AU\EQ^E;WZ52"_O)RA/! MPJW>%\.M9O/QY2\_CZ_[@^G,Z@^NAI?#N6%ECP=_Q$[TJ"YR7&QG0FA/MZ*L M!(+D:LI+4!5V\([!057)+7"[/J6S*E5M@F/^D,R5YN!?RU9"78?4T> M0U-JA6V-T9;F8:)C=E^3A\.46F'?U[6E>9A`E]W7Y)$MI5;8=R-M:1XF9F7W M-7F02JD5>E2*MC@;#C]I*H9WL_&]U&MC!^,@?5;[U79CV2O5?=@K@+@KSG@- M21@'7>J,Z<71K1^P%'<@R,I$YOO[(5P8C9'0YRCB3-.7B._G5[!L!BZ%8(3M M"BV*BN%',.2)L,_Q5>,P>*R;B-%!(L),>\$M#0GKJ!LB61G2-2$;^)-=*Z[\ M8$:">V=!I$8]O7ZPKX;@*5!-0"V=SG]TKB,1K9=+D>1[>RV%`(+;;9J)E]*R<(HX%+ MYEPUW+*D>+5XFM0]`V'[9#M>>.V'(9U4WN`AH@..G?`V26>U8KN#`*;I9 M$0P;6`ZHV8,V&R=*4[=X2[I#LU$2;^&0$!;&\J&<->CSY^'\\V`TGUF]49]E M$9H/1Y\&H\OA8&98/(N,^SU/ZG`7S6X057-\1YC4O?4UL>FTO(I97.1GQW,V M\6:R#;&:D@5Q[IE7?>C-Z>.GTBFYXKX5_0\OHB-6/5UN7CRH^# MAF=&IDML0S?&S"A)U,B),:7#WD;>CHAD452085O+6P"8+QG,V-3X)B1_Q&Q8 M]XQ1T(Y^_J84F/KE8C;XQQ>ZHUN#K\F^;M8N7F13O6&+*4R(E^QDI*H*A)>8 M5=-B(\V-6%I)0ZU5`O M^J.C(08(D2/X]N"N5[IY28L#$(B)('YFS]^=Z%&0SH'+9YZFH[%S/,8[DK(+ M.>4,(&67V(JU_0W[SXT=$OJ3_P=02P,$%`````@`V(AP1XLU%N.Q#0``.98` M`!$`'`!S:W9I+3(P,34P.3,P+GAS9%54"0`#=U-*5G=32E9U>`L``00E#@`` M!#D!``#M7>MOVS@2_WP'W/^@,W#`+G".XT?2))OLPO$C-3:QO9;3;?ME($+&Q95Z5 MJD?')069NC7%YORJ=*^6FVJKURLIO_WZKW\J\.?RW^6RTL7(F%XH;4LO]\R9 M]8O2UQ;H0KE!)B(:M<@ORB?-<%B)U<4&(DK+6BP-1!$0O)XNE,;1^40IEW,T M^PF94XO?GYR/3>M*>+?)H'^E6ON94RR$Z"MOZ?#VZ5=3? M/_64X_/Z\=%J!M*W-0J4VG'UY#^U=K7*_CD=UZH7C7/X^S5G-U2CCAUV<[PZ M]O_DJWZ';3VL7-&67^T/JQ'^/!^89\[=%_/Z[D^M]=&9#.G?)ZO3P=?'%5TL M_Y[\89R2=0.COCE=JW?&<'%3ZWR==[PN+VW]`2TT!0QNVE>E"(C/]2.+S"NU MX^-JY?/=K>KRE3S&BY6!S4<>>_7\_+SB4@/6%.=J0HR@Z7J%D2>:C<*6@8H% M_-BTJ6;J,?XI#2M$F4\J'C'&BKFLIQXK#EBG*,%G(_UH;CU5@`#\U4;YN%JN M5P-VQR[/-6T95IEI]L1MVB>P*B>I*L0RD,VMXU(XE4S+-)T%'YTI)16Z7J(* M,)6!"Q&LA_6V5XI7`!E8,5\ZE\*1C@5,6(']<'E8!,'P8:`%,FG7(HLVFFF. M`2;[YF@&GF$T+2E4(W-$F9?;2TU'&:T$(:*9I@61!$.&7\+*EDL,H0(%_[AD M/G7!,!R#I`I[@($BWB8KK$!\.4RJICGMF!33-0LVLG!;+BEX>E42W MMRF:81.[(ODA757*2E`]^JB94\5K2XDT=EE)-A-IW+'1=&#^ZCXO";*A&;?2 M+13X%7V6C$JZ9NB.L5N=C2C<*GY!@/).N%]K!@MA]0$A:GM`QXO$R-8`3C:2 M(A]:OZ[B52XNDD.-@#X/B&*0D@-KG"[&N"[$6/DIUM;/A<(\A,4>S`9+MKB! M7GPWSJ")L6XDL-XTHE@S9=-,85%N:?9#U[">.2!O2&*,3X08LU84MYE"8=Q& MMD[PDK4]F%T[-C:1;7_$-JS6US#CJ&`@& M@P&L%DC4'S.I8FS/T]B.F_V;WO5MQQT#!N./G5$1?56EEOXX<`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`PIH6W'/@6C2)AM]QT(1&]%0KJ7L8H!'W M#1:$7R40/FB`8LJJ#R/=**P?6,A67D-E0YOLJC)40<8;ZGK+VG]5)<'[=E4R MX;!OI&IKT\NK*@RALZO"\6A[(WW;82=1=?W[(2J;"R+\W\E+)"Y!<8M0Q4S= M0B&ZA<2[/^76TMVF!%78KW)0K\R*RM5:N5X]6MG3C:2["+&!83-/42:=*7HKQ<'+>M%\B3XSZ8 M/)X2K=GW*C)7.6>N4CW=4YB7"?)B*6+.AR'+LRG#NKZ+ST:J^<_E31,)0?Q[ M;KR5%JS,_F*W7#D4E2AQ MV/C';DNZ@'$16].Q.WQ[(PP-2!/OWHZKTA1-V%S9G/;6ASGN0WY\E[-N=);G/N MI>;W,"=["]Y%&G4(@@QG@LCF4-C8&CI$?X#\N&N1#O"NQ\^6^@!K<+MGVPZ[ MK3)J[3U;RH]2%`_;:^2U;1[U5(Y5AP0ML+/H(\IWA%VJ2^T=H@@^S1_LI^\Y MV$]S!_M>:KZM.8?$6F#;MLC:?:W;=A"[Q3G0+).Z0\+F"1[LV5P$!)42;,Y? M00/O2.0(SQ^H/2181T-$W"$D4$+$L.O@8CH+1G:K?Y=@^I`_F#Z\YV#ZD#N8 M]E+S;8/)CX\PAX[\EBA@-K-R--13I1))[!YD""]C\N1-E,GJ^.H#9F]5YNPS M/$U_A*<[@)=@S0BWR<0LDKIZ]#0ZV]O3812ZQ;.X>?ATB1S+WY4,A-[\E'5# M,@HKB],;MHS>++BSR3N#[G%,H9'O,L^=Y9_GSB0.]ZVSUUGN>6XO-=]XT>@G M;8-9Y$-6&+XBG^[YMYCZR\C\_+(&7I"QQA/<5.F!D]6X/.YBER]J0#KP^C5RH,L?:3-HDJ`;3^>2A0?. M.CQQ.+DT*"-U]AC8Q4! M*:P9;D-CGX)%8G=A5)3M6RZKP7-7L>M1SZ5&77H]&+CT:TNMQDDN/$WGT&#_#SW77!:J'@E-H*(X>#29T3J::YX M/I5'C^AI(']#/C%G"SEDE+^V57Z)YFFV0<<6Q`G0T\722%KC2RH1IAE1=Y8K M-L_DT:/#CJ-GCX_9Y(-+WL5/2#"[9E$/+G?")\2K97E7R57-3(Z"0HZ#RQ\, M(G7^V"(1TH%(#;ZD$F4<@4@G?$DERBD2OBG.[21".&,&.<\USYS+HT?;TAW_ MHI2."2VL>^;,(@NWSR:T231]\ZUB+E[-?PIT>O';Y]T8[*;1Q%!?45Q6O$NTX/%_ M4$L!`AX#%`````@`V(AP1_,CX0YF8```&%4%`!$`&````````0```*2!```` M`'-K=FDM,C`Q-3`Y,S`N>&UL550%``-W4TI6=7@+``$$)0X```0Y`0``4$L! M`AX#%`````@`V(AP1TF4")/J#```[Y```!4`&````````0```*2!L6```'-K M=FDM,C`Q-3`Y,S!?8V%L+GAM;%54!0`#=U-*5G5X"P`!!"4.```$.0$``%!+ M`0(>`Q0````(`-B(<$<;W1LJ!1(``"8``0`5`!@```````$```"D@>IM``!S M:W9I+3(P,34P.3,P7V1E9BYX;6Q55`4``W=32E9U>`L``00E#@``!#D!``!0 M2P$"'@,4````"`#8B'!'O9P^4!(R``"MW@(`%0`8```````!````I($^@``` M&UL550%``-W4TI6=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`V(AP1UC<_""))0``"G`"`!4`&````````0```*2!G[(` M`'-K=FDM,C`Q-3`Y,S!?<')E+GAM;%54!0`#=U-*5G5X"P`!!"4.```$.0$` M`%!+`0(>`Q0````(`-B(<$>+-1;CL0T``#F6```1`!@```````$```"D@7?8 M``!S:W9I+3(P,34P.3,P+GAS9%54!0`#=U-*5G5X"P`!!"4.```$.0$``%!+ 4!08`````!@`&`!H"``!SY@`````` ` end XML 60 R27.htm IDEA: XBRL DOCUMENT v3.3.0.814

INVENTORY - Schedule of Inventory (Details) - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Inventory Disclosure [Abstract]

Shipping and Packing Materials $ 13,033 $ 14,758

Marketing Supplies 19,761

Finished Goods 7,084 $ 51,756

Raw Materials 49,873 16,641

Total $ 89,751 $ 83,155

X

- References
No definition available.
+ Details

Name: SKVI_ShippingAndPackingMaterials

Namespace Prefix: SKVI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InventoryFinishedGoods

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InventoryGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(4))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InventoryRawMaterials

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Inventory

-URI http://asc.fasb.org/extlink&oid=6516093

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(5))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherInventorySupplies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 61 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.0.814 html 59 201 1 false 27 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://SKVI/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Balance Sheets Sheet http://SKVI/role/BalanceSheets Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Balance Sheets (Parenthetical) Sheet http://SKVI/role/BalanceSheetsParenthetical Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Statements of Operations Sheet http://SKVI/role/StatementsOfOperations Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Statements of Cash Flows Sheet http://SKVI/role/StatementsOfCashFlows Statements of Cash Flows Statements 5 false false R6.htm 00000006 - Disclosure - DESCRIPTION OF BUSINESS, HISTORY AND SUMMARY OF SIGNIFICANT POLICIES Sheet http://SKVI/role/DescriptionOfBusinessHistoryAndSummaryOfSignificantPolicies DESCRIPTION OF BUSINESS, HISTORY AND SUMMARY OF SIGNIFICANT POLICIES Notes 6 false false R7.htm 00000007 - Disclosure - FIXED ASSETS Sheet http://SKVI/role/FixedAssets FIXED ASSETS Notes 7 false false R8.htm 00000008 - Disclosure - INVENTORY Sheet http://SKVI/role/Inventory INVENTORY Notes 8 false false R9.htm 00000009 - Disclosure - INTANGIBLE AND OTHER ASSETS Sheet http://SKVI/role/IntangibleAndOtherAssets INTANGIBLE AND OTHER ASSETS Notes 9 false false R10.htm 00000010 - Disclosure - STOCK OPTIONS AND WARRANTS Sheet http://SKVI/role/StockOptionsAndWarrants STOCK OPTIONS AND WARRANTS Notes 10 false false R11.htm 00000011 - Disclosure - NOTES PAYABLE Notes http://SKVI/role/NotesPayable NOTES PAYABLE Notes 11 false false R12.htm 00000012 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://SKVI/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 12 false false R13.htm 00000013 - Disclosure - CONVERTIBLE NOTES PAYABLE Notes http://SKVI/role/ConvertibleNotesPayable CONVERTIBLE NOTES PAYABLE Notes 13 false false R14.htm 00000014 - Disclosure - CONVERTIBLE NOTES PAYABLE RELATED PARTY Notes http://SKVI/role/ConvertibleNotesPayableRelatedParty CONVERTIBLE NOTES PAYABLE RELATED PARTY Notes 14 false false R15.htm 00000015 - Disclosure - STOCKHOLDERS DEFICIT Sheet http://SKVI/role/StockholdersDeficit STOCKHOLDERS DEFICIT Notes 15 false false R16.htm 00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://SKVI/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 16 false false R17.htm 00000017 - Disclosure - SUBSEQUENT EVENTS Sheet http://SKVI/role/SubsequentEvents SUBSEQUENT EVENTS Notes 17 false false R18.htm 00000018 - Disclosure - DESCRIPTION OF BUSINESS, HISTORY AND SUMMARY OF SIGNIFICANT POLICIES (Policies) Sheet http://SKVI/role/DescriptionOfBusinessHistoryAndSummaryOfSignificantPoliciesPolicies DESCRIPTION OF BUSINESS, HISTORY AND SUMMARY OF SIGNIFICANT POLICIES (Policies) Policies 18 false false R19.htm 00000019 - Disclosure - FIXED ASSETS (Tables) Sheet http://SKVI/role/FixedAssetsTables FIXED ASSETS (Tables) Tables http://SKVI/role/FixedAssets 19 false false R20.htm 00000020 - Disclosure - INVENTORY (Tables) Sheet http://SKVI/role/InventoryTables INVENTORY (Tables) Tables http://SKVI/role/Inventory 20 false false R21.htm 00000021 - Disclosure - STOCK OPTIONS AND WARRANTS (Tables) Sheet http://SKVI/role/StockOptionsAndWarrantsTables STOCK OPTIONS AND WARRANTS (Tables) Tables http://SKVI/role/StockOptionsAndWarrants 21 false false R22.htm 00000022 - Disclosure - CONVERTIBLE NOTES PAYABLE (Tables) Notes http://SKVI/role/ConvertibleNotesPayableTables CONVERTIBLE NOTES PAYABLE (Tables) Tables http://SKVI/role/ConvertibleNotesPayable 22 false false R23.htm 00000023 - Disclosure - CONVERTIBLE NOTES PAYABLE RELATED PARTY (Tables) Notes http://SKVI/role/ConvertibleNotesPayableRelatedPartyTables CONVERTIBLE NOTES PAYABLE RELATED PARTY (Tables) Tables http://SKVI/role/ConvertibleNotesPayableRelatedParty 23 false false R24.htm 00000024 - Disclosure - DESCRIPTION OF BUSINESS, HISTORY AND SUMMARY OF SIGNIFICANT POLICIES (Details Narrative) Sheet http://SKVI/role/DescriptionOfBusinessHistoryAndSummaryOfSignificantPoliciesDetailsNarrative DESCRIPTION OF BUSINESS, HISTORY AND SUMMARY OF SIGNIFICANT POLICIES (Details Narrative) Details http://SKVI/role/DescriptionOfBusinessHistoryAndSummaryOfSignificantPoliciesPolicies 24 false false R25.htm 00000025 - Disclosure - FIXED ASSETS - Schedule of Property and Plan Equipment (Details) Sheet http://SKVI/role/FixedAssets-ScheduleOfPropertyAndPlanEquipmentDetails FIXED ASSETS - Schedule of Property and Plan Equipment (Details) Details 25 false false R26.htm 00000026 - Disclosure - FIXED ASSETS (Details Narrative) Sheet http://SKVI/role/FixedAssetsDetailsNarrative FIXED ASSETS (Details Narrative) Details http://SKVI/role/FixedAssetsTables 26 false false R27.htm 00000027 - Disclosure - INVENTORY - Schedule of Inventory (Details) Sheet http://SKVI/role/Inventory-ScheduleOfInventoryDetails INVENTORY - Schedule of Inventory (Details) Details 27 false false R28.htm 00000028 - Disclosure - INTANGIBLE AND OTHER ASSETS (Details Narrative) Sheet http://SKVI/role/IntangibleAndOtherAssetsDetailsNarrative INTANGIBLE AND OTHER ASSETS (Details Narrative) Details http://SKVI/role/IntangibleAndOtherAssets 28 false false R29.htm 00000029 - Disclosure - STOCK OPTIONS AND WARRANTS - Summary of Options (Details) Sheet http://SKVI/role/StockOptionsAndWarrants-SummaryOfOptionsDetails STOCK OPTIONS AND WARRANTS - Summary of Options (Details) Details 29 false false R30.htm 00000030 - Disclosure - STOCK OPTIONS AND WARRANTS - Summary of Warrants (Details) Sheet http://SKVI/role/StockOptionsAndWarrants-SummaryOfWarrantsDetails STOCK OPTIONS AND WARRANTS - Summary of Warrants (Details) Details 30 false false R31.htm 00000031 - Disclosure - STOCK OPTIONS AND WARRANTS (Details Narrative) Sheet http://SKVI/role/StockOptionsAndWarrantsDetailsNarrative STOCK OPTIONS AND WARRANTS (Details Narrative) Details http://SKVI/role/StockOptionsAndWarrantsTables 31 false false R32.htm 00000032 - Disclosure - NOTES PAYABLE (Details Narrative) Notes http://SKVI/role/NotesPayableDetailsNarrative NOTES PAYABLE (Details Narrative) Details http://SKVI/role/NotesPayable 32 false false R33.htm 00000033 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://SKVI/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://SKVI/role/RelatedPartyTransactions 33 false false R34.htm 00000034 - Disclosure - CONVERTIBLE NOTES PAYABLE - Schedule of Conversions of Stock (Details) Notes http://SKVI/role/ConvertibleNotesPayable-ScheduleOfConversionsOfStockDetails CONVERTIBLE NOTES PAYABLE - Schedule of Conversions of Stock (Details) Details 34 false false R35.htm 00000035 - Disclosure - CONVERTIBLE NOTES PAYABLE RELATED PARTY - Convertible Notes Payable Related Party Disclouser (Details) Notes http://SKVI/role/ConvertibleNotesPayableRelatedParty-ConvertibleNotesPayableRelatedPartyDisclouserDetails CONVERTIBLE NOTES PAYABLE RELATED PARTY - Convertible Notes Payable Related Party Disclouser (Details) Details 35 false false R36.htm 00000036 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details Narrative) Notes http://SKVI/role/ConvertibleNotesPayableDetailsNarrative CONVERTIBLE NOTES PAYABLE (Details Narrative) Details http://SKVI/role/ConvertibleNotesPayableTables 36 false false R37.htm 00000037 - Disclosure - CONVERTIBLE NOTES PAYABLE RELATED PARTY (Details Narrative) Notes http://SKVI/role/ConvertibleNotesPayableRelatedPartyDetailsNarrative CONVERTIBLE NOTES PAYABLE RELATED PARTY (Details Narrative) Details http://SKVI/role/ConvertibleNotesPayableRelatedPartyTables 37 false false R38.htm 00000038 - Disclosure - STOCKHOLDERS DEFICIT (Details Narrative) Sheet http://SKVI/role/StockholdersDeficitDetailsNarrative STOCKHOLDERS DEFICIT (Details Narrative) Details http://SKVI/role/StockholdersDeficit 38 false false R39.htm 00000039 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://SKVI/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://SKVI/role/CommitmentsAndContingencies 39 false false R40.htm 00000040 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://SKVI/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://SKVI/role/SubsequentEvents 40 false false All Reports Book All Reports In ''Balance Sheets'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''Statements of Cash Flows'', column(s) 1, 2, 5 are contained in other reports, so were removed by flow through suppression. skvi-20150930.xml skvi-20150930_cal.xml skvi-20150930_def.xml skvi-20150930_lab.xml skvi-20150930_pre.xml skvi-20150930.xsd true true XML 62 R38.htm IDEA: XBRL DOCUMENT v3.3.0.814

STOCKHOLDERS DEFICIT (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

Dec. 31, 2014

Common Stock, Par Value $ .001 $ .001 $ 0.001

Common Stock, Shares Authorized 200,000,000 200,000,000 200,000,000

Common Stock, Issued 113,957,969 113,957,969 111,813,969

Gain (Loss) on extinguishment of debt $ (400) $ 4,054 $ (1,840) $ 5,044

Issuance 1

Common Stock, Par Value $ .001 $ .001

Date of Issuance Jan. 26, 2015

Note, Face Amount $ 50,000 $ 50,000

Common Stock, Shares Issued 1,250,000

Warrants, Issued 625,000 625,000

Warrants, Exercise Price $ .07 $ .07

Issuance 2

Common Stock, Par Value $ .001 $ .001

Date of Issuance Jan. 27, 2015

Note, Face Amount $ 30,000 $ 30,000

Common Stock, Shares Issued 750,000

Warrants, Issued 375,000 375,000

Warrants, Exercise Price $ .07 $ .07

Issuance 3

Date of Issuance Apr. 01, 2015

Common Stock, Shares Issued 72,000

Common Stock, Share Value $ 3,600

Issuance 4

Date of Issuance Jun. 30, 2015

Common Stock, Shares Issued 72,000

Common Stock, Share Value $ 3,600

Gain (Loss) on extinguishment of debt $ 1,440

Issuance 5

Date of Issuance Aug. 24, 2015

Common Stock, Shares Issued, Debt Settlement 200,000

Common Stock, Shares Issued, Debt Settlement, Value $ 6,000

Gain (Loss) on extinguishment of debt $ 400

X

- References
No definition available.
+ Details

Name: SKVI_WarrantsIssued1

Namespace Prefix: SKVI_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The price per share of the conversion feature embedded in the debt instrument.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 20

-Section 50

-Paragraph 5

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6928298&loc=SL6031898-161870

+ Details

Name: us-gaap_DebtInstrumentConvertibleConversionPrice1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Date the debt instrument was issued, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentIssuanceDate1

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12317-112629

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12355-112629

+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesIssuedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesOther

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueIssuedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_ShareholdersEquityClassAxis=SKVI_Issuance1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShareholdersEquityClassAxis=SKVI_Issuance2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShareholdersEquityClassAxis=SKVI_Issuance3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShareholdersEquityClassAxis=SKVI_Issuance4Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShareholdersEquityClassAxis=SKVI_Issuance5Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 63 R20.htm IDEA: XBRL DOCUMENT v3.3.0.814

INVENTORY (Tables)
9 Months Ended

Sep. 30, 2015

Inventory Disclosure [Abstract]

Schedule of Inventory

September 30, 2015 December 31, 2014

Shipping and Packing materials $ 13,033 $ 14,758

Marketing Supplies 19,761 -

Finished Goods 7,084 $ 51,756

Raw Materials 49,873 16,641

Total 89,751 83,155

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 2

-Paragraph 6

-Subparagraph a,b,c

-Article 5

+ Details

Name: us-gaap_ScheduleOfInventoryCurrentTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]
Operating leases for 2015	$ 12,042
Operating leases for 2016	5,717
Rental expense	$ 32,619	$ 31,368

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Related Party Transactions [Abstract]
Due to Related Party	$ 1,145	$ 1,145

FIXED ASSETS - Schedule of Property and Plan Equipment (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Machinery and equipment	$ 48,163	$ 48,163
Furniture and fixtures	113,635	113,635
Computers, equipment and software	39,722	39,722
Leasehold improvements	12,569	12,569
Lab equipment	113,461	113,461
Total	327,550	327,550
Less: accumulated depreciation	(325,460)	(324,275)
Fixed assets, net of accumulated depreciation	$ 2,090	$ 3,275

CONVERTIBLE NOTES PAYABLE RELATED PARTY (Details Narrative)	9 Months Ended
	Sep. 30, 2015 USD ($) $ / shares shares
Convertible Notes Payable Related Party 1
Convertible Notes Payable, Value	$ 1,071,593
Due Date	5 years
Interest Rate	10.00%
Common Stock, Fixed Price \| $ / shares	$ .04
Conversion Feature, number of warrants to purchase for every two shares issued \| shares	1
Warrants, Exercise Price \| $ / shares	$ 0.06
Conversion Date	3 years
Beneficial Conversion Feature	$ 1,123,078
Financing Expense	124,544
Cash payments to reduce note balance	51,485
Convertible Notes Payable Related Party 2
Convertible Notes Payable, Value	$ 321,032
Due Date	5 years
Interest Rate	10.00%
Common Stock, Fixed Price \| $ / shares	$ 0.04
Conversion Feature, number of warrants to purchase for every two shares issued \| shares	1
Warrants, Exercise Price \| $ / shares	$ 0.06
Conversion Date	3 years
Beneficial Conversion Feature	$ 209,809
Financing Expense	31,098
Cash payments to reduce note balance	3,990
Convertible Notes Payable Related Party 3
Convertible Notes Payable, Value	$ 182,083
Due Date	5 years
Interest Rate	10.00%
Common Stock, Fixed Price \| $ / shares	$ 0.03
Conversion Feature, number of warrants to purchase for every two shares issued \| shares	1
Warrants, Exercise Price \| $ / shares	$ 0.04
Conversion Date	3 years
Beneficial Conversion Feature	$ 182,083
Financing Expense	27,223
Convertible Notes Payable Related Party 4
Convertible Notes Payable, Value	$ 106,153
Due Date	5 years
Interest Rate	10.00%
Common Stock, Fixed Price \| $ / shares	$ 0.03
Conversion Feature, number of warrants to purchase for every two shares issued \| shares	1
Warrants, Exercise Price \| $ / shares	$ 0.04
Conversion Date	3 years
Beneficial Conversion Feature	$ 70,768
Financing Expense	10,579
Convertible Notes Payable Related Party 5
Convertible Notes Payable, Value	$ 142,501
Due Date	5 years
Interest Rate	10.00%
Common Stock, Fixed Price \| $ / shares	$ 0.03
Conversion Feature, number of warrants to purchase for every two shares issued \| shares	1
Warrants, Exercise Price \| $ / shares	$ .04
Conversion Date	3 years
Beneficial Conversion Feature	$ 94,909
Financing Expense	14,189
Convertible Notes Payable Related Party 6
Convertible Notes Payable, Value	$ 118,126
Due Date	5 years
Interest Rate	10.00%
Common Stock, Fixed Price \| $ / shares	$ .025
Conversion Feature, number of warrants to purchase for every two shares issued \| shares	1
Warrants, Exercise Price \| $ / shares	$ .03
Conversion Date	3 years
Beneficial Conversion Feature	$ 118,126
Financing Expense	17,661
Convertible Notes Payable Related Party 7
Convertible Notes Payable, Value	$ 40,558
Due Date	5 years
Interest Rate	10.00%
Common Stock, Fixed Price \| $ / shares	$ 0.04
Conversion Feature, number of warrants to purchase for every two shares issued \| shares	1
Warrants, Exercise Price \| $ / shares	$ .05
Conversion Date	3 years
Beneficial Conversion Feature	$ 40,466
Financing Expense	6,050
Convertible Notes Payable Related Party 8
Convertible Notes Payable, Value	$ 65,295
Due Date	5 years
Interest Rate	10.00%
Common Stock, Fixed Price \| $ / shares	$ .04
Conversion Feature, number of warrants to purchase for every two shares issued \| shares	1
Warrants, Exercise Price \| $ / shares	$ .05
Conversion Date	3 years
Beneficial Conversion Feature	$ 57,439
Financing Expense	$ 8,589

STOCK OPTIONS AND WARRANTS - Summary of Options (Details) - $ / shares	3 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Stock Options And Warrants - Summary Of Options Details
Options granted and assumed, number of shares	200,000
Options granted and assumed, weighted average exercise price	$ 0.05
Options expired, number of shares	200,000
.	$ 0.05
Options cancelled, number of shares
Options cancelled, weighted average exercise price
Options exercised, number of shares
Options exercised, weighted average exercise price
Ending Balance, number of shares	9,750,000	9,750,000
Ending Balance, weighted average exercise price	$ 0.05	$ 0.05

STOCK OPTIONS AND WARRANTS - Summary of Warrants (Details) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Temporary Equity Disclosure [Abstract]
Beginning Balance, number of shares	2,541,030
Beginning Balance, weighted average exercise price	$ 0.05
Warrants granted and assumed, number of shares	1,000,000
Warrants granted and assumed, weighted average exercise price	$ 0.07
Warrants expired, number of shares	1,196,280
Warrants expired, weighted average exercise price	$ 0.05
Warrants cancelled, number of shares
Warrants cancelled, weighted average exercise price
Warrants exercised, number of shares
Warrants exercised, weighted average exercise price
Ending Balance, number of shares	2,334,750	2,541,030
Ending Balance, weighted average exercise price	$ 0.07	$ 0.05

STOCK OPTIONS AND WARRANTS (Details Narrative)	9 Months Ended
STOCK OPTIONS AND WARRANTS (Details Narrative)	Sep. 30, 2015 USD ($) $ / shares shares
Stock Options, exercisable	9,750,000
Stock Options Granted 1
Stock Options, Date Granted	Mar. 31, 2015
Stock Options, shares	200,000
Stock Options, strick price \| $ / shares	$ .05
Stock Options, expected life	5 years
Stock Options, value \| $	$ 8,800
Expense \| $	$ 8,800

NOTES PAYABLE (Details Narrative) - USD ($)	3 Months Ended	9 Months Ended
NOTES PAYABLE (Details Narrative) - USD ($)	Jun. 30, 2015	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014	May. 20, 2014
Loans payable		$ 1,549,900
Payments on notes payable		$ (89,500)
Twenty Four Notes Payble
Financing Plan Approved		May 22, 2013
Secured Promissory Notes, max amount offered		$ 1,000,000
Promissory Notes, Interest Rate		9.00%
Promissory Notes, Proceeds		$ 1,000,000
Promissory Notes, Due		2 years
Payments on notes payable		$ 89,000
Twenty Seven Notes Payable
Financing Plan Approved		May 19, 2014
Secured Promissory Notes, max amount offered					$ 1,000,000
Promissory Notes, Interest Rate					9.00%
Promissory Notes, Proceeds		$ 1,000,000
Promissory Notes, Due		2 years
Eight Notes Payable
Promissory Notes, Interest Rate		9.00%
Promissory Notes, Proceeds	$ 208,000
Promissory Notes, Due	2 years
Five Notes Payable
Promissory Notes, Interest Rate		9.00%
Promissory Notes, Proceeds		$ 131,000
Promissory Notes, Due		2 years

SUBSEQUENT EVENTS (Details Narrative)	9 Months Ended
SUBSEQUENT EVENTS (Details Narrative)	Sep. 30, 2015 USD ($)
Convertible Note 4
Convertible Note Payable, Date	Oct. 26, 2015
Convertible Notes Payable, Value	$ 135,000
Interest Rate	9.00%
Maturity Date	Oct. 26, 2017
Convertible Notes Payable Related Party 9
Convertible Note Payable, Date	Oct. 01, 2015
Convertible Notes Payable, Value	$ 108,000
Interest Rate	10.00%
Due Date	5 years

Balance Sheets - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Current assets
Cash		$ 196,602
Accounts receivable	$ 6,833	9,457
Inventory	89,751	83,155
Due from related party	$ 1,145	$ 1,145
Prepaid expense and other current assets
Total current assets	$ 97,729	$ 290,359
Fixed assets, net of accumulated depreciation of $325,460 and $324,275, respectively	2,090	3,275
Intangible and other assets:
Patents and trademarks, net of accumulated amortization of $330,215 and $288,203, respectively	315,954	352,420
Total assets	415,773	646,054
Current liabilities
Accounts payable and accrued liabilities	728,582	$ 420,762
Bank overdraft	32,787
Accrued interest payable	497,899	$ 348,111
Loans from related party	1,910	$ 1,910
Loans payable	1,549,900
Convertible notes payable, net of unamortized debt discount of $38,046 and $26,822, respectively	1,149,040	$ 1,112,764
Convertible notes payable related party, net of unamortized discount of $634,320 and $874,163, respectively	1,413,111	1,173,178
Total current liabilities	5,373,229	3,056,725
Loans payable	731,600	1,940,000
Total liabilities	6,104,829	4,996,725
Stockholders' deficit
Common stock; $0.001 par value; 200,000,000 shares authorized; 113,957,969 and 111,813,969 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively	114,158	111,814
Additional paid-in capital	$ 21,527,741	$ 21,378,656
Stock payable
Accumulated deficit	$ (27,330,955)	$ (25,841,141)
Total stockholders' deficit	(5,689,056)	(4,350,671)
Total liabilities and stockholders' deficit	$ 415,773	$ 646,054

CONVERTIBLE NOTES PAYABLE RELATED PARTY - Convertible Notes Payable Related Party Disclouser (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Notes to Financial Statements
Convertible Note Payable #1	$ 1,071,593	$ 1,071,593
Unamortized Debt Discount	(208,939)	(333,483)
Convertible Note Payable #2	321,032	321,032
Unamortized Debt Discount	(72,788)	(103,886)
Convertible Note Payable #3	182,083	182,083
Unamortized Debt Discount	(82,054)	(109,277)
Convertible Note Payable #4	106,152	106,152
Unamortized Debt Discount	(38,912)	(49,491)
Convertible Note Payable #5	142,501	142,501
Unamortized Debt Discount	(61,748)	(75,937)
Convertible Note Payable #6	118,126	118,126
Unamortized Debt Discount	(88,562)	(106,223)
Convertible Note Payable #7	40,558	40,558
Unamortized Debt Discount	(32,377)	(38,427)
Convertible Note Payable #8	65,295	65,295
Unamortized Debt Discount	(48,850)	(57,438)
Convertible Notes Payable	$ 1,413,111	$ 1,173,178

CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)	9 Months Ended
CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Convertible Note 1
Convertible Notes Payable, Value		$ 52,476
Interest Rate		10.00%
Option Rights, Price per Share		$ 0.10
Expiration Date	Jan. 12, 2010
Convertible Note 2
Convertible Notes Payable, Value		$ 1,000,000
Interest Rate		9.00%
Expiration Date	Oct. 01, 2016
Beneficial conversion feature	$ 111,110
Financing expense	$ 20,689
Convertible Note 3
Convertible Notes Payable, Value		$ 47,500
Interest Rate		8.00%
Expiration Date	Apr. 30, 2016
Beneficial conversion feature	$ 34,397
Financing expense	$ 7,947

Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Common Stock, Par Value	$ .001	$ 0.001
Common Stock, Shares Authorized	200,000,000	200,000,000
Common Stock, Issued	113,957,969	111,813,969
Accumulated Depreciation	$ 325,460	$ 324,275
Convertible Notes Payable, net of unamortized debt discount	38,046	26,822
Convertible Notes Payable, related party, net of unamortized discount	634,320	874,163
Accumulated Amortization	$ 330,215	$ 288,203

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2015	Oct. 25, 2015
Document And Entity Information
Entity Registrant Name	SKINVISIBLE INC
Entity Central Index Key	0001085277
Document Type	10-Q
Document Period End Date	Sep. 30, 2015
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		114,157,969
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2015

DESCRIPTION OF BUSINESS, HISTORY AND SUMMARY OF SIGNIFICANT POLICIES (Policies)	9 Months Ended
	Sep. 30, 2015
Accounting Policies [Abstract]
Description of Business	Skinvisible, Inc., (referred to as the “Company”) is focused on the development and manufacture and sales of innovative topical, transdermal and mucosal polymer-based delivery system technologies and formulations incorporating its patent-pending formula/process for combining hydrophilic and hydrophobic polymer emulsions. The technologies and formulations have broad industry applications within the pharmaceutical, over-the-counter, personal skincare and cosmetic arenas. Additionally, the Company’s non-dermatological formulations, offer solutions for a broad spectrum of markets women’s health, pain management, and others. The Company maintains executive and sales offices in Las Vegas, Nevada.
History	Skinvisible, Inc. (referred to as the “Company”) was incorporated in Nevada on March 6, 1998, under the name of Microbial Solutions, Inc. The Company underwent a name change on February 26, 1999, when it changed its name to Skinvisible, Inc. The Company’s subsidiary’s name of Manloe Labs, Inc. was also changed to Skinvisible Pharmaceuticals, Inc. On September 9, 2014, the Company formed Kinatri USA Inc., a new wholly-owned subsidiary, to market a premium line of scientifically formulated skincare products powered by our patented Invisicare® technology. As part of our strategic focus on revenue generation and creating shareholder value, Kintari USA Inc. products will be sold via network marketing. The Kintari product portfolio consists of anti-aging products to help fight the signs of aging. These products have been developed using proven anti-aging ingredients with scientific evidence of their effectiveness at reducing the look of fine lines and wrinkles resulting in youthful looking skin. These potent ingredients will be powered by patented Invisicare technology, providing consumers with unique, effective products which we believe cannot be duplicated. Additional products will be added to enhance this product line as the company grows and expands. Skinvisible, Inc. together with its subsidiary shall herein be collectively referred to as the “Company”.
Going Concern	The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred cumulative net losses of $27,330,955 since its inception and requires capital for its contemplated operational and marketing activities to take place. The Company’s ability to raise additional capital through the future issuances of common stock is unknown. The obtainment of additional financing, the successful development of the Company’s contemplated plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability to successfully resolve these factors raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties.
Principles of Consolidation	The consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated.
Use of Estimates	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	For purposes of the statement of cash flows, the Company considers all highly liquid investments and short-term debt instruments with original maturities of three months or less to be cash equivalents. There are $0 and $196,602 in cash and cash equivalents as of September 30, 2015 and December 31, 2014, respectively.
Fair Value of Financial Instruments	The carrying amounts reflected in the balance sheets for cash, accounts payable and accrued expenses approximate the respective fair values due to the short maturities of these items. As required by the Fair Value Measurements and Disclosures Topic of the FASB ASC, fair value is measured based on a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The three levels of the fair value hierarchy are described below: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).
Revenue Recognition	Product sales – Revenues from the sale of products (Invisicare® polymers) are recognized when title to the products are transferred to the customer and only when no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive reasonably assured payments for products sold and delivered. Royalty sales – The Company also recognizes royalty revenue from licensing its patented product formulations only when earned, when no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive and retain reasonably assured payments. Distribution and license rights sales – The Company also recognizes revenue from distribution and license rights only when earned (and are amortized over a five year period), when no further contingencies or material performance obligations are warranted, and thereby have earned the right to receive and retain reasonably assured payments. Costs of Revenue – Cost of revenue includes raw materials, component parts, and shipping supplies. Shipping and handling costs is not a significant portion of the cost of revenue.
Accounts Receivable	Accounts receivable is comprised of uncollateralized customer obligations due under normal trade terms requiring payment within 30 days from the invoice date. The carrying amount of accounts receivable is reviewed periodically for collectability. If management determines that collection is unlikely, an allowance that reflects management’s best estimate of the amounts that will not be collected is recorded. Management reviews each accounts receivable balance that exceeds 30 days from the invoice date and, based on an assessment of creditworthiness, estimates the portion, if any, of the balance that will not be collected. As of September 30, 2015, the Company had not recorded a reserve for doubtful accounts. The Company has $1,000,000 in convertible notes payable which are secured by the accounts receivable of a license agreement the Company has with Women's Choice Pharmaceuticals, LLC on its proprietary prescription product, ProCort®.
Inventory	Substantially all inventory consists of finished goods and are valued based upon first-in first-out ("FIFO") cost, not in excess of market. The determination of whether the carrying amount of inventory requires a write-down is based on an evaluation of inventory.
Goodwill and Intangible Assets	The Company follows Financial Accounting Standard Board’s (FASB) Codification Topic 350-10 (“ASC 350-10”), “Intangibles – Goodwill and Other”. According to this statement, goodwill and intangible assets with indefinite lives are no longer subject to amortization, but rather an annual assessment of impairment by applying a fair-value based test. Fair value for goodwill is based on discounted cash flows, market multiples and/or appraised values as appropriate. Under ASC 350-10, the carrying value of assets are calculated at the lowest level for which there are identifiable cash flows.
Income Taxes	The Company accounts for its income taxes in accordance with FASB Codification Topic ASC 740-10, “Income Taxes”, which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
Stock-based Compensation	The Company follows the guidelines in FASB Codification Topic ASC 718-10 “Compensation-Stock Compensation”, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees and directors including employee stock options and employee stock purchases related to a Employee Stock Purchase Plan based on the estimated fair values. Stock based compensation expense recognized under ASC 718-10 for the year ended September 30, 2015 and December 31, 2014 totaled $8,800 and $54,450, respectively.
Earnings (loss) Per Share	The Company reports earnings (loss) per share in accordance with FASB Codification Topic ASC 260-10 “Earnings Per Share”, Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted average number of common shares available. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Diluted earnings (loss) per share has not been presented since the effect of the assumed exercise of options and warrants to purchase common shares (common stock equivalents) would have an anti-dilutive effect.

Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
Statements of Operations - USD ($)	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Income Statement [Abstract]
Revenues	$ 30,377	$ 22,303	$ 158,428	$ 41,276
Cost of revenues	9,859	674	56,047	3,907
Gross profit	20,518	21,629	102,381	37,369
Operating expenses
Depreciation and amortization	14,631	9,680	43,377	28,027
Selling general and administrative	255,436	373,101	900,605	758,997
Total operating expenses	270,067	382,781	943,982	787,024
Loss from operations	$ (249,549)	(361,152)	(841,601)	(749,655)
Other income and (expense)
Other income		70	26	258
Interest expense	$ (232,107)	(200,944)	(650,079)	(551,872)
Gain on extinguishment of debt	400	(4,054)	1,840	(5,044)
Total other expense	(231,707)	(204,928)	(648,213)	(556,658)
Net loss	$ (481,256)	$ (566,080)	$ (1,489,814)	$ (1,306,313)
Basic loss per common share	$ (0.00)	$ (0.01)	$ (0.01)	$ (0.01)
Basic weighted average common shares outstanding	113,957,969	111,609,529	113,957,969	111,317,222

RELATED PARTY TRANSACTIONS	9 Months Ended
RELATED PARTY TRANSACTIONS	Sep. 30, 2015
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	During the year ended 2013 various officers advanced funds to support the daily operations of the company. As of September 30, 2015, $1,910 remained due to related parties as repayment for advanced monies, all related other party notes have been extinguished or re-negotiated as convertible notes. See note 10.

CONVERTIBLE NOTES PAYABLE - Schedule of Conversions of Stock (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Convertible Notes Payable	$ 1,149,040	$ 1,112,764
Convertible Note 3
Convertible Note Payable #1
Unamortized debt discount
Convertible Note 1 & 2
Convertible Note Payable #2	111,110	$ 111,110
Unamortized debt discount	(3,724)	(26,822)
Convertible Notes Payable	1,107,386	1,112,764
Convertible Note 1
Convertible Note Payable #1	28,476	28,476
Convertible Note 2
Convertible Note Payable #1	1,000,000	$ 1,000,000
Convertible Note 3
Convertible Note Payable #1	47,500
Unamortized debt discount	(34,322)
Convertible Notes Payable	$ 13,178

FIXED ASSETS (Details Narrative) - USD ($)	9 Months Ended
FIXED ASSETS (Details Narrative) - USD ($)	Sep. 30, 2015	Sep. 30, 2014
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 1,185	$ 1,067

Statements of Cash Flows - USD ($)	9 Months Ended
Statements of Cash Flows - USD ($)	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net loss	$ (1,489,814)	$ (1,306,313)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	43,377	28,027
Stock-based compensation	8,800	31,050
Amortization of debt discount	327,478	250,558
Gain (Loss) on extinguishment of debt	(1,840)	$ 5,044
Bank overdraft	32,787
Changes in operating assets and liabilities:
Increase in inventory	(6,596)	$ (59,393)
Decrease (increase) in accounts receivable	$ 2,624	(9,030)
Increase (decrease) in prepaid assets		1
Increase in accounts payable and accrued liabilities	$ 321,020	105,803
Increase in accrued interest	149,788	133,516
Net cash used in operating activities	(612,376)	(820,737)
Cash flows from investing activities:
Purchase of fixed and intangible assets	(5,726)	(15,855)
Net cash used in investing activities	(5,726)	$ (15,855)
Cash flows from financing activities:
Proceeds from sale of common stock	$ 80,000
Proceeds from related party loans, net of payments		$ 78
Payments on notes payable	$ (89,500)
Proceeds from notes payable	$ 431,000	$ 594,400
Payments on convertible notes payable		(13,000)
Net cash provided by (used in) financing activities	$ 421,500	581,478
Net change in cash	(196,602)	(255,114)
Cash, beginning of period	$ 196,602	513,420
Cash, end of period		258,306
Supplemental disclosure of cash flow information:
Cash paid for interest	$ 211,564	$ 144,708
Cash paid for tax
Non-cash investing and financing activities:
Accrued expenses converted to notes	$ 118,126	$ 156,684
Common stock issued on extiguishment of debts	$ 5,760	$ 20,644

INVENTORY - Schedule of Inventory (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Inventory Disclosure [Abstract]
Shipping and Packing Materials	$ 13,033	$ 14,758
Marketing Supplies	19,761
Finished Goods	7,084	$ 51,756
Raw Materials	49,873	16,641
Total	$ 89,751	$ 83,155

STOCKHOLDERS DEFICIT (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
STOCKHOLDERS DEFICIT (Details Narrative) - USD ($)	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Common Stock, Par Value	$ .001		$ .001		$ 0.001
Common Stock, Shares Authorized	200,000,000		200,000,000		200,000,000
Common Stock, Issued	113,957,969		113,957,969		111,813,969
Gain (Loss) on extinguishment of debt	$ (400)	$ 4,054	$ (1,840)	$ 5,044
Issuance 1
Common Stock, Par Value	$ .001		$ .001
Date of Issuance			Jan. 26, 2015
Note, Face Amount	$ 50,000		$ 50,000
Common Stock, Shares Issued			1,250,000
Warrants, Issued	625,000		625,000
Warrants, Exercise Price	$ .07		$ .07
Issuance 2
Common Stock, Par Value	$ .001		$ .001
Date of Issuance			Jan. 27, 2015
Note, Face Amount	$ 30,000		$ 30,000
Common Stock, Shares Issued			750,000
Warrants, Issued	375,000		375,000
Warrants, Exercise Price	$ .07		$ .07
Issuance 3
Date of Issuance			Apr. 01, 2015
Common Stock, Shares Issued			72,000
Common Stock, Share Value			$ 3,600
Issuance 4
Date of Issuance			Jun. 30, 2015
Common Stock, Shares Issued			72,000
Common Stock, Share Value			$ 3,600
Gain (Loss) on extinguishment of debt			$ 1,440
Issuance 5
Date of Issuance			Aug. 24, 2015
Common Stock, Shares Issued, Debt Settlement			200,000
Common Stock, Shares Issued, Debt Settlement, Value			$ 6,000
Gain (Loss) on extinguishment of debt			$ 400